id	sid	tid	token	lemma	pos
cord-303447-3a7jxl34	1	1	key	key	JJ
cord-303447-3a7jxl34	1	2	:	:	:
cord-303447-3a7jxl34	1	3	cord-303447	cord-303447	XX
cord-303447-3a7jxl34	1	4	-	-	HYPH
cord-303447-3a7jxl34	1	5	3a7jxl34	3a7jxl34	CD
cord-303447-3a7jxl34	1	6	authors	author	NNS
cord-303447-3a7jxl34	1	7	:	:	:
cord-303447-3a7jxl34	1	8	Cohn	Cohn	NNP
cord-303447-3a7jxl34	1	9	,	,	,
cord-303447-3a7jxl34	1	10	Amanda	Amanda	NNP
cord-303447-3a7jxl34	1	11	C.	C.	NNP
cord-303447-3a7jxl34	1	12	;	;	:
cord-303447-3a7jxl34	1	13	Broder	Broder	NNP
cord-303447-3a7jxl34	1	14	,	,	,
cord-303447-3a7jxl34	1	15	Karen	Karen	NNP
cord-303447-3a7jxl34	1	16	R.	R.	NNP
cord-303447-3a7jxl34	1	17	;	;	:
cord-303447-3a7jxl34	1	18	Pickering	Pickering	NNP
cord-303447-3a7jxl34	1	19	,	,	,
cord-303447-3a7jxl34	1	20	Larry	Larry	NNP
cord-303447-3a7jxl34	1	21	K.	K.	NNP
cord-303447-3a7jxl34	1	22	title	title	NN
cord-303447-3a7jxl34	1	23	:	:	:
cord-303447-3a7jxl34	1	24	Immunizations	immunization	NNS
cord-303447-3a7jxl34	1	25	in	in	IN
cord-303447-3a7jxl34	1	26	the	the	DT
cord-303447-3a7jxl34	1	27	United	United	NNP
cord-303447-3a7jxl34	1	28	States	States	NNP
cord-303447-3a7jxl34	1	29	:	:	:
cord-303447-3a7jxl34	1	30	A	a	DT
cord-303447-3a7jxl34	1	31	Rite	rite	NN
cord-303447-3a7jxl34	1	32	of	of	IN
cord-303447-3a7jxl34	1	33	Passage	passage	NN
cord-303447-3a7jxl34	1	34	date	date	NN
cord-303447-3a7jxl34	1	35	:	:	:
cord-303447-3a7jxl34	1	36	2005	2005	CD
cord-303447-3a7jxl34	1	37	-	-	HYPH
cord-303447-3a7jxl34	1	38	05	05	CD
cord-303447-3a7jxl34	1	39	-	-	HYPH
cord-303447-3a7jxl34	1	40	28	28	CD
cord-303447-3a7jxl34	1	41	journal	journal	NN
cord-303447-3a7jxl34	1	42	:	:	:
cord-303447-3a7jxl34	1	43	Pediatr	Pediatr	NNP
cord-303447-3a7jxl34	1	44	Clin	Clin	NNP
cord-303447-3a7jxl34	1	45	North	North	NNP
cord-303447-3a7jxl34	2	1	Am	Am	NNP
cord-303447-3a7jxl34	2	2	DOI	DOI	NNP
cord-303447-3a7jxl34	2	3	:	:	:
cord-303447-3a7jxl34	2	4	10.1016	10.1016	CD
cord-303447-3a7jxl34	2	5	/	/	SYM
cord-303447-3a7jxl34	2	6	j.pcl.2005.03.001	j.pcl.2005.03.001	NNP
cord-303447-3a7jxl34	2	7	sha	sha	NNP
cord-303447-3a7jxl34	2	8	:	:	:
cord-303447-3a7jxl34	2	9	4f673458ff8e464dab793d271b770820e4540ee3	4f673458ff8e464dab793d271b770820e4540ee3	CD
cord-303447-3a7jxl34	2	10	doc_id	doc_id	CD
cord-303447-3a7jxl34	2	11	:	:	:
cord-303447-3a7jxl34	2	12	303447	303447	CD
cord-303447-3a7jxl34	2	13	cord_uid	cord_uid	NNS
cord-303447-3a7jxl34	2	14	:	:	:
cord-303447-3a7jxl34	3	1	3a7jxl34	3a7jxl34	CD
cord-303447-3a7jxl34	4	1	Today	today	NN
cord-303447-3a7jxl34	4	2	,	,	,
cord-303447-3a7jxl34	4	3	vaccination	vaccination	NN
cord-303447-3a7jxl34	4	4	is	be	VBZ
cord-303447-3a7jxl34	4	5	a	a	DT
cord-303447-3a7jxl34	4	6	cornerstone	cornerstone	NN
cord-303447-3a7jxl34	4	7	of	of	IN
cord-303447-3a7jxl34	4	8	pediatric	pediatric	JJ
cord-303447-3a7jxl34	4	9	preventive	preventive	JJ
cord-303447-3a7jxl34	4	10	health	health	NN
cord-303447-3a7jxl34	4	11	care	care	NN
cord-303447-3a7jxl34	4	12	and	and	CC
cord-303447-3a7jxl34	4	13	a	a	DT
cord-303447-3a7jxl34	4	14	rite	rite	NN
cord-303447-3a7jxl34	4	15	of	of	IN
cord-303447-3a7jxl34	4	16	passage	passage	NN
cord-303447-3a7jxl34	4	17	for	for	IN
cord-303447-3a7jxl34	4	18	nearly	nearly	RB
cord-303447-3a7jxl34	4	19	all	all	DT
cord-303447-3a7jxl34	4	20	of	of	IN
cord-303447-3a7jxl34	4	21	the	the	DT
cord-303447-3a7jxl34	4	22	approximately	approximately	RB
cord-303447-3a7jxl34	4	23	11,000	11,000	CD
cord-303447-3a7jxl34	4	24	infants	infant	NNS
cord-303447-3a7jxl34	4	25	born	bear	VBN
cord-303447-3a7jxl34	4	26	daily	daily	RB
cord-303447-3a7jxl34	4	27	in	in	IN
cord-303447-3a7jxl34	4	28	the	the	DT
cord-303447-3a7jxl34	4	29	United	United	NNP
cord-303447-3a7jxl34	4	30	States	States	NNP
cord-303447-3a7jxl34	4	31	.	.	.
cord-303447-3a7jxl34	5	1	This	this	DT
cord-303447-3a7jxl34	5	2	article	article	NN
cord-303447-3a7jxl34	5	3	reviews	review	VBZ
cord-303447-3a7jxl34	5	4	the	the	DT
cord-303447-3a7jxl34	5	5	US	US	NNP
cord-303447-3a7jxl34	5	6	immunization	immunization	NN
cord-303447-3a7jxl34	5	7	program	program	NN
cord-303447-3a7jxl34	5	8	with	with	IN
cord-303447-3a7jxl34	5	9	an	an	DT
cord-303447-3a7jxl34	5	10	emphasis	emphasis	NN
cord-303447-3a7jxl34	5	11	on	on	IN
cord-303447-3a7jxl34	5	12	its	-PRON-	PRP$
cord-303447-3a7jxl34	5	13	role	role	NN
cord-303447-3a7jxl34	5	14	in	in	IN
cord-303447-3a7jxl34	5	15	ensuring	ensure	VBG
cord-303447-3a7jxl34	5	16	that	that	IN
cord-303447-3a7jxl34	5	17	vaccines	vaccine	NNS
cord-303447-3a7jxl34	5	18	are	be	VBP
cord-303447-3a7jxl34	5	19	effective	effective	JJ
cord-303447-3a7jxl34	5	20	,	,	,
cord-303447-3a7jxl34	5	21	safe	safe	JJ
cord-303447-3a7jxl34	5	22	,	,	,
cord-303447-3a7jxl34	5	23	and	and	CC
cord-303447-3a7jxl34	5	24	available	available	JJ
cord-303447-3a7jxl34	5	25	and	and	CC
cord-303447-3a7jxl34	5	26	highlights	highlight	VBZ
cord-303447-3a7jxl34	5	27	several	several	JJ
cord-303447-3a7jxl34	5	28	new	new	JJ
cord-303447-3a7jxl34	5	29	vaccines	vaccine	NNS
cord-303447-3a7jxl34	5	30	and	and	CC
cord-303447-3a7jxl34	5	31	recommendations	recommendation	NNS
cord-303447-3a7jxl34	5	32	that	that	WDT
cord-303447-3a7jxl34	5	33	will	will	MD
cord-303447-3a7jxl34	5	34	affect	affect	VB
cord-303447-3a7jxl34	5	35	the	the	DT
cord-303447-3a7jxl34	5	36	health	health	NN
cord-303447-3a7jxl34	5	37	of	of	IN
cord-303447-3a7jxl34	5	38	children	child	NNS
cord-303447-3a7jxl34	5	39	and	and	CC
cord-303447-3a7jxl34	5	40	adolescents	adolescent	NNS
cord-303447-3a7jxl34	5	41	and	and	CC
cord-303447-3a7jxl34	5	42	the	the	DT
cord-303447-3a7jxl34	5	43	practice	practice	NN
cord-303447-3a7jxl34	5	44	of	of	IN
cord-303447-3a7jxl34	5	45	pediatric	pediatric	JJ
cord-303447-3a7jxl34	5	46	medicine	medicine	NN
cord-303447-3a7jxl34	5	47	in	in	IN
cord-303447-3a7jxl34	5	48	future	future	JJ
cord-303447-3a7jxl34	5	49	decades	decade	NNS
cord-303447-3a7jxl34	5	50	.	.	.
cord-303447-3a7jxl34	6	1	We	-PRON-	PRP
cord-303447-3a7jxl34	6	2	must	must	MD
cord-303447-3a7jxl34	6	3	plan	plan	VB
cord-303447-3a7jxl34	6	4	for	for	IN
cord-303447-3a7jxl34	6	5	the	the	DT
cord-303447-3a7jxl34	6	6	future	future	NN
cord-303447-3a7jxl34	6	7	,	,	,
cord-303447-3a7jxl34	6	8	because	because	IN
cord-303447-3a7jxl34	6	9	people	people	NNS
cord-303447-3a7jxl34	6	10	who	who	WP
cord-303447-3a7jxl34	6	11	stay	stay	VBP
cord-303447-3a7jxl34	6	12	in	in	IN
cord-303447-3a7jxl34	6	13	the	the	DT
cord-303447-3a7jxl34	6	14	present	present	NN
cord-303447-3a7jxl34	6	15	will	will	MD
cord-303447-3a7jxl34	6	16	remain	remain	VB
cord-303447-3a7jxl34	6	17	in	in	IN
cord-303447-3a7jxl34	6	18	the	the	DT
cord-303447-3a7jxl34	6	19	past	past	NN
cord-303447-3a7jxl34	6	20	.	.	.
cord-303447-3a7jxl34	7	1	-Abraham	-Abraham	:
cord-303447-3a7jxl34	8	1	Lincoln	Lincoln	NNP
cord-303447-3a7jxl34	9	1	In	in	IN
cord-303447-3a7jxl34	9	2	1796	1796	CD
cord-303447-3a7jxl34	9	3	,	,	,
cord-303447-3a7jxl34	9	4	when	when	WRB
cord-303447-3a7jxl34	9	5	Jenner	Jenner	NNP
cord-303447-3a7jxl34	9	6	showed	show	VBD
cord-303447-3a7jxl34	9	7	successful	successful	JJ
cord-303447-3a7jxl34	9	8	inoculation	inoculation	NN
cord-303447-3a7jxl34	9	9	of	of	IN
cord-303447-3a7jxl34	9	10	humans	human	NNS
cord-303447-3a7jxl34	9	11	with	with	IN
cord-303447-3a7jxl34	9	12	cowpox	cowpox	NN
cord-303447-3a7jxl34	9	13	to	to	TO
cord-303447-3a7jxl34	9	14	protect	protect	VB
cord-303447-3a7jxl34	9	15	them	-PRON-	PRP
cord-303447-3a7jxl34	9	16	from	from	IN
cord-303447-3a7jxl34	9	17	the	the	DT
cord-303447-3a7jxl34	9	18	devastation	devastation	NN
cord-303447-3a7jxl34	9	19	of	of	IN
cord-303447-3a7jxl34	9	20	smallpox	smallpox	NN
cord-303447-3a7jxl34	9	21	,	,	,
cord-303447-3a7jxl34	9	22	a	a	DT
cord-303447-3a7jxl34	9	23	revolution	revolution	NN
cord-303447-3a7jxl34	9	24	in	in	IN
cord-303447-3a7jxl34	9	25	science	science	NN
cord-303447-3a7jxl34	9	26	and	and	CC
cord-303447-3a7jxl34	9	27	medicine	medicine	NN
cord-303447-3a7jxl34	9	28	began	begin	VBD
cord-303447-3a7jxl34	9	29	[	[	-LRB-
cord-303447-3a7jxl34	9	30	1	1	CD
cord-303447-3a7jxl34	9	31	]	]	-RRB-
cord-303447-3a7jxl34	9	32	.	.	.
cord-303447-3a7jxl34	10	1	More	More	JJR
cord-303447-3a7jxl34	10	2	than	than	IN
cord-303447-3a7jxl34	10	3	2	2	CD
cord-303447-3a7jxl34	10	4	centuries	century	NNS
cord-303447-3a7jxl34	10	5	later	later	RB
cord-303447-3a7jxl34	10	6	,	,	,
cord-303447-3a7jxl34	10	7	immunizations	immunization	NNS
cord-303447-3a7jxl34	10	8	were	be	VBD
cord-303447-3a7jxl34	10	9	hailed	hail	VBN
cord-303447-3a7jxl34	10	10	as	as	IN
cord-303447-3a7jxl34	10	11	one	one	CD
cord-303447-3a7jxl34	10	12	of	of	IN
cord-303447-3a7jxl34	10	13	'	'	''
cord-303447-3a7jxl34	10	14	'	'	''
cord-303447-3a7jxl34	10	15	ten	ten	CD
cord-303447-3a7jxl34	10	16	great	great	JJ
cord-303447-3a7jxl34	10	17	public	public	JJ
cord-303447-3a7jxl34	10	18	health	health	NN
cord-303447-3a7jxl34	10	19	achievements	achievement	NNS
cord-303447-3a7jxl34	10	20	'	'	''
cord-303447-3a7jxl34	10	21	'	'	''
cord-303447-3a7jxl34	10	22	of	of	IN
cord-303447-3a7jxl34	10	23	the	the	DT
cord-303447-3a7jxl34	10	24	twentieth	twentieth	JJ
cord-303447-3a7jxl34	10	25	century	century	NN
cord-303447-3a7jxl34	10	26	[	[	-LRB-
cord-303447-3a7jxl34	10	27	2	2	CD
cord-303447-3a7jxl34	10	28	,	,	,
cord-303447-3a7jxl34	10	29	3	3	CD
cord-303447-3a7jxl34	10	30	]	]	-RRB-
cord-303447-3a7jxl34	10	31	.	.	.
cord-303447-3a7jxl34	11	1	Today	today	NN
cord-303447-3a7jxl34	11	2	,	,	,
cord-303447-3a7jxl34	11	3	vaccination	vaccination	NN
cord-303447-3a7jxl34	11	4	is	be	VBZ
cord-303447-3a7jxl34	11	5	a	a	DT
cord-303447-3a7jxl34	11	6	cornerstone	cornerstone	NN
cord-303447-3a7jxl34	11	7	of	of	IN
cord-303447-3a7jxl34	11	8	pediatric	pediatric	JJ
cord-303447-3a7jxl34	11	9	preventive	preventive	JJ
cord-303447-3a7jxl34	11	10	health	health	NN
cord-303447-3a7jxl34	11	11	care	care	NN
cord-303447-3a7jxl34	11	12	and	and	CC
cord-303447-3a7jxl34	11	13	a	a	DT
cord-303447-3a7jxl34	11	14	rite	rite	NN
cord-303447-3a7jxl34	11	15	of	of	IN
cord-303447-3a7jxl34	11	16	passage	passage	NN
cord-303447-3a7jxl34	11	17	for	for	IN
cord-303447-3a7jxl34	11	18	nearly	nearly	RB
cord-303447-3a7jxl34	11	19	all	all	DT
cord-303447-3a7jxl34	11	20	of	of	IN
cord-303447-3a7jxl34	11	21	the	the	DT
cord-303447-3a7jxl34	11	22	approximately	approximately	RB
cord-303447-3a7jxl34	11	23	11,000	11,000	CD
cord-303447-3a7jxl34	11	24	infants	infant	NNS
cord-303447-3a7jxl34	11	25	born	bear	VBN
cord-303447-3a7jxl34	11	26	daily	daily	RB
cord-303447-3a7jxl34	11	27	in	in	IN
cord-303447-3a7jxl34	11	28	the	the	DT
cord-303447-3a7jxl34	11	29	United	United	NNP
cord-303447-3a7jxl34	11	30	States	States	NNP
cord-303447-3a7jxl34	11	31	.	.	.
cord-303447-3a7jxl34	12	1	Immunizations	immunization	NNS
cord-303447-3a7jxl34	12	2	have	have	VBP
cord-303447-3a7jxl34	12	3	had	have	VBN
cord-303447-3a7jxl34	12	4	a	a	DT
cord-303447-3a7jxl34	12	5	profound	profound	JJ
cord-303447-3a7jxl34	12	6	impact	impact	NN
cord-303447-3a7jxl34	12	7	on	on	IN
cord-303447-3a7jxl34	12	8	the	the	DT
cord-303447-3a7jxl34	12	9	health	health	NN
cord-303447-3a7jxl34	12	10	of	of	IN
cord-303447-3a7jxl34	12	11	children	child	NNS
cord-303447-3a7jxl34	12	12	,	,	,
cord-303447-3a7jxl34	12	13	adolescents	adolescent	NNS
cord-303447-3a7jxl34	12	14	,	,	,
cord-303447-3a7jxl34	12	15	and	and	CC
cord-303447-3a7jxl34	12	16	adults	adult	NNS
cord-303447-3a7jxl34	12	17	in	in	IN
cord-303447-3a7jxl34	12	18	the	the	DT
cord-303447-3a7jxl34	12	19	United	United	NNP
cord-303447-3a7jxl34	12	20	States	States	NNP
cord-303447-3a7jxl34	12	21	(	(	-LRB-
cord-303447-3a7jxl34	12	22	Table	Table	NNP
cord-303447-3a7jxl34	12	23	1	1	CD
cord-303447-3a7jxl34	12	24	)	)	-RRB-
cord-303447-3a7jxl34	12	25	.	.	.
cord-303447-3a7jxl34	13	1	The	the	DT
cord-303447-3a7jxl34	13	2	most	most	RBS
cord-303447-3a7jxl34	13	3	extraordinary	extraordinary	JJ
cord-303447-3a7jxl34	13	4	success	success	NN
cord-303447-3a7jxl34	13	5	of	of	IN
cord-303447-3a7jxl34	13	6	immunizations	immunization	NNS
cord-303447-3a7jxl34	13	7	was	be	VBD
cord-303447-3a7jxl34	13	8	the	the	DT
cord-303447-3a7jxl34	13	9	worldwide	worldwide	JJ
cord-303447-3a7jxl34	13	10	eradication	eradication	NN
cord-303447-3a7jxl34	13	11	of	of	IN
cord-303447-3a7jxl34	13	12	smallpox	smallpox	NN
cord-303447-3a7jxl34	13	13	.	.	.
cord-303447-3a7jxl34	14	1	Declared	declare	VBN
cord-303447-3a7jxl34	14	2	in	in	IN
cord-303447-3a7jxl34	14	3	1980	1980	CD
cord-303447-3a7jxl34	14	4	,	,	,
cord-303447-3a7jxl34	14	5	smallpox	smallpox	NN
cord-303447-3a7jxl34	14	6	eradication	eradication	NN
cord-303447-3a7jxl34	14	7	was	be	VBD
cord-303447-3a7jxl34	14	8	achieved	achieve	VBN
cord-303447-3a7jxl34	14	9	through	through	IN
cord-303447-3a7jxl34	14	10	an	an	DT
cord-303447-3a7jxl34	14	11	unprecedented	unprecedented	JJ
cord-303447-3a7jxl34	14	12	collaborative	collaborative	JJ
cord-303447-3a7jxl34	14	13	international	international	JJ
cord-303447-3a7jxl34	14	14	initiative	initiative	NN
cord-303447-3a7jxl34	14	15	,	,	,
cord-303447-3a7jxl34	14	16	led	lead	VBN
cord-303447-3a7jxl34	14	17	by	by	IN
cord-303447-3a7jxl34	14	18	the	the	DT
cord-303447-3a7jxl34	14	19	World	World	NNP
cord-303447-3a7jxl34	14	20	Health	Health	NNP
cord-303447-3a7jxl34	14	21	Organization	Organization	NNP
cord-303447-3a7jxl34	14	22	,	,	,
cord-303447-3a7jxl34	14	23	establishing	establish	VBG
cord-303447-3a7jxl34	14	24	an	an	DT
cord-303447-3a7jxl34	14	25	example	example	NN
cord-303447-3a7jxl34	14	26	for	for	IN
cord-303447-3a7jxl34	14	27	other	other	JJ
cord-303447-3a7jxl34	14	28	vaccine	vaccine	NN
cord-303447-3a7jxl34	14	29	-	-	HYPH
cord-303447-3a7jxl34	14	30	preventable	preventable	JJ
cord-303447-3a7jxl34	14	31	diseases	disease	NNS
cord-303447-3a7jxl34	14	32	[	[	-LRB-
cord-303447-3a7jxl34	14	33	1	1	CD
cord-303447-3a7jxl34	14	34	]	]	-RRB-
cord-303447-3a7jxl34	14	35	.	.	.
cord-303447-3a7jxl34	15	1	Vaccination	vaccination	NN
cord-303447-3a7jxl34	15	2	since	since	IN
cord-303447-3a7jxl34	15	3	has	have	VBZ
cord-303447-3a7jxl34	15	4	led	lead	VBN
cord-303447-3a7jxl34	15	5	to	to	IN
cord-303447-3a7jxl34	15	6	elimination	elimination	NN
cord-303447-3a7jxl34	15	7	of	of	IN
cord-303447-3a7jxl34	15	8	wild	wild	JJ
cord-303447-3a7jxl34	15	9	-	-	HYPH
cord-303447-3a7jxl34	15	10	type	type	NN
cord-303447-3a7jxl34	15	11	poliomyelitis	poliomyelitis	NN
cord-303447-3a7jxl34	15	12	and	and	CC
cord-303447-3a7jxl34	15	13	indigenous	indigenous	JJ
cord-303447-3a7jxl34	15	14	measles	measle	NNS
cord-303447-3a7jxl34	15	15	in	in	IN
cord-303447-3a7jxl34	15	16	the	the	DT
cord-303447-3a7jxl34	15	17	United	United	NNP
cord-303447-3a7jxl34	15	18	States	States	NNP
cord-303447-3a7jxl34	15	19	,	,	,
cord-303447-3a7jxl34	15	20	both	both	DT
cord-303447-3a7jxl34	15	21	major	major	JJ
cord-303447-3a7jxl34	15	22	causes	cause	NNS
cord-303447-3a7jxl34	15	23	of	of	IN
cord-303447-3a7jxl34	15	24	pediatric	pediatric	JJ
cord-303447-3a7jxl34	15	25	morbidity	morbidity	NN
cord-303447-3a7jxl34	15	26	and	and	CC
cord-303447-3a7jxl34	15	27	mortality	mortality	NN
cord-303447-3a7jxl34	15	28	in	in	IN
cord-303447-3a7jxl34	15	29	the	the	DT
cord-303447-3a7jxl34	15	30	prevaccine	prevaccine	NN
cord-303447-3a7jxl34	15	31	era	era	NN
cord-303447-3a7jxl34	15	32	[	[	-LRB-
cord-303447-3a7jxl34	15	33	4	4	CD
cord-303447-3a7jxl34	15	34	,	,	,
cord-303447-3a7jxl34	15	35	5	5	CD
cord-303447-3a7jxl34	15	36	]	]	-RRB-
cord-303447-3a7jxl34	15	37	.	.	.
cord-303447-3a7jxl34	16	1	An	an	DT
cord-303447-3a7jxl34	16	2	integral	integral	JJ
cord-303447-3a7jxl34	16	3	part	part	NN
cord-303447-3a7jxl34	16	4	of	of	IN
cord-303447-3a7jxl34	16	5	achieving	achieve	VBG
cord-303447-3a7jxl34	16	6	these	these	DT
cord-303447-3a7jxl34	16	7	successes	success	NNS
cord-303447-3a7jxl34	16	8	was	be	VBD
cord-303447-3a7jxl34	16	9	establishment	establishment	NN
cord-303447-3a7jxl34	16	10	of	of	IN
cord-303447-3a7jxl34	16	11	a	a	DT
cord-303447-3a7jxl34	16	12	federal	federal	JJ
cord-303447-3a7jxl34	16	13	immunization	immunization	NN
cord-303447-3a7jxl34	16	14	infrastructure	infrastructure	NN
cord-303447-3a7jxl34	16	15	,	,	,
cord-303447-3a7jxl34	16	16	which	which	WDT
cord-303447-3a7jxl34	16	17	followed	follow	VBD
cord-303447-3a7jxl34	16	18	the	the	DT
cord-303447-3a7jxl34	16	19	introduction	introduction	NN
cord-303447-3a7jxl34	16	20	of	of	IN
cord-303447-3a7jxl34	16	21	polio	polio	NN
cord-303447-3a7jxl34	16	22	vaccination	vaccination	NN
cord-303447-3a7jxl34	16	23	in	in	IN
cord-303447-3a7jxl34	16	24	the	the	DT
cord-303447-3a7jxl34	16	25	1950s	1950	NNS
cord-303447-3a7jxl34	16	26	[	[	-LRB-
cord-303447-3a7jxl34	16	27	3	3	CD
cord-303447-3a7jxl34	16	28	]	]	-RRB-
cord-303447-3a7jxl34	16	29	.	.	.
cord-303447-3a7jxl34	17	1	Immunization	immunization	NN
cord-303447-3a7jxl34	17	2	programs	program	NNS
cord-303447-3a7jxl34	17	3	,	,	,
cord-303447-3a7jxl34	17	4	legislation	legislation	NN
cord-303447-3a7jxl34	17	5	,	,	,
cord-303447-3a7jxl34	17	6	and	and	CC
cord-303447-3a7jxl34	17	7	funding	fund	VBG
cord-303447-3a7jxl34	17	8	mecha-	mecha-	NNP
cord-303447-3a7jxl34	17	9	nisms	nisms	NNP
cord-303447-3a7jxl34	17	10	are	be	VBP
cord-303447-3a7jxl34	17	11	now	now	RB
cord-303447-3a7jxl34	17	12	in	in	IN
cord-303447-3a7jxl34	17	13	place	place	NN
cord-303447-3a7jxl34	17	14	to	to	TO
cord-303447-3a7jxl34	17	15	ensure	ensure	VB
cord-303447-3a7jxl34	17	16	that	that	IN
cord-303447-3a7jxl34	17	17	immunizations	immunization	NNS
cord-303447-3a7jxl34	17	18	are	be	VBP
cord-303447-3a7jxl34	17	19	accessible	accessible	JJ
cord-303447-3a7jxl34	17	20	to	to	IN
cord-303447-3a7jxl34	17	21	all	all	DT
cord-303447-3a7jxl34	17	22	children	child	NNS
cord-303447-3a7jxl34	17	23	.	.	.
cord-303447-3a7jxl34	18	1	As	as	IN
cord-303447-3a7jxl34	18	2	a	a	DT
cord-303447-3a7jxl34	18	3	result	result	NN
cord-303447-3a7jxl34	18	4	,	,	,
cord-303447-3a7jxl34	18	5	coverage	coverage	NN
cord-303447-3a7jxl34	18	6	levels	level	NNS
cord-303447-3a7jxl34	18	7	for	for	IN
cord-303447-3a7jxl34	18	8	most	most	JJS
cord-303447-3a7jxl34	18	9	routinely	routinely	RB
cord-303447-3a7jxl34	18	10	recommended	recommend	VBN
cord-303447-3a7jxl34	18	11	childhood	childhood	NN
cord-303447-3a7jxl34	18	12	vaccines	vaccine	NNS
cord-303447-3a7jxl34	18	13	in	in	IN
cord-303447-3a7jxl34	18	14	the	the	DT
cord-303447-3a7jxl34	18	15	United	United	NNP
cord-303447-3a7jxl34	18	16	States	States	NNP
cord-303447-3a7jxl34	18	17	are	be	VBP
cord-303447-3a7jxl34	18	18	approaching	approach	VBG
cord-303447-3a7jxl34	18	19	or	or	CC
cord-303447-3a7jxl34	18	20	have	have	VBP
cord-303447-3a7jxl34	18	21	surpassed	surpass	VBN
cord-303447-3a7jxl34	18	22	the	the	DT
cord-303447-3a7jxl34	18	23	US	US	NNP
cord-303447-3a7jxl34	18	24	Department	Department	NNP
cord-303447-3a7jxl34	18	25	of	of	IN
cord-303447-3a7jxl34	18	26	Health	Health	NNP
cord-303447-3a7jxl34	18	27	and	and	CC
cord-303447-3a7jxl34	18	28	Human	Human	NNP
cord-303447-3a7jxl34	18	29	Services	Services	NNPS
cord-303447-3a7jxl34	18	30	Healthy	Healthy	NNP
cord-303447-3a7jxl34	18	31	People	People	NNPS
cord-303447-3a7jxl34	18	32	2010	2010	CD
cord-303447-3a7jxl34	18	33	goal	goal	NN
cord-303447-3a7jxl34	18	34	of	of	IN
cord-303447-3a7jxl34	18	35	90	90	CD
cord-303447-3a7jxl34	18	36	%	%	NN
cord-303447-3a7jxl34	18	37	coverage	coverage	NN
cord-303447-3a7jxl34	18	38	[	[	-LRB-
cord-303447-3a7jxl34	18	39	6	6	CD
cord-303447-3a7jxl34	18	40	]	]	-RRB-
cord-303447-3a7jxl34	18	41	.	.	.
cord-303447-3a7jxl34	19	1	Immunizations	immunization	NNS
cord-303447-3a7jxl34	19	2	have	have	VBP
cord-303447-3a7jxl34	19	3	changed	change	VBN
cord-303447-3a7jxl34	19	4	the	the	DT
cord-303447-3a7jxl34	19	5	scope	scope	NN
cord-303447-3a7jxl34	19	6	of	of	IN
cord-303447-3a7jxl34	19	7	pediatric	pediatric	JJ
cord-303447-3a7jxl34	19	8	practice	practice	NN
cord-303447-3a7jxl34	19	9	in	in	IN
cord-303447-3a7jxl34	19	10	the	the	DT
cord-303447-3a7jxl34	19	11	United	United	NNP
cord-303447-3a7jxl34	19	12	States	States	NNP
cord-303447-3a7jxl34	19	13	.	.	.
cord-303447-3a7jxl34	20	1	Pediatric	pediatric	JJ
cord-303447-3a7jxl34	20	2	residents	resident	NNS
cord-303447-3a7jxl34	20	3	now	now	RB
cord-303447-3a7jxl34	20	4	infrequently	infrequently	RB
cord-303447-3a7jxl34	20	5	encounter	encounter	VBP
cord-303447-3a7jxl34	20	6	varicella	varicella	NN
cord-303447-3a7jxl34	20	7	,	,	,
cord-303447-3a7jxl34	20	8	which	which	WDT
cord-303447-3a7jxl34	20	9	in	in	IN
cord-303447-3a7jxl34	20	10	the	the	DT
cord-303447-3a7jxl34	20	11	1990s	1990s	CD
cord-303447-3a7jxl34	20	12	was	be	VBD
cord-303447-3a7jxl34	20	13	commonplace	commonplace	JJ
cord-303447-3a7jxl34	20	14	.	.	.
cord-303447-3a7jxl34	21	1	Likewise	likewise	RB
cord-303447-3a7jxl34	21	2	,	,	,
cord-303447-3a7jxl34	21	3	although	although	IN
cord-303447-3a7jxl34	21	4	Haemophilus	haemophilus	JJ
cord-303447-3a7jxl34	21	5	influenzae	influenzae	NN
cord-303447-3a7jxl34	21	6	type	type	NN
cord-303447-3a7jxl34	21	7	b	b	NN
cord-303447-3a7jxl34	21	8	(	(	-LRB-
cord-303447-3a7jxl34	21	9	Hib	Hib	NNP
cord-303447-3a7jxl34	21	10	)	)	-RRB-
cord-303447-3a7jxl34	21	11	was	be	VBD
cord-303447-3a7jxl34	21	12	the	the	DT
cord-303447-3a7jxl34	21	13	leading	leading	JJ
cord-303447-3a7jxl34	21	14	cause	cause	NN
cord-303447-3a7jxl34	21	15	of	of	IN
cord-303447-3a7jxl34	21	16	meningitis	meningitis	NN
cord-303447-3a7jxl34	21	17	in	in	IN
cord-303447-3a7jxl34	21	18	young	young	JJ
cord-303447-3a7jxl34	21	19	children	child	NNS
cord-303447-3a7jxl34	21	20	before	before	IN
cord-303447-3a7jxl34	21	21	availability	availability	NN
cord-303447-3a7jxl34	21	22	of	of	IN
cord-303447-3a7jxl34	21	23	Hib	Hib	NNP
cord-303447-3a7jxl34	21	24	vaccines	vaccine	NNS
cord-303447-3a7jxl34	21	25	in	in	IN
cord-303447-3a7jxl34	21	26	1985	1985	CD
cord-303447-3a7jxl34	21	27	,	,	,
cord-303447-3a7jxl34	21	28	most	most	RBS
cord-303447-3a7jxl34	21	29	newly	newly	RB
cord-303447-3a7jxl34	21	30	trained	train	VBN
cord-303447-3a7jxl34	21	31	pediatricians	pediatrician	NNS
cord-303447-3a7jxl34	21	32	will	will	MD
cord-303447-3a7jxl34	21	33	never	never	RB
cord-303447-3a7jxl34	21	34	see	see	VB
cord-303447-3a7jxl34	21	35	a	a	DT
cord-303447-3a7jxl34	21	36	case	case	NN
cord-303447-3a7jxl34	21	37	of	of	IN
cord-303447-3a7jxl34	21	38	invasive	invasive	JJ
cord-303447-3a7jxl34	21	39	Hib	Hib	NNP
cord-303447-3a7jxl34	21	40	[	[	-LRB-
cord-303447-3a7jxl34	21	41	7	7	CD
cord-303447-3a7jxl34	21	42	]	]	-RRB-
cord-303447-3a7jxl34	21	43	.	.	.
cord-303447-3a7jxl34	22	1	This	this	DT
cord-303447-3a7jxl34	22	2	article	article	NN
cord-303447-3a7jxl34	22	3	reviews	review	VBZ
cord-303447-3a7jxl34	22	4	the	the	DT
cord-303447-3a7jxl34	22	5	US	US	NNP
cord-303447-3a7jxl34	22	6	immunization	immunization	NN
cord-303447-3a7jxl34	22	7	program	program	NN
cord-303447-3a7jxl34	22	8	with	with	IN
cord-303447-3a7jxl34	22	9	an	an	DT
cord-303447-3a7jxl34	22	10	emphasis	emphasis	NN
cord-303447-3a7jxl34	22	11	on	on	IN
cord-303447-3a7jxl34	22	12	its	-PRON-	PRP$
cord-303447-3a7jxl34	22	13	role	role	NN
cord-303447-3a7jxl34	22	14	in	in	IN
cord-303447-3a7jxl34	22	15	ensuring	ensure	VBG
cord-303447-3a7jxl34	22	16	that	that	IN
cord-303447-3a7jxl34	22	17	vaccines	vaccine	NNS
cord-303447-3a7jxl34	22	18	are	be	VBP
cord-303447-3a7jxl34	22	19	effective	effective	JJ
cord-303447-3a7jxl34	22	20	,	,	,
cord-303447-3a7jxl34	22	21	safe	safe	JJ
cord-303447-3a7jxl34	22	22	,	,	,
cord-303447-3a7jxl34	22	23	and	and	CC
cord-303447-3a7jxl34	22	24	available	available	JJ
cord-303447-3a7jxl34	22	25	and	and	CC
cord-303447-3a7jxl34	22	26	highlights	highlight	VBZ
cord-303447-3a7jxl34	22	27	several	several	JJ
cord-303447-3a7jxl34	22	28	new	new	JJ
cord-303447-3a7jxl34	22	29	vaccines	vaccine	NNS
cord-303447-3a7jxl34	22	30	and	and	CC
cord-303447-3a7jxl34	22	31	recommendations	recommendation	NNS
cord-303447-3a7jxl34	22	32	that	that	WDT
cord-303447-3a7jxl34	22	33	will	will	MD
cord-303447-3a7jxl34	22	34	affect	affect	VB
cord-303447-3a7jxl34	22	35	the	the	DT
cord-303447-3a7jxl34	22	36	health	health	NN
cord-303447-3a7jxl34	22	37	of	of	IN
cord-303447-3a7jxl34	22	38	children	child	NNS
cord-303447-3a7jxl34	22	39	and	and	CC
cord-303447-3a7jxl34	22	40	adolescents	adolescent	NNS
cord-303447-3a7jxl34	22	41	and	and	CC
cord-303447-3a7jxl34	22	42	the	the	DT
cord-303447-3a7jxl34	22	43	practice	practice	NN
cord-303447-3a7jxl34	22	44	of	of	IN
cord-303447-3a7jxl34	22	45	pediatric	pediatric	JJ
cord-303447-3a7jxl34	22	46	medicine	medicine	NN
cord-303447-3a7jxl34	22	47	in	in	IN
cord-303447-3a7jxl34	22	48	future	future	JJ
cord-303447-3a7jxl34	22	49	decades	decade	NNS
cord-303447-3a7jxl34	22	50	.	.	.
cord-303447-3a7jxl34	23	1	Childhood	childhood	NN
cord-303447-3a7jxl34	23	2	and	and	CC
cord-303447-3a7jxl34	23	3	adolescent	adolescent	JJ
cord-303447-3a7jxl34	23	4	immunization	immunization	NN
cord-303447-3a7jxl34	23	5	schedule	schedule	NN
cord-303447-3a7jxl34	24	1	The	the	DT
cord-303447-3a7jxl34	24	2	Centers	Centers	NNPS
cord-303447-3a7jxl34	24	3	for	for	IN
cord-303447-3a7jxl34	24	4	Disease	Disease	NNP
cord-303447-3a7jxl34	24	5	Control	Control	NNP
cord-303447-3a7jxl34	24	6	and	and	CC
cord-303447-3a7jxl34	24	7	Prevention	Prevention	NNP
cord-303447-3a7jxl34	24	8	(	(	-LRB-
cord-303447-3a7jxl34	24	9	CDC	CDC	NNP
cord-303447-3a7jxl34	24	10	)	)	-RRB-
cord-303447-3a7jxl34	24	11	,	,	,
cord-303447-3a7jxl34	24	12	American	American	NNP
cord-303447-3a7jxl34	24	13	Academy	Academy	NNP
cord-303447-3a7jxl34	24	14	of	of	IN
cord-303447-3a7jxl34	24	15	Family	Family	NNP
cord-303447-3a7jxl34	24	16	Physicians	Physicians	NNPS
cord-303447-3a7jxl34	24	17	,	,	,
cord-303447-3a7jxl34	24	18	and	and	CC
cord-303447-3a7jxl34	24	19	American	American	NNP
cord-303447-3a7jxl34	24	20	Academy	Academy	NNP
cord-303447-3a7jxl34	24	21	of	of	IN
cord-303447-3a7jxl34	24	22	Pediatrics	Pediatrics	NNP
cord-303447-3a7jxl34	24	23	(	(	-LRB-
cord-303447-3a7jxl34	24	24	AAP	AAP	NNP
cord-303447-3a7jxl34	24	25	)	)	-RRB-
cord-303447-3a7jxl34	24	26	annually	annually	RB
cord-303447-3a7jxl34	24	27	publish	publish	VB
cord-303447-3a7jxl34	24	28	a	a	DT
cord-303447-3a7jxl34	24	29	childhood	childhood	NN
cord-303447-3a7jxl34	24	30	and	and	CC
cord-303447-3a7jxl34	24	31	adolescent	adolescent	JJ
cord-303447-3a7jxl34	24	32	immunization	immunization	NN
cord-303447-3a7jxl34	24	33	schedule	schedule	NN
cord-303447-3a7jxl34	24	34	.	.	.
cord-303447-3a7jxl34	25	1	The	the	DT
cord-303447-3a7jxl34	25	2	Advisory	Advisory	NNP
cord-303447-3a7jxl34	25	3	Committee	Committee	NNP
cord-303447-3a7jxl34	25	4	on	on	IN
cord-303447-3a7jxl34	25	5	Immunization	Immunization	NNP
cord-303447-3a7jxl34	25	6	Practices	Practices	NNPS
cord-303447-3a7jxl34	25	7	(	(	-LRB-
cord-303447-3a7jxl34	25	8	ACIP	ACIP	NNP
cord-303447-3a7jxl34	25	9	)	)	-RRB-
cord-303447-3a7jxl34	25	10	,	,	,
cord-303447-3a7jxl34	25	11	with	with	IN
cord-303447-3a7jxl34	25	12	input	input	NN
cord-303447-3a7jxl34	25	13	from	from	IN
cord-303447-3a7jxl34	25	14	many	many	JJ
cord-303447-3a7jxl34	25	15	liaison	liaison	NN
cord-303447-3a7jxl34	25	16	organizations	organization	NNS
cord-303447-3a7jxl34	25	17	,	,	,
cord-303447-3a7jxl34	25	18	periodically	periodically	RB
cord-303447-3a7jxl34	25	19	reviews	review	VBZ
cord-303447-3a7jxl34	25	20	the	the	DT
cord-303447-3a7jxl34	25	21	schedule	schedule	NN
cord-303447-3a7jxl34	25	22	to	to	TO
cord-303447-3a7jxl34	25	23	ensure	ensure	VB
cord-303447-3a7jxl34	25	24	consistency	consistency	NN
cord-303447-3a7jxl34	25	25	with	with	IN
cord-303447-3a7jxl34	25	26	new	new	JJ
cord-303447-3a7jxl34	25	27	vaccine	vaccine	NN
cord-303447-3a7jxl34	25	28	developments	development	NNS
cord-303447-3a7jxl34	25	29	and	and	CC
cord-303447-3a7jxl34	25	30	policies	policy	NNS
cord-303447-3a7jxl34	25	31	[	[	-LRB-
cord-303447-3a7jxl34	25	32	8	8	CD
cord-303447-3a7jxl34	25	33	]	]	-RRB-
cord-303447-3a7jxl34	25	34	.	.	.
cord-303447-3a7jxl34	26	1	The	the	DT
cord-303447-3a7jxl34	26	2	first	first	JJ
cord-303447-3a7jxl34	26	3	combined	combined	JJ
cord-303447-3a7jxl34	26	4	immunization	immunization	NN
cord-303447-3a7jxl34	26	5	schedule	schedule	NN
cord-303447-3a7jxl34	26	6	was	be	VBD
cord-303447-3a7jxl34	26	7	published	publish	VBN
cord-303447-3a7jxl34	26	8	in	in	IN
cord-303447-3a7jxl34	26	9	1995	1995	CD
cord-303447-3a7jxl34	26	10	and	and	CC
cord-303447-3a7jxl34	26	11	recommended	recommend	VBD
cord-303447-3a7jxl34	26	12	six	six	CD
cord-303447-3a7jxl34	26	13	vaccines	vaccine	NNS
cord-303447-3a7jxl34	26	14	containing	contain	VBG
cord-303447-3a7jxl34	26	15	antigens	antigen	NNS
cord-303447-3a7jxl34	26	16	against	against	IN
cord-303447-3a7jxl34	26	17	nine	nine	CD
cord-303447-3a7jxl34	26	18	infectious	infectious	JJ
cord-303447-3a7jxl34	26	19	diseases	disease	NNS
cord-303447-3a7jxl34	26	20	[	[	-LRB-
cord-303447-3a7jxl34	26	21	9	9	CD
cord-303447-3a7jxl34	26	22	]	]	-RRB-
cord-303447-3a7jxl34	26	23	:	:	:
cord-303447-3a7jxl34	26	24	diphtheria	diphtheria	NN
cord-303447-3a7jxl34	26	25	and	and	CC
cord-303447-3a7jxl34	26	26	tetanus	tetanus	NN
cord-303447-3a7jxl34	26	27	toxoids	toxoid	NNS
cord-303447-3a7jxl34	26	28	and	and	CC
cord-303447-3a7jxl34	26	29	whole	whole	JJ
cord-303447-3a7jxl34	26	30	-	-	HYPH
cord-303447-3a7jxl34	26	31	cell	cell	NN
cord-303447-3a7jxl34	26	32	pertussis	pertussis	NN
cord-303447-3a7jxl34	26	33	vaccine	vaccine	NN
cord-303447-3a7jxl34	26	34	(	(	-LRB-
cord-303447-3a7jxl34	26	35	DTP	DTP	NNP
cord-303447-3a7jxl34	26	36	)	)	-RRB-
cord-303447-3a7jxl34	26	37	;	;	:
cord-303447-3a7jxl34	26	38	tetanus	tetanus	NN
cord-303447-3a7jxl34	26	39	and	and	CC
cord-303447-3a7jxl34	26	40	diphtheria	diphtheria	NN
cord-303447-3a7jxl34	26	41	toxoids	toxoid	NNS
cord-303447-3a7jxl34	26	42	(	(	-LRB-
cord-303447-3a7jxl34	26	43	Td	Td	NNP
cord-303447-3a7jxl34	26	44	)	)	-RRB-
cord-303447-3a7jxl34	26	45	;	;	:
cord-303447-3a7jxl34	26	46	measles	measle	NNS
cord-303447-3a7jxl34	26	47	,	,	,
cord-303447-3a7jxl34	26	48	mumps	mumps	NN
cord-303447-3a7jxl34	26	49	,	,	,
cord-303447-3a7jxl34	26	50	and	and	CC
cord-303447-3a7jxl34	26	51	rubella	rubella	NN
cord-303447-3a7jxl34	26	52	vaccine	vaccine	NN
cord-303447-3a7jxl34	26	53	(	(	-LRB-
cord-303447-3a7jxl34	26	54	MMR	MMR	NNP
cord-303447-3a7jxl34	26	55	)	)	-RRB-
cord-303447-3a7jxl34	26	56	;	;	:
cord-303447-3a7jxl34	26	57	Hib	Hib	NNP
cord-303447-3a7jxl34	26	58	;	;	:
cord-303447-3a7jxl34	26	59	oral	oral	JJ
cord-303447-3a7jxl34	26	60	polio	polio	NN
cord-303447-3a7jxl34	26	61	vaccine	vaccine	NN
cord-303447-3a7jxl34	26	62	(	(	-LRB-
cord-303447-3a7jxl34	26	63	OPV	OPV	NNP
cord-303447-3a7jxl34	26	64	)	)	-RRB-
cord-303447-3a7jxl34	26	65	;	;	:
cord-303447-3a7jxl34	26	66	and	and	CC
cord-303447-3a7jxl34	26	67	hepatitis	hepatitis	NNP
cord-303447-3a7jxl34	26	68	B	B	NNP
cord-303447-3a7jxl34	26	69	virus	virus	NN
cord-303447-3a7jxl34	26	70	vaccine	vaccine	NN
cord-303447-3a7jxl34	26	71	.	.	.
cord-303447-3a7jxl34	27	1	Ten	ten	CD
cord-303447-3a7jxl34	27	2	years	year	NNS
cord-303447-3a7jxl34	27	3	later	later	RB
cord-303447-3a7jxl34	27	4	in	in	IN
cord-303447-3a7jxl34	27	5	February	February	NNP
cord-303447-3a7jxl34	27	6	2005	2005	CD
cord-303447-3a7jxl34	27	7	,	,	,
cord-303447-3a7jxl34	27	8	there	there	EX
cord-303447-3a7jxl34	27	9	were	be	VBD
cord-303447-3a7jxl34	27	10	ten	ten	CD
cord-303447-3a7jxl34	27	11	vaccines	vaccine	NNS
cord-303447-3a7jxl34	27	12	against	against	IN
cord-303447-3a7jxl34	27	13	13	13	CD
cord-303447-3a7jxl34	27	14	[	[	-LRB-
cord-303447-3a7jxl34	27	15	8	8	CD
cord-303447-3a7jxl34	27	16	]	]	-RRB-
cord-303447-3a7jxl34	27	17	.	.	.
cord-303447-3a7jxl34	28	1	Before	before	IN
cord-303447-3a7jxl34	28	2	a	a	DT
cord-303447-3a7jxl34	28	3	vaccination	vaccination	NN
cord-303447-3a7jxl34	28	4	becomes	become	VBZ
cord-303447-3a7jxl34	28	5	part	part	NN
cord-303447-3a7jxl34	28	6	of	of	IN
cord-303447-3a7jxl34	28	7	routine	routine	JJ
cord-303447-3a7jxl34	28	8	clinical	clinical	JJ
cord-303447-3a7jxl34	28	9	pediatric	pediatric	JJ
cord-303447-3a7jxl34	28	10	practice	practice	NN
cord-303447-3a7jxl34	28	11	,	,	,
cord-303447-3a7jxl34	28	12	three	three	CD
cord-303447-3a7jxl34	28	13	steps	step	NNS
cord-303447-3a7jxl34	28	14	need	need	VBP
cord-303447-3a7jxl34	28	15	to	to	TO
cord-303447-3a7jxl34	28	16	be	be	VB
cord-303447-3a7jxl34	28	17	taken	take	VBN
cord-303447-3a7jxl34	28	18	:	:	:
cord-303447-3a7jxl34	28	19	(	(	-LRB-
cord-303447-3a7jxl34	28	20	1	1	LS
cord-303447-3a7jxl34	28	21	)	)	-RRB-
cord-303447-3a7jxl34	28	22	the	the	DT
cord-303447-3a7jxl34	28	23	FDA	FDA	NNP
cord-303447-3a7jxl34	28	24	must	must	MD
cord-303447-3a7jxl34	28	25	license	license	VB
cord-303447-3a7jxl34	28	26	the	the	DT
cord-303447-3a7jxl34	28	27	vaccine	vaccine	NN
cord-303447-3a7jxl34	28	28	,	,	,
cord-303447-3a7jxl34	28	29	(	(	-LRB-
cord-303447-3a7jxl34	28	30	2	2	LS
cord-303447-3a7jxl34	28	31	)	)	-RRB-
cord-303447-3a7jxl34	28	32	the	the	DT
cord-303447-3a7jxl34	28	33	ACIP	ACIP	NNP
cord-303447-3a7jxl34	28	34	and	and	CC
cord-303447-3a7jxl34	28	35	the	the	DT
cord-303447-3a7jxl34	28	36	Committee	Committee	NNP
cord-303447-3a7jxl34	28	37	on	on	IN
cord-303447-3a7jxl34	28	38	Infectious	Infectious	NNP
cord-303447-3a7jxl34	28	39	Diseases	Diseases	NNPS
cord-303447-3a7jxl34	28	40	of	of	IN
cord-303447-3a7jxl34	28	41	the	the	DT
cord-303447-3a7jxl34	28	42	AAP	AAP	NNP
cord-303447-3a7jxl34	28	43	and	and	CC
cord-303447-3a7jxl34	28	44	AAFP	AAFP	NNP
cord-303447-3a7jxl34	28	45	must	must	MD
cord-303447-3a7jxl34	28	46	recommend	recommend	VB
cord-303447-3a7jxl34	28	47	the	the	DT
cord-303447-3a7jxl34	28	48	vaccine	vaccine	NN
cord-303447-3a7jxl34	28	49	for	for	IN
cord-303447-3a7jxl34	28	50	use	use	NN
cord-303447-3a7jxl34	28	51	,	,	,
cord-303447-3a7jxl34	28	52	and	and	CC
cord-303447-3a7jxl34	28	53	(	(	-LRB-
cord-303447-3a7jxl34	28	54	3	3	LS
cord-303447-3a7jxl34	28	55	)	)	-RRB-
cord-303447-3a7jxl34	28	56	the	the	DT
cord-303447-3a7jxl34	28	57	vaccine	vaccine	NN
cord-303447-3a7jxl34	28	58	must	must	MD
cord-303447-3a7jxl34	28	59	be	be	VB
cord-303447-3a7jxl34	28	60	subsidized	subsidize	VBN
cord-303447-3a7jxl34	28	61	to	to	TO
cord-303447-3a7jxl34	28	62	cover	cover	VB
cord-303447-3a7jxl34	28	63	children	child	NNS
cord-303447-3a7jxl34	28	64	without	without	IN
cord-303447-3a7jxl34	28	65	private	private	JJ
cord-303447-3a7jxl34	28	66	health	health	NN
cord-303447-3a7jxl34	28	67	insurance	insurance	NN
cord-303447-3a7jxl34	28	68	.	.	.
cord-303447-3a7jxl34	29	1	Numerous	numerous	JJ
cord-303447-3a7jxl34	29	2	government	government	NN
cord-303447-3a7jxl34	29	3	and	and	CC
cord-303447-3a7jxl34	29	4	partner	partner	NN
cord-303447-3a7jxl34	29	5	organizations	organization	NNS
cord-303447-3a7jxl34	29	6	participate	participate	VBP
cord-303447-3a7jxl34	29	7	in	in	IN
cord-303447-3a7jxl34	29	8	bringing	bring	VBG
cord-303447-3a7jxl34	29	9	a	a	DT
cord-303447-3a7jxl34	29	10	vaccine	vaccine	NN
cord-303447-3a7jxl34	29	11	from	from	IN
cord-303447-3a7jxl34	29	12	the	the	DT
cord-303447-3a7jxl34	29	13	bench	bench	NN
cord-303447-3a7jxl34	29	14	into	into	IN
cord-303447-3a7jxl34	29	15	the	the	DT
cord-303447-3a7jxl34	29	16	clinic	clinic	NN
cord-303447-3a7jxl34	29	17	.	.	.
cord-303447-3a7jxl34	30	1	Table	table	NN
cord-303447-3a7jxl34	30	2	2	2	CD
cord-303447-3a7jxl34	30	3	provides	provide	VBZ
cord-303447-3a7jxl34	30	4	links	link	NNS
cord-303447-3a7jxl34	30	5	where	where	WRB
cord-303447-3a7jxl34	30	6	information	information	NN
cord-303447-3a7jxl34	30	7	about	about	IN
cord-303447-3a7jxl34	30	8	these	these	DT
cord-303447-3a7jxl34	30	9	organizations	organization	NNS
cord-303447-3a7jxl34	30	10	can	can	MD
cord-303447-3a7jxl34	30	11	be	be	VB
cord-303447-3a7jxl34	30	12	obtained	obtain	VBN
cord-303447-3a7jxl34	30	13	.	.	.
cord-303447-3a7jxl34	31	1	Before	before	IN
cord-303447-3a7jxl34	31	2	FDA	FDA	NNP
cord-303447-3a7jxl34	31	3	licensure	licensure	NN
cord-303447-3a7jxl34	31	4	,	,	,
cord-303447-3a7jxl34	31	5	a	a	DT
cord-303447-3a7jxl34	31	6	new	new	JJ
cord-303447-3a7jxl34	31	7	vaccine	vaccine	NN
cord-303447-3a7jxl34	31	8	goes	go	VBZ
cord-303447-3a7jxl34	31	9	through	through	IN
cord-303447-3a7jxl34	31	10	10	10	CD
cord-303447-3a7jxl34	31	11	to	to	TO
cord-303447-3a7jxl34	31	12	15	15	CD
cord-303447-3a7jxl34	31	13	years	year	NNS
cord-303447-3a7jxl34	31	14	of	of	IN
cord-303447-3a7jxl34	31	15	preclinical	preclinical	JJ
cord-303447-3a7jxl34	31	16	testing	testing	NN
cord-303447-3a7jxl34	31	17	and	and	CC
cord-303447-3a7jxl34	31	18	clinical	clinical	JJ
cord-303447-3a7jxl34	31	19	trials	trial	NNS
cord-303447-3a7jxl34	31	20	,	,	,
cord-303447-3a7jxl34	31	21	costing	cost	VBG
cord-303447-3a7jxl34	31	22	pharmaceutical	pharmaceutical	JJ
cord-303447-3a7jxl34	31	23	companies	company	NNS
cord-303447-3a7jxl34	31	24	millions	million	NNS
cord-303447-3a7jxl34	31	25	of	of	IN
cord-303447-3a7jxl34	31	26	dollars	dollar	NNS
cord-303447-3a7jxl34	31	27	in	in	IN
cord-303447-3a7jxl34	31	28	new	new	JJ
cord-303447-3a7jxl34	31	29	development	development	NN
cord-303447-3a7jxl34	31	30	costs	cost	NNS
cord-303447-3a7jxl34	31	31	.	.	.
cord-303447-3a7jxl34	32	1	Before	before	IN
cord-303447-3a7jxl34	32	2	testing	test	VBG
cord-303447-3a7jxl34	32	3	the	the	DT
cord-303447-3a7jxl34	32	4	vaccine	vaccine	NN
cord-303447-3a7jxl34	32	5	in	in	IN
cord-303447-3a7jxl34	32	6	humans	human	NNS
cord-303447-3a7jxl34	32	7	,	,	,
cord-303447-3a7jxl34	32	8	a	a	DT
cord-303447-3a7jxl34	32	9	company	company	NN
cord-303447-3a7jxl34	32	10	files	file	VBZ
cord-303447-3a7jxl34	32	11	an	an	DT
cord-303447-3a7jxl34	32	12	Investigational	Investigational	NNP
cord-303447-3a7jxl34	32	13	New	New	NNP
cord-303447-3a7jxl34	32	14	Drug	Drug	NNP
cord-303447-3a7jxl34	32	15	application	application	NN
cord-303447-3a7jxl34	32	16	with	with	IN
cord-303447-3a7jxl34	32	17	the	the	DT
cord-303447-3a7jxl34	32	18	FDA	FDA	NNP
cord-303447-3a7jxl34	32	19	followed	follow	VBD
cord-303447-3a7jxl34	32	20	by	by	IN
cord-303447-3a7jxl34	32	21	three	three	CD
cord-303447-3a7jxl34	32	22	phases	phase	NNS
cord-303447-3a7jxl34	32	23	of	of	IN
cord-303447-3a7jxl34	32	24	clinical	clinical	JJ
cord-303447-3a7jxl34	32	25	trials	trial	NNS
cord-303447-3a7jxl34	32	26	that	that	WDT
cord-303447-3a7jxl34	32	27	are	be	VBP
cord-303447-3a7jxl34	32	28	performed	perform	VBN
cord-303447-3a7jxl34	32	29	to	to	TO
cord-303447-3a7jxl34	32	30	study	study	VB
cord-303447-3a7jxl34	32	31	vaccine	vaccine	NN
cord-303447-3a7jxl34	32	32	safety	safety	NN
cord-303447-3a7jxl34	32	33	,	,	,
cord-303447-3a7jxl34	32	34	immunogenicity	immunogenicity	NN
cord-303447-3a7jxl34	32	35	,	,	,
cord-303447-3a7jxl34	32	36	and	and	CC
cord-303447-3a7jxl34	32	37	efficacy	efficacy	NN
cord-303447-3a7jxl34	32	38	(	(	-LRB-
cord-303447-3a7jxl34	32	39	Table	Table	NNP
cord-303447-3a7jxl34	32	40	3	3	CD
cord-303447-3a7jxl34	32	41	)	)	-RRB-
cord-303447-3a7jxl34	32	42	[	[	-LRB-
cord-303447-3a7jxl34	32	43	10	10	CD
cord-303447-3a7jxl34	32	44	]	]	-RRB-
cord-303447-3a7jxl34	32	45	.	.	.
cord-303447-3a7jxl34	33	1	After	after	IN
cord-303447-3a7jxl34	33	2	completion	completion	NN
cord-303447-3a7jxl34	33	3	of	of	IN
cord-303447-3a7jxl34	33	4	the	the	DT
cord-303447-3a7jxl34	33	5	prelicensure	prelicensure	JJ
cord-303447-3a7jxl34	33	6	clinical	clinical	JJ
cord-303447-3a7jxl34	33	7	trials	trial	NNS
cord-303447-3a7jxl34	33	8	,	,	,
cord-303447-3a7jxl34	33	9	the	the	DT
cord-303447-3a7jxl34	33	10	manufacturer	manufacturer	NN
cord-303447-3a7jxl34	33	11	files	file	VBZ
cord-303447-3a7jxl34	33	12	a	a	DT
cord-303447-3a7jxl34	33	13	Biologics	Biologics	NNP
cord-303447-3a7jxl34	33	14	Licensure	Licensure	NNP
cord-303447-3a7jxl34	33	15	Application	Application	NNP
cord-303447-3a7jxl34	33	16	(	(	-LRB-
cord-303447-3a7jxl34	33	17	BLA	BLA	NNP
cord-303447-3a7jxl34	33	18	)	)	-RRB-
cord-303447-3a7jxl34	33	19	,	,	,
cord-303447-3a7jxl34	33	20	and	and	CC
cord-303447-3a7jxl34	33	21	the	the	DT
cord-303447-3a7jxl34	33	22	FDA	FDA	NNP
cord-303447-3a7jxl34	33	23	,	,	,
cord-303447-3a7jxl34	33	24	with	with	IN
cord-303447-3a7jxl34	33	25	input	input	NN
cord-303447-3a7jxl34	33	26	from	from	IN
cord-303447-3a7jxl34	33	27	its	-PRON-	PRP$
cord-303447-3a7jxl34	33	28	advisory	advisory	JJ
cord-303447-3a7jxl34	33	29	committee	committee	NN
cord-303447-3a7jxl34	33	30	,	,	,
cord-303447-3a7jxl34	33	31	determines	determine	VBZ
cord-303447-3a7jxl34	33	32	if	if	IN
cord-303447-3a7jxl34	33	33	data	datum	NNS
cord-303447-3a7jxl34	33	34	support	support	NN
cord-303447-3a7jxl34	33	35	vaccine	vaccine	NN
cord-303447-3a7jxl34	33	36	safety	safety	NN
cord-303447-3a7jxl34	33	37	,	,	,
cord-303447-3a7jxl34	33	38	immunogenicity	immunogenicity	NN
cord-303447-3a7jxl34	33	39	,	,	,
cord-303447-3a7jxl34	33	40	and	and	CC
cord-303447-3a7jxl34	33	41	efficacy	efficacy	NN
cord-303447-3a7jxl34	33	42	(	(	-LRB-
cord-303447-3a7jxl34	33	43	Fig	Fig	NNP
cord-303447-3a7jxl34	33	44	.	.	.
cord-303447-3a7jxl34	33	45	1	1	CD
cord-303447-3a7jxl34	33	46	)	)	-RRB-
cord-303447-3a7jxl34	34	1	[	[	-LRB-
cord-303447-3a7jxl34	34	2	11	11	CD
cord-303447-3a7jxl34	34	3	]	]	-RRB-
cord-303447-3a7jxl34	34	4	.	.	.
cord-303447-3a7jxl34	35	1	After	after	IN
cord-303447-3a7jxl34	35	2	licensure	licensure	NN
cord-303447-3a7jxl34	35	3	,	,	,
cord-303447-3a7jxl34	35	4	monitoring	monitor	VBG
cord-303447-3a7jxl34	35	5	for	for	IN
cord-303447-3a7jxl34	35	6	rare	rare	JJ
cord-303447-3a7jxl34	35	7	adverse	adverse	JJ
cord-303447-3a7jxl34	35	8	events	event	NNS
cord-303447-3a7jxl34	35	9	continues	continue	VBZ
cord-303447-3a7jxl34	35	10	for	for	IN
cord-303447-3a7jxl34	35	11	some	some	DT
cord-303447-3a7jxl34	35	12	vaccines	vaccine	NNS
cord-303447-3a7jxl34	35	13	through	through	IN
cord-303447-3a7jxl34	35	14	formal	formal	JJ
cord-303447-3a7jxl34	35	15	phase	phase	NN
cord-303447-3a7jxl34	35	16	IV	IV	NNP
cord-303447-3a7jxl34	35	17	trials	trial	NNS
cord-303447-3a7jxl34	35	18	conducted	conduct	VBN
cord-303447-3a7jxl34	35	19	by	by	IN
cord-303447-3a7jxl34	35	20	the	the	DT
cord-303447-3a7jxl34	35	21	FDA	FDA	NNP
cord-303447-3a7jxl34	35	22	and	and	CC
cord-303447-3a7jxl34	35	23	manufacturer	manufacturer	NN
cord-303447-3a7jxl34	35	24	.	.	.
cord-303447-3a7jxl34	36	1	After	after	IN
cord-303447-3a7jxl34	36	2	FDA	FDA	NNP
cord-303447-3a7jxl34	36	3	licensure	licensure	NN
cord-303447-3a7jxl34	36	4	of	of	IN
cord-303447-3a7jxl34	36	5	a	a	DT
cord-303447-3a7jxl34	36	6	new	new	JJ
cord-303447-3a7jxl34	36	7	vaccine	vaccine	NN
cord-303447-3a7jxl34	36	8	,	,	,
cord-303447-3a7jxl34	36	9	information	information	NN
cord-303447-3a7jxl34	36	10	about	about	IN
cord-303447-3a7jxl34	36	11	the	the	DT
cord-303447-3a7jxl34	36	12	vaccine	vaccine	NN
cord-303447-3a7jxl34	36	13	is	be	VBZ
cord-303447-3a7jxl34	36	14	reviewed	review	VBN
cord-303447-3a7jxl34	36	15	by	by	IN
cord-303447-3a7jxl34	36	16	the	the	DT
cord-303447-3a7jxl34	36	17	ACIP	ACIP	NNP
cord-303447-3a7jxl34	36	18	.	.	.
cord-303447-3a7jxl34	37	1	The	the	DT
cord-303447-3a7jxl34	37	2	ACIP	ACIP	NNP
cord-303447-3a7jxl34	37	3	comprises	comprise	VBZ
cord-303447-3a7jxl34	37	4	15	15	CD
cord-303447-3a7jxl34	37	5	voting	voting	NN
cord-303447-3a7jxl34	37	6	members	member	NNS
cord-303447-3a7jxl34	37	7	appointed	appoint	VBN
cord-303447-3a7jxl34	37	8	by	by	IN
cord-303447-3a7jxl34	37	9	the	the	DT
cord-303447-3a7jxl34	37	10	Secretary	Secretary	NNP
cord-303447-3a7jxl34	37	11	of	of	IN
cord-303447-3a7jxl34	37	12	the	the	DT
cord-303447-3a7jxl34	37	13	Department	Department	NNP
cord-303447-3a7jxl34	37	14	of	of	IN
cord-303447-3a7jxl34	37	15	Health	Health	NNP
cord-303447-3a7jxl34	37	16	and	and	CC
cord-303447-3a7jxl34	37	17	Human	Human	NNP
cord-303447-3a7jxl34	37	18	Services	Services	NNPS
cord-303447-3a7jxl34	37	19	.	.	.
cord-303447-3a7jxl34	38	1	In	in	IN
cord-303447-3a7jxl34	38	2	addition	addition	NN
cord-303447-3a7jxl34	38	3	,	,	,
cord-303447-3a7jxl34	38	4	several	several	JJ
cord-303447-3a7jxl34	38	5	professional	professional	JJ
cord-303447-3a7jxl34	38	6	medical	medical	JJ
cord-303447-3a7jxl34	38	7	and	and	CC
cord-303447-3a7jxl34	38	8	public	public	JJ
cord-303447-3a7jxl34	38	9	health	health	NN
cord-303447-3a7jxl34	38	10	groups	group	NNS
cord-303447-3a7jxl34	38	11	and	and	CC
cord-303447-3a7jxl34	38	12	industry	industry	NN
cord-303447-3a7jxl34	38	13	representatives	representative	NNS
cord-303447-3a7jxl34	38	14	participate	participate	VBP
cord-303447-3a7jxl34	38	15	in	in	IN
cord-303447-3a7jxl34	38	16	ACIP	ACIP	NNP
cord-303447-3a7jxl34	38	17	discussions	discussion	NNS
cord-303447-3a7jxl34	38	18	.	.	.
cord-303447-3a7jxl34	39	1	To	to	TO
cord-303447-3a7jxl34	39	2	formulate	formulate	VB
cord-303447-3a7jxl34	39	3	recommendations	recommendation	NNS
cord-303447-3a7jxl34	39	4	,	,	,
cord-303447-3a7jxl34	39	5	the	the	DT
cord-303447-3a7jxl34	39	6	ACIP	ACIP	NNP
cord-303447-3a7jxl34	39	7	establishes	establish	VBZ
cord-303447-3a7jxl34	39	8	subject	subject	RB
cord-303447-3a7jxl34	39	9	-	-	HYPH
cord-303447-3a7jxl34	39	10	specific	specific	JJ
cord-303447-3a7jxl34	39	11	working	work	VBG
cord-303447-3a7jxl34	39	12	groups	group	NNS
cord-303447-3a7jxl34	39	13	to	to	TO
cord-303447-3a7jxl34	39	14	review	review	VB
cord-303447-3a7jxl34	39	15	and	and	CC
cord-303447-3a7jxl34	39	16	synthesize	synthesize	VB
cord-303447-3a7jxl34	39	17	data	datum	NNS
cord-303447-3a7jxl34	39	18	months	month	NNS
cord-303447-3a7jxl34	39	19	to	to	IN
cord-303447-3a7jxl34	39	20	Ensuring	ensure	VBG
cord-303447-3a7jxl34	39	21	that	that	IN
cord-303447-3a7jxl34	39	22	all	all	DT
cord-303447-3a7jxl34	39	23	US	US	NNP
cord-303447-3a7jxl34	39	24	children	child	NNS
cord-303447-3a7jxl34	39	25	and	and	CC
cord-303447-3a7jxl34	39	26	adolescents	adolescent	NNS
cord-303447-3a7jxl34	39	27	,	,	,
cord-303447-3a7jxl34	39	28	regardless	regardless	RB
cord-303447-3a7jxl34	39	29	of	of	IN
cord-303447-3a7jxl34	39	30	health	health	NN
cord-303447-3a7jxl34	39	31	insurance	insurance	NN
cord-303447-3a7jxl34	39	32	status	status	NN
cord-303447-3a7jxl34	39	33	or	or	CC
cord-303447-3a7jxl34	39	34	income	income	NN
cord-303447-3a7jxl34	39	35	level	level	NN
cord-303447-3a7jxl34	39	36	,	,	,
cord-303447-3a7jxl34	39	37	have	have	VBP
cord-303447-3a7jxl34	39	38	access	access	NN
cord-303447-3a7jxl34	39	39	to	to	IN
cord-303447-3a7jxl34	39	40	recommended	recommend	VBN
cord-303447-3a7jxl34	39	41	immunizations	immunization	NNS
cord-303447-3a7jxl34	39	42	requires	require	VBZ
cord-303447-3a7jxl34	39	43	a	a	DT
cord-303447-3a7jxl34	39	44	complex	complex	JJ
cord-303447-3a7jxl34	39	45	system	system	NN
cord-303447-3a7jxl34	39	46	of	of	IN
cord-303447-3a7jxl34	39	47	financing	financing	NN
cord-303447-3a7jxl34	39	48	comprised	comprise	VBN
cord-303447-3a7jxl34	39	49	of	of	IN
cord-303447-3a7jxl34	39	50	private	private	JJ
cord-303447-3a7jxl34	39	51	and	and	CC
cord-303447-3a7jxl34	39	52	public	public	JJ
cord-303447-3a7jxl34	39	53	funding	funding	NN
cord-303447-3a7jxl34	39	54	mechanisms	mechanism	NNS
cord-303447-3a7jxl34	39	55	(	(	-LRB-
cord-303447-3a7jxl34	39	56	Table	Table	NNP
cord-303447-3a7jxl34	39	57	4	4	CD
cord-303447-3a7jxl34	39	58	)	)	-RRB-
cord-303447-3a7jxl34	39	59	.	.	.
cord-303447-3a7jxl34	40	1	In	in	IN
cord-303447-3a7jxl34	40	2	2002	2002	CD
cord-303447-3a7jxl34	40	3	,	,	,
cord-303447-3a7jxl34	40	4	57	57	CD
cord-303447-3a7jxl34	40	5	%	%	NN
cord-303447-3a7jxl34	40	6	of	of	IN
cord-303447-3a7jxl34	40	7	US	US	NNP
cord-303447-3a7jxl34	40	8	children	child	NNS
cord-303447-3a7jxl34	40	9	received	receive	VBD
cord-303447-3a7jxl34	40	10	vaccines	vaccine	NNS
cord-303447-3a7jxl34	40	11	purchased	purchase	VBN
cord-303447-3a7jxl34	40	12	through	through	IN
cord-303447-3a7jxl34	40	13	the	the	DT
cord-303447-3a7jxl34	40	14	public	public	JJ
cord-303447-3a7jxl34	40	15	sector	sector	NN
cord-303447-3a7jxl34	40	16	,	,	,
cord-303447-3a7jxl34	40	17	and	and	CC
cord-303447-3a7jxl34	40	18	43	43	CD
cord-303447-3a7jxl34	40	19	%	%	NN
cord-303447-3a7jxl34	40	20	received	receive	VBD
cord-303447-3a7jxl34	40	21	vaccines	vaccine	NNS
cord-303447-3a7jxl34	40	22	purchased	purchase	VBN
cord-303447-3a7jxl34	40	23	through	through	IN
cord-303447-3a7jxl34	40	24	the	the	DT
cord-303447-3a7jxl34	40	25	private	private	JJ
cord-303447-3a7jxl34	40	26	sector	sector	NN
cord-303447-3a7jxl34	40	27	.	.	.
cord-303447-3a7jxl34	41	1	Most	Most	JJS
cord-303447-3a7jxl34	41	2	of	of	IN
cord-303447-3a7jxl34	41	3	the	the	DT
cord-303447-3a7jxl34	41	4	public	public	JJ
cord-303447-3a7jxl34	41	5	-	-	HYPH
cord-303447-3a7jxl34	41	6	purchase	purchase	NN
cord-303447-3a7jxl34	41	7	vaccines	vaccine	NNS
cord-303447-3a7jxl34	41	8	are	be	VBP
cord-303447-3a7jxl34	41	9	financed	finance	VBN
cord-303447-3a7jxl34	41	10	through	through	IN
cord-303447-3a7jxl34	41	11	the	the	DT
cord-303447-3a7jxl34	41	12	Vaccines	Vaccines	NNPS
cord-303447-3a7jxl34	41	13	for	for	IN
cord-303447-3a7jxl34	41	14	Children	child	NNS
cord-303447-3a7jxl34	41	15	(	(	-LRB-
cord-303447-3a7jxl34	41	16	VFC	VFC	NNP
cord-303447-3a7jxl34	41	17	)	)	-RRB-
cord-303447-3a7jxl34	41	18	program	program	NN
cord-303447-3a7jxl34	41	19	,	,	,
cord-303447-3a7jxl34	41	20	an	an	DT
cord-303447-3a7jxl34	41	21	entitlement	entitlement	NN
cord-303447-3a7jxl34	41	22	program	program	NN
cord-303447-3a7jxl34	41	23	established	establish	VBN
cord-303447-3a7jxl34	41	24	in	in	IN
cord-303447-3a7jxl34	41	25	1994	1994	CD
cord-303447-3a7jxl34	41	26	as	as	IN
cord-303447-3a7jxl34	41	27	part	part	NN
cord-303447-3a7jxl34	41	28	of	of	IN
cord-303447-3a7jxl34	41	29	the	the	DT
cord-303447-3a7jxl34	41	30	Social	Social	NNP
cord-303447-3a7jxl34	41	31	Security	Security	NNP
cord-303447-3a7jxl34	41	32	Act	Act	NNP
cord-303447-3a7jxl34	41	33	[	[	-LRB-
cord-303447-3a7jxl34	41	34	11	11	CD
cord-303447-3a7jxl34	41	35	,	,	,
cord-303447-3a7jxl34	41	36	12	12	CD
cord-303447-3a7jxl34	41	37	]	]	-RRB-
cord-303447-3a7jxl34	41	38	.	.	.
cord-303447-3a7jxl34	42	1	Other	other	JJ
cord-303447-3a7jxl34	42	2	government	government	NN
cord-303447-3a7jxl34	42	3	funding	funding	NN
cord-303447-3a7jxl34	42	4	mechanisms	mechanism	NNS
cord-303447-3a7jxl34	42	5	include	include	VBP
cord-303447-3a7jxl34	42	6	Section	section	NN
cord-303447-3a7jxl34	42	7	317	317	CD
cord-303447-3a7jxl34	42	8	of	of	IN
cord-303447-3a7jxl34	42	9	the	the	DT
cord-303447-3a7jxl34	42	10	Public	Public	NNP
cord-303447-3a7jxl34	42	11	Health	Health	NNP
cord-303447-3a7jxl34	42	12	Service	Service	NNP
cord-303447-3a7jxl34	42	13	Act	Act	NNP
cord-303447-3a7jxl34	42	14	of	of	IN
cord-303447-3a7jxl34	42	15	1962	1962	CD
cord-303447-3a7jxl34	42	16	,	,	,
cord-303447-3a7jxl34	42	17	a	a	DT
cord-303447-3a7jxl34	42	18	federal	federal	JJ
cord-303447-3a7jxl34	42	19	grant	grant	NN
cord-303447-3a7jxl34	42	20	program	program	NN
cord-303447-3a7jxl34	42	21	,	,	,
cord-303447-3a7jxl34	42	22	and	and	CC
cord-303447-3a7jxl34	42	23	state	state	NN
cord-303447-3a7jxl34	42	24	and	and	CC
cord-303447-3a7jxl34	42	25	local	local	JJ
cord-303447-3a7jxl34	42	26	government	government	NN
cord-303447-3a7jxl34	42	27	funding	funding	NN
cord-303447-3a7jxl34	42	28	.	.	.
cord-303447-3a7jxl34	43	1	These	these	DT
cord-303447-3a7jxl34	43	2	programs	program	NNS
cord-303447-3a7jxl34	43	3	provide	provide	VBP
cord-303447-3a7jxl34	43	4	support	support	NN
cord-303447-3a7jxl34	43	5	for	for	IN
cord-303447-3a7jxl34	43	6	states	state	NNS
cord-303447-3a7jxl34	43	7	to	to	TO
cord-303447-3a7jxl34	43	8	provide	provide	VB
cord-303447-3a7jxl34	43	9	immunizations	immunization	NNS
cord-303447-3a7jxl34	43	10	to	to	IN
cord-303447-3a7jxl34	43	11	children	child	NNS
cord-303447-3a7jxl34	43	12	who	who	WP
cord-303447-3a7jxl34	43	13	do	do	VBP
cord-303447-3a7jxl34	43	14	not	not	RB
cord-303447-3a7jxl34	43	15	qualify	qualify	VB
cord-303447-3a7jxl34	43	16	for	for	IN
cord-303447-3a7jxl34	43	17	the	the	DT
cord-303447-3a7jxl34	43	18	VFC	VFC	NNP
cord-303447-3a7jxl34	43	19	program	program	NN
cord-303447-3a7jxl34	43	20	but	but	CC
cord-303447-3a7jxl34	43	21	who	who	WP
cord-303447-3a7jxl34	43	22	are	be	VBP
cord-303447-3a7jxl34	43	23	not	not	RB
cord-303447-3a7jxl34	43	24	covered	cover	VBN
cord-303447-3a7jxl34	43	25	by	by	IN
cord-303447-3a7jxl34	43	26	private	private	JJ
cord-303447-3a7jxl34	43	27	insurance	insurance	NN
cord-303447-3a7jxl34	43	28	.	.	.
cord-303447-3a7jxl34	44	1	Fourteen	fourteen	CD
cord-303447-3a7jxl34	44	2	states	state	NNS
cord-303447-3a7jxl34	44	3	,	,	,
cord-303447-3a7jxl34	44	4	referred	refer	VBD
cord-303447-3a7jxl34	44	5	to	to	IN
cord-303447-3a7jxl34	44	6	as	as	IN
cord-303447-3a7jxl34	44	7	'	'	''
cord-303447-3a7jxl34	44	8	'	'	``
cord-303447-3a7jxl34	44	9	universal	universal	JJ
cord-303447-3a7jxl34	44	10	'	'	''
cord-303447-3a7jxl34	44	11	'	'	''
cord-303447-3a7jxl34	44	12	purchase	purchase	NN
cord-303447-3a7jxl34	44	13	states	state	NNS
cord-303447-3a7jxl34	44	14	,	,	,
cord-303447-3a7jxl34	44	15	use	use	VB
cord-303447-3a7jxl34	44	16	a	a	DT
cord-303447-3a7jxl34	44	17	combination	combination	NN
cord-303447-3a7jxl34	44	18	of	of	IN
cord-303447-3a7jxl34	44	19	federal	federal	JJ
cord-303447-3a7jxl34	44	20	and	and	CC
cord-303447-3a7jxl34	44	21	state	state	NN
cord-303447-3a7jxl34	44	22	funding	funding	NN
cord-303447-3a7jxl34	44	23	to	to	TO
cord-303447-3a7jxl34	44	24	purchase	purchase	VB
cord-303447-3a7jxl34	44	25	and	and	CC
cord-303447-3a7jxl34	44	26	distribute	distribute	VB
cord-303447-3a7jxl34	44	27	vaccines	vaccine	NNS
cord-303447-3a7jxl34	44	28	recommended	recommend	VBN
cord-303447-3a7jxl34	44	29	for	for	IN
cord-303447-3a7jxl34	44	30	children	child	NNS
cord-303447-3a7jxl34	44	31	to	to	IN
cord-303447-3a7jxl34	44	32	all	all	DT
cord-303447-3a7jxl34	44	33	immunization	immunization	NN
cord-303447-3a7jxl34	44	34	providers	provider	NNS
cord-303447-3a7jxl34	44	35	in	in	IN
cord-303447-3a7jxl34	44	36	private	private	JJ
cord-303447-3a7jxl34	44	37	and	and	CC
cord-303447-3a7jxl34	44	38	public	public	JJ
cord-303447-3a7jxl34	44	39	sectors	sector	NNS
cord-303447-3a7jxl34	44	40	.	.	.
cord-303447-3a7jxl34	45	1	The	the	DT
cord-303447-3a7jxl34	45	2	remaining	remain	VBG
cord-303447-3a7jxl34	45	3	36	36	CD
cord-303447-3a7jxl34	45	4	states	state	NNS
cord-303447-3a7jxl34	45	5	purchase	purchase	VBP
cord-303447-3a7jxl34	45	6	vaccines	vaccine	NNS
cord-303447-3a7jxl34	45	7	for	for	IN
cord-303447-3a7jxl34	45	8	uninsured	uninsured	JJ
cord-303447-3a7jxl34	45	9	and	and	CC
cord-303447-3a7jxl34	45	10	underinsured	underinsured	JJ
cord-303447-3a7jxl34	45	11	chil-	chil-	NN
cord-303447-3a7jxl34	45	12	immunizations	immunization	NNS
cord-303447-3a7jxl34	45	13	in	in	IN
cord-303447-3a7jxl34	45	14	the	the	DT
cord-303447-3a7jxl34	45	15	us	us	NNP
cord-303447-3a7jxl34	45	16	dren	dren	NNP
cord-303447-3a7jxl34	45	17	who	who	WP
cord-303447-3a7jxl34	45	18	are	be	VBP
cord-303447-3a7jxl34	45	19	not	not	RB
cord-303447-3a7jxl34	45	20	eligible	eligible	JJ
cord-303447-3a7jxl34	45	21	for	for	IN
cord-303447-3a7jxl34	45	22	VFC	VFC	NNP
cord-303447-3a7jxl34	45	23	.	.	.
cord-303447-3a7jxl34	46	1	In	in	IN
cord-303447-3a7jxl34	46	2	addition	addition	NN
cord-303447-3a7jxl34	46	3	,	,	,
cord-303447-3a7jxl34	46	4	insurance	insurance	NN
cord-303447-3a7jxl34	46	5	provides	provide	VBZ
cord-303447-3a7jxl34	46	6	vaccines	vaccine	NNS
cord-303447-3a7jxl34	46	7	for	for	IN
cord-303447-3a7jxl34	46	8	children	child	NNS
cord-303447-3a7jxl34	46	9	in	in	IN
cord-303447-3a7jxl34	46	10	the	the	DT
cord-303447-3a7jxl34	46	11	private	private	JJ
cord-303447-3a7jxl34	46	12	sector	sector	NN
cord-303447-3a7jxl34	46	13	.	.	.
cord-303447-3a7jxl34	47	1	As	as	IN
cord-303447-3a7jxl34	47	2	the	the	DT
cord-303447-3a7jxl34	47	3	number	number	NN
cord-303447-3a7jxl34	47	4	of	of	IN
cord-303447-3a7jxl34	47	5	vaccines	vaccine	NNS
cord-303447-3a7jxl34	47	6	has	have	VBZ
cord-303447-3a7jxl34	47	7	increased	increase	VBN
cord-303447-3a7jxl34	47	8	and	and	CC
cord-303447-3a7jxl34	47	9	the	the	DT
cord-303447-3a7jxl34	47	10	scope	scope	NN
cord-303447-3a7jxl34	47	11	of	of	IN
cord-303447-3a7jxl34	47	12	the	the	DT
cord-303447-3a7jxl34	47	13	immunization	immunization	NN
cord-303447-3a7jxl34	47	14	program	program	NN
cord-303447-3a7jxl34	47	15	has	have	VBZ
cord-303447-3a7jxl34	47	16	expanded	expand	VBN
cord-303447-3a7jxl34	47	17	,	,	,
cord-303447-3a7jxl34	47	18	new	new	JJ
cord-303447-3a7jxl34	47	19	challenges	challenge	NNS
cord-303447-3a7jxl34	47	20	have	have	VBP
cord-303447-3a7jxl34	47	21	emerged	emerge	VBN
cord-303447-3a7jxl34	47	22	.	.	.
cord-303447-3a7jxl34	48	1	The	the	DT
cord-303447-3a7jxl34	48	2	increasing	increase	VBG
cord-303447-3a7jxl34	48	3	cost	cost	NN
cord-303447-3a7jxl34	48	4	of	of	IN
cord-303447-3a7jxl34	48	5	vaccines	vaccine	NNS
cord-303447-3a7jxl34	48	6	,	,	,
cord-303447-3a7jxl34	48	7	vaccine	vaccine	NN
cord-303447-3a7jxl34	48	8	shortages	shortage	NNS
cord-303447-3a7jxl34	48	9	,	,	,
cord-303447-3a7jxl34	48	10	and	and	CC
cord-303447-3a7jxl34	48	11	immunization	immunization	NN
cord-303447-3a7jxl34	48	12	safety	safety	NN
cord-303447-3a7jxl34	48	13	are	be	VBP
cord-303447-3a7jxl34	48	14	important	important	JJ
cord-303447-3a7jxl34	48	15	concerns	concern	NNS
cord-303447-3a7jxl34	48	16	the	the	DT
cord-303447-3a7jxl34	48	17	immunization	immunization	NN
cord-303447-3a7jxl34	48	18	program	program	NN
cord-303447-3a7jxl34	48	19	will	will	MD
cord-303447-3a7jxl34	48	20	continue	continue	VB
cord-303447-3a7jxl34	48	21	to	to	TO
cord-303447-3a7jxl34	48	22	address	address	VB
cord-303447-3a7jxl34	48	23	in	in	IN
cord-303447-3a7jxl34	48	24	coming	come	VBG
cord-303447-3a7jxl34	48	25	years	year	NNS
cord-303447-3a7jxl34	48	26	.	.	.
cord-303447-3a7jxl34	49	1	The	the	DT
cord-303447-3a7jxl34	49	2	rising	rise	VBG
cord-303447-3a7jxl34	49	3	cost	cost	NN
cord-303447-3a7jxl34	49	4	of	of	IN
cord-303447-3a7jxl34	49	5	fully	fully	RB
cord-303447-3a7jxl34	49	6	immunizing	immunize	VBG
cord-303447-3a7jxl34	49	7	a	a	DT
cord-303447-3a7jxl34	49	8	child	child	NN
cord-303447-3a7jxl34	49	9	in	in	IN
cord-303447-3a7jxl34	49	10	the	the	DT
cord-303447-3a7jxl34	49	11	United	United	NNP
cord-303447-3a7jxl34	49	12	States	States	NNP
cord-303447-3a7jxl34	49	13	is	be	VBZ
cord-303447-3a7jxl34	49	14	due	due	JJ
cord-303447-3a7jxl34	49	15	to	to	IN
cord-303447-3a7jxl34	49	16	the	the	DT
cord-303447-3a7jxl34	49	17	increasing	increase	VBG
cord-303447-3a7jxl34	49	18	number	number	NN
cord-303447-3a7jxl34	49	19	of	of	IN
cord-303447-3a7jxl34	49	20	vaccines	vaccine	NNS
cord-303447-3a7jxl34	49	21	and	and	CC
cord-303447-3a7jxl34	49	22	the	the	DT
cord-303447-3a7jxl34	49	23	increasing	increase	VBG
cord-303447-3a7jxl34	49	24	price	price	NN
cord-303447-3a7jxl34	49	25	of	of	IN
cord-303447-3a7jxl34	49	26	existing	exist	VBG
cord-303447-3a7jxl34	49	27	vaccines	vaccine	NNS
cord-303447-3a7jxl34	49	28	.	.	.
cord-303447-3a7jxl34	50	1	The	the	DT
cord-303447-3a7jxl34	50	2	estimated	estimate	VBN
cord-303447-3a7jxl34	50	3	cost	cost	NN
cord-303447-3a7jxl34	50	4	of	of	IN
cord-303447-3a7jxl34	50	5	completing	complete	VBG
cord-303447-3a7jxl34	50	6	the	the	DT
cord-303447-3a7jxl34	50	7	childhood	childhood	NN
cord-303447-3a7jxl34	50	8	immunization	immunization	NN
cord-303447-3a7jxl34	50	9	series	series	NN
cord-303447-3a7jxl34	50	10	through	through	IN
cord-303447-3a7jxl34	50	11	6	6	CD
cord-303447-3a7jxl34	50	12	years	year	NNS
cord-303447-3a7jxl34	50	13	of	of	IN
cord-303447-3a7jxl34	50	14	age	age	NN
cord-303447-3a7jxl34	50	15	in	in	IN
cord-303447-3a7jxl34	50	16	1987	1987	CD
cord-303447-3a7jxl34	50	17	was	be	VBD
cord-303447-3a7jxl34	50	18	$	$	$
cord-303447-3a7jxl34	50	19	33.70	33.70	CD
cord-303447-3a7jxl34	50	20	per	per	IN
cord-303447-3a7jxl34	50	21	child	child	NN
cord-303447-3a7jxl34	50	22	at	at	IN
cord-303447-3a7jxl34	50	23	the	the	DT
cord-303447-3a7jxl34	50	24	government	government	NN
cord-303447-3a7jxl34	50	25	-	-	HYPH
cord-303447-3a7jxl34	50	26	purchasing	purchasing	NN
cord-303447-3a7jxl34	50	27	rate	rate	NN
cord-303447-3a7jxl34	50	28	.	.	.
cord-303447-3a7jxl34	51	1	The	the	DT
cord-303447-3a7jxl34	51	2	cost	cost	NN
cord-303447-3a7jxl34	51	3	of	of	IN
cord-303447-3a7jxl34	51	4	immunizing	immunize	VBG
cord-303447-3a7jxl34	51	5	a	a	DT
cord-303447-3a7jxl34	51	6	child	child	NN
cord-303447-3a7jxl34	51	7	through	through	IN
cord-303447-3a7jxl34	51	8	6	6	CD
cord-303447-3a7jxl34	51	9	years	year	NNS
cord-303447-3a7jxl34	51	10	of	of	IN
cord-303447-3a7jxl34	51	11	age	age	NN
cord-303447-3a7jxl34	51	12	in	in	IN
cord-303447-3a7jxl34	51	13	2003	2003	CD
cord-303447-3a7jxl34	51	14	was	be	VBD
cord-303447-3a7jxl34	51	15	$	$	$
cord-303447-3a7jxl34	51	16	436	436	CD
cord-303447-3a7jxl34	51	17	per	per	IN
cord-303447-3a7jxl34	51	18	child	child	NN
cord-303447-3a7jxl34	51	19	for	for	IN
cord-303447-3a7jxl34	51	20	all	all	DT
cord-303447-3a7jxl34	51	21	vaccines	vaccine	NNS
cord-303447-3a7jxl34	51	22	,	,	,
cord-303447-3a7jxl34	51	23	not	not	RB
cord-303447-3a7jxl34	51	24	including	include	VBG
cord-303447-3a7jxl34	51	25	influenza	influenza	NN
cord-303447-3a7jxl34	51	26	vaccine	vaccine	NN
cord-303447-3a7jxl34	51	27	[	[	-LRB-
cord-303447-3a7jxl34	51	28	12	12	CD
cord-303447-3a7jxl34	51	29	]	]	-RRB-
cord-303447-3a7jxl34	51	30	.	.	.
cord-303447-3a7jxl34	52	1	Increasingly	increasingly	RB
cord-303447-3a7jxl34	52	2	,	,	,
cord-303447-3a7jxl34	52	3	state	state	NN
cord-303447-3a7jxl34	52	4	and	and	CC
cord-303447-3a7jxl34	52	5	local	local	JJ
cord-303447-3a7jxl34	52	6	health	health	NN
cord-303447-3a7jxl34	52	7	departments	department	NNS
cord-303447-3a7jxl34	52	8	are	be	VBP
cord-303447-3a7jxl34	52	9	required	require	VBN
cord-303447-3a7jxl34	52	10	to	to	TO
cord-303447-3a7jxl34	52	11	make	make	VB
cord-303447-3a7jxl34	52	12	difficult	difficult	JJ
cord-303447-3a7jxl34	52	13	choices	choice	NNS
cord-303447-3a7jxl34	52	14	about	about	IN
cord-303447-3a7jxl34	52	15	which	which	WDT
cord-303447-3a7jxl34	52	16	vaccines	vaccine	NNS
cord-303447-3a7jxl34	52	17	to	to	TO
cord-303447-3a7jxl34	52	18	purchase	purchase	VB
cord-303447-3a7jxl34	52	19	using	use	VBG
cord-303447-3a7jxl34	52	20	public	public	JJ
cord-303447-3a7jxl34	52	21	funds	fund	NNS
cord-303447-3a7jxl34	52	22	,	,	,
cord-303447-3a7jxl34	52	23	including	include	VBG
cord-303447-3a7jxl34	52	24	Section	section	NN
cord-303447-3a7jxl34	52	25	317	317	CD
cord-303447-3a7jxl34	52	26	grant	grant	NN
cord-303447-3a7jxl34	52	27	funds	fund	NNS
cord-303447-3a7jxl34	52	28	.	.	.
cord-303447-3a7jxl34	53	1	The	the	DT
cord-303447-3a7jxl34	53	2	recommendation	recommendation	NN
cord-303447-3a7jxl34	53	3	in	in	IN
cord-303447-3a7jxl34	53	4	2000	2000	CD
cord-303447-3a7jxl34	53	5	to	to	TO
cord-303447-3a7jxl34	53	6	vaccinate	vaccinate	VB
cord-303447-3a7jxl34	53	7	routinely	routinely	RB
cord-303447-3a7jxl34	53	8	with	with	IN
cord-303447-3a7jxl34	53	9	PCV7	PCV7	NNP
cord-303447-3a7jxl34	53	10	doubled	double	VBD
cord-303447-3a7jxl34	53	11	the	the	DT
cord-303447-3a7jxl34	53	12	cost	cost	NN
cord-303447-3a7jxl34	53	13	of	of	IN
cord-303447-3a7jxl34	53	14	immunizing	immunize	VBG
cord-303447-3a7jxl34	53	15	a	a	DT
cord-303447-3a7jxl34	53	16	child	child	NN
cord-303447-3a7jxl34	53	17	.	.	.
cord-303447-3a7jxl34	54	1	Section	section	NN
cord-303447-3a7jxl34	54	2	317	317	CD
cord-303447-3a7jxl34	54	3	and	and	CC
cord-303447-3a7jxl34	54	4	state	state	NN
cord-303447-3a7jxl34	54	5	funding	funding	NN
cord-303447-3a7jxl34	54	6	have	have	VBP
cord-303447-3a7jxl34	54	7	not	not	RB
cord-303447-3a7jxl34	54	8	been	be	VBN
cord-303447-3a7jxl34	54	9	adequate	adequate	JJ
cord-303447-3a7jxl34	54	10	to	to	TO
cord-303447-3a7jxl34	54	11	cover	cover	VB
cord-303447-3a7jxl34	54	12	PCV7	PCV7	NNP
cord-303447-3a7jxl34	54	13	for	for	IN
cord-303447-3a7jxl34	54	14	underinsured	underinsured	JJ
cord-303447-3a7jxl34	54	15	children	child	NNS
cord-303447-3a7jxl34	54	16	in	in	IN
cord-303447-3a7jxl34	54	17	many	many	JJ
cord-303447-3a7jxl34	54	18	states	state	NNS
cord-303447-3a7jxl34	54	19	,	,	,
cord-303447-3a7jxl34	54	20	including	include	VBG
cord-303447-3a7jxl34	54	21	7	7	CD
cord-303447-3a7jxl34	54	22	of	of	IN
cord-303447-3a7jxl34	54	23	the	the	DT
cord-303447-3a7jxl34	54	24	14	14	CD
cord-303447-3a7jxl34	54	25	universal	universal	JJ
cord-303447-3a7jxl34	54	26	purchase	purchase	NN
cord-303447-3a7jxl34	54	27	states	state	NNS
cord-303447-3a7jxl34	54	28	.	.	.
cord-303447-3a7jxl34	55	1	The	the	DT
cord-303447-3a7jxl34	55	2	addition	addition	NN
cord-303447-3a7jxl34	55	3	of	of	IN
cord-303447-3a7jxl34	55	4	new	new	JJ
cord-303447-3a7jxl34	55	5	,	,	,
cord-303447-3a7jxl34	55	6	effective	effective	JJ
cord-303447-3a7jxl34	55	7	childhood	childhood	NN
cord-303447-3a7jxl34	55	8	and	and	CC
cord-303447-3a7jxl34	55	9	adolescent	adolescent	JJ
cord-303447-3a7jxl34	55	10	vaccines	vaccine	NNS
cord-303447-3a7jxl34	55	11	to	to	IN
cord-303447-3a7jxl34	55	12	the	the	DT
cord-303447-3a7jxl34	55	13	schedule	schedule	NN
cord-303447-3a7jxl34	55	14	has	have	VBZ
cord-303447-3a7jxl34	55	15	the	the	DT
cord-303447-3a7jxl34	55	16	potential	potential	NN
cord-303447-3a7jxl34	55	17	to	to	TO
cord-303447-3a7jxl34	55	18	create	create	VB
cord-303447-3a7jxl34	55	19	serious	serious	JJ
cord-303447-3a7jxl34	55	20	funding	funding	NN
cord-303447-3a7jxl34	55	21	challenges	challenge	NNS
cord-303447-3a7jxl34	55	22	in	in	IN
cord-303447-3a7jxl34	55	23	the	the	DT
cord-303447-3a7jxl34	55	24	future	future	NN
cord-303447-3a7jxl34	55	25	.	.	.
cord-303447-3a7jxl34	56	1	Despite	despite	IN
cord-303447-3a7jxl34	56	2	the	the	DT
cord-303447-3a7jxl34	56	3	increasing	increase	VBG
cord-303447-3a7jxl34	56	4	costs	cost	NNS
cord-303447-3a7jxl34	56	5	of	of	IN
cord-303447-3a7jxl34	56	6	immunization	immunization	NN
cord-303447-3a7jxl34	56	7	programs	program	NNS
cord-303447-3a7jxl34	56	8	,	,	,
cord-303447-3a7jxl34	56	9	numerous	numerous	JJ
cord-303447-3a7jxl34	56	10	studies	study	NNS
cord-303447-3a7jxl34	56	11	have	have	VBP
cord-303447-3a7jxl34	56	12	shown	show	VBN
cord-303447-3a7jxl34	56	13	that	that	IN
cord-303447-3a7jxl34	56	14	vaccination	vaccination	NN
cord-303447-3a7jxl34	56	15	continues	continue	VBZ
cord-303447-3a7jxl34	56	16	to	to	TO
cord-303447-3a7jxl34	56	17	be	be	VB
cord-303447-3a7jxl34	56	18	a	a	DT
cord-303447-3a7jxl34	56	19	cost	cost	NN
cord-303447-3a7jxl34	56	20	-	-	HYPH
cord-303447-3a7jxl34	56	21	effective	effective	JJ
cord-303447-3a7jxl34	56	22	public	public	JJ
cord-303447-3a7jxl34	56	23	health	health	NN
cord-303447-3a7jxl34	56	24	intervention	intervention	NN
cord-303447-3a7jxl34	56	25	.	.	.
cord-303447-3a7jxl34	57	1	These	these	DT
cord-303447-3a7jxl34	57	2	studies	study	NNS
cord-303447-3a7jxl34	57	3	show	show	VBP
cord-303447-3a7jxl34	57	4	the	the	DT
cord-303447-3a7jxl34	57	5	need	need	NN
cord-303447-3a7jxl34	57	6	to	to	TO
cord-303447-3a7jxl34	57	7	continue	continue	VB
cord-303447-3a7jxl34	57	8	to	to	TO
cord-303447-3a7jxl34	57	9	identify	identify	VB
cord-303447-3a7jxl34	57	10	adequate	adequate	JJ
cord-303447-3a7jxl34	57	11	funding	funding	NN
cord-303447-3a7jxl34	57	12	sources	source	NNS
cord-303447-3a7jxl34	57	13	to	to	TO
cord-303447-3a7jxl34	57	14	support	support	VB
cord-303447-3a7jxl34	57	15	immunization	immunization	NN
cord-303447-3a7jxl34	57	16	recommendations	recommendation	NNS
cord-303447-3a7jxl34	57	17	[	[	-LRB-
cord-303447-3a7jxl34	57	18	13	13	CD
cord-303447-3a7jxl34	57	19	]	]	-RRB-
cord-303447-3a7jxl34	57	20	[	[	-LRB-
cord-303447-3a7jxl34	57	21	14	14	CD
cord-303447-3a7jxl34	57	22	]	]	-RRB-
cord-303447-3a7jxl34	57	23	[	[	-LRB-
cord-303447-3a7jxl34	57	24	15	15	CD
cord-303447-3a7jxl34	57	25	]	]	-RRB-
cord-303447-3a7jxl34	57	26	[	[	-LRB-
cord-303447-3a7jxl34	57	27	16	16	CD
cord-303447-3a7jxl34	57	28	]	]	-RRB-
cord-303447-3a7jxl34	57	29	.	.	.
cord-303447-3a7jxl34	58	1	An	an	DT
cord-303447-3a7jxl34	58	2	Institute	Institute	NNP
cord-303447-3a7jxl34	58	3	of	of	IN
cord-303447-3a7jxl34	58	4	Medicine	Medicine	NNP
cord-303447-3a7jxl34	58	5	(	(	-LRB-
cord-303447-3a7jxl34	58	6	IOM	IOM	NNP
cord-303447-3a7jxl34	58	7	)	)	-RRB-
cord-303447-3a7jxl34	58	8	report	report	NN
cord-303447-3a7jxl34	58	9	on	on	IN
cord-303447-3a7jxl34	58	10	vaccine	vaccine	NN
cord-303447-3a7jxl34	58	11	financing	financing	NN
cord-303447-3a7jxl34	58	12	released	release	VBN
cord-303447-3a7jxl34	58	13	in	in	IN
cord-303447-3a7jxl34	58	14	2004	2004	CD
cord-303447-3a7jxl34	58	15	concluded	conclude	VBD
cord-303447-3a7jxl34	58	16	,	,	,
cord-303447-3a7jxl34	58	17	'	'	''
cord-303447-3a7jxl34	58	18	'	'	''
cord-303447-3a7jxl34	58	19	alternatives	alternative	NNS
cord-303447-3a7jxl34	58	20	to	to	IN
cord-303447-3a7jxl34	58	21	current	current	JJ
cord-303447-3a7jxl34	58	22	vaccine	vaccine	NN
cord-303447-3a7jxl34	58	23	pricing	pricing	NN
cord-303447-3a7jxl34	58	24	and	and	CC
cord-303447-3a7jxl34	58	25	purchasing	purchasing	NN
cord-303447-3a7jxl34	58	26	programs	program	NNS
cord-303447-3a7jxl34	58	27	are	be	VBP
cord-303447-3a7jxl34	58	28	required	require	VBN
cord-303447-3a7jxl34	58	29	to	to	TO
cord-303447-3a7jxl34	58	30	sustain	sustain	VB
cord-303447-3a7jxl34	58	31	stable	stable	JJ
cord-303447-3a7jxl34	58	32	investment	investment	NN
cord-303447-3a7jxl34	58	33	in	in	IN
cord-303447-3a7jxl34	58	34	development	development	NN
cord-303447-3a7jxl34	58	35	of	of	IN
cord-303447-3a7jxl34	58	36	new	new	JJ
cord-303447-3a7jxl34	58	37	vaccine	vaccine	NN
cord-303447-3a7jxl34	58	38	products	product	NNS
cord-303447-3a7jxl34	58	39	and	and	CC
cord-303447-3a7jxl34	58	40	attain	attain	VB
cord-303447-3a7jxl34	58	41	their	-PRON-	PRP$
cord-303447-3a7jxl34	58	42	social	social	JJ
cord-303447-3a7jxl34	58	43	benefits	benefit	NNS
cord-303447-3a7jxl34	58	44	for	for	IN
cord-303447-3a7jxl34	58	45	all	all	DT
cord-303447-3a7jxl34	58	46	'	'	''
cord-303447-3a7jxl34	58	47	'	'	''
cord-303447-3a7jxl34	58	48	[	[	-LRB-
cord-303447-3a7jxl34	58	49	17	17	CD
cord-303447-3a7jxl34	58	50	]	]	-RRB-
cord-303447-3a7jxl34	58	51	.	.	.
cord-303447-3a7jxl34	59	1	In	in	IN
cord-303447-3a7jxl34	59	2	addition	addition	NN
cord-303447-3a7jxl34	59	3	to	to	IN
cord-303447-3a7jxl34	59	4	the	the	DT
cord-303447-3a7jxl34	59	5	increasing	increase	VBG
cord-303447-3a7jxl34	59	6	cost	cost	NN
cord-303447-3a7jxl34	59	7	of	of	IN
cord-303447-3a7jxl34	59	8	vaccines	vaccine	NNS
cord-303447-3a7jxl34	59	9	,	,	,
cord-303447-3a7jxl34	59	10	an	an	DT
cord-303447-3a7jxl34	59	11	unparalleled	unparalleled	JJ
cord-303447-3a7jxl34	59	12	number	number	NN
cord-303447-3a7jxl34	59	13	of	of	IN
cord-303447-3a7jxl34	59	14	vaccine	vaccine	NN
cord-303447-3a7jxl34	59	15	shortages	shortage	NNS
cord-303447-3a7jxl34	59	16	in	in	IN
cord-303447-3a7jxl34	59	17	the	the	DT
cord-303447-3a7jxl34	59	18	United	United	NNP
cord-303447-3a7jxl34	59	19	States	States	NNP
cord-303447-3a7jxl34	59	20	has	have	VBZ
cord-303447-3a7jxl34	59	21	had	have	VBN
cord-303447-3a7jxl34	59	22	a	a	DT
cord-303447-3a7jxl34	59	23	substantial	substantial	JJ
cord-303447-3a7jxl34	59	24	impact	impact	NN
cord-303447-3a7jxl34	59	25	on	on	IN
cord-303447-3a7jxl34	59	26	vaccine	vaccine	NN
cord-303447-3a7jxl34	59	27	delivery	delivery	NN
cord-303447-3a7jxl34	59	28	.	.	.
cord-303447-3a7jxl34	60	1	From	from	IN
cord-303447-3a7jxl34	60	2	2000	2000	CD
cord-303447-3a7jxl34	60	3	through	through	IN
cord-303447-3a7jxl34	60	4	2005	2005	CD
cord-303447-3a7jxl34	60	5	,	,	,
cord-303447-3a7jxl34	60	6	vaccine	vaccine	NN
cord-303447-3a7jxl34	60	7	shortages	shortage	NNS
cord-303447-3a7jxl34	60	8	and	and	CC
cord-303447-3a7jxl34	60	9	changes	change	NNS
cord-303447-3a7jxl34	60	10	in	in	IN
cord-303447-3a7jxl34	60	11	routine	routine	JJ
cord-303447-3a7jxl34	60	12	recommendations	recommendation	NNS
cord-303447-3a7jxl34	60	13	occurred	occur	VBD
cord-303447-3a7jxl34	60	14	for	for	IN
cord-303447-3a7jxl34	60	15	9	9	CD
cord-303447-3a7jxl34	60	16	of	of	IN
cord-303447-3a7jxl34	60	17	the	the	DT
cord-303447-3a7jxl34	60	18	12	12	CD
cord-303447-3a7jxl34	60	19	diseases	disease	NNS
cord-303447-3a7jxl34	60	20	for	for	IN
cord-303447-3a7jxl34	60	21	which	which	WDT
cord-303447-3a7jxl34	60	22	childhood	childhood	NN
cord-303447-3a7jxl34	60	23	and	and	CC
cord-303447-3a7jxl34	60	24	adolescent	adolescent	JJ
cord-303447-3a7jxl34	60	25	vaccination	vaccination	NN
cord-303447-3a7jxl34	60	26	is	be	VBZ
cord-303447-3a7jxl34	60	27	recommended	recommend	VBN
cord-303447-3a7jxl34	60	28	(	(	-LRB-
cord-303447-3a7jxl34	60	29	Fig	Fig	NNP
cord-303447-3a7jxl34	60	30	.	.	NNP
cord-303447-3a7jxl34	60	31	2	2	LS
cord-303447-3a7jxl34	60	32	)	)	-RRB-
cord-303447-3a7jxl34	60	33	[	[	-LRB-
cord-303447-3a7jxl34	60	34	18	18	CD
cord-303447-3a7jxl34	60	35	]	]	-RRB-
cord-303447-3a7jxl34	60	36	[	[	-LRB-
cord-303447-3a7jxl34	60	37	19	19	CD
cord-303447-3a7jxl34	60	38	]	]	-RRB-
cord-303447-3a7jxl34	61	1	[	[	-LRB-
cord-303447-3a7jxl34	61	2	20	20	CD
cord-303447-3a7jxl34	61	3	]	]	-RRB-
cord-303447-3a7jxl34	61	4	[	[	-LRB-
cord-303447-3a7jxl34	61	5	21	21	CD
cord-303447-3a7jxl34	61	6	]	]	-RRB-
cord-303447-3a7jxl34	62	1	[	[	-LRB-
cord-303447-3a7jxl34	62	2	22	22	CD
cord-303447-3a7jxl34	62	3	]	]	-RRB-
cord-303447-3a7jxl34	62	4	[	[	-LRB-
cord-303447-3a7jxl34	62	5	23	23	CD
cord-303447-3a7jxl34	62	6	]	]	-RRB-
cord-303447-3a7jxl34	62	7	.	.	.
cord-303447-3a7jxl34	63	1	The	the	DT
cord-303447-3a7jxl34	63	2	shortages	shortage	NNS
cord-303447-3a7jxl34	63	3	affected	affect	VBD
cord-303447-3a7jxl34	63	4	millions	million	NNS
cord-303447-3a7jxl34	63	5	of	of	IN
cord-303447-3a7jxl34	63	6	children	child	NNS
cord-303447-3a7jxl34	63	7	and	and	CC
cord-303447-3a7jxl34	63	8	health	health	NN
cord-303447-3a7jxl34	63	9	care	care	NN
cord-303447-3a7jxl34	63	10	providers	provider	NNS
cord-303447-3a7jxl34	63	11	,	,	,
cord-303447-3a7jxl34	63	12	even	even	RB
cord-303447-3a7jxl34	63	13	triggering	trigger	VBG
cord-303447-3a7jxl34	63	14	suspension	suspension	NN
cord-303447-3a7jxl34	63	15	of	of	IN
cord-303447-3a7jxl34	63	16	vaccine	vaccine	NN
cord-303447-3a7jxl34	63	17	school	school	NN
cord-303447-3a7jxl34	63	18	entry	entry	NN
cord-303447-3a7jxl34	63	19	requirements	requirement	NNS
cord-303447-3a7jxl34	63	20	[	[	-LRB-
cord-303447-3a7jxl34	63	21	24	24	CD
cord-303447-3a7jxl34	63	22	,	,	,
cord-303447-3a7jxl34	63	23	25	25	CD
cord-303447-3a7jxl34	63	24	]	]	-RRB-
cord-303447-3a7jxl34	63	25	.	.	.
cord-303447-3a7jxl34	64	1	Two	two	CD
cord-303447-3a7jxl34	64	2	vaccine	vaccine	NN
cord-303447-3a7jxl34	64	3	shortages	shortage	NNS
cord-303447-3a7jxl34	64	4	(	(	-LRB-
cord-303447-3a7jxl34	64	5	PCV7	PCV7	NNP
cord-303447-3a7jxl34	64	6	and	and	CC
cord-303447-3a7jxl34	64	7	tetanus	tetanus	NN
cord-303447-3a7jxl34	64	8	and	and	CC
cord-303447-3a7jxl34	64	9	diphtheria	diphtheria	NN
cord-303447-3a7jxl34	64	10	toxoids	toxoid	NNS
cord-303447-3a7jxl34	64	11	[	[	-LRB-
cord-303447-3a7jxl34	64	12	Td	Td	NNP
cord-303447-3a7jxl34	64	13	]	]	-RRB-
cord-303447-3a7jxl34	64	14	)	)	-RRB-
cord-303447-3a7jxl34	64	15	lasted	last	VBD
cord-303447-3a7jxl34	64	16	nearly	nearly	RB
cord-303447-3a7jxl34	64	17	2	2	CD
cord-303447-3a7jxl34	64	18	years	year	NNS
cord-303447-3a7jxl34	64	19	,	,	,
cord-303447-3a7jxl34	64	20	one	one	CD
cord-303447-3a7jxl34	64	21	(	(	-LRB-
cord-303447-3a7jxl34	64	22	PCV7	PCV7	NNP
cord-303447-3a7jxl34	64	23	)	)	-RRB-
cord-303447-3a7jxl34	64	24	occurred	occur	VBD
cord-303447-3a7jxl34	64	25	twice	twice	RB
cord-303447-3a7jxl34	64	26	[	[	-LRB-
cord-303447-3a7jxl34	64	27	26	26	CD
cord-303447-3a7jxl34	64	28	]	]	-RRB-
cord-303447-3a7jxl34	64	29	,	,	,
cord-303447-3a7jxl34	64	30	and	and	CC
cord-303447-3a7jxl34	64	31	one	one	CD
cord-303447-3a7jxl34	64	32	(	(	-LRB-
cord-303447-3a7jxl34	64	33	inactivated	inactivate	VBN
cord-303447-3a7jxl34	64	34	influenza	influenza	NN
cord-303447-3a7jxl34	64	35	vaccine	vaccine	NN
cord-303447-3a7jxl34	64	36	,	,	,
cord-303447-3a7jxl34	64	37	2004	2004	CD
cord-303447-3a7jxl34	64	38	-	-	SYM
cord-303447-3a7jxl34	64	39	05	05	CD
cord-303447-3a7jxl34	64	40	season	season	NN
cord-303447-3a7jxl34	64	41	)	)	-RRB-
cord-303447-3a7jxl34	64	42	halved	halve	VBD
cord-303447-3a7jxl34	64	43	the	the	DT
cord-303447-3a7jxl34	64	44	US	US	NNP
cord-303447-3a7jxl34	64	45	influenza	influenza	NN
cord-303447-3a7jxl34	64	46	vaccine	vaccine	NN
cord-303447-3a7jxl34	64	47	supply	supply	NN
cord-303447-3a7jxl34	64	48	virtually	virtually	RB
cord-303447-3a7jxl34	64	49	overnight	overnight	RB
cord-303447-3a7jxl34	64	50	[	[	-LRB-
cord-303447-3a7jxl34	64	51	17	17	CD
cord-303447-3a7jxl34	64	52	,	,	,
cord-303447-3a7jxl34	64	53	22	22	CD
cord-303447-3a7jxl34	64	54	]	]	-RRB-
cord-303447-3a7jxl34	64	55	.	.	.
cord-303447-3a7jxl34	65	1	The	the	DT
cord-303447-3a7jxl34	65	2	causes	cause	NNS
cord-303447-3a7jxl34	65	3	of	of	IN
cord-303447-3a7jxl34	65	4	these	these	DT
cord-303447-3a7jxl34	65	5	widespread	widespread	JJ
cord-303447-3a7jxl34	65	6	vaccine	vaccine	NN
cord-303447-3a7jxl34	65	7	shortages	shortage	NNS
cord-303447-3a7jxl34	65	8	are	be	VBP
cord-303447-3a7jxl34	65	9	multifactorial	multifactorial	JJ
cord-303447-3a7jxl34	65	10	.	.	.
cord-303447-3a7jxl34	66	1	One	one	CD
cord-303447-3a7jxl34	66	2	important	important	JJ
cord-303447-3a7jxl34	66	3	long	long	JJ
cord-303447-3a7jxl34	66	4	-	-	HYPH
cord-303447-3a7jxl34	66	5	term	term	NN
cord-303447-3a7jxl34	66	6	factor	factor	NN
cord-303447-3a7jxl34	66	7	is	be	VBZ
cord-303447-3a7jxl34	66	8	the	the	DT
cord-303447-3a7jxl34	66	9	decrease	decrease	NN
cord-303447-3a7jxl34	66	10	in	in	IN
cord-303447-3a7jxl34	66	11	number	number	NN
cord-303447-3a7jxl34	66	12	of	of	IN
cord-303447-3a7jxl34	66	13	vaccine	vaccine	NN
cord-303447-3a7jxl34	66	14	manufacturers	manufacturer	NNS
cord-303447-3a7jxl34	66	15	of	of	IN
cord-303447-3a7jxl34	66	16	childhood	childhood	NN
cord-303447-3a7jxl34	66	17	vaccines	vaccine	NNS
cord-303447-3a7jxl34	66	18	routinely	routinely	RB
cord-303447-3a7jxl34	66	19	recommended	recommend	VBN
cord-303447-3a7jxl34	66	20	in	in	IN
cord-303447-3a7jxl34	66	21	the	the	DT
cord-303447-3a7jxl34	66	22	United	United	NNP
cord-303447-3a7jxl34	66	23	States	States	NNP
cord-303447-3a7jxl34	66	24	.	.	.
cord-303447-3a7jxl34	67	1	In	in	IN
cord-303447-3a7jxl34	67	2	1977	1977	CD
cord-303447-3a7jxl34	67	3	,	,	,
cord-303447-3a7jxl34	67	4	a	a	DT
cord-303447-3a7jxl34	67	5	federal	federal	JJ
cord-303447-3a7jxl34	67	6	immunization	immunization	NN
cord-303447-3a7jxl34	67	7	working	working	NN
cord-303447-3a7jxl34	67	8	group	group	NN
cord-303447-3a7jxl34	67	9	expressed	express	VBD
cord-303447-3a7jxl34	67	10	concern	concern	NN
cord-303447-3a7jxl34	67	11	about	about	IN
cord-303447-3a7jxl34	67	12	the	the	DT
cord-303447-3a7jxl34	67	13	stability	stability	NN
cord-303447-3a7jxl34	67	14	of	of	IN
cord-303447-3a7jxl34	67	15	the	the	DT
cord-303447-3a7jxl34	67	16	US	US	NNP
cord-303447-3a7jxl34	67	17	vaccine	vaccine	NN
cord-303447-3a7jxl34	67	18	supply	supply	NN
cord-303447-3a7jxl34	67	19	in	in	IN
cord-303447-3a7jxl34	67	20	the	the	DT
cord-303447-3a7jxl34	67	21	setting	setting	NN
cord-303447-3a7jxl34	67	22	of	of	IN
cord-303447-3a7jxl34	67	23	'	'	``
cord-303447-3a7jxl34	67	24	'	'	''
cord-303447-3a7jxl34	67	25	a	a	DT
cord-303447-3a7jxl34	67	26	steady	steady	JJ
cord-303447-3a7jxl34	67	27	attrition	attrition	NN
cord-303447-3a7jxl34	67	28	of	of	IN
cord-303447-3a7jxl34	67	29	specific	specific	JJ
cord-303447-3a7jxl34	67	30	pharmaceutical	pharmaceutical	JJ
cord-303447-3a7jxl34	67	31	manufacturers	manufacturer	NNS
cord-303447-3a7jxl34	67	32	from	from	IN
cord-303447-3a7jxl34	67	33	the	the	DT
cord-303447-3a7jxl34	67	34	entire	entire	JJ
cord-303447-3a7jxl34	67	35	field	field	NN
cord-303447-3a7jxl34	67	36	of	of	IN
cord-303447-3a7jxl34	67	37	biologics	biologic	NNS
cord-303447-3a7jxl34	67	38	'	'	POS
cord-303447-3a7jxl34	67	39	'	'	''
cord-303447-3a7jxl34	67	40	[	[	-LRB-
cord-303447-3a7jxl34	67	41	17	17	CD
cord-303447-3a7jxl34	67	42	]	]	-RRB-
cord-303447-3a7jxl34	67	43	.	.	.
cord-303447-3a7jxl34	68	1	In	in	IN
cord-303447-3a7jxl34	68	2	1993	1993	CD
cord-303447-3a7jxl34	68	3	,	,	,
cord-303447-3a7jxl34	68	4	six	six	CD
cord-303447-3a7jxl34	68	5	manufactures	manufacture	NNS
cord-303447-3a7jxl34	68	6	produced	produce	VBD
cord-303447-3a7jxl34	68	7	the	the	DT
cord-303447-3a7jxl34	68	8	six	six	CD
cord-303447-3a7jxl34	68	9	vaccines	vaccine	NNS
cord-303447-3a7jxl34	68	10	.	.	.
cord-303447-3a7jxl34	69	1	In	in	IN
cord-303447-3a7jxl34	69	2	2005	2005	CD
cord-303447-3a7jxl34	69	3	,	,	,
cord-303447-3a7jxl34	69	4	although	although	IN
cord-303447-3a7jxl34	69	5	four	four	CD
cord-303447-3a7jxl34	69	6	vaccines	vaccine	NNS
cord-303447-3a7jxl34	69	7	(	(	-LRB-
cord-303447-3a7jxl34	69	8	PCV7	PCV7	NNP
cord-303447-3a7jxl34	69	9	,	,	,
cord-303447-3a7jxl34	69	10	varicella	varicella	NN
cord-303447-3a7jxl34	69	11	,	,	,
cord-303447-3a7jxl34	69	12	influenza	influenza	NN
cord-303447-3a7jxl34	69	13	,	,	,
cord-303447-3a7jxl34	69	14	and	and	CC
cord-303447-3a7jxl34	69	15	MCV4	MCV4	NNP
cord-303447-3a7jxl34	69	16	)	)	-RRB-
cord-303447-3a7jxl34	69	17	have	have	VBP
cord-303447-3a7jxl34	69	18	been	be	VBN
cord-303447-3a7jxl34	69	19	added	add	VBN
cord-303447-3a7jxl34	69	20	to	to	IN
cord-303447-3a7jxl34	69	21	the	the	DT
cord-303447-3a7jxl34	69	22	recommended	recommend	VBN
cord-303447-3a7jxl34	69	23	schedule	schedule	NN
cord-303447-3a7jxl34	69	24	,	,	,
cord-303447-3a7jxl34	69	25	the	the	DT
cord-303447-3a7jxl34	69	26	number	number	NN
cord-303447-3a7jxl34	69	27	of	of	IN
cord-303447-3a7jxl34	69	28	manufacturers	manufacturer	NNS
cord-303447-3a7jxl34	69	29	decreased	decrease	VBD
cord-303447-3a7jxl34	69	30	to	to	IN
cord-303447-3a7jxl34	69	31	five	five	CD
cord-303447-3a7jxl34	69	32	.	.	.
cord-303447-3a7jxl34	70	1	In	in	IN
cord-303447-3a7jxl34	70	2	addition	addition	NN
cord-303447-3a7jxl34	70	3	,	,	,
cord-303447-3a7jxl34	70	4	there	there	EX
cord-303447-3a7jxl34	70	5	are	be	VBP
cord-303447-3a7jxl34	70	6	single	single	JJ
cord-303447-3a7jxl34	70	7	manufacturers	manufacturer	NNS
cord-303447-3a7jxl34	70	8	for	for	IN
cord-303447-3a7jxl34	70	9	four	four	CD
cord-303447-3a7jxl34	70	10	of	of	IN
cord-303447-3a7jxl34	70	11	the	the	DT
cord-303447-3a7jxl34	70	12	childhood	childhood	NN
cord-303447-3a7jxl34	70	13	and	and	CC
cord-303447-3a7jxl34	70	14	adolescent	adolescent	JJ
cord-303447-3a7jxl34	70	15	vaccines	vaccine	NNS
cord-303447-3a7jxl34	70	16	(	(	-LRB-
cord-303447-3a7jxl34	70	17	MMR	MMR	NNP
cord-303447-3a7jxl34	70	18	,	,	,
cord-303447-3a7jxl34	70	19	varicella	varicella	NN
cord-303447-3a7jxl34	70	20	,	,	,
cord-303447-3a7jxl34	70	21	PCV7	PCV7	NNP
cord-303447-3a7jxl34	70	22	,	,	,
cord-303447-3a7jxl34	70	23	and	and	CC
cord-303447-3a7jxl34	70	24	MCV4	MCV4	NNP
cord-303447-3a7jxl34	70	25	)	)	-RRB-
cord-303447-3a7jxl34	70	26	.	.	.
cord-303447-3a7jxl34	71	1	In	in	IN
cord-303447-3a7jxl34	71	2	response	response	NN
cord-303447-3a7jxl34	71	3	to	to	IN
cord-303447-3a7jxl34	71	4	concerns	concern	NNS
cord-303447-3a7jxl34	71	5	over	over	IN
cord-303447-3a7jxl34	71	6	fragility	fragility	NN
cord-303447-3a7jxl34	71	7	of	of	IN
cord-303447-3a7jxl34	71	8	the	the	DT
cord-303447-3a7jxl34	71	9	US	US	NNP
cord-303447-3a7jxl34	71	10	vaccine	vaccine	NN
cord-303447-3a7jxl34	71	11	supply	supply	NN
cord-303447-3a7jxl34	71	12	,	,	,
cord-303447-3a7jxl34	71	13	the	the	DT
cord-303447-3a7jxl34	71	14	General	General	NNP
cord-303447-3a7jxl34	71	15	Accounting	Accounting	NNP
cord-303447-3a7jxl34	71	16	Office	Office	NNP
cord-303447-3a7jxl34	71	17	and	and	CC
cord-303447-3a7jxl34	71	18	National	National	NNP
cord-303447-3a7jxl34	71	19	Vaccine	Vaccine	NNP
cord-303447-3a7jxl34	71	20	Advisory	Advisory	NNP
cord-303447-3a7jxl34	71	21	Committee	Committee	NNP
cord-303447-3a7jxl34	71	22	conducted	conduct	VBD
cord-303447-3a7jxl34	71	23	in	in	IN
cord-303447-3a7jxl34	71	24	-	-	HYPH
cord-303447-3a7jxl34	71	25	depth	depth	NN
cord-303447-3a7jxl34	71	26	reviews	review	NNS
cord-303447-3a7jxl34	71	27	of	of	IN
cord-303447-3a7jxl34	71	28	the	the	DT
cord-303447-3a7jxl34	71	29	vaccine	vaccine	NN
cord-303447-3a7jxl34	71	30	shortages	shortage	NNS
cord-303447-3a7jxl34	71	31	and	and	CC
cord-303447-3a7jxl34	71	32	concluded	conclude	VBD
cord-303447-3a7jxl34	71	33	that	that	IN
cord-303447-3a7jxl34	71	34	future	future	JJ
cord-303447-3a7jxl34	71	35	disruptions	disruption	NNS
cord-303447-3a7jxl34	71	36	in	in	IN
cord-303447-3a7jxl34	71	37	vaccine	vaccine	NN
cord-303447-3a7jxl34	71	38	supply	supply	NN
cord-303447-3a7jxl34	71	39	are	be	VBP
cord-303447-3a7jxl34	71	40	likely	likely	JJ
cord-303447-3a7jxl34	71	41	to	to	TO
cord-303447-3a7jxl34	71	42	continue	continue	VB
cord-303447-3a7jxl34	71	43	,	,	,
cord-303447-3a7jxl34	71	44	and	and	CC
cord-303447-3a7jxl34	71	45	proposed	propose	VBN
cord-303447-3a7jxl34	71	46	solutions	solution	NNS
cord-303447-3a7jxl34	71	47	[	[	-LRB-
cord-303447-3a7jxl34	71	48	17	17	CD
cord-303447-3a7jxl34	71	49	,	,	,
cord-303447-3a7jxl34	71	50	27	27	CD
cord-303447-3a7jxl34	71	51	]	]	-RRB-
cord-303447-3a7jxl34	71	52	.	.	.
cord-303447-3a7jxl34	72	1	Vaccines	vaccine	NNS
cord-303447-3a7jxl34	72	2	are	be	VBP
cord-303447-3a7jxl34	72	3	administered	administer	VBN
cord-303447-3a7jxl34	72	4	routinely	routinely	RB
cord-303447-3a7jxl34	72	5	to	to	IN
cord-303447-3a7jxl34	72	6	healthy	healthy	JJ
cord-303447-3a7jxl34	72	7	children	child	NNS
cord-303447-3a7jxl34	72	8	and	and	CC
cord-303447-3a7jxl34	72	9	must	must	MD
cord-303447-3a7jxl34	72	10	uphold	uphold	VB
cord-303447-3a7jxl34	72	11	a	a	DT
cord-303447-3a7jxl34	72	12	scrupulously	scrupulously	RB
cord-303447-3a7jxl34	72	13	high	high	JJ
cord-303447-3a7jxl34	72	14	safety	safety	NN
cord-303447-3a7jxl34	72	15	standard	standard	NN
cord-303447-3a7jxl34	72	16	;	;	:
cord-303447-3a7jxl34	72	17	however	however	RB
cord-303447-3a7jxl34	72	18	,	,	,
cord-303447-3a7jxl34	72	19	no	no	DT
cord-303447-3a7jxl34	72	20	vaccine	vaccine	NN
cord-303447-3a7jxl34	72	21	is	be	VBZ
cord-303447-3a7jxl34	72	22	completely	completely	RB
cord-303447-3a7jxl34	72	23	safe	safe	JJ
cord-303447-3a7jxl34	72	24	.	.	.
cord-303447-3a7jxl34	73	1	In	in	IN
cord-303447-3a7jxl34	73	2	1986	1986	CD
cord-303447-3a7jxl34	73	3	,	,	,
cord-303447-3a7jxl34	73	4	the	the	DT
cord-303447-3a7jxl34	73	5	National	National	NNP
cord-303447-3a7jxl34	73	6	Childhood	Childhood	NNP
cord-303447-3a7jxl34	73	7	Vaccine	Vaccine	NNP
cord-303447-3a7jxl34	73	8	Injury	Injury	NNP
cord-303447-3a7jxl34	73	9	Act	Act	NNP
cord-303447-3a7jxl34	73	10	was	be	VBD
cord-303447-3a7jxl34	73	11	passed	pass	VBN
cord-303447-3a7jxl34	73	12	creating	create	VBG
cord-303447-3a7jxl34	73	13	a	a	DT
cord-303447-3a7jxl34	73	14	compensation	compensation	NN
cord-303447-3a7jxl34	73	15	program	program	NN
cord-303447-3a7jxl34	73	16	for	for	IN
cord-303447-3a7jxl34	73	17	families	family	NNS
cord-303447-3a7jxl34	73	18	affected	affect	VBN
cord-303447-3a7jxl34	73	19	by	by	IN
cord-303447-3a7jxl34	73	20	childhood	childhood	NN
cord-303447-3a7jxl34	73	21	vaccine	vaccine	NN
cord-303447-3a7jxl34	73	22	-	-	HYPH
cord-303447-3a7jxl34	73	23	associated	associate	VBN
cord-303447-3a7jxl34	73	24	adverse	adverse	JJ
cord-303447-3a7jxl34	73	25	events	event	NNS
cord-303447-3a7jxl34	73	26	.	.	.
cord-303447-3a7jxl34	74	1	Several	several	JJ
cord-303447-3a7jxl34	74	2	other	other	JJ
cord-303447-3a7jxl34	74	3	government	government	NN
cord-303447-3a7jxl34	74	4	programs	program	NNS
cord-303447-3a7jxl34	74	5	and	and	CC
cord-303447-3a7jxl34	74	6	committees	committee	NNS
cord-303447-3a7jxl34	74	7	to	to	TO
cord-303447-3a7jxl34	74	8	ensure	ensure	VB
cord-303447-3a7jxl34	74	9	the	the	DT
cord-303447-3a7jxl34	74	10	safety	safety	NN
cord-303447-3a7jxl34	74	11	of	of	IN
cord-303447-3a7jxl34	74	12	the	the	DT
cord-303447-3a7jxl34	74	13	vaccine	vaccine	NN
cord-303447-3a7jxl34	74	14	supply	supply	NN
cord-303447-3a7jxl34	74	15	also	also	RB
cord-303447-3a7jxl34	74	16	were	be	VBD
cord-303447-3a7jxl34	74	17	created	create	VBN
cord-303447-3a7jxl34	74	18	by	by	IN
cord-303447-3a7jxl34	74	19	this	this	DT
cord-303447-3a7jxl34	74	20	Act	Act	NNP
cord-303447-3a7jxl34	74	21	(	(	-LRB-
cord-303447-3a7jxl34	74	22	Table	Table	NNP
cord-303447-3a7jxl34	74	23	5	5	CD
cord-303447-3a7jxl34	74	24	)	)	-RRB-
cord-303447-3a7jxl34	74	25	.	.	.
cord-303447-3a7jxl34	75	1	As	as	IN
cord-303447-3a7jxl34	75	2	many	many	JJ
cord-303447-3a7jxl34	75	3	vaccine	vaccine	NN
cord-303447-3a7jxl34	75	4	-	-	HYPH
cord-303447-3a7jxl34	75	5	preventable	preventable	JJ
cord-303447-3a7jxl34	75	6	diseases	disease	NNS
cord-303447-3a7jxl34	75	7	approach	approach	VBP
cord-303447-3a7jxl34	75	8	or	or	CC
cord-303447-3a7jxl34	75	9	reach	reach	VB
cord-303447-3a7jxl34	75	10	elimination	elimination	NN
cord-303447-3a7jxl34	75	11	in	in	IN
cord-303447-3a7jxl34	75	12	the	the	DT
cord-303447-3a7jxl34	75	13	United	United	NNP
cord-303447-3a7jxl34	75	14	States	States	NNP
cord-303447-3a7jxl34	75	15	,	,	,
cord-303447-3a7jxl34	75	16	continuing	continue	VBG
cord-303447-3a7jxl34	75	17	to	to	TO
cord-303447-3a7jxl34	75	18	balance	balance	VB
cord-303447-3a7jxl34	75	19	the	the	DT
cord-303447-3a7jxl34	75	20	risks	risk	NNS
cord-303447-3a7jxl34	75	21	and	and	CC
cord-303447-3a7jxl34	75	22	benefits	benefit	NNS
cord-303447-3a7jxl34	75	23	of	of	IN
cord-303447-3a7jxl34	75	24	each	each	DT
cord-303447-3a7jxl34	75	25	vaccine	vaccine	NN
cord-303447-3a7jxl34	75	26	becomes	become	VBZ
cord-303447-3a7jxl34	75	27	increasingly	increasingly	RB
cord-303447-3a7jxl34	75	28	important	important	JJ
cord-303447-3a7jxl34	75	29	[	[	-LRB-
cord-303447-3a7jxl34	75	30	28	28	CD
cord-303447-3a7jxl34	75	31	]	]	-RRB-
cord-303447-3a7jxl34	75	32	.	.	.
cord-303447-3a7jxl34	76	1	OPV	OPV	NNP
cord-303447-3a7jxl34	76	2	,	,	,
cord-303447-3a7jxl34	76	3	formerly	formerly	RB
cord-303447-3a7jxl34	76	4	recommended	recommend	VBD
cord-303447-3a7jxl34	76	5	for	for	IN
cord-303447-3a7jxl34	76	6	routine	routine	JJ
cord-303447-3a7jxl34	76	7	use	use	NN
cord-303447-3a7jxl34	76	8	in	in	IN
cord-303447-3a7jxl34	76	9	the	the	DT
cord-303447-3a7jxl34	76	10	United	United	NNP
cord-303447-3a7jxl34	76	11	States	States	NNP
cord-303447-3a7jxl34	76	12	,	,	,
cord-303447-3a7jxl34	76	13	was	be	VBD
cord-303447-3a7jxl34	76	14	associated	associate	VBN
cord-303447-3a7jxl34	76	15	with	with	IN
cord-303447-3a7jxl34	76	16	vaccine	vaccine	NN
cord-303447-3a7jxl34	76	17	-	-	HYPH
cord-303447-3a7jxl34	76	18	associated	associate	VBN
cord-303447-3a7jxl34	76	19	paralytic	paralytic	JJ
cord-303447-3a7jxl34	76	20	poliomyelitis	poliomyelitis	NN
cord-303447-3a7jxl34	76	21	(	(	-LRB-
cord-303447-3a7jxl34	76	22	1	1	CD
cord-303447-3a7jxl34	76	23	case	case	NN
cord-303447-3a7jxl34	76	24	among	among	IN
cord-303447-3a7jxl34	76	25	2.4	2.4	CD
cord-303447-3a7jxl34	76	26	million	million	CD
cord-303447-3a7jxl34	76	27	vaccine	vaccine	NN
cord-303447-3a7jxl34	76	28	doses	dose	NNS
cord-303447-3a7jxl34	76	29	distributed	distribute	VBN
cord-303447-3a7jxl34	76	30	)	)	-RRB-
cord-303447-3a7jxl34	76	31	.	.	.
cord-303447-3a7jxl34	77	1	This	this	DT
cord-303447-3a7jxl34	77	2	rare	rare	JJ
cord-303447-3a7jxl34	77	3	adverse	adverse	JJ
cord-303447-3a7jxl34	77	4	event	event	NN
cord-303447-3a7jxl34	77	5	was	be	VBD
cord-303447-3a7jxl34	77	6	no	no	RB
cord-303447-3a7jxl34	77	7	longer	long	RBR
cord-303447-3a7jxl34	77	8	considered	consider	VBN
cord-303447-3a7jxl34	77	9	acceptable	acceptable	JJ
cord-303447-3a7jxl34	77	10	after	after	IN
cord-303447-3a7jxl34	77	11	elimination	elimination	NN
cord-303447-3a7jxl34	77	12	of	of	IN
cord-303447-3a7jxl34	77	13	polio	polio	NN
cord-303447-3a7jxl34	77	14	in	in	IN
cord-303447-3a7jxl34	77	15	the	the	DT
cord-303447-3a7jxl34	77	16	United	United	NNP
cord-303447-3a7jxl34	77	17	States	States	NNP
cord-303447-3a7jxl34	77	18	[	[	-LRB-
cord-303447-3a7jxl34	77	19	29	29	CD
cord-303447-3a7jxl34	77	20	]	]	-RRB-
cord-303447-3a7jxl34	77	21	.	.	.
cord-303447-3a7jxl34	78	1	In	in	IN
cord-303447-3a7jxl34	78	2	2000	2000	CD
cord-303447-3a7jxl34	78	3	,	,	,
cord-303447-3a7jxl34	78	4	the	the	DT
cord-303447-3a7jxl34	78	5	ACIP	ACIP	NNP
cord-303447-3a7jxl34	78	6	recommended	recommend	VBD
cord-303447-3a7jxl34	78	7	using	use	VBG
cord-303447-3a7jxl34	78	8	IPV	IPV	NNP
cord-303447-3a7jxl34	78	9	for	for	IN
cord-303447-3a7jxl34	78	10	all	all	DT
cord-303447-3a7jxl34	78	11	doses	dose	NNS
cord-303447-3a7jxl34	78	12	of	of	IN
cord-303447-3a7jxl34	78	13	polio	polio	NN
cord-303447-3a7jxl34	78	14	vaccine	vaccine	NN
cord-303447-3a7jxl34	78	15	.	.	.
cord-303447-3a7jxl34	79	1	Public	public	JJ
cord-303447-3a7jxl34	79	2	perceptions	perception	NNS
cord-303447-3a7jxl34	79	3	of	of	IN
cord-303447-3a7jxl34	79	4	vaccine	vaccine	NN
cord-303447-3a7jxl34	79	5	safety	safety	NN
cord-303447-3a7jxl34	79	6	are	be	VBP
cord-303447-3a7jxl34	79	7	a	a	DT
cord-303447-3a7jxl34	79	8	challenge	challenge	NN
cord-303447-3a7jxl34	79	9	to	to	IN
cord-303447-3a7jxl34	79	10	the	the	DT
cord-303447-3a7jxl34	79	11	continued	continue	VBN
cord-303447-3a7jxl34	79	12	success	success	NN
cord-303447-3a7jxl34	79	13	of	of	IN
cord-303447-3a7jxl34	79	14	the	the	DT
cord-303447-3a7jxl34	79	15	vaccination	vaccination	NN
cord-303447-3a7jxl34	79	16	program	program	NN
cord-303447-3a7jxl34	79	17	.	.	.
cord-303447-3a7jxl34	80	1	New	new	JJ
cord-303447-3a7jxl34	80	2	parents	parent	NNS
cord-303447-3a7jxl34	80	3	and	and	CC
cord-303447-3a7jxl34	80	4	younger	young	JJR
cord-303447-3a7jxl34	80	5	physicians	physician	NNS
cord-303447-3a7jxl34	80	6	grew	grow	VBD
cord-303447-3a7jxl34	80	7	up	up	RP
cord-303447-3a7jxl34	80	8	without	without	IN
cord-303447-3a7jxl34	80	9	appreciation	appreciation	NN
cord-303447-3a7jxl34	80	10	of	of	IN
cord-303447-3a7jxl34	80	11	the	the	DT
cord-303447-3a7jxl34	80	12	morbidity	morbidity	NN
cord-303447-3a7jxl34	80	13	and	and	CC
cord-303447-3a7jxl34	80	14	mortality	mortality	NN
cord-303447-3a7jxl34	80	15	of	of	IN
cord-303447-3a7jxl34	80	16	immunizations	immunization	NNS
cord-303447-3a7jxl34	80	17	in	in	IN
cord-303447-3a7jxl34	80	18	the	the	DT
cord-303447-3a7jxl34	80	19	us	us	NNP
cord-303447-3a7jxl34	80	20	several	several	JJ
cord-303447-3a7jxl34	80	21	vaccine	vaccine	NN
cord-303447-3a7jxl34	80	22	-	-	HYPH
cord-303447-3a7jxl34	80	23	preventable	preventable	JJ
cord-303447-3a7jxl34	80	24	diseases	disease	NNS
cord-303447-3a7jxl34	80	25	.	.	.
cord-303447-3a7jxl34	81	1	Risk	risk	NN
cord-303447-3a7jxl34	81	2	or	or	CC
cord-303447-3a7jxl34	81	3	perception	perception	NN
cord-303447-3a7jxl34	81	4	of	of	IN
cord-303447-3a7jxl34	81	5	risk	risk	NN
cord-303447-3a7jxl34	81	6	for	for	IN
cord-303447-3a7jxl34	81	7	adverse	adverse	JJ
cord-303447-3a7jxl34	81	8	events	event	NNS
cord-303447-3a7jxl34	81	9	becomes	become	VBZ
cord-303447-3a7jxl34	81	10	an	an	DT
cord-303447-3a7jxl34	81	11	important	important	JJ
cord-303447-3a7jxl34	81	12	concern	concern	NN
cord-303447-3a7jxl34	81	13	.	.	.
cord-303447-3a7jxl34	82	1	Two	two	CD
cord-303447-3a7jxl34	82	2	current	current	JJ
cord-303447-3a7jxl34	82	3	prominent	prominent	JJ
cord-303447-3a7jxl34	82	4	public	public	JJ
cord-303447-3a7jxl34	82	5	vaccine	vaccine	NN
cord-303447-3a7jxl34	82	6	safety	safety	NN
cord-303447-3a7jxl34	82	7	concerns	concern	NNS
cord-303447-3a7jxl34	82	8	are	be	VBP
cord-303447-3a7jxl34	82	9	the	the	DT
cord-303447-3a7jxl34	82	10	perceived	perceive	VBN
cord-303447-3a7jxl34	82	11	causal	causal	JJ
cord-303447-3a7jxl34	82	12	association	association	NN
cord-303447-3a7jxl34	82	13	between	between	IN
cord-303447-3a7jxl34	82	14	MMR	MMR	NNP
cord-303447-3a7jxl34	82	15	and	and	CC
cord-303447-3a7jxl34	82	16	autism	autism	NN
cord-303447-3a7jxl34	82	17	and	and	CC
cord-303447-3a7jxl34	82	18	thimerosal	thimerosal	NN
cord-303447-3a7jxl34	82	19	-	-	HYPH
cord-303447-3a7jxl34	82	20	containing	contain	VBG
cord-303447-3a7jxl34	82	21	vaccines	vaccine	NNS
cord-303447-3a7jxl34	82	22	and	and	CC
cord-303447-3a7jxl34	82	23	autism	autism	NN
cord-303447-3a7jxl34	82	24	.	.	.
cord-303447-3a7jxl34	83	1	As	as	IN
cord-303447-3a7jxl34	83	2	a	a	DT
cord-303447-3a7jxl34	83	3	result	result	NN
cord-303447-3a7jxl34	83	4	of	of	IN
cord-303447-3a7jxl34	83	5	heightened	heightened	JJ
cord-303447-3a7jxl34	83	6	concerns	concern	NNS
cord-303447-3a7jxl34	83	7	about	about	IN
cord-303447-3a7jxl34	83	8	safety	safety	NN
cord-303447-3a7jxl34	83	9	,	,	,
cord-303447-3a7jxl34	83	10	in	in	IN
cord-303447-3a7jxl34	83	11	2000	2000	CD
cord-303447-3a7jxl34	83	12	the	the	DT
cord-303447-3a7jxl34	83	13	CDC	CDC	NNP
cord-303447-3a7jxl34	83	14	and	and	CC
cord-303447-3a7jxl34	83	15	National	National	NNP
cord-303447-3a7jxl34	83	16	Institutes	Institutes	NNPS
cord-303447-3a7jxl34	83	17	of	of	IN
cord-303447-3a7jxl34	83	18	Health	Health	NNP
cord-303447-3a7jxl34	83	19	commissioned	commission	VBD
cord-303447-3a7jxl34	83	20	the	the	DT
cord-303447-3a7jxl34	83	21	IOM	IOM	NNP
cord-303447-3a7jxl34	83	22	of	of	IN
cord-303447-3a7jxl34	83	23	the	the	DT
cord-303447-3a7jxl34	83	24	National	National	NNP
cord-303447-3a7jxl34	83	25	Academy	Academy	NNP
cord-303447-3a7jxl34	83	26	of	of	IN
cord-303447-3a7jxl34	83	27	Science	Science	NNP
cord-303447-3a7jxl34	83	28	to	to	TO
cord-303447-3a7jxl34	83	29	convene	convene	VB
cord-303447-3a7jxl34	83	30	an	an	DT
cord-303447-3a7jxl34	83	31	Immunization	Immunization	NNP
cord-303447-3a7jxl34	83	32	Safety	Safety	NNP
cord-303447-3a7jxl34	83	33	Review	Review	NNP
cord-303447-3a7jxl34	83	34	Committee	Committee	NNP
cord-303447-3a7jxl34	83	35	[	[	-LRB-
cord-303447-3a7jxl34	83	36	30	30	CD
cord-303447-3a7jxl34	83	37	]	]	-RRB-
cord-303447-3a7jxl34	83	38	.	.	.
cord-303447-3a7jxl34	84	1	Between	between	IN
cord-303447-3a7jxl34	84	2	2001	2001	CD
cord-303447-3a7jxl34	84	3	and	and	CC
cord-303447-3a7jxl34	84	4	2004	2004	CD
cord-303447-3a7jxl34	84	5	,	,	,
cord-303447-3a7jxl34	84	6	this	this	DT
cord-303447-3a7jxl34	84	7	independent	independent	JJ
cord-303447-3a7jxl34	84	8	expert	expert	NN
cord-303447-3a7jxl34	84	9	committee	committee	NN
cord-303447-3a7jxl34	84	10	published	publish	VBD
cord-303447-3a7jxl34	84	11	eight	eight	CD
cord-303447-3a7jxl34	84	12	reports	report	NNS
cord-303447-3a7jxl34	84	13	related	relate	VBN
cord-303447-3a7jxl34	84	14	to	to	IN
cord-303447-3a7jxl34	84	15	immunization	immunization	NN
cord-303447-3a7jxl34	84	16	safety	safety	NN
cord-303447-3a7jxl34	84	17	concerns	concern	NNS
cord-303447-3a7jxl34	84	18	.	.	.
cord-303447-3a7jxl34	85	1	The	the	DT
cord-303447-3a7jxl34	85	2	committee	committee	NN
cord-303447-3a7jxl34	85	3	has	have	VBZ
cord-303447-3a7jxl34	85	4	made	make	VBN
cord-303447-3a7jxl34	85	5	recommendations	recommendation	NNS
cord-303447-3a7jxl34	85	6	in	in	IN
cord-303447-3a7jxl34	85	7	the	the	DT
cord-303447-3a7jxl34	85	8	areas	area	NNS
cord-303447-3a7jxl34	85	9	of	of	IN
cord-303447-3a7jxl34	85	10	public	public	JJ
cord-303447-3a7jxl34	85	11	health	health	NN
cord-303447-3a7jxl34	85	12	response	response	NN
cord-303447-3a7jxl34	85	13	,	,	,
cord-303447-3a7jxl34	85	14	policy	policy	NN
cord-303447-3a7jxl34	85	15	review	review	NN
cord-303447-3a7jxl34	85	16	,	,	,
cord-303447-3a7jxl34	85	17	research	research	NN
cord-303447-3a7jxl34	85	18	,	,	,
cord-303447-3a7jxl34	85	19	and	and	CC
cord-303447-3a7jxl34	85	20	communications	communication	NNS
cord-303447-3a7jxl34	85	21	(	(	-LRB-
cord-303447-3a7jxl34	85	22	Box	Box	NNP
cord-303447-3a7jxl34	85	23	1	1	CD
cord-303447-3a7jxl34	85	24	)	)	-RRB-
cord-303447-3a7jxl34	85	25	.	.	.
cord-303447-3a7jxl34	86	1	With	with	IN
cord-303447-3a7jxl34	86	2	respect	respect	NN
cord-303447-3a7jxl34	86	3	to	to	IN
cord-303447-3a7jxl34	86	4	autism	autism	NN
cord-303447-3a7jxl34	86	5	,	,	,
cord-303447-3a7jxl34	86	6	the	the	DT
cord-303447-3a7jxl34	86	7	IOM	IOM	NNP
cord-303447-3a7jxl34	86	8	concluded	conclude	VBD
cord-303447-3a7jxl34	86	9	that	that	IN
cord-303447-3a7jxl34	86	10	the	the	DT
cord-303447-3a7jxl34	86	11	body	body	NN
cord-303447-3a7jxl34	86	12	of	of	IN
cord-303447-3a7jxl34	86	13	epidemiologic	epidemiologic	JJ
cord-303447-3a7jxl34	86	14	evidence	evidence	NN
cord-303447-3a7jxl34	86	15	favors	favor	VBZ
cord-303447-3a7jxl34	86	16	rejection	rejection	NN
cord-303447-3a7jxl34	86	17	of	of	IN
cord-303447-3a7jxl34	86	18	a	a	DT
cord-303447-3a7jxl34	86	19	causal	causal	JJ
cord-303447-3a7jxl34	86	20	relationship	relationship	NN
cord-303447-3a7jxl34	86	21	between	between	IN
cord-303447-3a7jxl34	86	22	the	the	DT
cord-303447-3a7jxl34	86	23	MMR	MMR	NNP
cord-303447-3a7jxl34	86	24	vaccine	vaccine	NN
cord-303447-3a7jxl34	86	25	and	and	CC
cord-303447-3a7jxl34	86	26	autism	autism	NN
cord-303447-3a7jxl34	86	27	.	.	.
cord-303447-3a7jxl34	87	1	The	the	DT
cord-303447-3a7jxl34	87	2	committee	committee	NN
cord-303447-3a7jxl34	87	3	also	also	RB
cord-303447-3a7jxl34	87	4	concluded	conclude	VBD
cord-303447-3a7jxl34	87	5	that	that	IN
cord-303447-3a7jxl34	87	6	there	there	EX
cord-303447-3a7jxl34	87	7	is	be	VBZ
cord-303447-3a7jxl34	87	8	no	no	DT
cord-303447-3a7jxl34	87	9	relationship	relationship	NN
cord-303447-3a7jxl34	87	10	between	between	IN
cord-303447-3a7jxl34	87	11	thimerosal	thimerosal	NN
cord-303447-3a7jxl34	87	12	-	-	HYPH
cord-303447-3a7jxl34	87	13	containing	contain	VBG
cord-303447-3a7jxl34	87	14	vaccines	vaccine	NNS
cord-303447-3a7jxl34	87	15	and	and	CC
cord-303447-3a7jxl34	87	16	autism	autism	NN
cord-303447-3a7jxl34	87	17	[	[	-LRB-
cord-303447-3a7jxl34	87	18	30	30	CD
cord-303447-3a7jxl34	87	19	]	]	-RRB-
cord-303447-3a7jxl34	87	20	.	.	.
cord-303447-3a7jxl34	88	1	None	none	NN
cord-303447-3a7jxl34	88	2	of	of	IN
cord-303447-3a7jxl34	88	3	the	the	DT
cord-303447-3a7jxl34	88	4	eight	eight	CD
cord-303447-3a7jxl34	88	5	IOM	IOM	NNP
cord-303447-3a7jxl34	88	6	reports	report	NNS
cord-303447-3a7jxl34	88	7	recommended	recommend	VBD
cord-303447-3a7jxl34	88	8	a	a	DT
cord-303447-3a7jxl34	88	9	policy	policy	NN
cord-303447-3a7jxl34	88	10	review	review	NN
cord-303447-3a7jxl34	88	11	of	of	IN
cord-303447-3a7jxl34	88	12	the	the	DT
cord-303447-3a7jxl34	88	13	current	current	JJ
cord-303447-3a7jxl34	88	14	vaccine	vaccine	NN
cord-303447-3a7jxl34	88	15	recommendations	recommendation	NNS
cord-303447-3a7jxl34	88	16	or	or	CC
cord-303447-3a7jxl34	88	17	change	change	NN
cord-303447-3a7jxl34	88	18	in	in	IN
cord-303447-3a7jxl34	88	19	the	the	DT
cord-303447-3a7jxl34	88	20	immunization	immunization	NN
cord-303447-3a7jxl34	88	21	schedule	schedule	NN
cord-303447-3a7jxl34	88	22	.	.	.
cord-303447-3a7jxl34	89	1	To	to	TO
cord-303447-3a7jxl34	89	2	help	help	VB
cord-303447-3a7jxl34	89	3	ensure	ensure	VB
cord-303447-3a7jxl34	89	4	safety	safety	NN
cord-303447-3a7jxl34	89	5	of	of	IN
cord-303447-3a7jxl34	89	6	vaccines	vaccine	NNS
cord-303447-3a7jxl34	89	7	,	,	,
cord-303447-3a7jxl34	89	8	a	a	DT
cord-303447-3a7jxl34	89	9	robust	robust	JJ
cord-303447-3a7jxl34	89	10	infrastructure	infrastructure	NN
cord-303447-3a7jxl34	89	11	consisting	consisting	NN
cord-303447-3a7jxl34	89	12	of	of	IN
cord-303447-3a7jxl34	89	13	several	several	JJ
cord-303447-3a7jxl34	89	14	systems	system	NNS
cord-303447-3a7jxl34	89	15	has	have	VBZ
cord-303447-3a7jxl34	89	16	been	be	VBN
cord-303447-3a7jxl34	89	17	established	establish	VBN
cord-303447-3a7jxl34	89	18	to	to	TO
cord-303447-3a7jxl34	89	19	monitor	monitor	VB
cord-303447-3a7jxl34	89	20	vaccine	vaccine	NN
cord-303447-3a7jxl34	89	21	safety	safety	NN
cord-303447-3a7jxl34	89	22	after	after	IN
cord-303447-3a7jxl34	89	23	vaccine	vaccine	NN
cord-303447-3a7jxl34	89	24	licensure	licensure	NN
cord-303447-3a7jxl34	89	25	.	.	.
cord-303447-3a7jxl34	90	1	The	the	DT
cord-303447-3a7jxl34	90	2	Vaccine	Vaccine	NNP
cord-303447-3a7jxl34	90	3	Adverse	adverse	JJ
cord-303447-3a7jxl34	90	4	Event	Event	NNP
cord-303447-3a7jxl34	90	5	Reporting	Reporting	NNP
cord-303447-3a7jxl34	90	6	System	System	NNP
cord-303447-3a7jxl34	90	7	,	,	,
cord-303447-3a7jxl34	90	8	operated	operate	VBD
cord-303447-3a7jxl34	90	9	jointly	jointly	RB
cord-303447-3a7jxl34	90	10	by	by	IN
cord-303447-3a7jxl34	90	11	CDC	CDC	NNP
cord-303447-3a7jxl34	90	12	and	and	CC
cord-303447-3a7jxl34	90	13	FDA	FDA	NNP
cord-303447-3a7jxl34	90	14	,	,	,
cord-303447-3a7jxl34	90	15	is	be	VBZ
cord-303447-3a7jxl34	90	16	a	a	DT
cord-303447-3a7jxl34	90	17	national	national	JJ
cord-303447-3a7jxl34	90	18	passive	passive	JJ
cord-303447-3a7jxl34	90	19	surveillance	surveillance	NN
cord-303447-3a7jxl34	90	20	system	system	NN
cord-303447-3a7jxl34	90	21	used	use	VBN
cord-303447-3a7jxl34	90	22	to	to	TO
cord-303447-3a7jxl34	90	23	detect	detect	VB
cord-303447-3a7jxl34	90	24	early	early	JJ
cord-303447-3a7jxl34	90	25	warning	warning	NN
cord-303447-3a7jxl34	90	26	signals	signal	NNS
cord-303447-3a7jxl34	90	27	and	and	CC
cord-303447-3a7jxl34	90	28	generate	generate	VB
cord-303447-3a7jxl34	90	29	hypotheses	hypothesis	NNS
cord-303447-3a7jxl34	90	30	about	about	IN
cord-303447-3a7jxl34	90	31	possible	possible	JJ
cord-303447-3a7jxl34	90	32	new	new	JJ
cord-303447-3a7jxl34	90	33	vaccine	vaccine	NN
cord-303447-3a7jxl34	90	34	adverse	adverse	JJ
cord-303447-3a7jxl34	90	35	events	event	NNS
cord-303447-3a7jxl34	90	36	or	or	CC
cord-303447-3a7jxl34	90	37	changes	change	NNS
cord-303447-3a7jxl34	90	38	in	in	IN
cord-303447-3a7jxl34	90	39	frequency	frequency	NN
cord-303447-3a7jxl34	90	40	of	of	IN
cord-303447-3a7jxl34	90	41	recognized	recognize	VBN
cord-303447-3a7jxl34	90	42	events	event	NNS
cord-303447-3a7jxl34	90	43	[	[	-LRB-
cord-303447-3a7jxl34	90	44	31	31	CD
cord-303447-3a7jxl34	90	45	]	]	-RRB-
cord-303447-3a7jxl34	90	46	.	.	.
cord-303447-3a7jxl34	91	1	Intussusception	intussusception	NN
cord-303447-3a7jxl34	91	2	associated	associate	VBN
cord-303447-3a7jxl34	91	3	with	with	IN
cord-303447-3a7jxl34	91	4	receipt	receipt	NN
cord-303447-3a7jxl34	91	5	of	of	IN
cord-303447-3a7jxl34	91	6	rotavirus	rotavirus	JJ
cord-303447-3a7jxl34	91	7	vaccine	vaccine	NN
cord-303447-3a7jxl34	91	8	,	,	,
cord-303447-3a7jxl34	91	9	leading	lead	VBG
cord-303447-3a7jxl34	91	10	to	to	IN
cord-303447-3a7jxl34	91	11	the	the	DT
cord-303447-3a7jxl34	91	12	withdrawal	withdrawal	NN
cord-303447-3a7jxl34	91	13	of	of	IN
cord-303447-3a7jxl34	91	14	the	the	DT
cord-303447-3a7jxl34	91	15	vaccine	vaccine	NN
cord-303447-3a7jxl34	91	16	from	from	IN
cord-303447-3a7jxl34	91	17	the	the	DT
cord-303447-3a7jxl34	91	18	market	market	NN
cord-303447-3a7jxl34	91	19	in	in	IN
cord-303447-3a7jxl34	91	20	1999	1999	CD
cord-303447-3a7jxl34	91	21	,	,	,
cord-303447-3a7jxl34	91	22	was	be	VBD
cord-303447-3a7jxl34	91	23	an	an	DT
cord-303447-3a7jxl34	91	24	adverse	adverse	JJ
cord-303447-3a7jxl34	91	25	event	event	NN
cord-303447-3a7jxl34	91	26	detected	detect	VBN
cord-303447-3a7jxl34	91	27	by	by	IN
cord-303447-3a7jxl34	91	28	the	the	DT
cord-303447-3a7jxl34	91	29	Vaccine	Vaccine	NNP
cord-303447-3a7jxl34	91	30	Adverse	Adverse	NNP
cord-303447-3a7jxl34	91	31	Event	Event	NNP
cord-303447-3a7jxl34	91	32	Reporting	Reporting	NNP
cord-303447-3a7jxl34	91	33	System	System	NNP
cord-303447-3a7jxl34	91	34	[	[	-LRB-
cord-303447-3a7jxl34	91	35	31	31	CD
cord-303447-3a7jxl34	91	36	,	,	,
cord-303447-3a7jxl34	91	37	32	32	CD
cord-303447-3a7jxl34	91	38	]	]	-RRB-
cord-303447-3a7jxl34	91	39	.	.	.
cord-303447-3a7jxl34	92	1	A	a	DT
cord-303447-3a7jxl34	92	2	third	third	JJ
cord-303447-3a7jxl34	92	3	system	system	NN
cord-303447-3a7jxl34	92	4	is	be	VBZ
cord-303447-3a7jxl34	92	5	the	the	DT
cord-303447-3a7jxl34	92	6	Vaccine	Vaccine	NNP
cord-303447-3a7jxl34	92	7	Safety	Safety	NNP
cord-303447-3a7jxl34	92	8	Datalink	Datalink	NNP
cord-303447-3a7jxl34	92	9	,	,	,
cord-303447-3a7jxl34	92	10	which	which	WDT
cord-303447-3a7jxl34	92	11	consists	consist	VBZ
cord-303447-3a7jxl34	92	12	of	of	IN
cord-303447-3a7jxl34	92	13	large	large	JJ
cord-303447-3a7jxl34	92	14	linked	link	VBN
cord-303447-3a7jxl34	92	15	databases	database	NNS
cord-303447-3a7jxl34	92	16	from	from	IN
cord-303447-3a7jxl34	92	17	health	health	NN
cord-303447-3a7jxl34	92	18	maintenance	maintenance	NN
cord-303447-3a7jxl34	92	19	organizations	organization	NNS
cord-303447-3a7jxl34	92	20	.	.	.
cord-303447-3a7jxl34	93	1	Associations	association	NNS
cord-303447-3a7jxl34	93	2	between	between	IN
cord-303447-3a7jxl34	93	3	serious	serious	JJ
cord-303447-3a7jxl34	93	4	medical	medical	JJ
cord-303447-3a7jxl34	93	5	events	event	NNS
cord-303447-3a7jxl34	93	6	and	and	CC
cord-303447-3a7jxl34	93	7	immunizations	immunization	NNS
cord-303447-3a7jxl34	93	8	can	can	MD
cord-303447-3a7jxl34	93	9	be	be	VB
cord-303447-3a7jxl34	93	10	evaluated	evaluate	VBN
cord-303447-3a7jxl34	93	11	through	through	IN
cord-303447-3a7jxl34	93	12	the	the	DT
cord-303447-3a7jxl34	93	13	Vaccine	Vaccine	NNP
cord-303447-3a7jxl34	93	14	Safety	Safety	NNP
cord-303447-3a7jxl34	93	15	Datalink	Datalink	NNP
cord-303447-3a7jxl34	93	16	.	.	.
cord-303447-3a7jxl34	94	1	The	the	DT
cord-303447-3a7jxl34	94	2	newest	new	JJS
cord-303447-3a7jxl34	94	3	system	system	NN
cord-303447-3a7jxl34	94	4	is	be	VBZ
cord-303447-3a7jxl34	94	5	the	the	DT
cord-303447-3a7jxl34	94	6	Clinical	Clinical	NNP
cord-303447-3a7jxl34	94	7	Immunization	Immunization	NNP
cord-303447-3a7jxl34	94	8	Safety	Safety	NNP
cord-303447-3a7jxl34	94	9	Assessment	Assessment	NNP
cord-303447-3a7jxl34	94	10	Centers	Centers	NNPS
cord-303447-3a7jxl34	94	11	network	network	NN
cord-303447-3a7jxl34	94	12	,	,	,
cord-303447-3a7jxl34	94	13	which	which	WDT
cord-303447-3a7jxl34	94	14	consists	consist	VBZ
cord-303447-3a7jxl34	94	15	of	of	IN
cord-303447-3a7jxl34	94	16	selected	select	VBN
cord-303447-3a7jxl34	94	17	clinical	clinical	JJ
cord-303447-3a7jxl34	94	18	academic	academic	JJ
cord-303447-3a7jxl34	94	19	medical	medical	JJ
cord-303447-3a7jxl34	94	20	centers	center	NNS
cord-303447-3a7jxl34	94	21	in	in	IN
cord-303447-3a7jxl34	94	22	partnership	partnership	NN
cord-303447-3a7jxl34	94	23	with	with	IN
cord-303447-3a7jxl34	94	24	CDC	CDC	NNP
cord-303447-3a7jxl34	94	25	to	to	TO
cord-303447-3a7jxl34	94	26	study	study	VB
cord-303447-3a7jxl34	94	27	the	the	DT
cord-303447-3a7jxl34	94	28	pathophysiology	pathophysiology	NN
cord-303447-3a7jxl34	94	29	of	of	IN
cord-303447-3a7jxl34	94	30	vaccine	vaccine	NN
cord-303447-3a7jxl34	94	31	reactions	reaction	NNS
cord-303447-3a7jxl34	94	32	and	and	CC
cord-303447-3a7jxl34	94	33	develop	develop	VB
cord-303447-3a7jxl34	94	34	clinical	clinical	JJ
cord-303447-3a7jxl34	94	35	management	management	NN
cord-303447-3a7jxl34	94	36	protocols	protocol	NNS
cord-303447-3a7jxl34	94	37	for	for	IN
cord-303447-3a7jxl34	94	38	affected	affected	JJ
cord-303447-3a7jxl34	94	39	patients	patient	NNS
cord-303447-3a7jxl34	94	40	[	[	-LRB-
cord-303447-3a7jxl34	94	41	34	34	CD
cord-303447-3a7jxl34	94	42	]	]	-RRB-
cord-303447-3a7jxl34	94	43	.	.	.
cord-303447-3a7jxl34	95	1	These	these	DT
cord-303447-3a7jxl34	95	2	systems	system	NNS
cord-303447-3a7jxl34	95	3	are	be	VBP
cord-303447-3a7jxl34	95	4	crucial	crucial	JJ
cord-303447-3a7jxl34	95	5	to	to	IN
cord-303447-3a7jxl34	95	6	the	the	DT
cord-303447-3a7jxl34	95	7	vitality	vitality	NN
cord-303447-3a7jxl34	95	8	and	and	CC
cord-303447-3a7jxl34	95	9	strength	strength	NN
cord-303447-3a7jxl34	95	10	of	of	IN
cord-303447-3a7jxl34	95	11	the	the	DT
cord-303447-3a7jxl34	95	12	US	US	NNP
cord-303447-3a7jxl34	95	13	immunization	immunization	NN
cord-303447-3a7jxl34	95	14	program	program	NN
cord-303447-3a7jxl34	95	15	.	.	.
cord-303447-3a7jxl34	96	1	Since	since	IN
cord-303447-3a7jxl34	96	2	its	-PRON-	PRP$
cord-303447-3a7jxl34	96	3	inception	inception	NN
cord-303447-3a7jxl34	96	4	,	,	,
cord-303447-3a7jxl34	96	5	the	the	DT
cord-303447-3a7jxl34	96	6	major	major	JJ
cord-303447-3a7jxl34	96	7	focus	focus	NN
cord-303447-3a7jxl34	96	8	of	of	IN
cord-303447-3a7jxl34	96	9	the	the	DT
cord-303447-3a7jxl34	96	10	US	US	NNP
cord-303447-3a7jxl34	96	11	immunization	immunization	NN
cord-303447-3a7jxl34	96	12	program	program	NN
cord-303447-3a7jxl34	96	13	has	have	VBZ
cord-303447-3a7jxl34	96	14	been	be	VBN
cord-303447-3a7jxl34	96	15	on	on	IN
cord-303447-3a7jxl34	96	16	vaccinating	vaccinate	VBG
cord-303447-3a7jxl34	96	17	infants	infant	NNS
cord-303447-3a7jxl34	96	18	and	and	CC
cord-303447-3a7jxl34	96	19	young	young	JJ
cord-303447-3a7jxl34	96	20	children	child	NNS
cord-303447-3a7jxl34	96	21	.	.	.
cord-303447-3a7jxl34	97	1	Of	of	IN
cord-303447-3a7jxl34	97	2	the	the	DT
cord-303447-3a7jxl34	97	3	10	10	CD
cord-303447-3a7jxl34	97	4	vaccines	vaccine	NNS
cord-303447-3a7jxl34	97	5	routinely	routinely	RB
cord-303447-3a7jxl34	97	6	recommended	recommend	VBN
cord-303447-3a7jxl34	97	7	for	for	IN
cord-303447-3a7jxl34	97	8	children	child	NNS
cord-303447-3a7jxl34	97	9	and	and	CC
cord-303447-3a7jxl34	97	10	adolescents	adolescent	NNS
cord-303447-3a7jxl34	97	11	,	,	,
cord-303447-3a7jxl34	97	12	only	only	RB
cord-303447-3a7jxl34	97	13	two	two	CD
cord-303447-3a7jxl34	97	14	,	,	,
cord-303447-3a7jxl34	97	15	Td	Td	NNP
cord-303447-3a7jxl34	97	16	vaccine	vaccine	NN
cord-303447-3a7jxl34	97	17	and	and	CC
cord-303447-3a7jxl34	97	18	the	the	DT
cord-303447-3a7jxl34	97	19	MCV4	MCV4	NNP
cord-303447-3a7jxl34	97	20	,	,	,
cord-303447-3a7jxl34	97	21	are	be	VBP
cord-303447-3a7jxl34	97	22	recommended	recommend	VBN
cord-303447-3a7jxl34	97	23	for	for	IN
cord-303447-3a7jxl34	97	24	all	all	DT
cord-303447-3a7jxl34	97	25	adolescents	adolescent	NNS
cord-303447-3a7jxl34	97	26	[	[	-LRB-
cord-303447-3a7jxl34	97	27	8	8	CD
cord-303447-3a7jxl34	97	28	]	]	-RRB-
cord-303447-3a7jxl34	97	29	.	.	.
cord-303447-3a7jxl34	98	1	In	in	IN
cord-303447-3a7jxl34	98	2	1996	1996	CD
cord-303447-3a7jxl34	98	3	,	,	,
cord-303447-3a7jxl34	98	4	as	as	IN
cord-303447-3a7jxl34	98	5	a	a	DT
cord-303447-3a7jxl34	98	6	result	result	NN
cord-303447-3a7jxl34	98	7	of	of	IN
cord-303447-3a7jxl34	98	8	growing	grow	VBG
cord-303447-3a7jxl34	98	9	concern	concern	NN
cord-303447-3a7jxl34	98	10	about	about	IN
cord-303447-3a7jxl34	98	11	morbidity	morbidity	NN
cord-303447-3a7jxl34	98	12	associated	associate	VBN
cord-303447-3a7jxl34	98	13	with	with	IN
cord-303447-3a7jxl34	98	14	vaccine	vaccine	NN
cord-303447-3a7jxl34	98	15	-	-	HYPH
cord-303447-3a7jxl34	98	16	preventable	preventable	JJ
cord-303447-3a7jxl34	98	17	diseases	disease	NNS
cord-303447-3a7jxl34	98	18	in	in	IN
cord-303447-3a7jxl34	98	19	the	the	DT
cord-303447-3a7jxl34	98	20	hard	hard	JJ
cord-303447-3a7jxl34	98	21	-	-	HYPH
cord-303447-3a7jxl34	98	22	to	to	TO
cord-303447-3a7jxl34	98	23	-	-	HYPH
cord-303447-3a7jxl34	98	24	reach	reach	VB
cord-303447-3a7jxl34	98	25	adolescent	adolescent	JJ
cord-303447-3a7jxl34	98	26	population	population	NN
cord-303447-3a7jxl34	98	27	,	,	,
cord-303447-3a7jxl34	98	28	the	the	DT
cord-303447-3a7jxl34	98	29	ACIP	ACIP	NNP
cord-303447-3a7jxl34	98	30	recommended	recommend	VBD
cord-303447-3a7jxl34	98	31	expanding	expand	VBG
cord-303447-3a7jxl34	98	32	efforts	effort	NNS
cord-303447-3a7jxl34	98	33	to	to	TO
cord-303447-3a7jxl34	98	34	immunize	immunize	VB
cord-303447-3a7jxl34	98	35	adolescents	adolescent	NNS
cord-303447-3a7jxl34	98	36	(	(	-LRB-
cord-303447-3a7jxl34	98	37	11	11	CD
cord-303447-3a7jxl34	98	38	-	-	SYM
cord-303447-3a7jxl34	98	39	21	21	CD
cord-303447-3a7jxl34	98	40	years	year	NNS
cord-303447-3a7jxl34	98	41	old	old	JJ
cord-303447-3a7jxl34	98	42	)	)	-RRB-
cord-303447-3a7jxl34	98	43	by	by	IN
cord-303447-3a7jxl34	98	44	establishing	establish	VBG
cord-303447-3a7jxl34	98	45	a	a	DT
cord-303447-3a7jxl34	98	46	routine	routine	JJ
cord-303447-3a7jxl34	98	47	vaccination	vaccination	NN
cord-303447-3a7jxl34	98	48	visit	visit	NN
cord-303447-3a7jxl34	98	49	at	at	IN
cord-303447-3a7jxl34	98	50	11	11	CD
cord-303447-3a7jxl34	98	51	to	to	TO
cord-303447-3a7jxl34	98	52	12	12	CD
cord-303447-3a7jxl34	98	53	years	year	NNS
cord-303447-3a7jxl34	98	54	old	old	JJ
cord-303447-3a7jxl34	98	55	[	[	-LRB-
cord-303447-3a7jxl34	98	56	35	35	CD
cord-303447-3a7jxl34	98	57	]	]	-RRB-
cord-303447-3a7jxl34	98	58	.	.	.
cord-303447-3a7jxl34	99	1	In	in	IN
cord-303447-3a7jxl34	99	2	addition	addition	NN
cord-303447-3a7jxl34	99	3	to	to	IN
cord-303447-3a7jxl34	99	4	providing	provide	VBG
cord-303447-3a7jxl34	99	5	Td	Td	NNP
cord-303447-3a7jxl34	99	6	and	and	CC
cord-303447-3a7jxl34	99	7	previously	previously	RB
cord-303447-3a7jxl34	99	8	missed	miss	VBN
cord-303447-3a7jxl34	99	9	vaccinations	vaccination	NNS
cord-303447-3a7jxl34	99	10	,	,	,
cord-303447-3a7jxl34	99	11	the	the	DT
cord-303447-3a7jxl34	99	12	report	report	NN
cord-303447-3a7jxl34	99	13	emphasized	emphasize	VBD
cord-303447-3a7jxl34	99	14	that	that	IN
cord-303447-3a7jxl34	99	15	this	this	DT
cord-303447-3a7jxl34	99	16	visit	visit	NN
cord-303447-3a7jxl34	99	17	should	should	MD
cord-303447-3a7jxl34	99	18	be	be	VB
cord-303447-3a7jxl34	99	19	used	use	VBN
cord-303447-3a7jxl34	99	20	to	to	TO
cord-303447-3a7jxl34	99	21	provide	provide	VB
cord-303447-3a7jxl34	99	22	other	other	JJ
cord-303447-3a7jxl34	99	23	important	important	JJ
cord-303447-3a7jxl34	99	24	preventive	preventive	JJ
cord-303447-3a7jxl34	99	25	health	health	NN
cord-303447-3a7jxl34	99	26	services	service	NNS
cord-303447-3a7jxl34	99	27	.	.	.
cord-303447-3a7jxl34	100	1	The	the	DT
cord-303447-3a7jxl34	100	2	anticipated	anticipated	JJ
cord-303447-3a7jxl34	100	3	addition	addition	NN
cord-303447-3a7jxl34	100	4	of	of	IN
cord-303447-3a7jxl34	100	5	several	several	JJ
cord-303447-3a7jxl34	100	6	new	new	JJ
cord-303447-3a7jxl34	100	7	adolescent	adolescent	JJ
cord-303447-3a7jxl34	100	8	vaccines	vaccine	NNS
cord-303447-3a7jxl34	100	9	to	to	IN
cord-303447-3a7jxl34	100	10	the	the	DT
cord-303447-3a7jxl34	100	11	recommended	recommend	VBN
cord-303447-3a7jxl34	100	12	schedule	schedule	NN
cord-303447-3a7jxl34	100	13	has	have	VBZ
cord-303447-3a7jxl34	100	14	stimulated	stimulate	VBN
cord-303447-3a7jxl34	100	15	a	a	DT
cord-303447-3a7jxl34	100	16	reappraisal	reappraisal	NN
cord-303447-3a7jxl34	100	17	of	of	IN
cord-303447-3a7jxl34	100	18	the	the	DT
cord-303447-3a7jxl34	100	19	approaches	approach	NNS
cord-303447-3a7jxl34	100	20	that	that	WDT
cord-303447-3a7jxl34	100	21	most	most	RBS
cord-303447-3a7jxl34	100	22	effectively	effectively	RB
cord-303447-3a7jxl34	100	23	and	and	CC
cord-303447-3a7jxl34	100	24	efficiently	efficiently	RB
cord-303447-3a7jxl34	100	25	would	would	MD
cord-303447-3a7jxl34	100	26	increase	increase	VB
cord-303447-3a7jxl34	100	27	the	the	DT
cord-303447-3a7jxl34	100	28	proportion	proportion	NN
cord-303447-3a7jxl34	100	29	of	of	IN
cord-303447-3a7jxl34	100	30	adolescents	adolescent	NNS
cord-303447-3a7jxl34	100	31	who	who	WP
cord-303447-3a7jxl34	100	32	receive	receive	VBP
cord-303447-3a7jxl34	100	33	newly	newly	RB
cord-303447-3a7jxl34	100	34	recommended	recommend	VBN
cord-303447-3a7jxl34	100	35	vaccines	vaccine	NNS
cord-303447-3a7jxl34	100	36	and	and	CC
cord-303447-3a7jxl34	100	37	develop	develop	VB
cord-303447-3a7jxl34	100	38	ways	way	NNS
cord-303447-3a7jxl34	100	39	to	to	TO
cord-303447-3a7jxl34	100	40	integrate	integrate	VB
cord-303447-3a7jxl34	100	41	these	these	DT
cord-303447-3a7jxl34	100	42	approaches	approach	NNS
cord-303447-3a7jxl34	100	43	with	with	IN
cord-303447-3a7jxl34	100	44	other	other	JJ
cord-303447-3a7jxl34	100	45	adolescent	adolescent	JJ
cord-303447-3a7jxl34	100	46	health	health	NN
cord-303447-3a7jxl34	100	47	,	,	,
cord-303447-3a7jxl34	100	48	education	education	NN
cord-303447-3a7jxl34	100	49	,	,	,
cord-303447-3a7jxl34	100	50	and	and	CC
cord-303447-3a7jxl34	100	51	development	development	NN
cord-303447-3a7jxl34	100	52	programs	program	NNS
cord-303447-3a7jxl34	100	53	.	.	.
cord-303447-3a7jxl34	101	1	Similar	similar	JJ
cord-303447-3a7jxl34	101	2	to	to	IN
cord-303447-3a7jxl34	101	3	all	all	DT
cord-303447-3a7jxl34	101	4	aspects	aspect	NNS
cord-303447-3a7jxl34	101	5	of	of	IN
cord-303447-3a7jxl34	101	6	clinical	clinical	JJ
cord-303447-3a7jxl34	101	7	medicine	medicine	NN
cord-303447-3a7jxl34	101	8	,	,	,
cord-303447-3a7jxl34	101	9	immunization	immunization	NN
cord-303447-3a7jxl34	101	10	recommendations	recommendation	NNS
cord-303447-3a7jxl34	101	11	continuously	continuously	RB
cord-303447-3a7jxl34	101	12	change	change	VBP
cord-303447-3a7jxl34	101	13	as	as	IN
cord-303447-3a7jxl34	101	14	new	new	JJ
cord-303447-3a7jxl34	101	15	vaccines	vaccine	NNS
cord-303447-3a7jxl34	101	16	are	be	VBP
cord-303447-3a7jxl34	101	17	licensed	licensed	JJ
cord-303447-3a7jxl34	101	18	and	and	CC
cord-303447-3a7jxl34	101	19	new	new	JJ
cord-303447-3a7jxl34	101	20	information	information	NN
cord-303447-3a7jxl34	101	21	becomes	become	VBZ
cord-303447-3a7jxl34	101	22	available	available	JJ
cord-303447-3a7jxl34	101	23	.	.	.
cord-303447-3a7jxl34	102	1	Since	since	IN
cord-303447-3a7jxl34	102	2	1990	1990	CD
cord-303447-3a7jxl34	102	3	,	,	,
cord-303447-3a7jxl34	102	4	several	several	JJ
cord-303447-3a7jxl34	102	5	new	new	JJ
cord-303447-3a7jxl34	102	6	vaccination	vaccination	NN
cord-303447-3a7jxl34	102	7	recommendations	recommendation	NNS
cord-303447-3a7jxl34	102	8	were	be	VBD
cord-303447-3a7jxl34	102	9	implemented	implement	VBN
cord-303447-3a7jxl34	102	10	for	for	IN
cord-303447-3a7jxl34	102	11	existing	exist	VBG
cord-303447-3a7jxl34	102	12	and	and	CC
cord-303447-3a7jxl34	102	13	new	new	JJ
cord-303447-3a7jxl34	102	14	vaccines	vaccine	NNS
cord-303447-3a7jxl34	102	15	.	.	.
cord-303447-3a7jxl34	103	1	Notable	notable	JJ
cord-303447-3a7jxl34	103	2	examples	example	NNS
cord-303447-3a7jxl34	103	3	are	be	VBP
cord-303447-3a7jxl34	103	4	PCV7	PCV7	NNP
cord-303447-3a7jxl34	103	5	and	and	CC
cord-303447-3a7jxl34	103	6	the	the	DT
cord-303447-3a7jxl34	103	7	hepatitis	hepatitis	NN
cord-303447-3a7jxl34	103	8	B	B	NNP
cord-303447-3a7jxl34	103	9	vaccine	vaccine	NN
cord-303447-3a7jxl34	103	10	;	;	:
cord-303447-3a7jxl34	103	11	new	new	JJ
cord-303447-3a7jxl34	103	12	recommendations	recommendation	NNS
cord-303447-3a7jxl34	103	13	for	for	IN
cord-303447-3a7jxl34	103	14	both	both	DT
cord-303447-3a7jxl34	103	15	have	have	VBP
cord-303447-3a7jxl34	103	16	affected	affect	VBN
cord-303447-3a7jxl34	103	17	children	child	NNS
cord-303447-3a7jxl34	103	18	and	and	CC
cord-303447-3a7jxl34	103	19	health	health	NN
cord-303447-3a7jxl34	103	20	care	care	NN
cord-303447-3a7jxl34	103	21	providers	provider	NNS
cord-303447-3a7jxl34	103	22	.	.	.
cord-303447-3a7jxl34	104	1	Several	several	JJ
cord-303447-3a7jxl34	104	2	vaccines	vaccine	NNS
cord-303447-3a7jxl34	104	3	with	with	IN
cord-303447-3a7jxl34	104	4	expected	expect	VBN
cord-303447-3a7jxl34	104	5	FDA	FDA	NNP
cord-303447-3a7jxl34	104	6	licensure	licensure	NN
cord-303447-3a7jxl34	104	7	in	in	IN
cord-303447-3a7jxl34	104	8	the	the	DT
cord-303447-3a7jxl34	104	9	near	near	JJ
cord-303447-3a7jxl34	104	10	future	future	NN
cord-303447-3a7jxl34	104	11	likely	likely	RB
cord-303447-3a7jxl34	104	12	will	will	MD
cord-303447-3a7jxl34	104	13	alter	alter	VB
cord-303447-3a7jxl34	104	14	the	the	DT
cord-303447-3a7jxl34	104	15	US	US	NNP
cord-303447-3a7jxl34	104	16	immunization	immunization	NN
cord-303447-3a7jxl34	104	17	program	program	NN
cord-303447-3a7jxl34	104	18	and	and	CC
cord-303447-3a7jxl34	104	19	preventive	preventive	JJ
cord-303447-3a7jxl34	104	20	health	health	NN
cord-303447-3a7jxl34	104	21	care	care	NN
cord-303447-3a7jxl34	104	22	practices	practice	NNS
cord-303447-3a7jxl34	104	23	(	(	-LRB-
cord-303447-3a7jxl34	104	24	Table	table	NN
cord-303447-3a7jxl34	104	25	6	6	CD
cord-303447-3a7jxl34	104	26	)	)	-RRB-
cord-303447-3a7jxl34	104	27	.	.	.
cord-303447-3a7jxl34	105	1	Vaccines	vaccine	NNS
cord-303447-3a7jxl34	105	2	with	with	IN
cord-303447-3a7jxl34	105	3	a	a	DT
cord-303447-3a7jxl34	105	4	pediatric	pediatric	JJ
cord-303447-3a7jxl34	105	5	or	or	CC
cord-303447-3a7jxl34	105	6	adolescent	adolescent	JJ
cord-303447-3a7jxl34	105	7	focus	focus	NN
cord-303447-3a7jxl34	105	8	under	under	IN
cord-303447-3a7jxl34	105	9	review	review	NN
cord-303447-3a7jxl34	105	10	by	by	IN
cord-303447-3a7jxl34	105	11	the	the	DT
cord-303447-3a7jxl34	105	12	ACIP	ACIP	NNP
cord-303447-3a7jxl34	105	13	are	be	VBP
cord-303447-3a7jxl34	105	14	relevant	relevant	JJ
cord-303447-3a7jxl34	105	15	to	to	IN
cord-303447-3a7jxl34	105	16	the	the	DT
cord-303447-3a7jxl34	105	17	prevention	prevention	NN
cord-303447-3a7jxl34	105	18	of	of	IN
cord-303447-3a7jxl34	105	19	pertussis	pertussis	NN
cord-303447-3a7jxl34	105	20	,	,	,
cord-303447-3a7jxl34	105	21	human	human	JJ
cord-303447-3a7jxl34	105	22	papillomavirus	papillomavirus	NN
cord-303447-3a7jxl34	105	23	(	(	-LRB-
cord-303447-3a7jxl34	105	24	HPV	HPV	NNP
cord-303447-3a7jxl34	105	25	)	)	-RRB-
cord-303447-3a7jxl34	105	26	,	,	,
cord-303447-3a7jxl34	105	27	influenza	influenza	NN
cord-303447-3a7jxl34	105	28	,	,	,
cord-303447-3a7jxl34	105	29	varicella	varicella	NN
cord-303447-3a7jxl34	105	30	,	,	,
cord-303447-3a7jxl34	105	31	and	and	CC
cord-303447-3a7jxl34	105	32	rotavirus	rotavirus	NN
cord-303447-3a7jxl34	105	33	.	.	.
cord-303447-3a7jxl34	106	1	This	this	DT
cord-303447-3a7jxl34	106	2	section	section	NN
cord-303447-3a7jxl34	106	3	presents	present	VBZ
cord-303447-3a7jxl34	106	4	a	a	DT
cord-303447-3a7jxl34	106	5	summary	summary	NN
cord-303447-3a7jxl34	106	6	of	of	IN
cord-303447-3a7jxl34	106	7	these	these	DT
cord-303447-3a7jxl34	106	8	vaccines	vaccine	NNS
cord-303447-3a7jxl34	106	9	in	in	IN
cord-303447-3a7jxl34	106	10	addition	addition	NN
cord-303447-3a7jxl34	106	11	to	to	IN
cord-303447-3a7jxl34	106	12	information	information	NN
cord-303447-3a7jxl34	106	13	on	on	IN
cord-303447-3a7jxl34	106	14	PCV7	PCV7	NNP
cord-303447-3a7jxl34	106	15	,	,	,
cord-303447-3a7jxl34	106	16	hepatitis	hepatitis	NNP
cord-303447-3a7jxl34	106	17	B	B	NNP
cord-303447-3a7jxl34	106	18	vaccine	vaccine	NN
cord-303447-3a7jxl34	106	19	,	,	,
cord-303447-3a7jxl34	106	20	and	and	CC
cord-303447-3a7jxl34	106	21	MCV4	MCV4	NNP
cord-303447-3a7jxl34	106	22	.	.	.
cord-303447-3a7jxl34	107	1	The	the	DT
cord-303447-3a7jxl34	107	2	potential	potential	JJ
cord-303447-3a7jxl34	107	3	impact	impact	NN
cord-303447-3a7jxl34	107	4	of	of	IN
cord-303447-3a7jxl34	107	5	vaccines	vaccine	NNS
cord-303447-3a7jxl34	107	6	on	on	IN
cord-303447-3a7jxl34	107	7	the	the	DT
cord-303447-3a7jxl34	107	8	distant	distant	JJ
cord-303447-3a7jxl34	107	9	horizon	horizon	NN
cord-303447-3a7jxl34	107	10	also	also	RB
cord-303447-3a7jxl34	107	11	will	will	MD
cord-303447-3a7jxl34	107	12	be	be	VB
cord-303447-3a7jxl34	107	13	highlighted	highlight	VBN
cord-303447-3a7jxl34	107	14	.	.	.
cord-303447-3a7jxl34	108	1	Emphasis	emphasis	NN
cord-303447-3a7jxl34	108	2	is	be	VBZ
cord-303447-3a7jxl34	108	3	on	on	IN
cord-303447-3a7jxl34	108	4	how	how	WRB
cord-303447-3a7jxl34	108	5	recent	recent	JJ
cord-303447-3a7jxl34	108	6	and	and	CC
cord-303447-3a7jxl34	108	7	upcoming	upcoming	JJ
cord-303447-3a7jxl34	108	8	policy	policy	NN
cord-303447-3a7jxl34	108	9	decisions	decision	NNS
cord-303447-3a7jxl34	108	10	might	may	MD
cord-303447-3a7jxl34	108	11	affect	affect	VB
cord-303447-3a7jxl34	108	12	children	child	NNS
cord-303447-3a7jxl34	108	13	and	and	CC
cord-303447-3a7jxl34	108	14	adolescents	adolescent	NNS
cord-303447-3a7jxl34	108	15	,	,	,
cord-303447-3a7jxl34	108	16	health	health	NN
cord-303447-3a7jxl34	108	17	care	care	NN
cord-303447-3a7jxl34	108	18	providers	provider	NNS
cord-303447-3a7jxl34	108	19	,	,	,
cord-303447-3a7jxl34	108	20	and	and	CC
cord-303447-3a7jxl34	108	21	society	society	NN
cord-303447-3a7jxl34	108	22	during	during	IN
cord-303447-3a7jxl34	108	23	the	the	DT
cord-303447-3a7jxl34	108	24	next	next	JJ
cord-303447-3a7jxl34	108	25	decade	decade	NN
cord-303447-3a7jxl34	108	26	.	.	.
cord-303447-3a7jxl34	108	27	 	 	_SP
cord-303447-3a7jxl34	109	1	PCV7	PCV7	NNP
cord-303447-3a7jxl34	109	2	was	be	VBD
cord-303447-3a7jxl34	109	3	recommended	recommend	VBN
cord-303447-3a7jxl34	109	4	for	for	IN
cord-303447-3a7jxl34	109	5	routine	routine	JJ
cord-303447-3a7jxl34	109	6	use	use	NN
cord-303447-3a7jxl34	109	7	in	in	IN
cord-303447-3a7jxl34	109	8	infants	infant	NNS
cord-303447-3a7jxl34	109	9	in	in	IN
cord-303447-3a7jxl34	109	10	the	the	DT
cord-303447-3a7jxl34	109	11	United	United	NNP
cord-303447-3a7jxl34	109	12	States	States	NNP
cord-303447-3a7jxl34	109	13	beginning	begin	VBG
cord-303447-3a7jxl34	109	14	in	in	IN
cord-303447-3a7jxl34	109	15	2000	2000	CD
cord-303447-3a7jxl34	109	16	.	.	.
cord-303447-3a7jxl34	110	1	Before	before	IN
cord-303447-3a7jxl34	110	2	introduction	introduction	NN
cord-303447-3a7jxl34	110	3	of	of	IN
cord-303447-3a7jxl34	110	4	PCV7	PCV7	NNP
cord-303447-3a7jxl34	110	5	,	,	,
cord-303447-3a7jxl34	110	6	Streptococcus	Streptococcus	NNP
cord-303447-3a7jxl34	110	7	pneumoniae	pneumoniae	NN
cord-303447-3a7jxl34	110	8	(	(	-LRB-
cord-303447-3a7jxl34	110	9	pneumococcus	pneumococcus	NNP
cord-303447-3a7jxl34	110	10	)	)	-RRB-
cord-303447-3a7jxl34	110	11	was	be	VBD
cord-303447-3a7jxl34	110	12	a	a	DT
cord-303447-3a7jxl34	110	13	leading	leading	JJ
cord-303447-3a7jxl34	110	14	cause	cause	NN
cord-303447-3a7jxl34	110	15	of	of	IN
cord-303447-3a7jxl34	110	16	infectious	infectious	JJ
cord-303447-3a7jxl34	110	17	morbidity	morbidity	NN
cord-303447-3a7jxl34	110	18	in	in	IN
cord-303447-3a7jxl34	110	19	young	young	JJ
cord-303447-3a7jxl34	110	20	children	child	NNS
cord-303447-3a7jxl34	110	21	in	in	IN
cord-303447-3a7jxl34	110	22	the	the	DT
cord-303447-3a7jxl34	110	23	United	United	NNP
cord-303447-3a7jxl34	110	24	States	States	NNP
cord-303447-3a7jxl34	110	25	,	,	,
cord-303447-3a7jxl34	110	26	annually	annually	RB
cord-303447-3a7jxl34	110	27	causing	cause	VBG
cord-303447-3a7jxl34	110	28	approximately	approximately	RB
cord-303447-3a7jxl34	110	29	17,000	17,000	CD
cord-303447-3a7jxl34	110	30	cases	case	NNS
cord-303447-3a7jxl34	110	31	of	of	IN
cord-303447-3a7jxl34	110	32	invasive	invasive	JJ
cord-303447-3a7jxl34	110	33	disease	disease	NN
cord-303447-3a7jxl34	110	34	in	in	IN
cord-303447-3a7jxl34	110	35	children	child	NNS
cord-303447-3a7jxl34	110	36	younger	young	JJR
cord-303447-3a7jxl34	110	37	than	than	IN
cord-303447-3a7jxl34	110	38	5	5	CD
cord-303447-3a7jxl34	110	39	years	year	NNS
cord-303447-3a7jxl34	110	40	old	old	JJ
cord-303447-3a7jxl34	110	41	,	,	,
cord-303447-3a7jxl34	110	42	including	include	VBG
cord-303447-3a7jxl34	110	43	700	700	CD
cord-303447-3a7jxl34	110	44	cases	case	NNS
cord-303447-3a7jxl34	110	45	of	of	IN
cord-303447-3a7jxl34	110	46	meningitis	meningitis	NN
cord-303447-3a7jxl34	110	47	and	and	CC
cord-303447-3a7jxl34	110	48	200	200	CD
cord-303447-3a7jxl34	110	49	deaths	death	NNS
cord-303447-3a7jxl34	110	50	.	.	.
cord-303447-3a7jxl34	111	1	In	in	IN
cord-303447-3a7jxl34	111	2	addition	addition	NN
cord-303447-3a7jxl34	111	3	,	,	,
cord-303447-3a7jxl34	111	4	the	the	DT
cord-303447-3a7jxl34	111	5	burden	burden	NN
cord-303447-3a7jxl34	111	6	of	of	IN
cord-303447-3a7jxl34	111	7	pneumonia	pneumonia	NN
cord-303447-3a7jxl34	111	8	without	without	IN
cord-303447-3a7jxl34	111	9	bacteremia	bacteremia	NN
cord-303447-3a7jxl34	111	10	,	,	,
cord-303447-3a7jxl34	111	11	otitis	otitis	NN
cord-303447-3a7jxl34	111	12	media	medium	NNS
cord-303447-3a7jxl34	111	13	,	,	,
cord-303447-3a7jxl34	111	14	and	and	CC
cord-303447-3a7jxl34	111	15	sinusitis	sinusitis	NN
cord-303447-3a7jxl34	111	16	was	be	VBD
cord-303447-3a7jxl34	111	17	substantial	substantial	JJ
cord-303447-3a7jxl34	111	18	[	[	-LRB-
cord-303447-3a7jxl34	111	19	36	36	CD
cord-303447-3a7jxl34	111	20	]	]	-RRB-
cord-303447-3a7jxl34	111	21	.	.	.
cord-303447-3a7jxl34	112	1	After	after	IN
cord-303447-3a7jxl34	112	2	introduction	introduction	NN
cord-303447-3a7jxl34	112	3	of	of	IN
cord-303447-3a7jxl34	112	4	routine	routine	JJ
cord-303447-3a7jxl34	112	5	PCV7	PCV7	NNP
cord-303447-3a7jxl34	112	6	vaccination	vaccination	NN
cord-303447-3a7jxl34	112	7	,	,	,
cord-303447-3a7jxl34	112	8	the	the	DT
cord-303447-3a7jxl34	112	9	incidence	incidence	NN
cord-303447-3a7jxl34	112	10	of	of	IN
cord-303447-3a7jxl34	112	11	invasive	invasive	JJ
cord-303447-3a7jxl34	112	12	pneumococcal	pneumococcal	JJ
cord-303447-3a7jxl34	112	13	disease	disease	NN
cord-303447-3a7jxl34	112	14	declined	decline	VBD
cord-303447-3a7jxl34	112	15	dramatically	dramatically	RB
cord-303447-3a7jxl34	112	16	,	,	,
cord-303447-3a7jxl34	112	17	especially	especially	RB
cord-303447-3a7jxl34	112	18	in	in	IN
cord-303447-3a7jxl34	112	19	children	child	NNS
cord-303447-3a7jxl34	112	20	younger	young	JJR
cord-303447-3a7jxl34	112	21	than	than	IN
cord-303447-3a7jxl34	112	22	2	2	CD
cord-303447-3a7jxl34	112	23	years	year	NNS
cord-303447-3a7jxl34	112	24	old	old	JJ
cord-303447-3a7jxl34	112	25	[	[	-LRB-
cord-303447-3a7jxl34	112	26	37	37	CD
cord-303447-3a7jxl34	112	27	]	]	-RRB-
cord-303447-3a7jxl34	112	28	[	[	-LRB-
cord-303447-3a7jxl34	112	29	38	38	CD
cord-303447-3a7jxl34	112	30	]	]	-RRB-
cord-303447-3a7jxl34	112	31	[	[	-LRB-
cord-303447-3a7jxl34	112	32	39	39	CD
cord-303447-3a7jxl34	112	33	]	]	-RRB-
cord-303447-3a7jxl34	112	34	.	.	.
cord-303447-3a7jxl34	113	1	Active	active	JJ
cord-303447-3a7jxl34	113	2	US	US	NNP
cord-303447-3a7jxl34	113	3	population	population	NN
cord-303447-3a7jxl34	113	4	-	-	HYPH
cord-303447-3a7jxl34	113	5	based	base	VBN
cord-303447-3a7jxl34	113	6	surveillance	surveillance	NN
cord-303447-3a7jxl34	113	7	data	datum	NNS
cord-303447-3a7jxl34	113	8	show	show	VBP
cord-303447-3a7jxl34	113	9	that	that	IN
cord-303447-3a7jxl34	113	10	within	within	IN
cord-303447-3a7jxl34	113	11	2	2	CD
cord-303447-3a7jxl34	113	12	years	year	NNS
cord-303447-3a7jxl34	113	13	of	of	IN
cord-303447-3a7jxl34	113	14	PCV7	PCV7	NNP
cord-303447-3a7jxl34	113	15	licensure	licensure	NN
cord-303447-3a7jxl34	113	16	,	,	,
cord-303447-3a7jxl34	113	17	the	the	DT
cord-303447-3a7jxl34	113	18	rate	rate	NN
cord-303447-3a7jxl34	113	19	of	of	IN
cord-303447-3a7jxl34	113	20	invasive	invasive	JJ
cord-303447-3a7jxl34	113	21	pneumococcal	pneumococcal	JJ
cord-303447-3a7jxl34	113	22	disease	disease	NN
cord-303447-3a7jxl34	113	23	in	in	IN
cord-303447-3a7jxl34	113	24	children	child	NNS
cord-303447-3a7jxl34	113	25	younger	young	JJR
cord-303447-3a7jxl34	113	26	than	than	IN
cord-303447-3a7jxl34	113	27	2	2	CD
cord-303447-3a7jxl34	113	28	years	year	NNS
cord-303447-3a7jxl34	113	29	old	old	JJ
cord-303447-3a7jxl34	113	30	declined	decline	VBD
cord-303447-3a7jxl34	113	31	by	by	IN
cord-303447-3a7jxl34	113	32	69	69	CD
cord-303447-3a7jxl34	113	33	%	%	NN
cord-303447-3a7jxl34	113	34	[	[	-LRB-
cord-303447-3a7jxl34	113	35	39	39	CD
cord-303447-3a7jxl34	113	36	]	]	-RRB-
cord-303447-3a7jxl34	113	37	.	.	.
cord-303447-3a7jxl34	114	1	In	in	IN
cord-303447-3a7jxl34	114	2	tandem	tandem	NN
cord-303447-3a7jxl34	114	3	with	with	IN
cord-303447-3a7jxl34	114	4	the	the	DT
cord-303447-3a7jxl34	114	5	decrease	decrease	NN
cord-303447-3a7jxl34	114	6	in	in	IN
cord-303447-3a7jxl34	114	7	invasive	invasive	JJ
cord-303447-3a7jxl34	114	8	disease	disease	NN
cord-303447-3a7jxl34	114	9	,	,	,
cord-303447-3a7jxl34	114	10	data	datum	NNS
cord-303447-3a7jxl34	114	11	suggest	suggest	VBP
cord-303447-3a7jxl34	114	12	the	the	DT
cord-303447-3a7jxl34	114	13	incidence	incidence	NN
cord-303447-3a7jxl34	114	14	of	of	IN
cord-303447-3a7jxl34	114	15	pneumococcal	pneumococcal	JJ
cord-303447-3a7jxl34	114	16	noninvasive	noninvasive	JJ
cord-303447-3a7jxl34	114	17	disease	disease	NN
cord-303447-3a7jxl34	114	18	,	,	,
cord-303447-3a7jxl34	114	19	including	include	VBG
cord-303447-3a7jxl34	114	20	otitis	otitis	NN
cord-303447-3a7jxl34	114	21	media	medium	NNS
cord-303447-3a7jxl34	114	22	,	,	,
cord-303447-3a7jxl34	114	23	also	also	RB
cord-303447-3a7jxl34	114	24	decreased	decrease	VBD
cord-303447-3a7jxl34	114	25	[	[	-LRB-
cord-303447-3a7jxl34	114	26	40	40	CD
cord-303447-3a7jxl34	114	27	,	,	,
cord-303447-3a7jxl34	114	28	41	41	CD
cord-303447-3a7jxl34	114	29	]	]	-RRB-
cord-303447-3a7jxl34	114	30	.	.	.
cord-303447-3a7jxl34	115	1	In	in	IN
cord-303447-3a7jxl34	115	2	addition	addition	NN
cord-303447-3a7jxl34	115	3	to	to	IN
cord-303447-3a7jxl34	115	4	decreasing	decrease	VBG
cord-303447-3a7jxl34	115	5	the	the	DT
cord-303447-3a7jxl34	115	6	burden	burden	NN
cord-303447-3a7jxl34	115	7	of	of	IN
cord-303447-3a7jxl34	115	8	pediatric	pediatric	JJ
cord-303447-3a7jxl34	115	9	pneumococcal	pneumococcal	JJ
cord-303447-3a7jxl34	115	10	disease	disease	NN
cord-303447-3a7jxl34	115	11	,	,	,
cord-303447-3a7jxl34	115	12	PCV7	PCV7	NNP
cord-303447-3a7jxl34	115	13	may	may	MD
cord-303447-3a7jxl34	115	14	have	have	VB
cord-303447-3a7jxl34	115	15	an	an	DT
cord-303447-3a7jxl34	115	16	impact	impact	NN
cord-303447-3a7jxl34	115	17	on	on	IN
cord-303447-3a7jxl34	115	18	reducing	reduce	VBG
cord-303447-3a7jxl34	115	19	pediatric	pediatric	JJ
cord-303447-3a7jxl34	115	20	antibiotic	antibiotic	JJ
cord-303447-3a7jxl34	115	21	prescriptions	prescription	NNS
cord-303447-3a7jxl34	115	22	and	and	CC
cord-303447-3a7jxl34	115	23	procedures	procedure	NNS
cord-303447-3a7jxl34	115	24	such	such	JJ
cord-303447-3a7jxl34	115	25	as	as	IN
cord-303447-3a7jxl34	115	26	blood	blood	NN
cord-303447-3a7jxl34	115	27	cultures	culture	NNS
cord-303447-3a7jxl34	115	28	in	in	IN
cord-303447-3a7jxl34	115	29	young	young	JJ
cord-303447-3a7jxl34	115	30	,	,	,
cord-303447-3a7jxl34	115	31	febrile	febrile	JJ
cord-303447-3a7jxl34	115	32	children	child	NNS
cord-303447-3a7jxl34	115	33	[	[	-LRB-
cord-303447-3a7jxl34	115	34	42	42	CD
cord-303447-3a7jxl34	115	35	]	]	-RRB-
cord-303447-3a7jxl34	115	36	.	.	.
cord-303447-3a7jxl34	116	1	The	the	DT
cord-303447-3a7jxl34	116	2	decline	decline	NN
cord-303447-3a7jxl34	116	3	in	in	IN
cord-303447-3a7jxl34	116	4	invasive	invasive	JJ
cord-303447-3a7jxl34	116	5	pneumococcal	pneumococcal	JJ
cord-303447-3a7jxl34	116	6	disease	disease	NN
cord-303447-3a7jxl34	116	7	is	be	VBZ
cord-303447-3a7jxl34	116	8	beyond	beyond	IN
cord-303447-3a7jxl34	116	9	what	what	WP
cord-303447-3a7jxl34	116	10	would	would	MD
cord-303447-3a7jxl34	116	11	be	be	VB
cord-303447-3a7jxl34	116	12	expected	expect	VBN
cord-303447-3a7jxl34	116	13	from	from	IN
cord-303447-3a7jxl34	116	14	childhood	childhood	NN
cord-303447-3a7jxl34	116	15	vaccination	vaccination	NN
cord-303447-3a7jxl34	116	16	,	,	,
cord-303447-3a7jxl34	116	17	given	give	VBN
cord-303447-3a7jxl34	116	18	vaccine	vaccine	NN
cord-303447-3a7jxl34	116	19	efficacy	efficacy	NN
cord-303447-3a7jxl34	116	20	and	and	CC
cord-303447-3a7jxl34	116	21	PCV7	PCV7	NNP
cord-303447-3a7jxl34	116	22	coverage	coverage	NN
cord-303447-3a7jxl34	116	23	data	datum	NNS
cord-303447-3a7jxl34	116	24	,	,	,
cord-303447-3a7jxl34	116	25	suggesting	suggest	VBG
cord-303447-3a7jxl34	116	26	that	that	IN
cord-303447-3a7jxl34	116	27	herd	herd	NN
cord-303447-3a7jxl34	116	28	immunity	immunity	NN
cord-303447-3a7jxl34	116	29	may	may	MD
cord-303447-3a7jxl34	116	30	play	play	VB
cord-303447-3a7jxl34	116	31	a	a	DT
cord-303447-3a7jxl34	116	32	role	role	NN
cord-303447-3a7jxl34	116	33	in	in	IN
cord-303447-3a7jxl34	116	34	protecting	protect	VBG
cord-303447-3a7jxl34	116	35	unimmunized	unimmunized	JJ
cord-303447-3a7jxl34	116	36	people	people	NNS
cord-303447-3a7jxl34	116	37	from	from	IN
cord-303447-3a7jxl34	116	38	invasive	invasive	JJ
cord-303447-3a7jxl34	116	39	disease	disease	NN
cord-303447-3a7jxl34	116	40	[	[	-LRB-
cord-303447-3a7jxl34	116	41	37	37	CD
cord-303447-3a7jxl34	116	42	]	]	-RRB-
cord-303447-3a7jxl34	116	43	.	.	.
cord-303447-3a7jxl34	117	1	Reduced	reduce	VBN
cord-303447-3a7jxl34	117	2	nasopharyngeal	nasopharyngeal	JJ
cord-303447-3a7jxl34	117	3	carriage	carriage	NN
cord-303447-3a7jxl34	117	4	of	of	IN
cord-303447-3a7jxl34	117	5	vaccinecontaining	vaccinecontaine	VBG
cord-303447-3a7jxl34	117	6	serotypes	serotype	NNS
cord-303447-3a7jxl34	117	7	in	in	IN
cord-303447-3a7jxl34	117	8	vaccinated	vaccinated	JJ
cord-303447-3a7jxl34	117	9	children	child	NNS
cord-303447-3a7jxl34	117	10	is	be	VBZ
cord-303447-3a7jxl34	117	11	believed	believe	VBN
cord-303447-3a7jxl34	117	12	to	to	TO
cord-303447-3a7jxl34	117	13	contribute	contribute	VB
cord-303447-3a7jxl34	117	14	to	to	IN
cord-303447-3a7jxl34	117	15	development	development	NN
cord-303447-3a7jxl34	117	16	of	of	IN
cord-303447-3a7jxl34	117	17	herd	herd	NN
cord-303447-3a7jxl34	117	18	immunity	immunity	NN
cord-303447-3a7jxl34	117	19	against	against	IN
cord-303447-3a7jxl34	117	20	pneumococcus	pneumococcus	NNP
cord-303447-3a7jxl34	117	21	.	.	.
cord-303447-3a7jxl34	118	1	Rates	rate	NNS
cord-303447-3a7jxl34	118	2	of	of	IN
cord-303447-3a7jxl34	118	3	invasive	invasive	JJ
cord-303447-3a7jxl34	118	4	pneumococcal	pneumococcal	JJ
cord-303447-3a7jxl34	118	5	disease	disease	NN
cord-303447-3a7jxl34	118	6	seem	seem	VBP
cord-303447-3a7jxl34	118	7	to	to	TO
cord-303447-3a7jxl34	118	8	be	be	VB
cord-303447-3a7jxl34	118	9	declining	decline	VBG
cord-303447-3a7jxl34	118	10	among	among	IN
cord-303447-3a7jxl34	118	11	some	some	DT
cord-303447-3a7jxl34	118	12	unvaccinated	unvaccinated	JJ
cord-303447-3a7jxl34	118	13	groups	group	NNS
cord-303447-3a7jxl34	118	14	after	after	IN
cord-303447-3a7jxl34	118	15	implementation	implementation	NN
cord-303447-3a7jxl34	118	16	of	of	IN
cord-303447-3a7jxl34	118	17	universal	universal	JJ
cord-303447-3a7jxl34	118	18	infant	infant	NN
cord-303447-3a7jxl34	118	19	PCV7	PCV7	NNP
cord-303447-3a7jxl34	118	20	vaccination	vaccination	NN
cord-303447-3a7jxl34	118	21	.	.	.
cord-303447-3a7jxl34	119	1	In	in	IN
cord-303447-3a7jxl34	119	2	addition	addition	NN
cord-303447-3a7jxl34	119	3	,	,	,
cord-303447-3a7jxl34	119	4	postlicensure	postlicensure	NN
cord-303447-3a7jxl34	119	5	surveillance	surveillance	NN
cord-303447-3a7jxl34	119	6	data	datum	NNS
cord-303447-3a7jxl34	119	7	suggest	suggest	VBP
cord-303447-3a7jxl34	119	8	a	a	DT
cord-303447-3a7jxl34	119	9	decrease	decrease	NN
cord-303447-3a7jxl34	119	10	in	in	IN
cord-303447-3a7jxl34	119	11	antibiotic	antibiotic	JJ
cord-303447-3a7jxl34	119	12	-	-	HYPH
cord-303447-3a7jxl34	119	13	resistant	resistant	JJ
cord-303447-3a7jxl34	119	14	strains	strain	NNS
cord-303447-3a7jxl34	119	15	of	of	IN
cord-303447-3a7jxl34	119	16	S.	S.	NNP
cord-303447-3a7jxl34	119	17	pneumoniae	pneumoniae	NN
cord-303447-3a7jxl34	119	18	[	[	-LRB-
cord-303447-3a7jxl34	119	19	37	37	CD
cord-303447-3a7jxl34	119	20	,	,	,
cord-303447-3a7jxl34	119	21	39	39	CD
cord-303447-3a7jxl34	119	22	]	]	-RRB-
cord-303447-3a7jxl34	119	23	.	.	.
cord-303447-3a7jxl34	120	1	Because	because	IN
cord-303447-3a7jxl34	120	2	PCV7	PCV7	NNP
cord-303447-3a7jxl34	120	3	includes	include	VBZ
cord-303447-3a7jxl34	120	4	only	only	RB
cord-303447-3a7jxl34	120	5	7	7	CD
cord-303447-3a7jxl34	120	6	of	of	IN
cord-303447-3a7jxl34	120	7	the	the	DT
cord-303447-3a7jxl34	120	8	more	more	JJR
cord-303447-3a7jxl34	120	9	than	than	IN
cord-303447-3a7jxl34	120	10	90	90	CD
cord-303447-3a7jxl34	120	11	serotypes	serotype	NNS
cord-303447-3a7jxl34	120	12	of	of	IN
cord-303447-3a7jxl34	120	13	pneumococcus	pneumococcus	NN
cord-303447-3a7jxl34	120	14	,	,	,
cord-303447-3a7jxl34	120	15	there	there	EX
cord-303447-3a7jxl34	120	16	is	be	VBZ
cord-303447-3a7jxl34	120	17	theoretical	theoretical	JJ
cord-303447-3a7jxl34	120	18	concern	concern	NN
cord-303447-3a7jxl34	120	19	that	that	DT
cord-303447-3a7jxl34	120	20	serotype	serotype	NN
cord-303447-3a7jxl34	120	21	replacement	replacement	NN
cord-303447-3a7jxl34	120	22	might	may	MD
cord-303447-3a7jxl34	120	23	occur	occur	VB
cord-303447-3a7jxl34	120	24	in	in	IN
cord-303447-3a7jxl34	120	25	highly	highly	RB
cord-303447-3a7jxl34	120	26	vaccinated	vaccinate	VBN
cord-303447-3a7jxl34	120	27	populations	population	NNS
cord-303447-3a7jxl34	120	28	.	.	.
cord-303447-3a7jxl34	121	1	One	one	CD
cord-303447-3a7jxl34	121	2	study	study	NN
cord-303447-3a7jxl34	121	3	noted	note	VBD
cord-303447-3a7jxl34	121	4	an	an	DT
cord-303447-3a7jxl34	121	5	increase	increase	NN
cord-303447-3a7jxl34	121	6	in	in	IN
cord-303447-3a7jxl34	121	7	the	the	DT
cord-303447-3a7jxl34	121	8	proportion	proportion	NN
cord-303447-3a7jxl34	121	9	of	of	IN
cord-303447-3a7jxl34	121	10	cases	case	NNS
cord-303447-3a7jxl34	121	11	of	of	IN
cord-303447-3a7jxl34	121	12	invasive	invasive	JJ
cord-303447-3a7jxl34	121	13	pneumococcal	pneumococcal	JJ
cord-303447-3a7jxl34	121	14	disease	disease	NN
cord-303447-3a7jxl34	121	15	resulting	result	VBG
cord-303447-3a7jxl34	121	16	from	from	IN
cord-303447-3a7jxl34	121	17	nonvaccine	nonvaccine	NNP
cord-303447-3a7jxl34	121	18	serotypes	serotype	NNS
cord-303447-3a7jxl34	121	19	,	,	,
cord-303447-3a7jxl34	121	20	but	but	CC
cord-303447-3a7jxl34	121	21	the	the	DT
cord-303447-3a7jxl34	121	22	total	total	JJ
cord-303447-3a7jxl34	121	23	number	number	NN
cord-303447-3a7jxl34	121	24	of	of	IN
cord-303447-3a7jxl34	121	25	cases	case	NNS
cord-303447-3a7jxl34	121	26	was	be	VBD
cord-303447-3a7jxl34	121	27	not	not	RB
cord-303447-3a7jxl34	121	28	changed	change	VBN
cord-303447-3a7jxl34	121	29	[	[	-LRB-
cord-303447-3a7jxl34	121	30	38	38	CD
cord-303447-3a7jxl34	121	31	]	]	-RRB-
cord-303447-3a7jxl34	121	32	.	.	.
cord-303447-3a7jxl34	122	1	This	this	DT
cord-303447-3a7jxl34	122	2	study	study	NN
cord-303447-3a7jxl34	122	3	supports	support	VBZ
cord-303447-3a7jxl34	122	4	the	the	DT
cord-303447-3a7jxl34	122	5	need	need	NN
cord-303447-3a7jxl34	122	6	for	for	IN
cord-303447-3a7jxl34	122	7	continued	continued	JJ
cord-303447-3a7jxl34	122	8	pneumococcal	pneumococcal	JJ
cord-303447-3a7jxl34	122	9	surveillance	surveillance	NN
cord-303447-3a7jxl34	122	10	in	in	IN
cord-303447-3a7jxl34	122	11	the	the	DT
cord-303447-3a7jxl34	122	12	post	post	JJ
cord-303447-3a7jxl34	122	13	-	-	JJ
cord-303447-3a7jxl34	122	14	PCV7	pcv7	JJ
cord-303447-3a7jxl34	122	15	era	era	NN
cord-303447-3a7jxl34	122	16	[	[	-LRB-
cord-303447-3a7jxl34	122	17	43	43	CD
cord-303447-3a7jxl34	122	18	]	]	-RRB-
cord-303447-3a7jxl34	122	19	.	.	.
cord-303447-3a7jxl34	123	1	Hepatitis	Hepatitis	NNP
cord-303447-3a7jxl34	123	2	B	B	NNP
cord-303447-3a7jxl34	123	3	vaccine	vaccine	NN
cord-303447-3a7jxl34	123	4	holds	hold	VBZ
cord-303447-3a7jxl34	123	5	a	a	DT
cord-303447-3a7jxl34	123	6	unique	unique	JJ
cord-303447-3a7jxl34	123	7	place	place	NN
cord-303447-3a7jxl34	123	8	in	in	IN
cord-303447-3a7jxl34	123	9	the	the	DT
cord-303447-3a7jxl34	123	10	US	US	NNP
cord-303447-3a7jxl34	123	11	immunization	immunization	NN
cord-303447-3a7jxl34	123	12	schedule	schedule	NN
cord-303447-3a7jxl34	123	13	because	because	IN
cord-303447-3a7jxl34	123	14	they	-PRON-	PRP
cord-303447-3a7jxl34	123	15	are	be	VBP
cord-303447-3a7jxl34	123	16	the	the	DT
cord-303447-3a7jxl34	123	17	only	only	JJ
cord-303447-3a7jxl34	123	18	vaccines	vaccine	NNS
cord-303447-3a7jxl34	123	19	licensed	license	VBN
cord-303447-3a7jxl34	123	20	for	for	IN
cord-303447-3a7jxl34	123	21	neonates	neonate	NNS
cord-303447-3a7jxl34	123	22	and	and	CC
cord-303447-3a7jxl34	123	23	the	the	DT
cord-303447-3a7jxl34	123	24	only	only	JJ
cord-303447-3a7jxl34	123	25	licensed	licensed	JJ
cord-303447-3a7jxl34	123	26	vaccine	vaccine	NN
cord-303447-3a7jxl34	123	27	that	that	WDT
cord-303447-3a7jxl34	123	28	prevents	prevent	VBZ
cord-303447-3a7jxl34	123	29	cancer	cancer	NN
cord-303447-3a7jxl34	123	30	.	.	.
cord-303447-3a7jxl34	124	1	The	the	DT
cord-303447-3a7jxl34	124	2	continued	continued	JJ
cord-303447-3a7jxl34	124	3	evolution	evolution	NN
cord-303447-3a7jxl34	124	4	of	of	IN
cord-303447-3a7jxl34	124	5	hepatitis	hepatitis	NNP
cord-303447-3a7jxl34	124	6	B	B	NNP
cord-303447-3a7jxl34	124	7	vaccine	vaccine	NN
cord-303447-3a7jxl34	124	8	recommendations	recommendation	NNS
cord-303447-3a7jxl34	124	9	reflects	reflect	VBZ
cord-303447-3a7jxl34	124	10	many	many	JJ
cord-303447-3a7jxl34	124	11	of	of	IN
cord-303447-3a7jxl34	124	12	the	the	DT
cord-303447-3a7jxl34	124	13	challenges	challenge	NNS
cord-303447-3a7jxl34	124	14	associated	associate	VBN
cord-303447-3a7jxl34	124	15	with	with	IN
cord-303447-3a7jxl34	124	16	vaccines	vaccine	NNS
cord-303447-3a7jxl34	124	17	that	that	WDT
cord-303447-3a7jxl34	124	18	will	will	MD
cord-303447-3a7jxl34	124	19	be	be	VB
cord-303447-3a7jxl34	124	20	licensed	license	VBN
cord-303447-3a7jxl34	124	21	in	in	IN
cord-303447-3a7jxl34	124	22	the	the	DT
cord-303447-3a7jxl34	124	23	near	near	JJ
cord-303447-3a7jxl34	124	24	future	future	NN
cord-303447-3a7jxl34	124	25	.	.	.
cord-303447-3a7jxl34	125	1	Before	before	IN
cord-303447-3a7jxl34	125	2	1982	1982	CD
cord-303447-3a7jxl34	125	3	,	,	,
cord-303447-3a7jxl34	125	4	an	an	DT
cord-303447-3a7jxl34	125	5	estimated	estimate	VBN
cord-303447-3a7jxl34	125	6	200,000	200,000	CD
cord-303447-3a7jxl34	125	7	to	to	TO
cord-303447-3a7jxl34	125	8	300,000	300,000	CD
cord-303447-3a7jxl34	125	9	people	people	NNS
cord-303447-3a7jxl34	125	10	in	in	IN
cord-303447-3a7jxl34	125	11	the	the	DT
cord-303447-3a7jxl34	125	12	United	United	NNP
cord-303447-3a7jxl34	125	13	States	States	NNP
cord-303447-3a7jxl34	125	14	were	be	VBD
cord-303447-3a7jxl34	125	15	infected	infect	VBN
cord-303447-3a7jxl34	125	16	annually	annually	RB
cord-303447-3a7jxl34	125	17	with	with	IN
cord-303447-3a7jxl34	125	18	hepatitis	hepatitis	NN
cord-303447-3a7jxl34	125	19	B	B	NNP
cord-303447-3a7jxl34	125	20	virus	virus	NN
cord-303447-3a7jxl34	125	21	,	,	,
cord-303447-3a7jxl34	125	22	including	include	VBG
cord-303447-3a7jxl34	125	23	approximately	approximately	RB
cord-303447-3a7jxl34	125	24	20,000	20,000	CD
cord-303447-3a7jxl34	125	25	children	child	NNS
cord-303447-3a7jxl34	125	26	[	[	-LRB-
cord-303447-3a7jxl34	125	27	44	44	CD
cord-303447-3a7jxl34	125	28	]	]	-RRB-
cord-303447-3a7jxl34	125	29	.	.	.
cord-303447-3a7jxl34	126	1	Although	although	IN
cord-303447-3a7jxl34	126	2	most	most	JJS
cord-303447-3a7jxl34	126	3	vaccine	vaccine	NN
cord-303447-3a7jxl34	126	4	-	-	HYPH
cord-303447-3a7jxl34	126	5	preventable	preventable	JJ
cord-303447-3a7jxl34	126	6	diseases	disease	NNS
cord-303447-3a7jxl34	126	7	are	be	VBP
cord-303447-3a7jxl34	126	8	spread	spread	VBN
cord-303447-3a7jxl34	126	9	via	via	IN
cord-303447-3a7jxl34	126	10	contact	contact	NN
cord-303447-3a7jxl34	126	11	or	or	CC
cord-303447-3a7jxl34	126	12	airborne	airborne	JJ
cord-303447-3a7jxl34	126	13	droplets	droplet	NNS
cord-303447-3a7jxl34	126	14	,	,	,
cord-303447-3a7jxl34	126	15	hepatitis	hepatitis	NN
cord-303447-3a7jxl34	126	16	B	b	NN
cord-303447-3a7jxl34	126	17	infection	infection	NN
cord-303447-3a7jxl34	126	18	is	be	VBZ
cord-303447-3a7jxl34	126	19	spread	spread	VBN
cord-303447-3a7jxl34	126	20	via	via	IN
cord-303447-3a7jxl34	126	21	exposure	exposure	NN
cord-303447-3a7jxl34	126	22	to	to	IN
cord-303447-3a7jxl34	126	23	infected	infected	JJ
cord-303447-3a7jxl34	126	24	blood	blood	NN
cord-303447-3a7jxl34	126	25	or	or	CC
cord-303447-3a7jxl34	126	26	blood	blood	NN
cord-303447-3a7jxl34	126	27	products	product	NNS
cord-303447-3a7jxl34	126	28	,	,	,
cord-303447-3a7jxl34	126	29	sexual	sexual	JJ
cord-303447-3a7jxl34	126	30	contact	contact	NN
cord-303447-3a7jxl34	126	31	,	,	,
cord-303447-3a7jxl34	126	32	and	and	CC
cord-303447-3a7jxl34	126	33	injection	injection	NN
cord-303447-3a7jxl34	126	34	devices	device	NNS
cord-303447-3a7jxl34	126	35	.	.	.
cord-303447-3a7jxl34	127	1	Much	much	JJ
cord-303447-3a7jxl34	127	2	of	of	IN
cord-303447-3a7jxl34	127	3	the	the	DT
cord-303447-3a7jxl34	127	4	transmission	transmission	NN
cord-303447-3a7jxl34	127	5	of	of	IN
cord-303447-3a7jxl34	127	6	hepatitis	hepatitis	NN
cord-303447-3a7jxl34	127	7	B	B	NNP
cord-303447-3a7jxl34	127	8	in	in	IN
cord-303447-3a7jxl34	127	9	adults	adult	NNS
cord-303447-3a7jxl34	127	10	is	be	VBZ
cord-303447-3a7jxl34	127	11	silent	silent	JJ
cord-303447-3a7jxl34	127	12	;	;	:
cord-303447-3a7jxl34	127	13	there	there	EX
cord-303447-3a7jxl34	127	14	is	be	VBZ
cord-303447-3a7jxl34	127	15	no	no	DT
cord-303447-3a7jxl34	127	16	accompanying	accompany	VBG
cord-303447-3a7jxl34	127	17	rash	rash	NN
cord-303447-3a7jxl34	127	18	or	or	CC
cord-303447-3a7jxl34	127	19	symptoms	symptom	NNS
cord-303447-3a7jxl34	127	20	.	.	.
cord-303447-3a7jxl34	128	1	Although	although	IN
cord-303447-3a7jxl34	128	2	adults	adult	NNS
cord-303447-3a7jxl34	128	3	have	have	VBP
cord-303447-3a7jxl34	128	4	a	a	DT
cord-303447-3a7jxl34	128	5	10	10	CD
cord-303447-3a7jxl34	128	6	%	%	NN
cord-303447-3a7jxl34	128	7	chance	chance	NN
cord-303447-3a7jxl34	128	8	of	of	IN
cord-303447-3a7jxl34	128	9	developing	develop	VBG
cord-303447-3a7jxl34	128	10	chronic	chronic	JJ
cord-303447-3a7jxl34	128	11	hepatitis	hepatitis	NN
cord-303447-3a7jxl34	128	12	B	b	NN
cord-303447-3a7jxl34	128	13	virus	virus	NN
cord-303447-3a7jxl34	128	14	infection	infection	NN
cord-303447-3a7jxl34	128	15	,	,	,
cord-303447-3a7jxl34	128	16	infants	infant	NNS
cord-303447-3a7jxl34	128	17	infected	infect	VBN
cord-303447-3a7jxl34	128	18	perinatally	perinatally	RB
cord-303447-3a7jxl34	128	19	who	who	WP
cord-303447-3a7jxl34	128	20	do	do	VBP
cord-303447-3a7jxl34	128	21	not	not	RB
cord-303447-3a7jxl34	128	22	receive	receive	VB
cord-303447-3a7jxl34	128	23	hepatitis	hepatitis	NN
cord-303447-3a7jxl34	128	24	B	B	NNP
cord-303447-3a7jxl34	128	25	immunoglobulin	immunoglobulin	NN
cord-303447-3a7jxl34	128	26	and	and	CC
cord-303447-3a7jxl34	128	27	vaccine	vaccine	NN
cord-303447-3a7jxl34	128	28	at	at	IN
cord-303447-3a7jxl34	128	29	birth	birth	NN
cord-303447-3a7jxl34	129	1	have	have	VB
cord-303447-3a7jxl34	129	2	a	a	DT
cord-303447-3a7jxl34	129	3	90	90	CD
cord-303447-3a7jxl34	129	4	%	%	NN
cord-303447-3a7jxl34	129	5	chance	chance	NN
cord-303447-3a7jxl34	129	6	of	of	IN
cord-303447-3a7jxl34	129	7	developing	develop	VBG
cord-303447-3a7jxl34	129	8	chronic	chronic	JJ
cord-303447-3a7jxl34	129	9	infection	infection	NN
cord-303447-3a7jxl34	129	10	.	.	.
cord-303447-3a7jxl34	130	1	Twenty	twenty	CD
cord-303447-3a7jxl34	130	2	-	-	HYPH
cord-303447-3a7jxl34	130	3	five	five	CD
cord-303447-3a7jxl34	130	4	percent	percent	NN
cord-303447-3a7jxl34	130	5	of	of	IN
cord-303447-3a7jxl34	130	6	these	these	DT
cord-303447-3a7jxl34	130	7	infections	infection	NNS
cord-303447-3a7jxl34	130	8	lead	lead	VBP
cord-303447-3a7jxl34	130	9	to	to	IN
cord-303447-3a7jxl34	130	10	hepatocellular	hepatocellular	JJ
cord-303447-3a7jxl34	130	11	carcinoma	carcinoma	NN
cord-303447-3a7jxl34	130	12	[	[	-LRB-
cord-303447-3a7jxl34	130	13	45	45	CD
cord-303447-3a7jxl34	130	14	]	]	-RRB-
cord-303447-3a7jxl34	130	15	.	.	.
cord-303447-3a7jxl34	131	1	The	the	DT
cord-303447-3a7jxl34	131	2	complexity	complexity	NN
cord-303447-3a7jxl34	131	3	of	of	IN
cord-303447-3a7jxl34	131	4	hepatitis	hepatitis	NN
cord-303447-3a7jxl34	131	5	B	b	NN
cord-303447-3a7jxl34	131	6	transmission	transmission	NN
cord-303447-3a7jxl34	131	7	required	require	VBD
cord-303447-3a7jxl34	131	8	a	a	DT
cord-303447-3a7jxl34	131	9	vaccination	vaccination	NN
cord-303447-3a7jxl34	131	10	strategy	strategy	NN
cord-303447-3a7jxl34	131	11	to	to	TO
cord-303447-3a7jxl34	131	12	protect	protect	VB
cord-303447-3a7jxl34	131	13	infants	infant	NNS
cord-303447-3a7jxl34	131	14	and	and	CC
cord-303447-3a7jxl34	131	15	high	high	JJ
cord-303447-3a7jxl34	131	16	-	-	HYPH
cord-303447-3a7jxl34	131	17	risk	risk	NN
cord-303447-3a7jxl34	131	18	adults	adult	NNS
cord-303447-3a7jxl34	131	19	from	from	IN
cord-303447-3a7jxl34	131	20	infection	infection	NN
cord-303447-3a7jxl34	131	21	.	.	.
cord-303447-3a7jxl34	132	1	The	the	DT
cord-303447-3a7jxl34	132	2	first	first	JJ
cord-303447-3a7jxl34	132	3	ACIP	ACIP	NNP
cord-303447-3a7jxl34	132	4	hepatitis	hepatitis	NN
cord-303447-3a7jxl34	132	5	B	B	NNP
cord-303447-3a7jxl34	132	6	recommendation	recommendation	NN
cord-303447-3a7jxl34	132	7	in	in	IN
cord-303447-3a7jxl34	132	8	1982	1982	CD
cord-303447-3a7jxl34	132	9	was	be	VBD
cord-303447-3a7jxl34	132	10	to	to	TO
cord-303447-3a7jxl34	132	11	vaccinate	vaccinate	VB
cord-303447-3a7jxl34	132	12	groups	group	NNS
cord-303447-3a7jxl34	132	13	known	know	VBN
cord-303447-3a7jxl34	132	14	to	to	TO
cord-303447-3a7jxl34	132	15	be	be	VB
cord-303447-3a7jxl34	132	16	at	at	IN
cord-303447-3a7jxl34	132	17	high	high	JJ
cord-303447-3a7jxl34	132	18	risk	risk	NN
cord-303447-3a7jxl34	132	19	for	for	IN
cord-303447-3a7jxl34	132	20	hepatitis	hepatitis	NN
cord-303447-3a7jxl34	132	21	B	B	NNP
cord-303447-3a7jxl34	132	22	virus	virus	NN
cord-303447-3a7jxl34	132	23	infection	infection	NN
cord-303447-3a7jxl34	132	24	,	,	,
cord-303447-3a7jxl34	132	25	such	such	JJ
cord-303447-3a7jxl34	132	26	as	as	IN
cord-303447-3a7jxl34	132	27	health	health	NN
cord-303447-3a7jxl34	132	28	care	care	NN
cord-303447-3a7jxl34	132	29	workers	worker	NNS
cord-303447-3a7jxl34	132	30	,	,	,
cord-303447-3a7jxl34	132	31	men	man	NNS
cord-303447-3a7jxl34	132	32	who	who	WP
cord-303447-3a7jxl34	132	33	have	have	VBP
cord-303447-3a7jxl34	132	34	sex	sex	NN
cord-303447-3a7jxl34	132	35	with	with	IN
cord-303447-3a7jxl34	132	36	men	man	NNS
cord-303447-3a7jxl34	132	37	,	,	,
cord-303447-3a7jxl34	132	38	and	and	CC
cord-303447-3a7jxl34	132	39	intravenous	intravenous	JJ
cord-303447-3a7jxl34	132	40	drug	drug	NN
cord-303447-3a7jxl34	132	41	users	user	NNS
cord-303447-3a7jxl34	132	42	[	[	-LRB-
cord-303447-3a7jxl34	132	43	46	46	CD
cord-303447-3a7jxl34	132	44	]	]	-RRB-
cord-303447-3a7jxl34	132	45	.	.	.
cord-303447-3a7jxl34	133	1	In	in	IN
cord-303447-3a7jxl34	133	2	1984	1984	CD
cord-303447-3a7jxl34	133	3	,	,	,
cord-303447-3a7jxl34	133	4	the	the	DT
cord-303447-3a7jxl34	133	5	ACIP	ACIP	NNP
cord-303447-3a7jxl34	133	6	expanded	expand	VBD
cord-303447-3a7jxl34	133	7	recommendations	recommendation	NNS
cord-303447-3a7jxl34	133	8	to	to	TO
cord-303447-3a7jxl34	133	9	include	include	VB
cord-303447-3a7jxl34	133	10	infants	infant	NNS
cord-303447-3a7jxl34	133	11	born	bear	VBN
cord-303447-3a7jxl34	133	12	to	to	IN
cord-303447-3a7jxl34	133	13	mothers	mother	NNS
cord-303447-3a7jxl34	133	14	who	who	WP
cord-303447-3a7jxl34	133	15	were	be	VBD
cord-303447-3a7jxl34	133	16	hepatitis	hepatitis	NNP
cord-303447-3a7jxl34	133	17	B	B	NNP
cord-303447-3a7jxl34	133	18	surface	surface	NN
cord-303447-3a7jxl34	133	19	antigen	antigen	NN
cord-303447-3a7jxl34	133	20	(	(	-LRB-
cord-303447-3a7jxl34	133	21	HBsAg	HBsAg	NNP
cord-303447-3a7jxl34	133	22	)	)	-RRB-
cord-303447-3a7jxl34	133	23	positive	positive	JJ
cord-303447-3a7jxl34	133	24	.	.	.
cord-303447-3a7jxl34	134	1	Recognition	recognition	NN
cord-303447-3a7jxl34	134	2	of	of	IN
cord-303447-3a7jxl34	134	3	the	the	DT
cord-303447-3a7jxl34	134	4	difficulty	difficulty	NN
cord-303447-3a7jxl34	134	5	in	in	IN
cord-303447-3a7jxl34	134	6	identifying	identify	VBG
cord-303447-3a7jxl34	134	7	mothers	mother	NNS
cord-303447-3a7jxl34	134	8	infected	infect	VBN
cord-303447-3a7jxl34	134	9	with	with	IN
cord-303447-3a7jxl34	134	10	hepatitis	hepatitis	NN
cord-303447-3a7jxl34	134	11	B	B	NNP
cord-303447-3a7jxl34	134	12	led	lead	VBD
cord-303447-3a7jxl34	134	13	to	to	IN
cord-303447-3a7jxl34	134	14	a	a	DT
cord-303447-3a7jxl34	134	15	recommendation	recommendation	NN
cord-303447-3a7jxl34	134	16	in	in	IN
cord-303447-3a7jxl34	134	17	1988	1988	CD
cord-303447-3a7jxl34	134	18	to	to	TO
cord-303447-3a7jxl34	134	19	test	test	VB
cord-303447-3a7jxl34	134	20	all	all	DT
cord-303447-3a7jxl34	134	21	women	woman	NNS
cord-303447-3a7jxl34	134	22	for	for	IN
cord-303447-3a7jxl34	134	23	HBsAg	hbsag	ADD
cord-303447-3a7jxl34	134	24	during	during	IN
cord-303447-3a7jxl34	134	25	the	the	DT
cord-303447-3a7jxl34	134	26	prenatal	prenatal	JJ
cord-303447-3a7jxl34	134	27	period	period	NN
cord-303447-3a7jxl34	134	28	.	.	.
cord-303447-3a7jxl34	135	1	Vaccinating	vaccinate	VBG
cord-303447-3a7jxl34	135	2	high	high	JJ
cord-303447-3a7jxl34	135	3	-	-	HYPH
cord-303447-3a7jxl34	135	4	risk	risk	NN
cord-303447-3a7jxl34	135	5	groups	group	NNS
cord-303447-3a7jxl34	135	6	continued	continue	VBD
cord-303447-3a7jxl34	135	7	to	to	TO
cord-303447-3a7jxl34	135	8	be	be	VB
cord-303447-3a7jxl34	135	9	difficult	difficult	JJ
cord-303447-3a7jxl34	135	10	because	because	IN
cord-303447-3a7jxl34	135	11	no	no	DT
cord-303447-3a7jxl34	135	12	foundation	foundation	NN
cord-303447-3a7jxl34	135	13	existed	exist	VBD
cord-303447-3a7jxl34	135	14	to	to	TO
cord-303447-3a7jxl34	135	15	vaccinate	vaccinate	VB
cord-303447-3a7jxl34	135	16	adolescents	adolescent	NNS
cord-303447-3a7jxl34	135	17	and	and	CC
cord-303447-3a7jxl34	135	18	adults	adult	NNS
cord-303447-3a7jxl34	135	19	who	who	WP
cord-303447-3a7jxl34	135	20	already	already	RB
cord-303447-3a7jxl34	135	21	were	be	VBD
cord-303447-3a7jxl34	135	22	participating	participate	VBG
cord-303447-3a7jxl34	135	23	in	in	IN
cord-303447-3a7jxl34	135	24	high	high	JJ
cord-303447-3a7jxl34	135	25	-	-	HYPH
cord-303447-3a7jxl34	135	26	risk	risk	NN
cord-303447-3a7jxl34	135	27	activities	activity	NNS
cord-303447-3a7jxl34	135	28	.	.	.
cord-303447-3a7jxl34	136	1	In	in	IN
cord-303447-3a7jxl34	136	2	1991	1991	CD
cord-303447-3a7jxl34	136	3	,	,	,
cord-303447-3a7jxl34	136	4	a	a	DT
cord-303447-3a7jxl34	136	5	universal	universal	JJ
cord-303447-3a7jxl34	136	6	infant	infant	NN
cord-303447-3a7jxl34	136	7	vaccination	vaccination	NN
cord-303447-3a7jxl34	136	8	strategy	strategy	NN
cord-303447-3a7jxl34	136	9	was	be	VBD
cord-303447-3a7jxl34	136	10	instituted	institute	VBN
cord-303447-3a7jxl34	136	11	to	to	TO
cord-303447-3a7jxl34	136	12	achieve	achieve	VB
cord-303447-3a7jxl34	136	13	the	the	DT
cord-303447-3a7jxl34	136	14	goal	goal	NN
cord-303447-3a7jxl34	136	15	of	of	IN
cord-303447-3a7jxl34	136	16	reducing	reduce	VBG
cord-303447-3a7jxl34	136	17	transmission	transmission	NN
cord-303447-3a7jxl34	136	18	of	of	IN
cord-303447-3a7jxl34	136	19	hepatitis	hepatitis	NN
cord-303447-3a7jxl34	136	20	B	B	NNP
cord-303447-3a7jxl34	136	21	virus	virus	NN
cord-303447-3a7jxl34	136	22	[	[	-LRB-
cord-303447-3a7jxl34	136	23	46	46	CD
cord-303447-3a7jxl34	136	24	]	]	-RRB-
cord-303447-3a7jxl34	136	25	.	.	.
cord-303447-3a7jxl34	137	1	It	-PRON-	PRP
cord-303447-3a7jxl34	137	2	is	be	VBZ
cord-303447-3a7jxl34	137	3	recommended	recommend	VBN
cord-303447-3a7jxl34	137	4	that	that	IN
cord-303447-3a7jxl34	137	5	the	the	DT
cord-303447-3a7jxl34	137	6	first	first	JJ
cord-303447-3a7jxl34	137	7	dose	dose	NN
cord-303447-3a7jxl34	137	8	be	be	VB
cord-303447-3a7jxl34	137	9	given	give	VBN
cord-303447-3a7jxl34	137	10	at	at	IN
cord-303447-3a7jxl34	137	11	or	or	CC
cord-303447-3a7jxl34	137	12	before	before	IN
cord-303447-3a7jxl34	137	13	2	2	CD
cord-303447-3a7jxl34	137	14	months	month	NNS
cord-303447-3a7jxl34	137	15	of	of	IN
cord-303447-3a7jxl34	137	16	age	age	NN
cord-303447-3a7jxl34	137	17	with	with	IN
cord-303447-3a7jxl34	137	18	a	a	DT
cord-303447-3a7jxl34	137	19	preference	preference	NN
cord-303447-3a7jxl34	137	20	for	for	IN
cord-303447-3a7jxl34	137	21	all	all	DT
cord-303447-3a7jxl34	137	22	infants	infant	NNS
cord-303447-3a7jxl34	137	23	to	to	TO
cord-303447-3a7jxl34	137	24	receive	receive	VB
cord-303447-3a7jxl34	137	25	the	the	DT
cord-303447-3a7jxl34	137	26	first	first	JJ
cord-303447-3a7jxl34	137	27	dose	dose	NN
cord-303447-3a7jxl34	137	28	at	at	IN
cord-303447-3a7jxl34	137	29	birth	birth	NN
cord-303447-3a7jxl34	137	30	.	.	.
cord-303447-3a7jxl34	138	1	Neonatal	neonatal	JJ
cord-303447-3a7jxl34	138	2	vaccination	vaccination	NN
cord-303447-3a7jxl34	138	3	works	work	VBZ
cord-303447-3a7jxl34	138	4	by	by	IN
cord-303447-3a7jxl34	138	5	protecting	protect	VBG
cord-303447-3a7jxl34	138	6	the	the	DT
cord-303447-3a7jxl34	138	7	infant	infant	NN
cord-303447-3a7jxl34	138	8	from	from	IN
cord-303447-3a7jxl34	138	9	contracting	contract	VBG
cord-303447-3a7jxl34	138	10	hepatitis	hepatitis	NN
cord-303447-3a7jxl34	138	11	after	after	IN
cord-303447-3a7jxl34	138	12	vertical	vertical	JJ
cord-303447-3a7jxl34	138	13	or	or	CC
cord-303447-3a7jxl34	138	14	horizontal	horizontal	JJ
cord-303447-3a7jxl34	138	15	exposure	exposure	NN
cord-303447-3a7jxl34	138	16	.	.	.
cord-303447-3a7jxl34	139	1	Giving	give	VBG
cord-303447-3a7jxl34	139	2	all	all	DT
cord-303447-3a7jxl34	139	3	infants	infant	NNS
cord-303447-3a7jxl34	139	4	the	the	DT
cord-303447-3a7jxl34	139	5	birth	birth	NN
cord-303447-3a7jxl34	139	6	dose	dose	NN
cord-303447-3a7jxl34	139	7	protects	protect	VBZ
cord-303447-3a7jxl34	139	8	infants	infant	NNS
cord-303447-3a7jxl34	139	9	whose	whose	WP$
cord-303447-3a7jxl34	139	10	mothers	mother	NNS
cord-303447-3a7jxl34	139	11	were	be	VBD
cord-303447-3a7jxl34	139	12	not	not	RB
cord-303447-3a7jxl34	139	13	tested	test	VBN
cord-303447-3a7jxl34	139	14	for	for	IN
cord-303447-3a7jxl34	139	15	HBsAg	hbsag	ADD
cord-303447-3a7jxl34	139	16	during	during	IN
cord-303447-3a7jxl34	139	17	pregnancy	pregnancy	NN
cord-303447-3a7jxl34	139	18	.	.	.
cord-303447-3a7jxl34	140	1	Infant	infant	NN
cord-303447-3a7jxl34	140	2	vaccination	vaccination	NN
cord-303447-3a7jxl34	140	3	eventually	eventually	RB
cord-303447-3a7jxl34	140	4	will	will	MD
cord-303447-3a7jxl34	140	5	provide	provide	VB
cord-303447-3a7jxl34	140	6	protection	protection	NN
cord-303447-3a7jxl34	140	7	against	against	IN
cord-303447-3a7jxl34	140	8	hepatitis	hepatitis	NN
cord-303447-3a7jxl34	140	9	B	B	NNP
cord-303447-3a7jxl34	140	10	virus	virus	NN
cord-303447-3a7jxl34	140	11	to	to	IN
cord-303447-3a7jxl34	140	12	adolescents	adolescent	NNS
cord-303447-3a7jxl34	140	13	who	who	WP
cord-303447-3a7jxl34	140	14	may	may	MD
cord-303447-3a7jxl34	140	15	engage	engage	VB
cord-303447-3a7jxl34	140	16	in	in	IN
cord-303447-3a7jxl34	140	17	high	high	JJ
cord-303447-3a7jxl34	140	18	-	-	HYPH
cord-303447-3a7jxl34	140	19	risk	risk	NN
cord-303447-3a7jxl34	140	20	activities	activity	NNS
cord-303447-3a7jxl34	140	21	before	before	IN
cord-303447-3a7jxl34	140	22	exposure	exposure	NN
cord-303447-3a7jxl34	140	23	.	.	.
cord-303447-3a7jxl34	141	1	From	from	IN
cord-303447-3a7jxl34	141	2	1990	1990	CD
cord-303447-3a7jxl34	141	3	to	to	IN
cord-303447-3a7jxl34	141	4	2002	2002	CD
cord-303447-3a7jxl34	141	5	,	,	,
cord-303447-3a7jxl34	141	6	rates	rate	NNS
cord-303447-3a7jxl34	141	7	of	of	IN
cord-303447-3a7jxl34	141	8	hepatitis	hepatitis	NN
cord-303447-3a7jxl34	141	9	B	B	NNP
cord-303447-3a7jxl34	141	10	virus	virus	NN
cord-303447-3a7jxl34	141	11	infection	infection	NN
cord-303447-3a7jxl34	141	12	in	in	IN
cord-303447-3a7jxl34	141	13	children	child	NNS
cord-303447-3a7jxl34	141	14	and	and	CC
cord-303447-3a7jxl34	141	15	adolescents	adolescent	NNS
cord-303447-3a7jxl34	141	16	younger	young	JJR
cord-303447-3a7jxl34	141	17	than	than	IN
cord-303447-3a7jxl34	141	18	20	20	CD
cord-303447-3a7jxl34	141	19	years	year	NNS
cord-303447-3a7jxl34	141	20	old	old	JJ
cord-303447-3a7jxl34	141	21	declined	decline	VBD
cord-303447-3a7jxl34	141	22	more	more	JJR
cord-303447-3a7jxl34	141	23	than	than	IN
cord-303447-3a7jxl34	141	24	88	88	CD
cord-303447-3a7jxl34	141	25	%	%	NN
cord-303447-3a7jxl34	141	26	in	in	IN
cord-303447-3a7jxl34	141	27	the	the	DT
cord-303447-3a7jxl34	141	28	United	United	NNP
cord-303447-3a7jxl34	141	29	States	States	NNP
cord-303447-3a7jxl34	141	30	[	[	-LRB-
cord-303447-3a7jxl34	141	31	47	47	CD
cord-303447-3a7jxl34	141	32	]	]	-RRB-
cord-303447-3a7jxl34	141	33	.	.	.
cord-303447-3a7jxl34	142	1	From	from	IN
cord-303447-3a7jxl34	142	2	2000	2000	CD
cord-303447-3a7jxl34	142	3	to	to	IN
cord-303447-3a7jxl34	142	4	2002	2002	CD
cord-303447-3a7jxl34	142	5	,	,	,
cord-303447-3a7jxl34	142	6	approximately	approximately	RB
cord-303447-3a7jxl34	142	7	2400	2400	CD
cord-303447-3a7jxl34	142	8	to	to	IN
cord-303447-3a7jxl34	142	9	3000	3000	CD
cord-303447-3a7jxl34	142	10	cases	case	NNS
cord-303447-3a7jxl34	142	11	of	of	IN
cord-303447-3a7jxl34	142	12	invasive	invasive	JJ
cord-303447-3a7jxl34	142	13	meningococcal	meningococcal	JJ
cord-303447-3a7jxl34	142	14	disease	disease	NN
cord-303447-3a7jxl34	142	15	occurred	occur	VBD
cord-303447-3a7jxl34	142	16	annually	annually	RB
cord-303447-3a7jxl34	142	17	in	in	IN
cord-303447-3a7jxl34	142	18	the	the	DT
cord-303447-3a7jxl34	142	19	United	United	NNP
cord-303447-3a7jxl34	142	20	States	States	NNP
cord-303447-3a7jxl34	142	21	[	[	-LRB-
cord-303447-3a7jxl34	142	22	48	48	CD
cord-303447-3a7jxl34	142	23	]	]	-RRB-
cord-303447-3a7jxl34	142	24	.	.	.
cord-303447-3a7jxl34	143	1	The	the	DT
cord-303447-3a7jxl34	143	2	case	case	NN
cord-303447-3a7jxl34	143	3	-	-	HYPH
cord-303447-3a7jxl34	143	4	fatality	fatality	NN
cord-303447-3a7jxl34	143	5	ratio	ratio	NN
cord-303447-3a7jxl34	143	6	for	for	IN
cord-303447-3a7jxl34	143	7	meningococcal	meningococcal	JJ
cord-303447-3a7jxl34	143	8	disease	disease	NN
cord-303447-3a7jxl34	143	9	is	be	VBZ
cord-303447-3a7jxl34	143	10	approximately	approximately	RB
cord-303447-3a7jxl34	143	11	10	10	CD
cord-303447-3a7jxl34	143	12	%	%	NN
cord-303447-3a7jxl34	143	13	,	,	,
cord-303447-3a7jxl34	143	14	and	and	CC
cord-303447-3a7jxl34	143	15	severe	severe	JJ
cord-303447-3a7jxl34	143	16	sequelae	sequela	NNS
cord-303447-3a7jxl34	143	17	(	(	-LRB-
cord-303447-3a7jxl34	143	18	eg	eg	IN
cord-303447-3a7jxl34	143	19	,	,	,
cord-303447-3a7jxl34	143	20	neurologic	neurologic	JJ
cord-303447-3a7jxl34	143	21	disability	disability	NN
cord-303447-3a7jxl34	143	22	,	,	,
cord-303447-3a7jxl34	143	23	limb	limb	NN
cord-303447-3a7jxl34	143	24	loss	loss	NN
cord-303447-3a7jxl34	143	25	)	)	-RRB-
cord-303447-3a7jxl34	143	26	occur	occur	VBP
cord-303447-3a7jxl34	143	27	in	in	IN
cord-303447-3a7jxl34	143	28	approximately	approximately	RB
cord-303447-3a7jxl34	143	29	10	10	CD
cord-303447-3a7jxl34	143	30	%	%	NN
cord-303447-3a7jxl34	143	31	of	of	IN
cord-303447-3a7jxl34	143	32	survivors	survivor	NNS
cord-303447-3a7jxl34	143	33	[	[	-LRB-
cord-303447-3a7jxl34	143	34	49	49	CD
cord-303447-3a7jxl34	143	35	]	]	-RRB-
cord-303447-3a7jxl34	143	36	.	.	.
cord-303447-3a7jxl34	144	1	Nasopharyngeal	nasopharyngeal	JJ
cord-303447-3a7jxl34	144	2	carriage	carriage	NN
cord-303447-3a7jxl34	144	3	of	of	IN
cord-303447-3a7jxl34	144	4	Neisseria	Neisseria	NNP
cord-303447-3a7jxl34	144	5	meningitidis	meningitidis	NN
cord-303447-3a7jxl34	144	6	occurs	occur	VBZ
cord-303447-3a7jxl34	144	7	in	in	IN
cord-303447-3a7jxl34	144	8	approximately	approximately	RB
cord-303447-3a7jxl34	144	9	5	5	CD
cord-303447-3a7jxl34	144	10	%	%	NN
cord-303447-3a7jxl34	144	11	to	to	TO
cord-303447-3a7jxl34	144	12	10	10	CD
cord-303447-3a7jxl34	144	13	%	%	NN
cord-303447-3a7jxl34	144	14	of	of	IN
cord-303447-3a7jxl34	144	15	the	the	DT
cord-303447-3a7jxl34	144	16	US	US	NNP
cord-303447-3a7jxl34	144	17	population	population	NN
cord-303447-3a7jxl34	144	18	[	[	-LRB-
cord-303447-3a7jxl34	144	19	48	48	CD
cord-303447-3a7jxl34	144	20	]	]	-RRB-
cord-303447-3a7jxl34	144	21	.	.	.
cord-303447-3a7jxl34	145	1	Transmission	transmission	NN
cord-303447-3a7jxl34	145	2	is	be	VBZ
cord-303447-3a7jxl34	145	3	through	through	IN
cord-303447-3a7jxl34	145	4	direct	direct	JJ
cord-303447-3a7jxl34	145	5	contact	contact	NN
cord-303447-3a7jxl34	145	6	with	with	IN
cord-303447-3a7jxl34	145	7	respiratory	respiratory	JJ
cord-303447-3a7jxl34	145	8	tract	tract	NN
cord-303447-3a7jxl34	145	9	droplets	droplet	NNS
cord-303447-3a7jxl34	145	10	of	of	IN
cord-303447-3a7jxl34	145	11	infected	infected	JJ
cord-303447-3a7jxl34	145	12	individuals	individual	NNS
cord-303447-3a7jxl34	145	13	.	.	.
cord-303447-3a7jxl34	146	1	Infants	infant	NNS
cord-303447-3a7jxl34	146	2	younger	young	JJR
cord-303447-3a7jxl34	146	3	than	than	IN
cord-303447-3a7jxl34	146	4	1	1	CD
cord-303447-3a7jxl34	146	5	year	year	NN
cord-303447-3a7jxl34	146	6	of	of	IN
cord-303447-3a7jxl34	146	7	age	age	NN
cord-303447-3a7jxl34	146	8	have	have	VBP
cord-303447-3a7jxl34	146	9	the	the	DT
cord-303447-3a7jxl34	146	10	highest	high	JJS
cord-303447-3a7jxl34	146	11	rates	rate	NNS
cord-303447-3a7jxl34	146	12	of	of	IN
cord-303447-3a7jxl34	146	13	meningococcal	meningococcal	JJ
cord-303447-3a7jxl34	146	14	disease	disease	NN
cord-303447-3a7jxl34	146	15	,	,	,
cord-303447-3a7jxl34	146	16	with	with	IN
cord-303447-3a7jxl34	146	17	an	an	DT
cord-303447-3a7jxl34	146	18	annual	annual	JJ
cord-303447-3a7jxl34	146	19	incidence	incidence	NN
cord-303447-3a7jxl34	146	20	of	of	IN
cord-303447-3a7jxl34	146	21	6.5	6.5	CD
cord-303447-3a7jxl34	146	22	cases	case	NNS
cord-303447-3a7jxl34	146	23	per	per	IN
cord-303447-3a7jxl34	146	24	100,000	100,000	CD
cord-303447-3a7jxl34	146	25	population	population	NN
cord-303447-3a7jxl34	146	26	during	during	IN
cord-303447-3a7jxl34	146	27	2002	2002	CD
cord-303447-3a7jxl34	146	28	[	[	-LRB-
cord-303447-3a7jxl34	146	29	50	50	CD
cord-303447-3a7jxl34	146	30	]	]	-RRB-
cord-303447-3a7jxl34	146	31	.	.	.
cord-303447-3a7jxl34	147	1	During	during	IN
cord-303447-3a7jxl34	147	2	the	the	DT
cord-303447-3a7jxl34	147	3	1990s	1990	NNS
cord-303447-3a7jxl34	147	4	,	,	,
cord-303447-3a7jxl34	147	5	incidence	incidence	NN
cord-303447-3a7jxl34	147	6	rates	rate	NNS
cord-303447-3a7jxl34	147	7	of	of	IN
cord-303447-3a7jxl34	147	8	meningococcal	meningococcal	JJ
cord-303447-3a7jxl34	147	9	disease	disease	NN
cord-303447-3a7jxl34	147	10	increased	increase	VBD
cord-303447-3a7jxl34	147	11	among	among	IN
cord-303447-3a7jxl34	147	12	adolescents	adolescent	NNS
cord-303447-3a7jxl34	147	13	and	and	CC
cord-303447-3a7jxl34	147	14	young	young	JJ
cord-303447-3a7jxl34	147	15	adults	adult	NNS
cord-303447-3a7jxl34	147	16	[	[	-LRB-
cord-303447-3a7jxl34	147	17	49	49	CD
cord-303447-3a7jxl34	147	18	]	]	-RRB-
cord-303447-3a7jxl34	147	19	.	.	.
cord-303447-3a7jxl34	148	1	Evidence	evidence	NN
cord-303447-3a7jxl34	148	2	also	also	RB
cord-303447-3a7jxl34	148	3	showed	show	VBD
cord-303447-3a7jxl34	148	4	that	that	IN
cord-303447-3a7jxl34	148	5	college	college	NN
cord-303447-3a7jxl34	148	6	freshmen	freshman	NNS
cord-303447-3a7jxl34	148	7	living	live	VBG
cord-303447-3a7jxl34	148	8	in	in	IN
cord-303447-3a7jxl34	148	9	dormitories	dormitory	NNS
cord-303447-3a7jxl34	148	10	have	have	VBP
cord-303447-3a7jxl34	148	11	a	a	DT
cord-303447-3a7jxl34	148	12	modestly	modestly	RB
cord-303447-3a7jxl34	148	13	increased	increase	VBN
cord-303447-3a7jxl34	148	14	risk	risk	NN
cord-303447-3a7jxl34	148	15	of	of	IN
cord-303447-3a7jxl34	148	16	meningococcal	meningococcal	JJ
cord-303447-3a7jxl34	148	17	disease	disease	NN
cord-303447-3a7jxl34	148	18	(	(	-LRB-
cord-303447-3a7jxl34	148	19	4.6	4.6	CD
cord-303447-3a7jxl34	148	20	cases	case	NNS
cord-303447-3a7jxl34	148	21	per	per	IN
cord-303447-3a7jxl34	148	22	100,000	100,000	CD
cord-303447-3a7jxl34	148	23	)	)	-RRB-
cord-303447-3a7jxl34	148	24	compared	compare	VBN
cord-303447-3a7jxl34	148	25	with	with	IN
cord-303447-3a7jxl34	148	26	other	other	JJ
cord-303447-3a7jxl34	148	27	persons	person	NNS
cord-303447-3a7jxl34	148	28	the	the	DT
cord-303447-3a7jxl34	148	29	same	same	JJ
cord-303447-3a7jxl34	148	30	age	age	NN
cord-303447-3a7jxl34	148	31	[	[	-LRB-
cord-303447-3a7jxl34	148	32	49	49	CD
cord-303447-3a7jxl34	148	33	]	]	-RRB-
cord-303447-3a7jxl34	148	34	.	.	.
cord-303447-3a7jxl34	149	1	A	a	DT
cord-303447-3a7jxl34	149	2	meningococcal	meningococcal	JJ
cord-303447-3a7jxl34	149	3	polysaccharide	polysaccharide	NN
cord-303447-3a7jxl34	149	4	(	(	-LRB-
cord-303447-3a7jxl34	149	5	MPS	MPS	NNP
cord-303447-3a7jxl34	149	6	)	)	-RRB-
cord-303447-3a7jxl34	149	7	vaccine	vaccine	NN
cord-303447-3a7jxl34	149	8	containing	contain	VBG
cord-303447-3a7jxl34	149	9	the	the	DT
cord-303447-3a7jxl34	149	10	antigens	antigen	NNS
cord-303447-3a7jxl34	149	11	of	of	IN
cord-303447-3a7jxl34	149	12	serogroups	serogroup	NNS
cord-303447-3a7jxl34	149	13	A	A	NNP
cord-303447-3a7jxl34	149	14	,	,	,
cord-303447-3a7jxl34	149	15	C	C	NNP
cord-303447-3a7jxl34	149	16	,	,	,
cord-303447-3a7jxl34	149	17	Y	Y	NNP
cord-303447-3a7jxl34	149	18	,	,	,
cord-303447-3a7jxl34	149	19	and	and	CC
cord-303447-3a7jxl34	149	20	W135	W135	NNPS
cord-303447-3a7jxl34	149	21	has	have	VBZ
cord-303447-3a7jxl34	149	22	been	be	VBN
cord-303447-3a7jxl34	149	23	used	use	VBN
cord-303447-3a7jxl34	149	24	in	in	IN
cord-303447-3a7jxl34	149	25	the	the	DT
cord-303447-3a7jxl34	149	26	United	United	NNP
cord-303447-3a7jxl34	149	27	States	States	NNP
cord-303447-3a7jxl34	149	28	since	since	IN
cord-303447-3a7jxl34	149	29	licensure	licensure	NN
cord-303447-3a7jxl34	149	30	in	in	IN
cord-303447-3a7jxl34	149	31	1981	1981	CD
cord-303447-3a7jxl34	149	32	.	.	.
cord-303447-3a7jxl34	150	1	This	this	DT
cord-303447-3a7jxl34	150	2	vaccine	vaccine	NN
cord-303447-3a7jxl34	150	3	protects	protect	VBZ
cord-303447-3a7jxl34	150	4	against	against	IN
cord-303447-3a7jxl34	150	5	the	the	DT
cord-303447-3a7jxl34	150	6	serogroups	serogroup	NNS
cord-303447-3a7jxl34	150	7	that	that	WDT
cord-303447-3a7jxl34	150	8	cause	cause	VBP
cord-303447-3a7jxl34	150	9	approximately	approximately	RB
cord-303447-3a7jxl34	150	10	two	two	CD
cord-303447-3a7jxl34	150	11	thirds	third	NNS
cord-303447-3a7jxl34	150	12	of	of	IN
cord-303447-3a7jxl34	150	13	meningococcal	meningococcal	JJ
cord-303447-3a7jxl34	150	14	disease	disease	NN
cord-303447-3a7jxl34	150	15	that	that	WDT
cord-303447-3a7jxl34	150	16	occurs	occur	VBZ
cord-303447-3a7jxl34	150	17	in	in	IN
cord-303447-3a7jxl34	150	18	persons	person	NNS
cord-303447-3a7jxl34	150	19	18	18	CD
cord-303447-3a7jxl34	150	20	to	to	TO
cord-303447-3a7jxl34	150	21	23	23	CD
cord-303447-3a7jxl34	150	22	years	year	NNS
cord-303447-3a7jxl34	150	23	old	old	JJ
cord-303447-3a7jxl34	150	24	in	in	IN
cord-303447-3a7jxl34	150	25	the	the	DT
cord-303447-3a7jxl34	150	26	United	United	NNP
cord-303447-3a7jxl34	150	27	States	States	NNP
cord-303447-3a7jxl34	150	28	.	.	.
cord-303447-3a7jxl34	151	1	More	More	JJR
cord-303447-3a7jxl34	151	2	than	than	IN
cord-303447-3a7jxl34	151	3	half	half	NN
cord-303447-3a7jxl34	151	4	of	of	IN
cord-303447-3a7jxl34	151	5	cases	case	NNS
cord-303447-3a7jxl34	151	6	in	in	IN
cord-303447-3a7jxl34	151	7	infants	infant	NNS
cord-303447-3a7jxl34	151	8	are	be	VBP
cord-303447-3a7jxl34	151	9	due	due	JJ
cord-303447-3a7jxl34	151	10	to	to	TO
cord-303447-3a7jxl34	151	11	serogroup	serogroup	NNP
cord-303447-3a7jxl34	151	12	B	B	NNP
cord-303447-3a7jxl34	151	13	,	,	,
cord-303447-3a7jxl34	151	14	however	however	RB
cord-303447-3a7jxl34	151	15	,	,	,
cord-303447-3a7jxl34	151	16	for	for	IN
cord-303447-3a7jxl34	151	17	which	which	WDT
cord-303447-3a7jxl34	151	18	a	a	DT
cord-303447-3a7jxl34	151	19	licensed	licensed	JJ
cord-303447-3a7jxl34	151	20	vaccine	vaccine	NN
cord-303447-3a7jxl34	151	21	does	do	VBZ
cord-303447-3a7jxl34	151	22	not	not	RB
cord-303447-3a7jxl34	151	23	exist	exist	VB
cord-303447-3a7jxl34	151	24	in	in	IN
cord-303447-3a7jxl34	151	25	the	the	DT
cord-303447-3a7jxl34	151	26	United	United	NNP
cord-303447-3a7jxl34	151	27	States	States	NNP
cord-303447-3a7jxl34	151	28	[	[	-LRB-
cord-303447-3a7jxl34	151	29	49	49	CD
cord-303447-3a7jxl34	151	30	]	]	-RRB-
cord-303447-3a7jxl34	151	31	.	.	.
cord-303447-3a7jxl34	152	1	Similar	similar	JJ
cord-303447-3a7jxl34	152	2	to	to	IN
cord-303447-3a7jxl34	152	3	other	other	JJ
cord-303447-3a7jxl34	152	4	polysaccharide	polysaccharide	NN
cord-303447-3a7jxl34	152	5	vaccines	vaccine	NNS
cord-303447-3a7jxl34	152	6	,	,	,
cord-303447-3a7jxl34	152	7	MPS	MPS	NNP
cord-303447-3a7jxl34	152	8	induces	induce	VBZ
cord-303447-3a7jxl34	152	9	a	a	DT
cord-303447-3a7jxl34	152	10	T	T	NNP
cord-303447-3a7jxl34	152	11	cell	cell	NN
cord-303447-3a7jxl34	152	12	-	-	HYPH
cord-303447-3a7jxl34	152	13	independent	independent	JJ
cord-303447-3a7jxl34	152	14	immune	immune	JJ
cord-303447-3a7jxl34	152	15	response	response	NN
cord-303447-3a7jxl34	152	16	resulting	result	VBG
cord-303447-3a7jxl34	152	17	in	in	IN
cord-303447-3a7jxl34	152	18	poor	poor	JJ
cord-303447-3a7jxl34	152	19	long	long	JJ
cord-303447-3a7jxl34	152	20	-	-	HYPH
cord-303447-3a7jxl34	152	21	term	term	NN
cord-303447-3a7jxl34	152	22	immunity	immunity	NN
cord-303447-3a7jxl34	152	23	and	and	CC
cord-303447-3a7jxl34	152	24	inconsistent	inconsistent	JJ
cord-303447-3a7jxl34	152	25	immunogenicity	immunogenicity	NN
cord-303447-3a7jxl34	152	26	in	in	IN
cord-303447-3a7jxl34	152	27	children	child	NNS
cord-303447-3a7jxl34	152	28	younger	young	JJR
cord-303447-3a7jxl34	152	29	than	than	IN
cord-303447-3a7jxl34	152	30	2	2	CD
cord-303447-3a7jxl34	152	31	years	year	NNS
cord-303447-3a7jxl34	152	32	old	old	JJ
cord-303447-3a7jxl34	152	33	.	.	.
cord-303447-3a7jxl34	153	1	An	an	DT
cord-303447-3a7jxl34	153	2	additional	additional	JJ
cord-303447-3a7jxl34	153	3	shortcoming	shortcoming	NN
cord-303447-3a7jxl34	153	4	is	be	VBZ
cord-303447-3a7jxl34	153	5	that	that	IN
cord-303447-3a7jxl34	153	6	MPS	MPS	NNP
cord-303447-3a7jxl34	153	7	does	do	VBZ
cord-303447-3a7jxl34	153	8	not	not	RB
cord-303447-3a7jxl34	153	9	reduce	reduce	VB
cord-303447-3a7jxl34	153	10	nasopharyngeal	nasopharyngeal	JJ
cord-303447-3a7jxl34	153	11	carriage	carriage	NN
cord-303447-3a7jxl34	153	12	or	or	CC
cord-303447-3a7jxl34	153	13	induce	induce	VB
cord-303447-3a7jxl34	153	14	herd	herd	NN
cord-303447-3a7jxl34	153	15	immunity	immunity	NN
cord-303447-3a7jxl34	153	16	[	[	-LRB-
cord-303447-3a7jxl34	153	17	48	48	CD
cord-303447-3a7jxl34	153	18	]	]	-RRB-
cord-303447-3a7jxl34	153	19	.	.	.
cord-303447-3a7jxl34	154	1	Before	before	IN
cord-303447-3a7jxl34	154	2	February	February	NNP
cord-303447-3a7jxl34	154	3	2005	2005	CD
cord-303447-3a7jxl34	154	4	,	,	,
cord-303447-3a7jxl34	154	5	MPS	MPS	NNP
cord-303447-3a7jxl34	154	6	vaccine	vaccine	NN
cord-303447-3a7jxl34	154	7	was	be	VBD
cord-303447-3a7jxl34	154	8	recommended	recommend	VBN
cord-303447-3a7jxl34	154	9	for	for	IN
cord-303447-3a7jxl34	154	10	groups	group	NNS
cord-303447-3a7jxl34	154	11	at	at	IN
cord-303447-3a7jxl34	154	12	high	high	JJ
cord-303447-3a7jxl34	154	13	risk	risk	NN
cord-303447-3a7jxl34	154	14	for	for	IN
cord-303447-3a7jxl34	154	15	meningococcal	meningococcal	JJ
cord-303447-3a7jxl34	154	16	disease	disease	NN
cord-303447-3a7jxl34	154	17	and	and	CC
cord-303447-3a7jxl34	154	18	for	for	IN
cord-303447-3a7jxl34	154	19	outbreak	outbreak	NN
cord-303447-3a7jxl34	154	20	control	control	NN
cord-303447-3a7jxl34	154	21	.	.	.
cord-303447-3a7jxl34	155	1	Educating	educate	VBG
cord-303447-3a7jxl34	155	2	college	college	NN
cord-303447-3a7jxl34	155	3	freshmen	freshman	NNS
cord-303447-3a7jxl34	155	4	about	about	IN
cord-303447-3a7jxl34	155	5	the	the	DT
cord-303447-3a7jxl34	155	6	potential	potential	NN
cord-303447-3a7jxl34	155	7	for	for	IN
cord-303447-3a7jxl34	155	8	the	the	DT
cord-303447-3a7jxl34	155	9	MPS	MPS	NNP
cord-303447-3a7jxl34	155	10	vaccine	vaccine	NN
cord-303447-3a7jxl34	155	11	to	to	TO
cord-303447-3a7jxl34	155	12	prevent	prevent	VB
cord-303447-3a7jxl34	155	13	severe	severe	JJ
cord-303447-3a7jxl34	155	14	infection	infection	NN
cord-303447-3a7jxl34	155	15	also	also	RB
cord-303447-3a7jxl34	155	16	was	be	VBD
cord-303447-3a7jxl34	155	17	recommended	recommend	VBN
cord-303447-3a7jxl34	155	18	.	.	.
cord-303447-3a7jxl34	156	1	Some	some	DT
cord-303447-3a7jxl34	156	2	states	state	NNS
cord-303447-3a7jxl34	156	3	required	require	VBD
cord-303447-3a7jxl34	156	4	proof	proof	NN
cord-303447-3a7jxl34	156	5	of	of	IN
cord-303447-3a7jxl34	156	6	vaccination	vaccination	NN
cord-303447-3a7jxl34	156	7	or	or	CC
cord-303447-3a7jxl34	156	8	vaccine	vaccine	NN
cord-303447-3a7jxl34	156	9	waiver	waiver	NN
cord-303447-3a7jxl34	156	10	for	for	IN
cord-303447-3a7jxl34	156	11	entry	entry	NN
cord-303447-3a7jxl34	156	12	into	into	IN
cord-303447-3a7jxl34	156	13	colleges	college	NNS
cord-303447-3a7jxl34	156	14	and	and	CC
cord-303447-3a7jxl34	156	15	universities	university	NNS
cord-303447-3a7jxl34	156	16	[	[	-LRB-
cord-303447-3a7jxl34	156	17	49	49	CD
cord-303447-3a7jxl34	156	18	]	]	-RRB-
cord-303447-3a7jxl34	156	19	.	.	.
cord-303447-3a7jxl34	157	1	Employing	employ	VBG
cord-303447-3a7jxl34	157	2	the	the	DT
cord-303447-3a7jxl34	157	3	same	same	JJ
cord-303447-3a7jxl34	157	4	technology	technology	NN
cord-303447-3a7jxl34	157	5	used	use	VBN
cord-303447-3a7jxl34	157	6	to	to	TO
cord-303447-3a7jxl34	157	7	develop	develop	VB
cord-303447-3a7jxl34	157	8	PCV7	PCV7	NNP
cord-303447-3a7jxl34	157	9	,	,	,
cord-303447-3a7jxl34	157	10	a	a	DT
cord-303447-3a7jxl34	157	11	meningococcal	meningococcal	JJ
cord-303447-3a7jxl34	157	12	serogroup	serogroup	NN
cord-303447-3a7jxl34	157	13	C	C	NNP
cord-303447-3a7jxl34	157	14	conjugate	conjugate	NN
cord-303447-3a7jxl34	157	15	vaccine	vaccine	NN
cord-303447-3a7jxl34	157	16	was	be	VBD
cord-303447-3a7jxl34	157	17	licensed	license	VBN
cord-303447-3a7jxl34	157	18	in	in	IN
cord-303447-3a7jxl34	157	19	the	the	DT
cord-303447-3a7jxl34	157	20	United	United	NNP
cord-303447-3a7jxl34	157	21	Kingdom	Kingdom	NNP
cord-303447-3a7jxl34	157	22	in	in	IN
cord-303447-3a7jxl34	157	23	1999	1999	CD
cord-303447-3a7jxl34	157	24	.	.	.
cord-303447-3a7jxl34	158	1	The	the	DT
cord-303447-3a7jxl34	158	2	vaccine	vaccine	NN
cord-303447-3a7jxl34	158	3	was	be	VBD
cord-303447-3a7jxl34	158	4	introduced	introduce	VBN
cord-303447-3a7jxl34	158	5	into	into	IN
cord-303447-3a7jxl34	158	6	the	the	DT
cord-303447-3a7jxl34	158	7	routine	routine	JJ
cord-303447-3a7jxl34	158	8	infant	infant	NN
cord-303447-3a7jxl34	158	9	schedule	schedule	NN
cord-303447-3a7jxl34	158	10	,	,	,
cord-303447-3a7jxl34	158	11	with	with	IN
cord-303447-3a7jxl34	158	12	catch	catch	VB
cord-303447-3a7jxl34	158	13	-	-	HYPH
cord-303447-3a7jxl34	158	14	up	up	RP
cord-303447-3a7jxl34	158	15	vaccination	vaccination	NN
cord-303447-3a7jxl34	158	16	for	for	IN
cord-303447-3a7jxl34	158	17	older	old	JJR
cord-303447-3a7jxl34	158	18	children	child	NNS
cord-303447-3a7jxl34	158	19	and	and	CC
cord-303447-3a7jxl34	158	20	adolescents	adolescent	NNS
cord-303447-3a7jxl34	158	21	.	.	.
cord-303447-3a7jxl34	159	1	In	in	IN
cord-303447-3a7jxl34	159	2	the	the	DT
cord-303447-3a7jxl34	159	3	2	2	CD
cord-303447-3a7jxl34	159	4	years	year	NNS
cord-303447-3a7jxl34	159	5	after	after	IN
cord-303447-3a7jxl34	159	6	introduction	introduction	NN
cord-303447-3a7jxl34	159	7	of	of	IN
cord-303447-3a7jxl34	159	8	infant	infant	NN
cord-303447-3a7jxl34	159	9	meningococcal	meningococcal	JJ
cord-303447-3a7jxl34	159	10	conjugate	conjugate	NN
cord-303447-3a7jxl34	159	11	vaccine	vaccine	NN
cord-303447-3a7jxl34	159	12	,	,	,
cord-303447-3a7jxl34	159	13	the	the	DT
cord-303447-3a7jxl34	159	14	incidence	incidence	NN
cord-303447-3a7jxl34	159	15	of	of	IN
cord-303447-3a7jxl34	159	16	serogroup	serogroup	NNP
cord-303447-3a7jxl34	159	17	C	C	NNP
cord-303447-3a7jxl34	159	18	meningococcal	meningococcal	NNP
cord-303447-3a7jxl34	159	19	disease	disease	NN
cord-303447-3a7jxl34	159	20	declined	decline	VBD
cord-303447-3a7jxl34	159	21	by	by	IN
cord-303447-3a7jxl34	159	22	87	87	CD
cord-303447-3a7jxl34	159	23	%	%	NN
cord-303447-3a7jxl34	159	24	in	in	IN
cord-303447-3a7jxl34	159	25	vaccinated	vaccinated	JJ
cord-303447-3a7jxl34	159	26	persons	person	NNS
cord-303447-3a7jxl34	159	27	and	and	CC
cord-303447-3a7jxl34	159	28	at	at	RB
cord-303447-3a7jxl34	159	29	least	least	RBS
cord-303447-3a7jxl34	159	30	34	34	CD
cord-303447-3a7jxl34	159	31	%	%	NN
cord-303447-3a7jxl34	159	32	in	in	IN
cord-303447-3a7jxl34	159	33	unvaccinated	unvaccinated	JJ
cord-303447-3a7jxl34	159	34	persons	person	NNS
cord-303447-3a7jxl34	159	35	,	,	,
cord-303447-3a7jxl34	159	36	suggesting	suggest	VBG
cord-303447-3a7jxl34	159	37	the	the	DT
cord-303447-3a7jxl34	159	38	vaccine	vaccine	NN
cord-303447-3a7jxl34	159	39	produced	produce	VBD
cord-303447-3a7jxl34	159	40	herd	herd	NN
cord-303447-3a7jxl34	159	41	immunity	immunity	NN
cord-303447-3a7jxl34	159	42	[	[	-LRB-
cord-303447-3a7jxl34	159	43	48	48	CD
cord-303447-3a7jxl34	159	44	]	]	-RRB-
cord-303447-3a7jxl34	159	45	.	.	.
cord-303447-3a7jxl34	160	1	In	in	IN
cord-303447-3a7jxl34	160	2	the	the	DT
cord-303447-3a7jxl34	160	3	United	United	NNP
cord-303447-3a7jxl34	160	4	States	States	NNP
cord-303447-3a7jxl34	160	5	,	,	,
cord-303447-3a7jxl34	160	6	a	a	DT
cord-303447-3a7jxl34	160	7	quadrivalet	quadrivalet	NN
cord-303447-3a7jxl34	160	8	meningococcal	meningococcal	JJ
cord-303447-3a7jxl34	160	9	conjugate	conjugate	NN
cord-303447-3a7jxl34	160	10	vaccine	vaccine	NN
cord-303447-3a7jxl34	160	11	(	(	-LRB-
cord-303447-3a7jxl34	160	12	serogroups	serogroup	NNS
cord-303447-3a7jxl34	160	13	A	A	NNP
cord-303447-3a7jxl34	160	14	,	,	,
cord-303447-3a7jxl34	160	15	C	C	NNP
cord-303447-3a7jxl34	160	16	,	,	,
cord-303447-3a7jxl34	160	17	Y	Y	NNP
cord-303447-3a7jxl34	160	18	,	,	,
cord-303447-3a7jxl34	160	19	and	and	CC
cord-303447-3a7jxl34	160	20	W-135	w-135	NN
cord-303447-3a7jxl34	160	21	)	)	-RRB-
cord-303447-3a7jxl34	161	1	(	(	-LRB-
cord-303447-3a7jxl34	161	2	MCV4	MCV4	NNP
cord-303447-3a7jxl34	161	3	)	)	-RRB-
cord-303447-3a7jxl34	161	4	was	be	VBD
cord-303447-3a7jxl34	161	5	licensed	license	VBN
cord-303447-3a7jxl34	161	6	on	on	IN
cord-303447-3a7jxl34	161	7	January	January	NNP
cord-303447-3a7jxl34	161	8	14	14	CD
cord-303447-3a7jxl34	161	9	,	,	,
cord-303447-3a7jxl34	161	10	2005	2005	CD
cord-303447-3a7jxl34	161	11	,	,	,
cord-303447-3a7jxl34	161	12	for	for	IN
cord-303447-3a7jxl34	161	13	use	use	NN
cord-303447-3a7jxl34	161	14	in	in	IN
cord-303447-3a7jxl34	161	15	persons	person	NNS
cord-303447-3a7jxl34	161	16	11	11	CD
cord-303447-3a7jxl34	161	17	to	to	TO
cord-303447-3a7jxl34	161	18	55	55	CD
cord-303447-3a7jxl34	161	19	years	year	NNS
cord-303447-3a7jxl34	161	20	old	old	JJ
cord-303447-3a7jxl34	161	21	.	.	.
cord-303447-3a7jxl34	162	1	During	during	IN
cord-303447-3a7jxl34	162	2	prelicensure	prelicensure	JJ
cord-303447-3a7jxl34	162	3	clinical	clinical	JJ
cord-303447-3a7jxl34	162	4	trials	trial	NNS
cord-303447-3a7jxl34	162	5	,	,	,
cord-303447-3a7jxl34	162	6	immune	immune	JJ
cord-303447-3a7jxl34	162	7	responses	response	NNS
cord-303447-3a7jxl34	162	8	to	to	IN
cord-303447-3a7jxl34	162	9	MPS	MPS	NNP
cord-303447-3a7jxl34	162	10	and	and	CC
cord-303447-3a7jxl34	162	11	MCV4	MCV4	NNP
cord-303447-3a7jxl34	162	12	were	be	VBD
cord-303447-3a7jxl34	162	13	similar	similar	JJ
cord-303447-3a7jxl34	162	14	in	in	IN
cord-303447-3a7jxl34	162	15	adolescents	adolescent	NNS
cord-303447-3a7jxl34	162	16	and	and	CC
cord-303447-3a7jxl34	162	17	adults	adult	NNS
cord-303447-3a7jxl34	162	18	.	.	.
cord-303447-3a7jxl34	163	1	Because	because	IN
cord-303447-3a7jxl34	163	2	MCV4	MCV4	NNP
cord-303447-3a7jxl34	163	3	induces	induce	VBZ
cord-303447-3a7jxl34	163	4	T	T	NNP
cord-303447-3a7jxl34	163	5	cell	cell	NN
cord-303447-3a7jxl34	163	6	-	-	HYPH
cord-303447-3a7jxl34	163	7	mediated	mediate	VBN
cord-303447-3a7jxl34	163	8	immunity	immunity	NN
cord-303447-3a7jxl34	163	9	,	,	,
cord-303447-3a7jxl34	163	10	the	the	DT
cord-303447-3a7jxl34	163	11	duration	duration	NN
cord-303447-3a7jxl34	163	12	of	of	IN
cord-303447-3a7jxl34	163	13	protection	protection	NN
cord-303447-3a7jxl34	163	14	is	be	VBZ
cord-303447-3a7jxl34	163	15	thought	think	VBN
cord-303447-3a7jxl34	163	16	to	to	TO
cord-303447-3a7jxl34	163	17	be	be	VB
cord-303447-3a7jxl34	163	18	longer	long	JJR
cord-303447-3a7jxl34	163	19	than	than	IN
cord-303447-3a7jxl34	163	20	immunity	immunity	NN
cord-303447-3a7jxl34	163	21	produced	produce	VBN
cord-303447-3a7jxl34	163	22	by	by	IN
cord-303447-3a7jxl34	163	23	MPS	MPS	NNP
cord-303447-3a7jxl34	163	24	.	.	.
cord-303447-3a7jxl34	164	1	On	on	IN
cord-303447-3a7jxl34	164	2	February	February	NNP
cord-303447-3a7jxl34	164	3	10	10	CD
cord-303447-3a7jxl34	164	4	,	,	,
cord-303447-3a7jxl34	164	5	2005	2005	CD
cord-303447-3a7jxl34	164	6	,	,	,
cord-303447-3a7jxl34	164	7	the	the	DT
cord-303447-3a7jxl34	164	8	ACIP	ACIP	NNP
cord-303447-3a7jxl34	164	9	voted	vote	VBD
cord-303447-3a7jxl34	164	10	to	to	TO
cord-303447-3a7jxl34	164	11	recommend	recommend	VB
cord-303447-3a7jxl34	164	12	that	that	IN
cord-303447-3a7jxl34	164	13	MCV4	MCV4	NNP
cord-303447-3a7jxl34	164	14	be	be	VB
cord-303447-3a7jxl34	164	15	administered	administer	VBN
cord-303447-3a7jxl34	164	16	universally	universally	RB
cord-303447-3a7jxl34	164	17	to	to	IN
cord-303447-3a7jxl34	164	18	adolescents	adolescent	NNS
cord-303447-3a7jxl34	164	19	ages	age	NNS
cord-303447-3a7jxl34	164	20	11	11	CD
cord-303447-3a7jxl34	164	21	to	to	TO
cord-303447-3a7jxl34	164	22	12	12	CD
cord-303447-3a7jxl34	164	23	and	and	CC
cord-303447-3a7jxl34	164	24	around	around	RB
cord-303447-3a7jxl34	164	25	15	15	CD
cord-303447-3a7jxl34	164	26	years	year	NNS
cord-303447-3a7jxl34	164	27	of	of	IN
cord-303447-3a7jxl34	164	28	age	age	NN
cord-303447-3a7jxl34	164	29	,	,	,
cord-303447-3a7jxl34	164	30	and	and	CC
cord-303447-3a7jxl34	164	31	college	college	NN
cord-303447-3a7jxl34	164	32	freshmen	freshman	NNS
cord-303447-3a7jxl34	164	33	living	live	VBG
cord-303447-3a7jxl34	164	34	in	in	IN
cord-303447-3a7jxl34	164	35	dormitories	dormitory	NNS
cord-303447-3a7jxl34	164	36	;	;	:
cord-303447-3a7jxl34	164	37	a	a	DT
cord-303447-3a7jxl34	164	38	VFC	VFC	NNP
cord-303447-3a7jxl34	164	39	resolution	resolution	NN
cord-303447-3a7jxl34	164	40	also	also	RB
cord-303447-3a7jxl34	164	41	was	be	VBD
cord-303447-3a7jxl34	164	42	passed	pass	VBN
cord-303447-3a7jxl34	164	43	.	.	.
cord-303447-3a7jxl34	165	1	With	with	IN
cord-303447-3a7jxl34	165	2	the	the	DT
cord-303447-3a7jxl34	165	3	addition	addition	NN
cord-303447-3a7jxl34	165	4	of	of	IN
cord-303447-3a7jxl34	165	5	MCV4	MCV4	NNP
cord-303447-3a7jxl34	165	6	to	to	IN
cord-303447-3a7jxl34	165	7	the	the	DT
cord-303447-3a7jxl34	165	8	immunization	immunization	NN
cord-303447-3a7jxl34	165	9	schedule	schedule	NN
cord-303447-3a7jxl34	165	10	,	,	,
cord-303447-3a7jxl34	165	11	a	a	DT
cord-303447-3a7jxl34	165	12	new	new	JJ
cord-303447-3a7jxl34	165	13	era	era	NN
cord-303447-3a7jxl34	165	14	of	of	IN
cord-303447-3a7jxl34	165	15	adolescent	adolescent	JJ
cord-303447-3a7jxl34	165	16	vaccination	vaccination	NN
cord-303447-3a7jxl34	165	17	was	be	VBD
cord-303447-3a7jxl34	165	18	launched	launch	VBN
cord-303447-3a7jxl34	165	19	.	.	.
cord-303447-3a7jxl34	166	1	In	in	IN
cord-303447-3a7jxl34	166	2	the	the	DT
cord-303447-3a7jxl34	166	3	United	United	NNP
cord-303447-3a7jxl34	166	4	States	States	NNP
cord-303447-3a7jxl34	166	5	,	,	,
cord-303447-3a7jxl34	166	6	meningococcal	meningococcal	JJ
cord-303447-3a7jxl34	166	7	conjugate	conjugate	NN
cord-303447-3a7jxl34	166	8	vaccines	vaccine	NNS
cord-303447-3a7jxl34	166	9	for	for	IN
cord-303447-3a7jxl34	166	10	use	use	NN
cord-303447-3a7jxl34	166	11	in	in	IN
cord-303447-3a7jxl34	166	12	children	child	NNS
cord-303447-3a7jxl34	166	13	younger	young	JJR
cord-303447-3a7jxl34	166	14	than	than	IN
cord-303447-3a7jxl34	166	15	11	11	CD
cord-303447-3a7jxl34	166	16	years	year	NNS
cord-303447-3a7jxl34	166	17	of	of	IN
cord-303447-3a7jxl34	166	18	age	age	NN
cord-303447-3a7jxl34	166	19	are	be	VBP
cord-303447-3a7jxl34	166	20	under	under	IN
cord-303447-3a7jxl34	166	21	study	study	NN
cord-303447-3a7jxl34	166	22	.	.	.
cord-303447-3a7jxl34	167	1	Pertussis	pertussis	NN
cord-303447-3a7jxl34	167	2	remains	remain	VBZ
cord-303447-3a7jxl34	167	3	endemic	endemic	JJ
cord-303447-3a7jxl34	167	4	in	in	IN
cord-303447-3a7jxl34	167	5	the	the	DT
cord-303447-3a7jxl34	167	6	United	United	NNP
cord-303447-3a7jxl34	167	7	States	States	NNP
cord-303447-3a7jxl34	167	8	despite	despite	IN
cord-303447-3a7jxl34	167	9	high	high	JJ
cord-303447-3a7jxl34	167	10	immunization	immunization	NN
cord-303447-3a7jxl34	167	11	coverage	coverage	NN
cord-303447-3a7jxl34	167	12	rates	rate	NNS
cord-303447-3a7jxl34	167	13	of	of	IN
cord-303447-3a7jxl34	167	14	infants	infant	NNS
cord-303447-3a7jxl34	167	15	and	and	CC
cord-303447-3a7jxl34	167	16	young	young	JJ
cord-303447-3a7jxl34	167	17	children	child	NNS
cord-303447-3a7jxl34	167	18	[	[	-LRB-
cord-303447-3a7jxl34	167	19	51	51	CD
cord-303447-3a7jxl34	167	20	]	]	-RRB-
cord-303447-3a7jxl34	167	21	.	.	.
cord-303447-3a7jxl34	168	1	Immunity	immunity	NN
cord-303447-3a7jxl34	168	2	to	to	IN
cord-303447-3a7jxl34	168	3	pertussis	pertussis	NN
cord-303447-3a7jxl34	168	4	wanes	wane	VBZ
cord-303447-3a7jxl34	168	5	approximately	approximately	RB
cord-303447-3a7jxl34	168	6	5	5	CD
cord-303447-3a7jxl34	168	7	to	to	TO
cord-303447-3a7jxl34	168	8	10	10	CD
cord-303447-3a7jxl34	168	9	years	year	NNS
cord-303447-3a7jxl34	168	10	after	after	IN
cord-303447-3a7jxl34	168	11	vaccination	vaccination	NN
cord-303447-3a7jxl34	168	12	,	,	,
cord-303447-3a7jxl34	168	13	and	and	CC
cord-303447-3a7jxl34	168	14	loss	loss	NN
cord-303447-3a7jxl34	168	15	of	of	IN
cord-303447-3a7jxl34	168	16	immunity	immunity	NN
cord-303447-3a7jxl34	168	17	seems	seem	VBZ
cord-303447-3a7jxl34	168	18	to	to	TO
cord-303447-3a7jxl34	168	19	play	play	VB
cord-303447-3a7jxl34	168	20	a	a	DT
cord-303447-3a7jxl34	168	21	major	major	JJ
cord-303447-3a7jxl34	168	22	role	role	NN
cord-303447-3a7jxl34	168	23	in	in	IN
cord-303447-3a7jxl34	168	24	the	the	DT
cord-303447-3a7jxl34	168	25	continued	continued	JJ
cord-303447-3a7jxl34	168	26	circulation	circulation	NN
cord-303447-3a7jxl34	168	27	of	of	IN
cord-303447-3a7jxl34	168	28	pertussis	pertussis	NN
cord-303447-3a7jxl34	168	29	[	[	-LRB-
cord-303447-3a7jxl34	168	30	52	52	CD
cord-303447-3a7jxl34	168	31	]	]	-RRB-
cord-303447-3a7jxl34	168	32	.	.	.
cord-303447-3a7jxl34	169	1	In	in	IN
cord-303447-3a7jxl34	169	2	2003	2003	CD
cord-303447-3a7jxl34	169	3	and	and	CC
cord-303447-3a7jxl34	169	4	2004	2004	CD
cord-303447-3a7jxl34	169	5	,	,	,
cord-303447-3a7jxl34	169	6	11,647	11,647	CD
cord-303447-3a7jxl34	169	7	and	and	CC
cord-303447-3a7jxl34	169	8	more	more	JJR
cord-303447-3a7jxl34	169	9	than	than	IN
cord-303447-3a7jxl34	169	10	18,000	18,000	CD
cord-303447-3a7jxl34	169	11	cases	case	NNS
cord-303447-3a7jxl34	169	12	of	of	IN
cord-303447-3a7jxl34	169	13	pertussis	pertussis	NN
cord-303447-3a7jxl34	169	14	were	be	VBD
cord-303447-3a7jxl34	169	15	reported	report	VBN
cord-303447-3a7jxl34	169	16	to	to	IN
cord-303447-3a7jxl34	169	17	the	the	DT
cord-303447-3a7jxl34	169	18	CDC	CDC	NNP
cord-303447-3a7jxl34	169	19	,	,	,
cord-303447-3a7jxl34	169	20	respectively	respectively	RB
cord-303447-3a7jxl34	169	21	[	[	-LRB-
cord-303447-3a7jxl34	169	22	53	53	CD
cord-303447-3a7jxl34	169	23	]	]	-RRB-
cord-303447-3a7jxl34	169	24	.	.	.
cord-303447-3a7jxl34	170	1	Much	much	JJ
cord-303447-3a7jxl34	170	2	of	of	IN
cord-303447-3a7jxl34	170	3	the	the	DT
cord-303447-3a7jxl34	170	4	reported	report	VBN
cord-303447-3a7jxl34	170	5	increase	increase	NN
cord-303447-3a7jxl34	170	6	is	be	VBZ
cord-303447-3a7jxl34	170	7	thought	think	VBN
cord-303447-3a7jxl34	170	8	to	to	TO
cord-303447-3a7jxl34	170	9	be	be	VB
cord-303447-3a7jxl34	170	10	due	due	JJ
cord-303447-3a7jxl34	170	11	to	to	IN
cord-303447-3a7jxl34	170	12	increasing	increase	VBG
cord-303447-3a7jxl34	170	13	physician	physician	NN
cord-303447-3a7jxl34	170	14	recognition	recognition	NN
cord-303447-3a7jxl34	170	15	of	of	IN
cord-303447-3a7jxl34	170	16	pertussis	pertussis	NN
cord-303447-3a7jxl34	170	17	as	as	IN
cord-303447-3a7jxl34	170	18	a	a	DT
cord-303447-3a7jxl34	170	19	nonspecific	nonspecific	JJ
cord-303447-3a7jxl34	170	20	,	,	,
cord-303447-3a7jxl34	170	21	persistent	persistent	JJ
cord-303447-3a7jxl34	170	22	cough	cough	NN
cord-303447-3a7jxl34	170	23	illness	illness	NN
cord-303447-3a7jxl34	170	24	in	in	IN
cord-303447-3a7jxl34	170	25	adolescents	adolescent	NNS
cord-303447-3a7jxl34	170	26	and	and	CC
cord-303447-3a7jxl34	170	27	adults	adult	NNS
cord-303447-3a7jxl34	170	28	,	,	,
cord-303447-3a7jxl34	170	29	coupled	couple	VBN
cord-303447-3a7jxl34	170	30	with	with	IN
cord-303447-3a7jxl34	170	31	increasing	increase	VBG
cord-303447-3a7jxl34	170	32	use	use	NN
cord-303447-3a7jxl34	170	33	of	of	IN
cord-303447-3a7jxl34	170	34	polymerase	polymerase	NN
cord-303447-3a7jxl34	170	35	chain	chain	NN
cord-303447-3a7jxl34	170	36	reaction	reaction	NN
cord-303447-3a7jxl34	170	37	testing	testing	NN
cord-303447-3a7jxl34	170	38	for	for	IN
cord-303447-3a7jxl34	170	39	diagnosis	diagnosis	NN
cord-303447-3a7jxl34	170	40	of	of	IN
cord-303447-3a7jxl34	170	41	all	all	DT
cord-303447-3a7jxl34	170	42	age	age	NN
cord-303447-3a7jxl34	170	43	groups	group	NNS
cord-303447-3a7jxl34	170	44	.	.	.
cord-303447-3a7jxl34	171	1	How	how	WRB
cord-303447-3a7jxl34	171	2	much	much	JJ
cord-303447-3a7jxl34	171	3	of	of	IN
cord-303447-3a7jxl34	171	4	the	the	DT
cord-303447-3a7jxl34	171	5	reported	report	VBN
cord-303447-3a7jxl34	171	6	increase	increase	NN
cord-303447-3a7jxl34	171	7	is	be	VBZ
cord-303447-3a7jxl34	171	8	due	due	JJ
cord-303447-3a7jxl34	171	9	to	to	IN
cord-303447-3a7jxl34	171	10	enhanced	enhance	VBN
cord-303447-3a7jxl34	171	11	surveillance	surveillance	NN
cord-303447-3a7jxl34	171	12	or	or	CC
cord-303447-3a7jxl34	171	13	improved	improve	VBN
cord-303447-3a7jxl34	171	14	diagnostic	diagnostic	JJ
cord-303447-3a7jxl34	171	15	methodology	methodology	NN
cord-303447-3a7jxl34	171	16	is	be	VBZ
cord-303447-3a7jxl34	171	17	unclear	unclear	JJ
cord-303447-3a7jxl34	171	18	.	.	.
cord-303447-3a7jxl34	172	1	One	one	CD
cord-303447-3a7jxl34	172	2	study	study	NN
cord-303447-3a7jxl34	172	3	suggested	suggest	VBD
cord-303447-3a7jxl34	172	4	that	that	IN
cord-303447-3a7jxl34	172	5	a	a	DT
cord-303447-3a7jxl34	172	6	true	true	JJ
cord-303447-3a7jxl34	172	7	increase	increase	NN
cord-303447-3a7jxl34	172	8	in	in	IN
cord-303447-3a7jxl34	172	9	the	the	DT
cord-303447-3a7jxl34	172	10	incidence	incidence	NN
cord-303447-3a7jxl34	172	11	of	of	IN
cord-303447-3a7jxl34	172	12	pertussis	pertussis	NN
cord-303447-3a7jxl34	172	13	disease	disease	NN
cord-303447-3a7jxl34	172	14	occurred	occur	VBD
cord-303447-3a7jxl34	172	15	in	in	IN
cord-303447-3a7jxl34	172	16	young	young	JJ
cord-303447-3a7jxl34	172	17	infants	infant	NNS
cord-303447-3a7jxl34	172	18	in	in	IN
cord-303447-3a7jxl34	172	19	the	the	DT
cord-303447-3a7jxl34	172	20	United	United	NNP
cord-303447-3a7jxl34	172	21	States	States	NNP
cord-303447-3a7jxl34	172	22	between	between	IN
cord-303447-3a7jxl34	172	23	1980	1980	CD
cord-303447-3a7jxl34	172	24	and	and	CC
cord-303447-3a7jxl34	172	25	1999	1999	CD
cord-303447-3a7jxl34	172	26	[	[	-LRB-
cord-303447-3a7jxl34	172	27	54	54	CD
cord-303447-3a7jxl34	172	28	]	]	-RRB-
cord-303447-3a7jxl34	172	29	.	.	.
cord-303447-3a7jxl34	173	1	The	the	DT
cord-303447-3a7jxl34	173	2	burden	burden	NN
cord-303447-3a7jxl34	173	3	of	of	IN
cord-303447-3a7jxl34	173	4	pertussis	pertussis	NN
cord-303447-3a7jxl34	173	5	disease	disease	NN
cord-303447-3a7jxl34	173	6	in	in	IN
cord-303447-3a7jxl34	173	7	adolescents	adolescent	NNS
cord-303447-3a7jxl34	173	8	is	be	VBZ
cord-303447-3a7jxl34	173	9	substantial	substantial	JJ
cord-303447-3a7jxl34	173	10	.	.	.
cord-303447-3a7jxl34	174	1	Of	of	IN
cord-303447-3a7jxl34	174	2	the	the	DT
cord-303447-3a7jxl34	174	3	reported	report	VBN
cord-303447-3a7jxl34	174	4	cases	case	NNS
cord-303447-3a7jxl34	174	5	of	of	IN
cord-303447-3a7jxl34	174	6	pertussis	pertussis	NN
cord-303447-3a7jxl34	174	7	in	in	IN
cord-303447-3a7jxl34	174	8	the	the	DT
cord-303447-3a7jxl34	174	9	United	United	NNP
cord-303447-3a7jxl34	174	10	States	States	NNP
cord-303447-3a7jxl34	174	11	in	in	IN
cord-303447-3a7jxl34	174	12	2003	2003	CD
cord-303447-3a7jxl34	174	13	,	,	,
cord-303447-3a7jxl34	174	14	39	39	CD
cord-303447-3a7jxl34	174	15	%	%	NN
cord-303447-3a7jxl34	174	16	were	be	VBD
cord-303447-3a7jxl34	174	17	in	in	IN
cord-303447-3a7jxl34	174	18	adolescents	adolescent	NNS
cord-303447-3a7jxl34	174	19	;	;	:
cord-303447-3a7jxl34	174	20	the	the	DT
cord-303447-3a7jxl34	174	21	true	true	JJ
cord-303447-3a7jxl34	174	22	number	number	NN
cord-303447-3a7jxl34	174	23	of	of	IN
cord-303447-3a7jxl34	174	24	cases	case	NNS
cord-303447-3a7jxl34	174	25	is	be	VBZ
cord-303447-3a7jxl34	174	26	likely	likely	JJ
cord-303447-3a7jxl34	174	27	to	to	TO
cord-303447-3a7jxl34	174	28	be	be	VB
cord-303447-3a7jxl34	174	29	much	much	RB
cord-303447-3a7jxl34	174	30	higher	high	JJR
cord-303447-3a7jxl34	174	31	(	(	-LRB-
cord-303447-3a7jxl34	174	32	CDC	CDC	NNP
cord-303447-3a7jxl34	174	33	,	,	,
cord-303447-3a7jxl34	174	34	unpublished	unpublished	JJ
cord-303447-3a7jxl34	174	35	data	datum	NNS
cord-303447-3a7jxl34	174	36	)	)	-RRB-
cord-303447-3a7jxl34	174	37	.	.	.
cord-303447-3a7jxl34	175	1	Although	although	IN
cord-303447-3a7jxl34	175	2	pertussis	pertussis	NN
cord-303447-3a7jxl34	175	3	is	be	VBZ
cord-303447-3a7jxl34	175	4	rarely	rarely	RB
cord-303447-3a7jxl34	175	5	life	life	NN
cord-303447-3a7jxl34	175	6	-	-	HYPH
cord-303447-3a7jxl34	175	7	threatening	threaten	VBG
cord-303447-3a7jxl34	175	8	in	in	IN
cord-303447-3a7jxl34	175	9	adolescents	adolescent	NNS
cord-303447-3a7jxl34	175	10	,	,	,
cord-303447-3a7jxl34	175	11	the	the	DT
cord-303447-3a7jxl34	175	12	morbidity	morbidity	NN
cord-303447-3a7jxl34	175	13	and	and	CC
cord-303447-3a7jxl34	175	14	societal	societal	JJ
cord-303447-3a7jxl34	175	15	costs	cost	NNS
cord-303447-3a7jxl34	175	16	associated	associate	VBN
cord-303447-3a7jxl34	175	17	with	with	IN
cord-303447-3a7jxl34	175	18	adolescent	adolescent	JJ
cord-303447-3a7jxl34	175	19	pertussis	pertussis	NN
cord-303447-3a7jxl34	175	20	disease	disease	NN
cord-303447-3a7jxl34	175	21	are	be	VBP
cord-303447-3a7jxl34	175	22	important	important	JJ
cord-303447-3a7jxl34	175	23	[	[	-LRB-
cord-303447-3a7jxl34	175	24	55	55	CD
cord-303447-3a7jxl34	175	25	]	]	-RRB-
cord-303447-3a7jxl34	175	26	.	.	.
cord-303447-3a7jxl34	176	1	In	in	IN
cord-303447-3a7jxl34	176	2	a	a	DT
cord-303447-3a7jxl34	176	3	Canadian	canadian	JJ
cord-303447-3a7jxl34	176	4	study	study	NN
cord-303447-3a7jxl34	176	5	,	,	,
cord-303447-3a7jxl34	176	6	47	47	CD
cord-303447-3a7jxl34	176	7	%	%	NN
cord-303447-3a7jxl34	176	8	of	of	IN
cord-303447-3a7jxl34	176	9	adolescents	adolescent	NNS
cord-303447-3a7jxl34	176	10	with	with	IN
cord-303447-3a7jxl34	176	11	pertussis	pertussis	NN
cord-303447-3a7jxl34	176	12	reported	report	VBD
cord-303447-3a7jxl34	176	13	a	a	DT
cord-303447-3a7jxl34	176	14	cough	cough	NN
cord-303447-3a7jxl34	176	15	duration	duration	NN
cord-303447-3a7jxl34	176	16	of	of	IN
cord-303447-3a7jxl34	176	17	at	at	RB
cord-303447-3a7jxl34	176	18	least	least	JJS
cord-303447-3a7jxl34	176	19	9	9	CD
cord-303447-3a7jxl34	176	20	weeks	week	NNS
cord-303447-3a7jxl34	176	21	[	[	-LRB-
cord-303447-3a7jxl34	176	22	56	56	CD
cord-303447-3a7jxl34	176	23	]	]	-RRB-
cord-303447-3a7jxl34	176	24	.	.	.
cord-303447-3a7jxl34	177	1	Paroxysms	paroxysm	NNS
cord-303447-3a7jxl34	177	2	,	,	,
cord-303447-3a7jxl34	177	3	shortness	shortness	NN
cord-303447-3a7jxl34	177	4	of	of	IN
cord-303447-3a7jxl34	177	5	breath	breath	NN
cord-303447-3a7jxl34	177	6	,	,	,
cord-303447-3a7jxl34	177	7	posttussive	posttussive	JJ
cord-303447-3a7jxl34	177	8	vomiting	vomiting	NN
cord-303447-3a7jxl34	177	9	,	,	,
cord-303447-3a7jxl34	177	10	and	and	CC
cord-303447-3a7jxl34	177	11	difficulty	difficulty	NN
cord-303447-3a7jxl34	177	12	sleeping	sleep	VBG
cord-303447-3a7jxl34	177	13	occur	occur	VBP
cord-303447-3a7jxl34	177	14	commonly	commonly	RB
cord-303447-3a7jxl34	177	15	in	in	IN
cord-303447-3a7jxl34	177	16	adolescents	adolescent	NNS
cord-303447-3a7jxl34	177	17	with	with	IN
cord-303447-3a7jxl34	177	18	pertussis	pertussis	NN
cord-303447-3a7jxl34	177	19	disease	disease	NN
cord-303447-3a7jxl34	177	20	[	[	-LRB-
cord-303447-3a7jxl34	177	21	55	55	CD
cord-303447-3a7jxl34	177	22	,	,	,
cord-303447-3a7jxl34	177	23	56	56	CD
cord-303447-3a7jxl34	177	24	]	]	-RRB-
cord-303447-3a7jxl34	177	25	.	.	.
cord-303447-3a7jxl34	178	1	To	to	TO
cord-303447-3a7jxl34	178	2	reduce	reduce	VB
cord-303447-3a7jxl34	178	3	pertussis	pertussis	NN
cord-303447-3a7jxl34	178	4	disease	disease	NN
cord-303447-3a7jxl34	178	5	in	in	IN
cord-303447-3a7jxl34	178	6	adolescents	adolescent	NNS
cord-303447-3a7jxl34	178	7	,	,	,
cord-303447-3a7jxl34	178	8	some	some	DT
cord-303447-3a7jxl34	178	9	countries	country	NNS
cord-303447-3a7jxl34	178	10	have	have	VBP
cord-303447-3a7jxl34	178	11	recommended	recommend	VBN
cord-303447-3a7jxl34	178	12	an	an	DT
cord-303447-3a7jxl34	178	13	adolescent	adolescent	JJ
cord-303447-3a7jxl34	178	14	booster	booster	NN
cord-303447-3a7jxl34	178	15	dose	dose	NN
cord-303447-3a7jxl34	178	16	.	.	.
cord-303447-3a7jxl34	179	1	In	in	IN
cord-303447-3a7jxl34	179	2	summer	summer	NN
cord-303447-3a7jxl34	179	3	2004	2004	CD
cord-303447-3a7jxl34	179	4	,	,	,
cord-303447-3a7jxl34	179	5	two	two	CD
cord-303447-3a7jxl34	179	6	manufacturers	manufacturer	NNS
cord-303447-3a7jxl34	179	7	submitted	submit	VBD
cord-303447-3a7jxl34	179	8	BLAs	bla	NNS
cord-303447-3a7jxl34	179	9	to	to	IN
cord-303447-3a7jxl34	179	10	the	the	DT
cord-303447-3a7jxl34	179	11	FDA	FDA	NNP
cord-303447-3a7jxl34	179	12	for	for	IN
cord-303447-3a7jxl34	179	13	use	use	NN
cord-303447-3a7jxl34	179	14	of	of	IN
cord-303447-3a7jxl34	179	15	adolescent	adolescent	JJ
cord-303447-3a7jxl34	179	16	and	and	CC
cord-303447-3a7jxl34	179	17	adult	adult	NN
cord-303447-3a7jxl34	179	18	pertussis	pertussis	NN
cord-303447-3a7jxl34	179	19	vaccines	vaccine	NNS
cord-303447-3a7jxl34	179	20	in	in	IN
cord-303447-3a7jxl34	179	21	the	the	DT
cord-303447-3a7jxl34	179	22	United	United	NNP
cord-303447-3a7jxl34	179	23	States	States	NNP
cord-303447-3a7jxl34	179	24	(	(	-LRB-
cord-303447-3a7jxl34	179	25	tetanus	tetanus	JJ
cord-303447-3a7jxl34	179	26	toxoid	toxoid	NN
cord-303447-3a7jxl34	179	27	,	,	,
cord-303447-3a7jxl34	179	28	reduced	reduce	VBN
cord-303447-3a7jxl34	179	29	diphtheria	diphtheria	NN
cord-303447-3a7jxl34	179	30	toxoid	toxoid	NN
cord-303447-3a7jxl34	179	31	and	and	CC
cord-303447-3a7jxl34	179	32	acellular	acellular	JJ
cord-303447-3a7jxl34	179	33	pertussis	pertussis	NN
cord-303447-3a7jxl34	179	34	vaccine	vaccine	NN
cord-303447-3a7jxl34	179	35	adsorbed	adsorb	VBN
cord-303447-3a7jxl34	179	36	(	(	-LRB-
cord-303447-3a7jxl34	179	37	Tdap	Tdap	NNP
cord-303447-3a7jxl34	179	38	)	)	-RRB-
cord-303447-3a7jxl34	179	39	.	.	.
cord-303447-3a7jxl34	180	1	The	the	DT
cord-303447-3a7jxl34	180	2	BLA	BLA	NNP
cord-303447-3a7jxl34	180	3	indication	indication	NN
cord-303447-3a7jxl34	180	4	for	for	IN
cord-303447-3a7jxl34	180	5	one	one	CD
cord-303447-3a7jxl34	180	6	vaccine	vaccine	NN
cord-303447-3a7jxl34	180	7	includes	include	VBZ
cord-303447-3a7jxl34	180	8	persons	person	NNS
cord-303447-3a7jxl34	180	9	10	10	CD
cord-303447-3a7jxl34	180	10	to	to	TO
cord-303447-3a7jxl34	180	11	18	18	CD
cord-303447-3a7jxl34	180	12	years	year	NNS
cord-303447-3a7jxl34	180	13	old	old	JJ
cord-303447-3a7jxl34	180	14	,	,	,
cord-303447-3a7jxl34	180	15	and	and	CC
cord-303447-3a7jxl34	180	16	the	the	DT
cord-303447-3a7jxl34	180	17	other	other	JJ
cord-303447-3a7jxl34	180	18	includes	include	VBZ
cord-303447-3a7jxl34	180	19	persons	person	NNS
cord-303447-3a7jxl34	180	20	11	11	CD
cord-303447-3a7jxl34	180	21	to	to	IN
cord-303447-3a7jxl34	180	22	64	64	CD
cord-303447-3a7jxl34	180	23	years	year	NNS
cord-303447-3a7jxl34	180	24	old	old	JJ
cord-303447-3a7jxl34	180	25	.	.	.
cord-303447-3a7jxl34	181	1	Policymakers	policymaker	NNS
cord-303447-3a7jxl34	181	2	are	be	VBP
cord-303447-3a7jxl34	181	3	reviewing	review	VBG
cord-303447-3a7jxl34	181	4	several	several	JJ
cord-303447-3a7jxl34	181	5	strategies	strategy	NNS
cord-303447-3a7jxl34	181	6	for	for	IN
cord-303447-3a7jxl34	181	7	pertussis	pertussis	NN
cord-303447-3a7jxl34	181	8	vaccination	vaccination	NN
cord-303447-3a7jxl34	181	9	in	in	IN
cord-303447-3a7jxl34	181	10	adolescents	adolescent	NNS
cord-303447-3a7jxl34	181	11	and	and	CC
cord-303447-3a7jxl34	181	12	adults	adult	NNS
cord-303447-3a7jxl34	181	13	.	.	.
cord-303447-3a7jxl34	182	1	A	a	DT
cord-303447-3a7jxl34	182	2	cost	cost	NN
cord-303447-3a7jxl34	182	3	-	-	HYPH
cord-303447-3a7jxl34	182	4	benefit	benefit	NN
cord-303447-3a7jxl34	182	5	analysis	analysis	NN
cord-303447-3a7jxl34	182	6	in	in	IN
cord-303447-3a7jxl34	182	7	the	the	DT
cord-303447-3a7jxl34	182	8	United	United	NNP
cord-303447-3a7jxl34	182	9	States	States	NNP
cord-303447-3a7jxl34	182	10	found	find	VBD
cord-303447-3a7jxl34	182	11	universal	universal	JJ
cord-303447-3a7jxl34	182	12	vaccination	vaccination	NN
cord-303447-3a7jxl34	182	13	for	for	IN
cord-303447-3a7jxl34	182	14	persons	person	NNS
cord-303447-3a7jxl34	182	15	10	10	CD
cord-303447-3a7jxl34	182	16	to	to	TO
cord-303447-3a7jxl34	182	17	19	19	CD
cord-303447-3a7jxl34	182	18	years	year	NNS
cord-303447-3a7jxl34	182	19	old	old	JJ
cord-303447-3a7jxl34	182	20	to	to	TO
cord-303447-3a7jxl34	182	21	be	be	VB
cord-303447-3a7jxl34	182	22	the	the	DT
cord-303447-3a7jxl34	182	23	most	most	RBS
cord-303447-3a7jxl34	182	24	economic	economic	JJ
cord-303447-3a7jxl34	182	25	strategy	strategy	NN
cord-303447-3a7jxl34	182	26	[	[	-LRB-
cord-303447-3a7jxl34	182	27	57	57	CD
cord-303447-3a7jxl34	182	28	]	]	-RRB-
cord-303447-3a7jxl34	182	29	.	.	.
cord-303447-3a7jxl34	183	1	The	the	DT
cord-303447-3a7jxl34	183	2	expected	expected	JJ
cord-303447-3a7jxl34	183	3	impact	impact	NN
cord-303447-3a7jxl34	183	4	of	of	IN
cord-303447-3a7jxl34	183	5	adolescent	adolescent	JJ
cord-303447-3a7jxl34	183	6	pertussis	pertussis	NN
cord-303447-3a7jxl34	183	7	vaccination	vaccination	NN
cord-303447-3a7jxl34	183	8	would	would	MD
cord-303447-3a7jxl34	183	9	be	be	VB
cord-303447-3a7jxl34	183	10	to	to	TO
cord-303447-3a7jxl34	183	11	reduce	reduce	VB
cord-303447-3a7jxl34	183	12	the	the	DT
cord-303447-3a7jxl34	183	13	risk	risk	NN
cord-303447-3a7jxl34	183	14	of	of	IN
cord-303447-3a7jxl34	183	15	pertussis	pertussis	NN
cord-303447-3a7jxl34	183	16	in	in	IN
cord-303447-3a7jxl34	183	17	vaccinated	vaccinate	VBN
cord-303447-3a7jxl34	183	18	adolescents	adolescent	NNS
cord-303447-3a7jxl34	183	19	.	.	.
cord-303447-3a7jxl34	184	1	Ideally	ideally	RB
cord-303447-3a7jxl34	184	2	,	,	,
cord-303447-3a7jxl34	184	3	another	another	DT
cord-303447-3a7jxl34	184	4	public	public	JJ
cord-303447-3a7jxl34	184	5	health	health	NN
cord-303447-3a7jxl34	184	6	goal	goal	NN
cord-303447-3a7jxl34	184	7	of	of	IN
cord-303447-3a7jxl34	184	8	pertussis	pertussis	NN
cord-303447-3a7jxl34	184	9	vaccination	vaccination	NN
cord-303447-3a7jxl34	184	10	is	be	VBZ
cord-303447-3a7jxl34	184	11	to	to	TO
cord-303447-3a7jxl34	184	12	reduce	reduce	VB
cord-303447-3a7jxl34	184	13	transmission	transmission	NN
cord-303447-3a7jxl34	184	14	to	to	IN
cord-303447-3a7jxl34	184	15	infants	infant	NNS
cord-303447-3a7jxl34	184	16	younger	young	JJR
cord-303447-3a7jxl34	184	17	than	than	IN
cord-303447-3a7jxl34	184	18	6	6	CD
cord-303447-3a7jxl34	184	19	months	month	NNS
cord-303447-3a7jxl34	184	20	old	old	JJ
cord-303447-3a7jxl34	184	21	who	who	WP
cord-303447-3a7jxl34	184	22	have	have	VBP
cord-303447-3a7jxl34	184	23	not	not	RB
cord-303447-3a7jxl34	184	24	completed	complete	VBN
cord-303447-3a7jxl34	184	25	the	the	DT
cord-303447-3a7jxl34	184	26	primary	primary	JJ
cord-303447-3a7jxl34	184	27	vaccination	vaccination	NN
cord-303447-3a7jxl34	184	28	series	series	NN
cord-303447-3a7jxl34	184	29	and	and	CC
cord-303447-3a7jxl34	184	30	are	be	VBP
cord-303447-3a7jxl34	184	31	at	at	IN
cord-303447-3a7jxl34	184	32	highest	high	JJS
cord-303447-3a7jxl34	184	33	risk	risk	NN
cord-303447-3a7jxl34	184	34	of	of	IN
cord-303447-3a7jxl34	184	35	death	death	NN
cord-303447-3a7jxl34	184	36	from	from	IN
cord-303447-3a7jxl34	184	37	pertussis	pertussis	NN
cord-303447-3a7jxl34	184	38	.	.	.
cord-303447-3a7jxl34	185	1	The	the	DT
cord-303447-3a7jxl34	185	2	role	role	NN
cord-303447-3a7jxl34	185	3	of	of	IN
cord-303447-3a7jxl34	185	4	an	an	DT
cord-303447-3a7jxl34	185	5	adolescent	adolescent	JJ
cord-303447-3a7jxl34	185	6	vaccination	vaccination	NN
cord-303447-3a7jxl34	185	7	program	program	NN
cord-303447-3a7jxl34	185	8	in	in	IN
cord-303447-3a7jxl34	185	9	reducing	reduce	VBG
cord-303447-3a7jxl34	185	10	transmission	transmission	NN
cord-303447-3a7jxl34	185	11	to	to	IN
cord-303447-3a7jxl34	185	12	infants	infant	NNS
cord-303447-3a7jxl34	185	13	is	be	VBZ
cord-303447-3a7jxl34	185	14	unknown	unknown	JJ
cord-303447-3a7jxl34	185	15	.	.	.
cord-303447-3a7jxl34	186	1	Vaccinating	vaccinate	VBG
cord-303447-3a7jxl34	186	2	mothers	mother	NNS
cord-303447-3a7jxl34	186	3	and	and	CC
cord-303447-3a7jxl34	186	4	other	other	JJ
cord-303447-3a7jxl34	186	5	close	close	JJ
cord-303447-3a7jxl34	186	6	family	family	NN
cord-303447-3a7jxl34	186	7	members	member	NNS
cord-303447-3a7jxl34	186	8	of	of	IN
cord-303447-3a7jxl34	186	9	young	young	JJ
cord-303447-3a7jxl34	186	10	infants	infant	NNS
cord-303447-3a7jxl34	186	11	,	,	,
cord-303447-3a7jxl34	186	12	referred	refer	VBD
cord-303447-3a7jxl34	186	13	to	to	IN
cord-303447-3a7jxl34	186	14	as	as	IN
cord-303447-3a7jxl34	186	15	a	a	DT
cord-303447-3a7jxl34	186	16	'	'	''
cord-303447-3a7jxl34	186	17	'	'	''
cord-303447-3a7jxl34	186	18	cocoon	cocoon	NN
cord-303447-3a7jxl34	186	19	strategy	strategy	NN
cord-303447-3a7jxl34	186	20	,	,	,
cord-303447-3a7jxl34	186	21	'	'	''
cord-303447-3a7jxl34	186	22	'	'	''
cord-303447-3a7jxl34	186	23	is	be	VBZ
cord-303447-3a7jxl34	186	24	one	one	CD
cord-303447-3a7jxl34	186	25	method	method	NN
cord-303447-3a7jxl34	186	26	under	under	IN
cord-303447-3a7jxl34	186	27	consideration	consideration	NN
cord-303447-3a7jxl34	186	28	to	to	TO
cord-303447-3a7jxl34	186	29	decrease	decrease	VB
cord-303447-3a7jxl34	186	30	pertussis	pertussis	NN
cord-303447-3a7jxl34	186	31	transmission	transmission	NN
cord-303447-3a7jxl34	186	32	to	to	IN
cord-303447-3a7jxl34	186	33	infants	infant	NNS
cord-303447-3a7jxl34	186	34	.	.	.
cord-303447-3a7jxl34	187	1	One	one	CD
cord-303447-3a7jxl34	187	2	study	study	NN
cord-303447-3a7jxl34	187	3	suggested	suggest	VBD
cord-303447-3a7jxl34	187	4	that	that	IN
cord-303447-3a7jxl34	187	5	adult	adult	NN
cord-303447-3a7jxl34	187	6	family	family	NN
cord-303447-3a7jxl34	187	7	members	member	NNS
cord-303447-3a7jxl34	187	8	are	be	VBP
cord-303447-3a7jxl34	187	9	the	the	DT
cord-303447-3a7jxl34	187	10	most	most	RBS
cord-303447-3a7jxl34	187	11	frequently	frequently	RB
cord-303447-3a7jxl34	187	12	identified	identify	VBN
cord-303447-3a7jxl34	187	13	source	source	NN
cord-303447-3a7jxl34	187	14	for	for	IN
cord-303447-3a7jxl34	187	15	pertussis	pertussis	NN
cord-303447-3a7jxl34	187	16	transmission	transmission	NN
cord-303447-3a7jxl34	187	17	to	to	IN
cord-303447-3a7jxl34	187	18	infants	infant	NNS
cord-303447-3a7jxl34	187	19	[	[	-LRB-
cord-303447-3a7jxl34	187	20	58	58	CD
cord-303447-3a7jxl34	187	21	]	]	-RRB-
cord-303447-3a7jxl34	187	22	.	.	.
cord-303447-3a7jxl34	188	1	Universal	universal	JJ
cord-303447-3a7jxl34	188	2	replacement	replacement	NN
cord-303447-3a7jxl34	188	3	of	of	IN
cord-303447-3a7jxl34	188	4	the	the	DT
cord-303447-3a7jxl34	188	5	Td	Td	NNP
cord-303447-3a7jxl34	188	6	booster	booster	NN
cord-303447-3a7jxl34	188	7	given	give	VBN
cord-303447-3a7jxl34	188	8	every	every	DT
cord-303447-3a7jxl34	188	9	10	10	CD
cord-303447-3a7jxl34	188	10	years	year	NNS
cord-303447-3a7jxl34	188	11	with	with	IN
cord-303447-3a7jxl34	188	12	Tdap	Tdap	NNP
cord-303447-3a7jxl34	188	13	is	be	VBZ
cord-303447-3a7jxl34	188	14	another	another	DT
cord-303447-3a7jxl34	188	15	strategy	strategy	NN
cord-303447-3a7jxl34	188	16	being	be	VBG
cord-303447-3a7jxl34	188	17	discussed	discuss	VBN
cord-303447-3a7jxl34	188	18	.	.	.
cord-303447-3a7jxl34	189	1	Finally	finally	RB
cord-303447-3a7jxl34	189	2	,	,	,
cord-303447-3a7jxl34	189	3	vaccinating	vaccinate	VBG
cord-303447-3a7jxl34	189	4	women	woman	NNS
cord-303447-3a7jxl34	189	5	during	during	IN
cord-303447-3a7jxl34	189	6	pregnancy	pregnancy	NN
cord-303447-3a7jxl34	189	7	and	and	CC
cord-303447-3a7jxl34	189	8	vaccinating	vaccinate	VBG
cord-303447-3a7jxl34	189	9	neonates	neonate	NNS
cord-303447-3a7jxl34	189	10	against	against	IN
cord-303447-3a7jxl34	189	11	pertussis	pertussis	NN
cord-303447-3a7jxl34	189	12	have	have	VBP
cord-303447-3a7jxl34	189	13	been	be	VBN
cord-303447-3a7jxl34	189	14	raised	raise	VBN
cord-303447-3a7jxl34	189	15	as	as	IN
cord-303447-3a7jxl34	189	16	potential	potential	JJ
cord-303447-3a7jxl34	189	17	strategies	strategy	NNS
cord-303447-3a7jxl34	189	18	to	to	TO
cord-303447-3a7jxl34	189	19	improve	improve	VB
cord-303447-3a7jxl34	189	20	control	control	NN
cord-303447-3a7jxl34	189	21	of	of	IN
cord-303447-3a7jxl34	189	22	pertussis	pertussis	NN
cord-303447-3a7jxl34	189	23	,	,	,
cord-303447-3a7jxl34	189	24	although	although	IN
cord-303447-3a7jxl34	189	25	pertussis	pertussis	NN
cord-303447-3a7jxl34	189	26	vaccines	vaccine	NNS
cord-303447-3a7jxl34	189	27	for	for	IN
cord-303447-3a7jxl34	189	28	these	these	DT
cord-303447-3a7jxl34	189	29	indications	indication	NNS
cord-303447-3a7jxl34	189	30	are	be	VBP
cord-303447-3a7jxl34	189	31	unlikely	unlikely	JJ
cord-303447-3a7jxl34	189	32	to	to	TO
cord-303447-3a7jxl34	189	33	be	be	VB
cord-303447-3a7jxl34	189	34	licensed	license	VBN
cord-303447-3a7jxl34	189	35	in	in	IN
cord-303447-3a7jxl34	189	36	the	the	DT
cord-303447-3a7jxl34	189	37	United	United	NNP
cord-303447-3a7jxl34	189	38	States	States	NNP
cord-303447-3a7jxl34	189	39	in	in	IN
cord-303447-3a7jxl34	189	40	the	the	DT
cord-303447-3a7jxl34	189	41	near	near	JJ
cord-303447-3a7jxl34	189	42	future	future	NN
cord-303447-3a7jxl34	189	43	[	[	-LRB-
cord-303447-3a7jxl34	189	44	59	59	CD
cord-303447-3a7jxl34	189	45	,	,	,
cord-303447-3a7jxl34	189	46	60	60	CD
cord-303447-3a7jxl34	189	47	]	]	-RRB-
cord-303447-3a7jxl34	189	48	.	.	.
cord-303447-3a7jxl34	190	1	More	More	JJR
cord-303447-3a7jxl34	190	2	than	than	IN
cord-303447-3a7jxl34	190	3	200	200	CD
cord-303447-3a7jxl34	190	4	types	type	NNS
cord-303447-3a7jxl34	190	5	of	of	IN
cord-303447-3a7jxl34	190	6	papillomaviruses	papillomaviruse	NNS
cord-303447-3a7jxl34	190	7	have	have	VBP
cord-303447-3a7jxl34	190	8	been	be	VBN
cord-303447-3a7jxl34	190	9	recognized	recognize	VBN
cord-303447-3a7jxl34	190	10	on	on	IN
cord-303447-3a7jxl34	190	11	the	the	DT
cord-303447-3a7jxl34	190	12	basis	basis	NN
cord-303447-3a7jxl34	190	13	of	of	IN
cord-303447-3a7jxl34	190	14	DNA	dna	NN
cord-303447-3a7jxl34	190	15	sequence	sequence	NN
cord-303447-3a7jxl34	190	16	analyses	analysis	NNS
cord-303447-3a7jxl34	190	17	[	[	-LRB-
cord-303447-3a7jxl34	190	18	61	61	CD
cord-303447-3a7jxl34	190	19	]	]	-RRB-
cord-303447-3a7jxl34	190	20	.	.	.
cord-303447-3a7jxl34	191	1	Papillomaviruses	papillomaviruse	NNS
cord-303447-3a7jxl34	191	2	are	be	VBP
cord-303447-3a7jxl34	191	3	ubiquitous	ubiquitous	JJ
cord-303447-3a7jxl34	191	4	,	,	,
cord-303447-3a7jxl34	191	5	have	have	VBP
cord-303447-3a7jxl34	191	6	been	be	VBN
cord-303447-3a7jxl34	191	7	detected	detect	VBN
cord-303447-3a7jxl34	191	8	in	in	IN
cord-303447-3a7jxl34	191	9	a	a	DT
cord-303447-3a7jxl34	191	10	wide	wide	JJ
cord-303447-3a7jxl34	191	11	variety	variety	NN
cord-303447-3a7jxl34	191	12	of	of	IN
cord-303447-3a7jxl34	191	13	animals	animal	NNS
cord-303447-3a7jxl34	191	14	and	and	CC
cord-303447-3a7jxl34	191	15	humans	human	NNS
cord-303447-3a7jxl34	191	16	,	,	,
cord-303447-3a7jxl34	191	17	and	and	CC
cord-303447-3a7jxl34	191	18	are	be	VBP
cord-303447-3a7jxl34	191	19	specific	specific	JJ
cord-303447-3a7jxl34	191	20	to	to	IN
cord-303447-3a7jxl34	191	21	their	-PRON-	PRP$
cord-303447-3a7jxl34	191	22	respective	respective	JJ
cord-303447-3a7jxl34	191	23	hosts	host	NNS
cord-303447-3a7jxl34	191	24	.	.	.
cord-303447-3a7jxl34	192	1	HPV	HPV	NNP
cord-303447-3a7jxl34	192	2	is	be	VBZ
cord-303447-3a7jxl34	192	3	associated	associate	VBN
cord-303447-3a7jxl34	192	4	with	with	IN
cord-303447-3a7jxl34	192	5	a	a	DT
cord-303447-3a7jxl34	192	6	variety	variety	NN
cord-303447-3a7jxl34	192	7	of	of	IN
cord-303447-3a7jxl34	192	8	clinical	clinical	JJ
cord-303447-3a7jxl34	192	9	conditions	condition	NNS
cord-303447-3a7jxl34	192	10	that	that	WDT
cord-303447-3a7jxl34	192	11	range	range	VBP
cord-303447-3a7jxl34	192	12	from	from	IN
cord-303447-3a7jxl34	192	13	benign	benign	JJ
cord-303447-3a7jxl34	192	14	skin	skin	NN
cord-303447-3a7jxl34	192	15	and	and	CC
cord-303447-3a7jxl34	192	16	mucous	mucous	JJ
cord-303447-3a7jxl34	192	17	membrane	membrane	NN
cord-303447-3a7jxl34	192	18	lesions	lesion	NNS
cord-303447-3a7jxl34	192	19	to	to	IN
cord-303447-3a7jxl34	192	20	cancer	cancer	NN
cord-303447-3a7jxl34	192	21	.	.	.
cord-303447-3a7jxl34	193	1	Most	Most	JJS
cord-303447-3a7jxl34	193	2	HPV	hpv	NN
cord-303447-3a7jxl34	193	3	infections	infection	NNS
cord-303447-3a7jxl34	193	4	are	be	VBP
cord-303447-3a7jxl34	193	5	benign	benign	JJ
cord-303447-3a7jxl34	193	6	.	.	.
cord-303447-3a7jxl34	194	1	Clinical	clinical	JJ
cord-303447-3a7jxl34	194	2	manifestations	manifestation	NNS
cord-303447-3a7jxl34	194	3	with	with	IN
cord-303447-3a7jxl34	194	4	the	the	DT
cord-303447-3a7jxl34	194	5	most	most	RBS
cord-303447-3a7jxl34	194	6	frequently	frequently	RB
cord-303447-3a7jxl34	194	7	associated	associate	VBN
cord-303447-3a7jxl34	194	8	HPV	hpv	NN
cord-303447-3a7jxl34	194	9	type	type	NN
cord-303447-3a7jxl34	194	10	are	be	VBP
cord-303447-3a7jxl34	194	11	as	as	IN
cord-303447-3a7jxl34	194	12	follows	follow	VBZ
cord-303447-3a7jxl34	194	13	:	:	:
cord-303447-3a7jxl34	194	14	skin	skin	NN
cord-303447-3a7jxl34	194	15	warts	wart	NNS
cord-303447-3a7jxl34	194	16	(	(	-LRB-
cord-303447-3a7jxl34	194	17	types	type	NNS
cord-303447-3a7jxl34	194	18	1	1	CD
cord-303447-3a7jxl34	194	19	,	,	,
cord-303447-3a7jxl34	194	20	2	2	CD
cord-303447-3a7jxl34	194	21	,	,	,
cord-303447-3a7jxl34	194	22	3	3	CD
cord-303447-3a7jxl34	194	23	,	,	,
cord-303447-3a7jxl34	194	24	and	and	CC
cord-303447-3a7jxl34	194	25	10	10	CD
cord-303447-3a7jxl34	194	26	)	)	-RRB-
cord-303447-3a7jxl34	194	27	,	,	,
cord-303447-3a7jxl34	194	28	recurrent	recurrent	JJ
cord-303447-3a7jxl34	194	29	respiratory	respiratory	JJ
cord-303447-3a7jxl34	194	30	papillomatosis	papillomatosis	NN
cord-303447-3a7jxl34	194	31	(	(	-LRB-
cord-303447-3a7jxl34	194	32	types	type	NNS
cord-303447-3a7jxl34	194	33	6	6	CD
cord-303447-3a7jxl34	194	34	and	and	CC
cord-303447-3a7jxl34	194	35	11	11	CD
cord-303447-3a7jxl34	194	36	)	)	-RRB-
cord-303447-3a7jxl34	194	37	,	,	,
cord-303447-3a7jxl34	194	38	condyloma	condyloma	NNP
cord-303447-3a7jxl34	194	39	acuminata	acuminata	NNP
cord-303447-3a7jxl34	194	40	(	(	-LRB-
cord-303447-3a7jxl34	194	41	types	type	NNS
cord-303447-3a7jxl34	194	42	6	6	CD
cord-303447-3a7jxl34	194	43	and	and	CC
cord-303447-3a7jxl34	194	44	11	11	CD
cord-303447-3a7jxl34	194	45	)	)	-RRB-
cord-303447-3a7jxl34	194	46	,	,	,
cord-303447-3a7jxl34	194	47	and	and	CC
cord-303447-3a7jxl34	194	48	cervical	cervical	JJ
cord-303447-3a7jxl34	194	49	cancer	cancer	NN
cord-303447-3a7jxl34	194	50	(	(	-LRB-
cord-303447-3a7jxl34	194	51	types	type	NNS
cord-303447-3a7jxl34	194	52	16	16	CD
cord-303447-3a7jxl34	194	53	,	,	,
cord-303447-3a7jxl34	194	54	18	18	CD
cord-303447-3a7jxl34	194	55	,	,	,
cord-303447-3a7jxl34	194	56	31	31	CD
cord-303447-3a7jxl34	194	57	,	,	,
cord-303447-3a7jxl34	194	58	33	33	CD
cord-303447-3a7jxl34	194	59	,	,	,
cord-303447-3a7jxl34	194	60	and	and	CC
cord-303447-3a7jxl34	194	61	45	45	CD
cord-303447-3a7jxl34	194	62	)	)	-RRB-
cord-303447-3a7jxl34	194	63	.	.	.
cord-303447-3a7jxl34	195	1	Based	base	VBN
cord-303447-3a7jxl34	195	2	on	on	IN
cord-303447-3a7jxl34	195	3	the	the	DT
cord-303447-3a7jxl34	195	4	association	association	NN
cord-303447-3a7jxl34	195	5	of	of	IN
cord-303447-3a7jxl34	195	6	HPV	HPV	NNP
cord-303447-3a7jxl34	195	7	with	with	IN
cord-303447-3a7jxl34	195	8	cervical	cervical	JJ
cord-303447-3a7jxl34	195	9	cancer	cancer	NN
cord-303447-3a7jxl34	195	10	and	and	CC
cord-303447-3a7jxl34	195	11	precursor	precursor	NN
cord-303447-3a7jxl34	195	12	lesions	lesion	NNS
cord-303447-3a7jxl34	195	13	,	,	,
cord-303447-3a7jxl34	195	14	HPVs	HPVs	NNP
cord-303447-3a7jxl34	195	15	can	can	MD
cord-303447-3a7jxl34	195	16	be	be	VB
cord-303447-3a7jxl34	195	17	grouped	group	VBN
cord-303447-3a7jxl34	195	18	into	into	IN
cord-303447-3a7jxl34	195	19	low	low	JJ
cord-303447-3a7jxl34	195	20	-	-	HYPH
cord-303447-3a7jxl34	195	21	risk	risk	NN
cord-303447-3a7jxl34	195	22	and	and	CC
cord-303447-3a7jxl34	195	23	high	high	JJ
cord-303447-3a7jxl34	195	24	-	-	HYPH
cord-303447-3a7jxl34	195	25	risk	risk	NN
cord-303447-3a7jxl34	195	26	HPV	hpv	NN
cord-303447-3a7jxl34	195	27	types	type	NNS
cord-303447-3a7jxl34	195	28	[	[	-LRB-
cord-303447-3a7jxl34	195	29	61	61	CD
cord-303447-3a7jxl34	195	30	]	]	-RRB-
cord-303447-3a7jxl34	195	31	.	.	.
cord-303447-3a7jxl34	196	1	In	in	IN
cord-303447-3a7jxl34	196	2	the	the	DT
cord-303447-3a7jxl34	196	3	United	United	NNP
cord-303447-3a7jxl34	196	4	States	States	NNP
cord-303447-3a7jxl34	196	5	and	and	CC
cord-303447-3a7jxl34	196	6	Europe	Europe	NNP
cord-303447-3a7jxl34	196	7	,	,	,
cord-303447-3a7jxl34	196	8	HPV	HPV	NNP
cord-303447-3a7jxl34	196	9	16	16	CD
cord-303447-3a7jxl34	196	10	accounts	account	NNS
cord-303447-3a7jxl34	196	11	for	for	IN
cord-303447-3a7jxl34	196	12	approximately	approximately	RB
cord-303447-3a7jxl34	196	13	50	50	CD
cord-303447-3a7jxl34	196	14	%	%	NN
cord-303447-3a7jxl34	196	15	of	of	IN
cord-303447-3a7jxl34	196	16	the	the	DT
cord-303447-3a7jxl34	196	17	cases	case	NNS
cord-303447-3a7jxl34	196	18	of	of	IN
cord-303447-3a7jxl34	196	19	cervical	cervical	JJ
cord-303447-3a7jxl34	196	20	cancer	cancer	NN
cord-303447-3a7jxl34	196	21	,	,	,
cord-303447-3a7jxl34	196	22	with	with	IN
cord-303447-3a7jxl34	196	23	types	type	NNS
cord-303447-3a7jxl34	196	24	18	18	CD
cord-303447-3a7jxl34	196	25	,	,	,
cord-303447-3a7jxl34	196	26	31	31	CD
cord-303447-3a7jxl34	196	27	,	,	,
cord-303447-3a7jxl34	196	28	and	and	CC
cord-303447-3a7jxl34	196	29	45	45	CD
cord-303447-3a7jxl34	196	30	accounting	accounting	NN
cord-303447-3a7jxl34	196	31	for	for	IN
cord-303447-3a7jxl34	196	32	an	an	DT
cord-303447-3a7jxl34	196	33	additional	additional	JJ
cord-303447-3a7jxl34	196	34	25	25	CD
cord-303447-3a7jxl34	196	35	%	%	NN
cord-303447-3a7jxl34	196	36	to	to	TO
cord-303447-3a7jxl34	196	37	30	30	CD
cord-303447-3a7jxl34	196	38	%	%	NN
cord-303447-3a7jxl34	196	39	of	of	IN
cord-303447-3a7jxl34	196	40	cases	case	NNS
cord-303447-3a7jxl34	196	41	[	[	-LRB-
cord-303447-3a7jxl34	196	42	62	62	CD
cord-303447-3a7jxl34	196	43	]	]	-RRB-
cord-303447-3a7jxl34	196	44	.	.	.
cord-303447-3a7jxl34	197	1	HPV	HPV	NNP
cord-303447-3a7jxl34	197	2	is	be	VBZ
cord-303447-3a7jxl34	197	3	one	one	CD
cord-303447-3a7jxl34	197	4	of	of	IN
cord-303447-3a7jxl34	197	5	the	the	DT
cord-303447-3a7jxl34	197	6	most	most	RBS
cord-303447-3a7jxl34	197	7	common	common	JJ
cord-303447-3a7jxl34	197	8	causes	cause	NNS
cord-303447-3a7jxl34	197	9	of	of	IN
cord-303447-3a7jxl34	197	10	sexually	sexually	RB
cord-303447-3a7jxl34	197	11	transmitted	transmit	VBN
cord-303447-3a7jxl34	197	12	diseases	disease	NNS
cord-303447-3a7jxl34	197	13	in	in	IN
cord-303447-3a7jxl34	197	14	men	man	NNS
cord-303447-3a7jxl34	197	15	and	and	CC
cord-303447-3a7jxl34	197	16	women	woman	NNS
cord-303447-3a7jxl34	197	17	worldwide	worldwide	RB
cord-303447-3a7jxl34	197	18	,	,	,
cord-303447-3a7jxl34	197	19	causing	cause	VBG
cord-303447-3a7jxl34	197	20	almost	almost	RB
cord-303447-3a7jxl34	197	21	all	all	DT
cord-303447-3a7jxl34	197	22	of	of	IN
cord-303447-3a7jxl34	197	23	the	the	DT
cord-303447-3a7jxl34	197	24	morbidity	morbidity	NN
cord-303447-3a7jxl34	197	25	and	and	CC
cord-303447-3a7jxl34	197	26	mortality	mortality	NN
cord-303447-3a7jxl34	197	27	associated	associate	VBN
cord-303447-3a7jxl34	197	28	with	with	IN
cord-303447-3a7jxl34	197	29	cervical	cervical	JJ
cord-303447-3a7jxl34	197	30	cancer	cancer	NN
cord-303447-3a7jxl34	197	31	[	[	-LRB-
cord-303447-3a7jxl34	197	32	61	61	CD
cord-303447-3a7jxl34	197	33	]	]	-RRB-
cord-303447-3a7jxl34	197	34	.	.	.
cord-303447-3a7jxl34	198	1	Epidemiologic	epidemiologic	JJ
cord-303447-3a7jxl34	198	2	studies	study	NNS
cord-303447-3a7jxl34	198	3	have	have	VBP
cord-303447-3a7jxl34	198	4	shown	show	VBN
cord-303447-3a7jxl34	198	5	that	that	IN
cord-303447-3a7jxl34	198	6	the	the	DT
cord-303447-3a7jxl34	198	7	risk	risk	NN
cord-303447-3a7jxl34	198	8	of	of	IN
cord-303447-3a7jxl34	198	9	contracting	contract	VBG
cord-303447-3a7jxl34	198	10	genital	genital	JJ
cord-303447-3a7jxl34	198	11	HPV	HPV	NNP
cord-303447-3a7jxl34	198	12	infection	infection	NN
cord-303447-3a7jxl34	198	13	and	and	CC
cord-303447-3a7jxl34	198	14	cervical	cervical	JJ
cord-303447-3a7jxl34	198	15	cancer	cancer	NN
cord-303447-3a7jxl34	198	16	is	be	VBZ
cord-303447-3a7jxl34	198	17	related	relate	VBN
cord-303447-3a7jxl34	198	18	directly	directly	RB
cord-303447-3a7jxl34	198	19	to	to	IN
cord-303447-3a7jxl34	198	20	sexual	sexual	JJ
cord-303447-3a7jxl34	198	21	activity	activity	NN
cord-303447-3a7jxl34	198	22	.	.	.
cord-303447-3a7jxl34	199	1	Several	several	JJ
cord-303447-3a7jxl34	199	2	specific	specific	JJ
cord-303447-3a7jxl34	199	3	factors	factor	NNS
cord-303447-3a7jxl34	199	4	increase	increase	VBP
cord-303447-3a7jxl34	199	5	the	the	DT
cord-303447-3a7jxl34	199	6	risk	risk	NN
cord-303447-3a7jxl34	199	7	of	of	IN
cord-303447-3a7jxl34	199	8	becoming	become	VBG
cord-303447-3a7jxl34	199	9	infected	infect	VBN
cord-303447-3a7jxl34	199	10	with	with	IN
cord-303447-3a7jxl34	199	11	HPV	HPV	NNP
cord-303447-3a7jxl34	199	12	,	,	,
cord-303447-3a7jxl34	199	13	including	include	VBG
cord-303447-3a7jxl34	199	14	multiple	multiple	JJ
cord-303447-3a7jxl34	199	15	sexual	sexual	JJ
cord-303447-3a7jxl34	199	16	partners	partner	NNS
cord-303447-3a7jxl34	199	17	at	at	IN
cord-303447-3a7jxl34	199	18	any	any	DT
cord-303447-3a7jxl34	199	19	time	time	NN
cord-303447-3a7jxl34	199	20	,	,	,
cord-303447-3a7jxl34	199	21	having	have	VBG
cord-303447-3a7jxl34	199	22	sex	sex	NN
cord-303447-3a7jxl34	199	23	with	with	IN
cord-303447-3a7jxl34	199	24	a	a	DT
cord-303447-3a7jxl34	199	25	person	person	NN
cord-303447-3a7jxl34	199	26	who	who	WP
cord-303447-3a7jxl34	199	27	has	have	VBZ
cord-303447-3a7jxl34	199	28	had	have	VBN
cord-303447-3a7jxl34	199	29	multiple	multiple	JJ
cord-303447-3a7jxl34	199	30	sexual	sexual	JJ
cord-303447-3a7jxl34	199	31	partners	partner	NNS
cord-303447-3a7jxl34	199	32	,	,	,
cord-303447-3a7jxl34	199	33	sexual	sexual	JJ
cord-303447-3a7jxl34	199	34	activity	activity	NN
cord-303447-3a7jxl34	199	35	at	at	IN
cord-303447-3a7jxl34	199	36	an	an	DT
cord-303447-3a7jxl34	199	37	early	early	JJ
cord-303447-3a7jxl34	199	38	age	age	NN
cord-303447-3a7jxl34	199	39	,	,	,
cord-303447-3a7jxl34	199	40	presence	presence	NN
cord-303447-3a7jxl34	199	41	of	of	IN
cord-303447-3a7jxl34	199	42	other	other	JJ
cord-303447-3a7jxl34	199	43	sexually	sexually	RB
cord-303447-3a7jxl34	199	44	transmitted	transmit	VBN
cord-303447-3a7jxl34	199	45	diseases	disease	NNS
cord-303447-3a7jxl34	199	46	,	,	,
cord-303447-3a7jxl34	199	47	and	and	CC
cord-303447-3a7jxl34	199	48	HPV	HPV	NNP
cord-303447-3a7jxl34	199	49	type	type	NN
cord-303447-3a7jxl34	199	50	.	.	.
cord-303447-3a7jxl34	200	1	Vaccination	vaccination	NN
cord-303447-3a7jxl34	200	2	against	against	IN
cord-303447-3a7jxl34	200	3	high	high	JJ
cord-303447-3a7jxl34	200	4	-	-	HYPH
cord-303447-3a7jxl34	200	5	risk	risk	NN
cord-303447-3a7jxl34	200	6	HPV	hpv	NN
cord-303447-3a7jxl34	200	7	types	type	NNS
cord-303447-3a7jxl34	200	8	could	could	MD
cord-303447-3a7jxl34	200	9	reduce	reduce	VB
cord-303447-3a7jxl34	200	10	substantially	substantially	RB
cord-303447-3a7jxl34	200	11	the	the	DT
cord-303447-3a7jxl34	200	12	incidence	incidence	NN
cord-303447-3a7jxl34	200	13	of	of	IN
cord-303447-3a7jxl34	200	14	cervical	cervical	JJ
cord-303447-3a7jxl34	200	15	cancer	cancer	NN
cord-303447-3a7jxl34	200	16	.	.	.
cord-303447-3a7jxl34	201	1	Administration	administration	NN
cord-303447-3a7jxl34	201	2	of	of	IN
cord-303447-3a7jxl34	201	3	HPV-16	HPV-16	NNP
cord-303447-3a7jxl34	201	4	vaccine	vaccine	NN
cord-303447-3a7jxl34	201	5	has	have	VBZ
cord-303447-3a7jxl34	201	6	been	be	VBN
cord-303447-3a7jxl34	201	7	shown	show	VBN
cord-303447-3a7jxl34	201	8	to	to	TO
cord-303447-3a7jxl34	201	9	reduce	reduce	VB
cord-303447-3a7jxl34	201	10	the	the	DT
cord-303447-3a7jxl34	201	11	incidence	incidence	NN
cord-303447-3a7jxl34	201	12	of	of	IN
cord-303447-3a7jxl34	201	13	HPV-16	HPV-16	NNP
cord-303447-3a7jxl34	201	14	infection	infection	NN
cord-303447-3a7jxl34	201	15	and	and	CC
cord-303447-3a7jxl34	201	16	HPV	hpv	NN
cord-303447-3a7jxl34	201	17	-	-	HYPH
cord-303447-3a7jxl34	201	18	related	relate	VBN
cord-303447-3a7jxl34	201	19	cervical	cervical	JJ
cord-303447-3a7jxl34	201	20	intraepithelial	intraepithelial	JJ
cord-303447-3a7jxl34	201	21	neoplasia	neoplasia	NN
cord-303447-3a7jxl34	201	22	[	[	-LRB-
cord-303447-3a7jxl34	201	23	63	63	CD
cord-303447-3a7jxl34	201	24	]	]	-RRB-
cord-303447-3a7jxl34	201	25	.	.	.
cord-303447-3a7jxl34	202	1	In	in	IN
cord-303447-3a7jxl34	202	2	addition	addition	NN
cord-303447-3a7jxl34	202	3	,	,	,
cord-303447-3a7jxl34	202	4	a	a	DT
cord-303447-3a7jxl34	202	5	bivalent	bivalent	JJ
cord-303447-3a7jxl34	202	6	HPV	HPV	NNP
cord-303447-3a7jxl34	202	7	vaccine	vaccine	NN
cord-303447-3a7jxl34	202	8	was	be	VBD
cord-303447-3a7jxl34	202	9	efficacious	efficacious	JJ
cord-303447-3a7jxl34	202	10	in	in	IN
cord-303447-3a7jxl34	202	11	preventing	prevent	VBG
cord-303447-3a7jxl34	202	12	persistent	persistent	JJ
cord-303447-3a7jxl34	202	13	cervical	cervical	JJ
cord-303447-3a7jxl34	202	14	infections	infection	NNS
cord-303447-3a7jxl34	202	15	with	with	IN
cord-303447-3a7jxl34	202	16	HPV-16	HPV-16	NNP
cord-303447-3a7jxl34	202	17	and	and	CC
cord-303447-3a7jxl34	202	18	HPV-18	HPV-18	NNP
cord-303447-3a7jxl34	202	19	and	and	CC
cord-303447-3a7jxl34	202	20	associated	associate	VBD
cord-303447-3a7jxl34	202	21	cytologic	cytologic	JJ
cord-303447-3a7jxl34	202	22	abnormalities	abnormality	NNS
cord-303447-3a7jxl34	202	23	and	and	CC
cord-303447-3a7jxl34	202	24	lesions	lesion	NNS
cord-303447-3a7jxl34	202	25	[	[	-LRB-
cord-303447-3a7jxl34	202	26	64	64	CD
cord-303447-3a7jxl34	202	27	]	]	-RRB-
cord-303447-3a7jxl34	202	28	.	.	.
cord-303447-3a7jxl34	203	1	Currently	currently	RB
cord-303447-3a7jxl34	203	2	,	,	,
cord-303447-3a7jxl34	203	3	two	two	CD
cord-303447-3a7jxl34	203	4	HPV	HPV	NNP
cord-303447-3a7jxl34	203	5	vaccines	vaccine	NNS
cord-303447-3a7jxl34	203	6	are	be	VBP
cord-303447-3a7jxl34	203	7	in	in	IN
cord-303447-3a7jxl34	203	8	the	the	DT
cord-303447-3a7jxl34	203	9	final	final	JJ
cord-303447-3a7jxl34	203	10	stages	stage	NNS
cord-303447-3a7jxl34	203	11	of	of	IN
cord-303447-3a7jxl34	203	12	phase	phase	NN
cord-303447-3a7jxl34	203	13	III	iii	CD
cord-303447-3a7jxl34	203	14	testing	testing	NN
cord-303447-3a7jxl34	203	15	.	.	.
cord-303447-3a7jxl34	204	1	One	one	CD
cord-303447-3a7jxl34	204	2	vaccine	vaccine	NN
cord-303447-3a7jxl34	204	3	contains	contain	VBZ
cord-303447-3a7jxl34	204	4	HPV	hpv	NN
cord-303447-3a7jxl34	204	5	types	type	NNS
cord-303447-3a7jxl34	204	6	16	16	CD
cord-303447-3a7jxl34	204	7	,	,	,
cord-303447-3a7jxl34	204	8	18	18	CD
cord-303447-3a7jxl34	204	9	,	,	,
cord-303447-3a7jxl34	204	10	6	6	CD
cord-303447-3a7jxl34	204	11	,	,	,
cord-303447-3a7jxl34	204	12	and	and	CC
cord-303447-3a7jxl34	204	13	11	11	CD
cord-303447-3a7jxl34	204	14	,	,	,
cord-303447-3a7jxl34	204	15	and	and	CC
cord-303447-3a7jxl34	204	16	the	the	DT
cord-303447-3a7jxl34	204	17	second	second	JJ
cord-303447-3a7jxl34	204	18	HPV	HPV	NNP
cord-303447-3a7jxl34	204	19	vaccine	vaccine	NN
cord-303447-3a7jxl34	204	20	contains	contain	VBZ
cord-303447-3a7jxl34	204	21	types	type	NNS
cord-303447-3a7jxl34	204	22	16	16	CD
cord-303447-3a7jxl34	204	23	and	and	CC
cord-303447-3a7jxl34	204	24	18	18	CD
cord-303447-3a7jxl34	204	25	.	.	.
cord-303447-3a7jxl34	205	1	Applications	application	NNS
cord-303447-3a7jxl34	205	2	for	for	IN
cord-303447-3a7jxl34	205	3	licensure	licensure	NN
cord-303447-3a7jxl34	205	4	are	be	VBP
cord-303447-3a7jxl34	205	5	expected	expect	VBN
cord-303447-3a7jxl34	205	6	to	to	TO
cord-303447-3a7jxl34	205	7	be	be	VB
cord-303447-3a7jxl34	205	8	filed	file	VBN
cord-303447-3a7jxl34	205	9	with	with	IN
cord-303447-3a7jxl34	205	10	the	the	DT
cord-303447-3a7jxl34	205	11	US	US	NNP
cord-303447-3a7jxl34	205	12	FDA	FDA	NNP
cord-303447-3a7jxl34	205	13	in	in	IN
cord-303447-3a7jxl34	205	14	late	late	JJ
cord-303447-3a7jxl34	205	15	2005	2005	CD
cord-303447-3a7jxl34	205	16	or	or	CC
cord-303447-3a7jxl34	205	17	2006	2006	CD
cord-303447-3a7jxl34	205	18	.	.	.
cord-303447-3a7jxl34	206	1	Rotavirus	rotavirus	NN
cord-303447-3a7jxl34	206	2	is	be	VBZ
cord-303447-3a7jxl34	206	3	a	a	DT
cord-303447-3a7jxl34	206	4	common	common	JJ
cord-303447-3a7jxl34	206	5	cause	cause	NN
cord-303447-3a7jxl34	206	6	of	of	IN
cord-303447-3a7jxl34	206	7	gastrointestinal	gastrointestinal	JJ
cord-303447-3a7jxl34	206	8	tract	tract	JJ
cord-303447-3a7jxl34	206	9	illness	illness	NN
cord-303447-3a7jxl34	206	10	in	in	IN
cord-303447-3a7jxl34	206	11	young	young	JJ
cord-303447-3a7jxl34	206	12	children	child	NNS
cord-303447-3a7jxl34	206	13	.	.	.
cord-303447-3a7jxl34	207	1	By	by	IN
cord-303447-3a7jxl34	207	2	5	5	CD
cord-303447-3a7jxl34	207	3	years	year	NNS
cord-303447-3a7jxl34	207	4	of	of	IN
cord-303447-3a7jxl34	207	5	age	age	NN
cord-303447-3a7jxl34	207	6	,	,	,
cord-303447-3a7jxl34	207	7	nearly	nearly	RB
cord-303447-3a7jxl34	207	8	all	all	DT
cord-303447-3a7jxl34	207	9	children	child	NNS
cord-303447-3a7jxl34	207	10	test	test	VBP
cord-303447-3a7jxl34	207	11	seropositive	seropositive	JJ
cord-303447-3a7jxl34	207	12	for	for	IN
cord-303447-3a7jxl34	207	13	rotavirus	rotavirus	NN
cord-303447-3a7jxl34	207	14	,	,	,
cord-303447-3a7jxl34	207	15	indicating	indicate	VBG
cord-303447-3a7jxl34	207	16	previous	previous	JJ
cord-303447-3a7jxl34	207	17	infection	infection	NN
cord-303447-3a7jxl34	207	18	.	.	.
cord-303447-3a7jxl34	208	1	In	in	IN
cord-303447-3a7jxl34	208	2	the	the	DT
cord-303447-3a7jxl34	208	3	United	United	NNP
cord-303447-3a7jxl34	208	4	States	States	NNP
cord-303447-3a7jxl34	208	5	,	,	,
cord-303447-3a7jxl34	208	6	rotavirus	rotavirus	JJ
cord-303447-3a7jxl34	208	7	disease	disease	NN
cord-303447-3a7jxl34	208	8	leads	lead	VBZ
cord-303447-3a7jxl34	208	9	to	to	IN
cord-303447-3a7jxl34	208	10	an	an	DT
cord-303447-3a7jxl34	208	11	estimated	estimated	JJ
cord-303447-3a7jxl34	208	12	600,000	600,000	CD
cord-303447-3a7jxl34	208	13	clinic	clinic	NN
cord-303447-3a7jxl34	208	14	visits	visit	NNS
cord-303447-3a7jxl34	208	15	,	,	,
cord-303447-3a7jxl34	208	16	50,000	50,000	CD
cord-303447-3a7jxl34	208	17	to	to	TO
cord-303447-3a7jxl34	208	18	60,000	60,000	CD
cord-303447-3a7jxl34	208	19	hospital	hospital	NN
cord-303447-3a7jxl34	208	20	admissions	admission	NNS
cord-303447-3a7jxl34	208	21	,	,	,
cord-303447-3a7jxl34	208	22	and	and	CC
cord-303447-3a7jxl34	208	23	20	20	CD
cord-303447-3a7jxl34	208	24	to	to	TO
cord-303447-3a7jxl34	208	25	40	40	CD
cord-303447-3a7jxl34	208	26	deaths	death	NNS
cord-303447-3a7jxl34	208	27	annually	annually	RB
cord-303447-3a7jxl34	208	28	[	[	-LRB-
cord-303447-3a7jxl34	208	29	33	33	CD
cord-303447-3a7jxl34	208	30	]	]	-RRB-
cord-303447-3a7jxl34	208	31	.	.	.
cord-303447-3a7jxl34	209	1	The	the	DT
cord-303447-3a7jxl34	209	2	first	first	JJ
cord-303447-3a7jxl34	209	3	rotavirus	rotavirus	JJ
cord-303447-3a7jxl34	209	4	vaccine	vaccine	NN
cord-303447-3a7jxl34	209	5	was	be	VBD
cord-303447-3a7jxl34	209	6	licensed	license	VBN
cord-303447-3a7jxl34	209	7	in	in	IN
cord-303447-3a7jxl34	209	8	the	the	DT
cord-303447-3a7jxl34	209	9	United	United	NNP
cord-303447-3a7jxl34	209	10	States	States	NNP
cord-303447-3a7jxl34	209	11	in	in	IN
cord-303447-3a7jxl34	209	12	1998	1998	CD
cord-303447-3a7jxl34	209	13	and	and	CC
cord-303447-3a7jxl34	209	14	was	be	VBD
cord-303447-3a7jxl34	209	15	removed	remove	VBN
cord-303447-3a7jxl34	209	16	from	from	IN
cord-303447-3a7jxl34	209	17	the	the	DT
cord-303447-3a7jxl34	209	18	market	market	NN
cord-303447-3a7jxl34	209	19	and	and	CC
cord-303447-3a7jxl34	209	20	from	from	IN
cord-303447-3a7jxl34	209	21	the	the	DT
cord-303447-3a7jxl34	209	22	immunization	immunization	NN
cord-303447-3a7jxl34	209	23	schedule	schedule	NN
cord-303447-3a7jxl34	209	24	in	in	IN
cord-303447-3a7jxl34	209	25	1999	1999	CD
cord-303447-3a7jxl34	209	26	because	because	IN
cord-303447-3a7jxl34	209	27	of	of	IN
cord-303447-3a7jxl34	209	28	an	an	DT
cord-303447-3a7jxl34	209	29	association	association	NN
cord-303447-3a7jxl34	209	30	with	with	IN
cord-303447-3a7jxl34	209	31	intussusception	intussusception	NN
cord-303447-3a7jxl34	209	32	.	.	.
cord-303447-3a7jxl34	210	1	This	this	DT
cord-303447-3a7jxl34	210	2	vaccine	vaccine	NN
cord-303447-3a7jxl34	210	3	was	be	VBD
cord-303447-3a7jxl34	210	4	a	a	DT
cord-303447-3a7jxl34	210	5	tetravalent	tetravalent	NN
cord-303447-3a7jxl34	210	6	rhesus	rhesus	NNP
cord-303447-3a7jxl34	210	7	human	human	JJ
cord-303447-3a7jxl34	210	8	reassortant	reassortant	JJ
cord-303447-3a7jxl34	210	9	vaccine	vaccine	NN
cord-303447-3a7jxl34	210	10	[	[	-LRB-
cord-303447-3a7jxl34	210	11	65	65	CD
cord-303447-3a7jxl34	210	12	,	,	,
cord-303447-3a7jxl34	210	13	66	66	CD
cord-303447-3a7jxl34	210	14	]	]	-RRB-
cord-303447-3a7jxl34	210	15	.	.	.
cord-303447-3a7jxl34	211	1	Currently	currently	RB
cord-303447-3a7jxl34	211	2	,	,	,
cord-303447-3a7jxl34	211	3	several	several	JJ
cord-303447-3a7jxl34	211	4	other	other	JJ
cord-303447-3a7jxl34	211	5	rotavirus	rotavirus	JJ
cord-303447-3a7jxl34	211	6	vaccines	vaccine	NNS
cord-303447-3a7jxl34	211	7	are	be	VBP
cord-303447-3a7jxl34	211	8	in	in	IN
cord-303447-3a7jxl34	211	9	different	different	JJ
cord-303447-3a7jxl34	211	10	stages	stage	NNS
cord-303447-3a7jxl34	211	11	of	of	IN
cord-303447-3a7jxl34	211	12	development	development	NN
cord-303447-3a7jxl34	211	13	.	.	.
cord-303447-3a7jxl34	212	1	Two	two	CD
cord-303447-3a7jxl34	212	2	late	late	JJ
cord-303447-3a7jxl34	212	3	-	-	HYPH
cord-303447-3a7jxl34	212	4	stage	stage	NN
cord-303447-3a7jxl34	212	5	vaccines	vaccine	NNS
cord-303447-3a7jxl34	212	6	have	have	VBP
cord-303447-3a7jxl34	212	7	completed	complete	VBN
cord-303447-3a7jxl34	212	8	phase	phase	NN
cord-303447-3a7jxl34	212	9	III	iii	CD
cord-303447-3a7jxl34	212	10	clinical	clinical	JJ
cord-303447-3a7jxl34	212	11	trials	trial	NNS
cord-303447-3a7jxl34	212	12	.	.	.
cord-303447-3a7jxl34	213	1	One	one	CD
cord-303447-3a7jxl34	213	2	vaccine	vaccine	NN
cord-303447-3a7jxl34	213	3	is	be	VBZ
cord-303447-3a7jxl34	213	4	derived	derive	VBN
cord-303447-3a7jxl34	213	5	from	from	IN
cord-303447-3a7jxl34	213	6	a	a	DT
cord-303447-3a7jxl34	213	7	monovalent	monovalent	JJ
cord-303447-3a7jxl34	213	8	human	human	JJ
cord-303447-3a7jxl34	213	9	strain	strain	NN
cord-303447-3a7jxl34	213	10	,	,	,
cord-303447-3a7jxl34	213	11	and	and	CC
cord-303447-3a7jxl34	213	12	the	the	DT
cord-303447-3a7jxl34	213	13	other	other	JJ
cord-303447-3a7jxl34	213	14	is	be	VBZ
cord-303447-3a7jxl34	213	15	a	a	DT
cord-303447-3a7jxl34	213	16	pentavalent	pentavalent	JJ
cord-303447-3a7jxl34	213	17	bovine	bovine	JJ
cord-303447-3a7jxl34	213	18	-	-	HYPH
cord-303447-3a7jxl34	213	19	human	human	JJ
cord-303447-3a7jxl34	213	20	reassortant	reassortant	JJ
cord-303447-3a7jxl34	213	21	vaccine	vaccine	NN
cord-303447-3a7jxl34	213	22	.	.	.
cord-303447-3a7jxl34	214	1	Large	large	JJ
cord-303447-3a7jxl34	214	2	-	-	HYPH
cord-303447-3a7jxl34	214	3	scale	scale	NN
cord-303447-3a7jxl34	214	4	phase	phase	NN
cord-303447-3a7jxl34	214	5	III	iii	CD
cord-303447-3a7jxl34	214	6	trials	trial	NNS
cord-303447-3a7jxl34	214	7	did	do	VBD
cord-303447-3a7jxl34	214	8	not	not	RB
cord-303447-3a7jxl34	214	9	show	show	VB
cord-303447-3a7jxl34	214	10	an	an	DT
cord-303447-3a7jxl34	214	11	association	association	NN
cord-303447-3a7jxl34	214	12	of	of	IN
cord-303447-3a7jxl34	214	13	these	these	DT
cord-303447-3a7jxl34	214	14	vaccines	vaccine	NNS
cord-303447-3a7jxl34	214	15	with	with	IN
cord-303447-3a7jxl34	214	16	intussusception	intussusception	NN
cord-303447-3a7jxl34	214	17	,	,	,
cord-303447-3a7jxl34	214	18	but	but	CC
cord-303447-3a7jxl34	214	19	postlicensure	postlicensure	NN
cord-303447-3a7jxl34	214	20	monitoring	monitoring	NN
cord-303447-3a7jxl34	214	21	is	be	VBZ
cord-303447-3a7jxl34	214	22	planned	plan	VBN
cord-303447-3a7jxl34	214	23	.	.	.
cord-303447-3a7jxl34	215	1	In	in	IN
cord-303447-3a7jxl34	215	2	January	January	NNP
cord-303447-3a7jxl34	215	3	2005	2005	CD
cord-303447-3a7jxl34	215	4	,	,	,
cord-303447-3a7jxl34	215	5	Mexico	Mexico	NNP
cord-303447-3a7jxl34	215	6	became	become	VBD
cord-303447-3a7jxl34	215	7	the	the	DT
cord-303447-3a7jxl34	215	8	first	first	JJ
cord-303447-3a7jxl34	215	9	country	country	NN
cord-303447-3a7jxl34	215	10	to	to	TO
cord-303447-3a7jxl34	215	11	make	make	VB
cord-303447-3a7jxl34	215	12	a	a	DT
cord-303447-3a7jxl34	215	13	new	new	JJ
cord-303447-3a7jxl34	215	14	rotavirus	rotavirus	JJ
cord-303447-3a7jxl34	215	15	vaccine	vaccine	NN
cord-303447-3a7jxl34	215	16	available	available	JJ
cord-303447-3a7jxl34	215	17	.	.	.
cord-303447-3a7jxl34	216	1	The	the	DT
cord-303447-3a7jxl34	216	2	company	company	NN
cord-303447-3a7jxl34	216	3	has	have	VBZ
cord-303447-3a7jxl34	216	4	filed	file	VBN
cord-303447-3a7jxl34	216	5	license	license	NN
cord-303447-3a7jxl34	216	6	applications	application	NNS
cord-303447-3a7jxl34	216	7	in	in	IN
cord-303447-3a7jxl34	216	8	more	more	JJR
cord-303447-3a7jxl34	216	9	than	than	IN
cord-303447-3a7jxl34	216	10	20	20	CD
cord-303447-3a7jxl34	216	11	other	other	JJ
cord-303447-3a7jxl34	216	12	countries	country	NNS
cord-303447-3a7jxl34	216	13	outside	outside	IN
cord-303447-3a7jxl34	216	14	the	the	DT
cord-303447-3a7jxl34	216	15	United	United	NNP
cord-303447-3a7jxl34	216	16	States	States	NNP
cord-303447-3a7jxl34	216	17	.	.	.
cord-303447-3a7jxl34	217	1	The	the	DT
cord-303447-3a7jxl34	217	2	manufacturer	manufacturer	NN
cord-303447-3a7jxl34	217	3	of	of	IN
cord-303447-3a7jxl34	217	4	the	the	DT
cord-303447-3a7jxl34	217	5	second	second	JJ
cord-303447-3a7jxl34	217	6	rotavirus	rotavirus	JJ
cord-303447-3a7jxl34	217	7	vaccine	vaccine	NN
cord-303447-3a7jxl34	217	8	plans	plan	NNS
cord-303447-3a7jxl34	217	9	to	to	TO
cord-303447-3a7jxl34	217	10	release	release	VB
cord-303447-3a7jxl34	217	11	it	-PRON-	PRP
cord-303447-3a7jxl34	217	12	first	first	RB
cord-303447-3a7jxl34	217	13	in	in	IN
cord-303447-3a7jxl34	217	14	the	the	DT
cord-303447-3a7jxl34	217	15	United	United	NNP
cord-303447-3a7jxl34	217	16	States	States	NNP
cord-303447-3a7jxl34	217	17	after	after	IN
cord-303447-3a7jxl34	217	18	licensure	licensure	NN
cord-303447-3a7jxl34	217	19	by	by	IN
cord-303447-3a7jxl34	217	20	the	the	DT
cord-303447-3a7jxl34	217	21	US	US	NNP
cord-303447-3a7jxl34	217	22	FDA	FDA	NNP
cord-303447-3a7jxl34	217	23	.	.	.
cord-303447-3a7jxl34	218	1	After	after	IN
cord-303447-3a7jxl34	218	2	licensure	licensure	NN
cord-303447-3a7jxl34	218	3	in	in	IN
cord-303447-3a7jxl34	218	4	the	the	DT
cord-303447-3a7jxl34	218	5	United	United	NNP
cord-303447-3a7jxl34	218	6	States	States	NNP
cord-303447-3a7jxl34	218	7	,	,	,
cord-303447-3a7jxl34	218	8	educational	educational	JJ
cord-303447-3a7jxl34	218	9	efforts	effort	NNS
cord-303447-3a7jxl34	218	10	that	that	WDT
cord-303447-3a7jxl34	218	11	address	address	VBP
cord-303447-3a7jxl34	218	12	identifiable	identifiable	JJ
cord-303447-3a7jxl34	218	13	barriers	barrier	NNS
cord-303447-3a7jxl34	218	14	to	to	IN
cord-303447-3a7jxl34	218	15	achieving	achieve	VBG
cord-303447-3a7jxl34	218	16	practitioner	practitioner	NN
cord-303447-3a7jxl34	218	17	advocacy	advocacy	NN
cord-303447-3a7jxl34	218	18	and	and	CC
cord-303447-3a7jxl34	218	19	patient	patient	JJ
cord-303447-3a7jxl34	218	20	acceptance	acceptance	NN
cord-303447-3a7jxl34	218	21	will	will	MD
cord-303447-3a7jxl34	218	22	be	be	VB
cord-303447-3a7jxl34	218	23	necessary	necessary	JJ
cord-303447-3a7jxl34	218	24	to	to	TO
cord-303447-3a7jxl34	218	25	ensure	ensure	VB
cord-303447-3a7jxl34	218	26	implementation	implementation	NN
cord-303447-3a7jxl34	218	27	of	of	IN
cord-303447-3a7jxl34	218	28	rotavirus	rotavirus	JJ
cord-303447-3a7jxl34	218	29	vaccine	vaccine	NN
cord-303447-3a7jxl34	218	30	recommendations	recommendation	NNS
cord-303447-3a7jxl34	218	31	[	[	-LRB-
cord-303447-3a7jxl34	218	32	67	67	CD
cord-303447-3a7jxl34	218	33	]	]	-RRB-
cord-303447-3a7jxl34	218	34	.	.	.
cord-303447-3a7jxl34	219	1	Ensuring	ensure	VBG
cord-303447-3a7jxl34	219	2	physician	physician	NN
cord-303447-3a7jxl34	219	3	acceptance	acceptance	NN
cord-303447-3a7jxl34	219	4	of	of	IN
cord-303447-3a7jxl34	219	5	the	the	DT
cord-303447-3a7jxl34	219	6	vaccine	vaccine	NN
cord-303447-3a7jxl34	219	7	is	be	VBZ
cord-303447-3a7jxl34	219	8	critical	critical	JJ
cord-303447-3a7jxl34	219	9	to	to	IN
cord-303447-3a7jxl34	219	10	achieving	achieve	VBG
cord-303447-3a7jxl34	219	11	high	high	JJ
cord-303447-3a7jxl34	219	12	coverage	coverage	NN
cord-303447-3a7jxl34	219	13	levels	level	NNS
cord-303447-3a7jxl34	219	14	[	[	-LRB-
cord-303447-3a7jxl34	219	15	67	67	CD
cord-303447-3a7jxl34	219	16	]	]	-RRB-
cord-303447-3a7jxl34	219	17	.	.	.
cord-303447-3a7jxl34	220	1	Varicella	Varicella	NNP
cord-303447-3a7jxl34	220	2	vaccine	vaccine	NN
cord-303447-3a7jxl34	220	3	,	,	,
cord-303447-3a7jxl34	220	4	licensed	license	VBN
cord-303447-3a7jxl34	220	5	for	for	IN
cord-303447-3a7jxl34	220	6	use	use	NN
cord-303447-3a7jxl34	220	7	in	in	IN
cord-303447-3a7jxl34	220	8	the	the	DT
cord-303447-3a7jxl34	220	9	United	United	NNP
cord-303447-3a7jxl34	220	10	States	States	NNP
cord-303447-3a7jxl34	220	11	in	in	IN
cord-303447-3a7jxl34	220	12	1995	1995	CD
cord-303447-3a7jxl34	220	13	,	,	,
cord-303447-3a7jxl34	220	14	is	be	VBZ
cord-303447-3a7jxl34	220	15	a	a	DT
cord-303447-3a7jxl34	220	16	live	live	JJ
cord-303447-3a7jxl34	220	17	,	,	,
cord-303447-3a7jxl34	220	18	attenuated	attenuated	JJ
cord-303447-3a7jxl34	220	19	virus	virus	NN
cord-303447-3a7jxl34	220	20	vaccine	vaccine	NN
cord-303447-3a7jxl34	220	21	developed	develop	VBN
cord-303447-3a7jxl34	220	22	from	from	IN
cord-303447-3a7jxl34	220	23	the	the	DT
cord-303447-3a7jxl34	220	24	vesicles	vesicle	NNS
cord-303447-3a7jxl34	220	25	of	of	IN
cord-303447-3a7jxl34	220	26	a	a	DT
cord-303447-3a7jxl34	220	27	healthy	healthy	JJ
cord-303447-3a7jxl34	220	28	infected	infected	JJ
cord-303447-3a7jxl34	220	29	child	child	NN
cord-303447-3a7jxl34	220	30	with	with	IN
cord-303447-3a7jxl34	220	31	chickenpox	chickenpox	NN
cord-303447-3a7jxl34	220	32	.	.	.
cord-303447-3a7jxl34	221	1	This	this	DT
cord-303447-3a7jxl34	221	2	vaccine	vaccine	NN
cord-303447-3a7jxl34	221	3	is	be	VBZ
cord-303447-3a7jxl34	221	4	recommended	recommend	VBN
cord-303447-3a7jxl34	221	5	as	as	IN
cord-303447-3a7jxl34	221	6	a	a	DT
cord-303447-3a7jxl34	221	7	single	single	JJ
cord-303447-3a7jxl34	221	8	dose	dose	NN
cord-303447-3a7jxl34	221	9	for	for	IN
cord-303447-3a7jxl34	221	10	children	child	NNS
cord-303447-3a7jxl34	221	11	12	12	CD
cord-303447-3a7jxl34	221	12	months	month	NNS
cord-303447-3a7jxl34	221	13	to	to	IN
cord-303447-3a7jxl34	221	14	12	12	CD
cord-303447-3a7jxl34	221	15	years	year	NNS
cord-303447-3a7jxl34	221	16	old	old	JJ
cord-303447-3a7jxl34	221	17	.	.	.
cord-303447-3a7jxl34	222	1	Susceptible	susceptible	JJ
cord-303447-3a7jxl34	222	2	persons	person	NNS
cord-303447-3a7jxl34	222	3	13	13	CD
cord-303447-3a7jxl34	222	4	years	year	NNS
cord-303447-3a7jxl34	222	5	old	old	JJ
cord-303447-3a7jxl34	222	6	or	or	CC
cord-303447-3a7jxl34	222	7	older	old	JJR
cord-303447-3a7jxl34	222	8	should	should	MD
cord-303447-3a7jxl34	222	9	receive	receive	VB
cord-303447-3a7jxl34	222	10	two	two	CD
cord-303447-3a7jxl34	222	11	doses	dose	NNS
cord-303447-3a7jxl34	222	12	administered	administer	VBN
cord-303447-3a7jxl34	222	13	4	4	CD
cord-303447-3a7jxl34	222	14	weeks	week	NNS
cord-303447-3a7jxl34	222	15	apart	apart	RB
cord-303447-3a7jxl34	222	16	.	.	.
cord-303447-3a7jxl34	223	1	Before	before	IN
cord-303447-3a7jxl34	223	2	varicella	varicella	NN
cord-303447-3a7jxl34	223	3	vaccine	vaccine	NN
cord-303447-3a7jxl34	223	4	became	become	VBD
cord-303447-3a7jxl34	223	5	widely	widely	RB
cord-303447-3a7jxl34	223	6	used	use	VBN
cord-303447-3a7jxl34	223	7	,	,	,
cord-303447-3a7jxl34	223	8	varicella	varicella	NN
cord-303447-3a7jxl34	223	9	was	be	VBD
cord-303447-3a7jxl34	223	10	one	one	CD
cord-303447-3a7jxl34	223	11	of	of	IN
cord-303447-3a7jxl34	223	12	the	the	DT
cord-303447-3a7jxl34	223	13	most	most	RBS
cord-303447-3a7jxl34	223	14	recognizable	recognizable	JJ
cord-303447-3a7jxl34	223	15	rashes	rash	NNS
cord-303447-3a7jxl34	223	16	seen	see	VBN
cord-303447-3a7jxl34	223	17	by	by	IN
cord-303447-3a7jxl34	223	18	pediatricians	pediatrician	NNS
cord-303447-3a7jxl34	223	19	and	and	CC
cord-303447-3a7jxl34	223	20	was	be	VBD
cord-303447-3a7jxl34	223	21	associated	associate	VBN
cord-303447-3a7jxl34	223	22	with	with	IN
cord-303447-3a7jxl34	223	23	11,000	11,000	CD
cord-303447-3a7jxl34	223	24	hospitalizations	hospitalization	NNS
cord-303447-3a7jxl34	223	25	and	and	CC
cord-303447-3a7jxl34	223	26	100	100	CD
cord-303447-3a7jxl34	223	27	deaths	death	NNS
cord-303447-3a7jxl34	223	28	in	in	IN
cord-303447-3a7jxl34	223	29	the	the	DT
cord-303447-3a7jxl34	223	30	United	United	NNP
cord-303447-3a7jxl34	223	31	States	States	NNP
cord-303447-3a7jxl34	223	32	each	each	DT
cord-303447-3a7jxl34	223	33	year	year	NN
cord-303447-3a7jxl34	223	34	[	[	-LRB-
cord-303447-3a7jxl34	223	35	68	68	CD
cord-303447-3a7jxl34	223	36	]	]	-RRB-
cord-303447-3a7jxl34	223	37	.	.	.
cord-303447-3a7jxl34	224	1	In	in	IN
cord-303447-3a7jxl34	224	2	2003	2003	CD
cord-303447-3a7jxl34	224	3	,	,	,
cord-303447-3a7jxl34	224	4	the	the	DT
cord-303447-3a7jxl34	224	5	vaccine	vaccine	NN
cord-303447-3a7jxl34	224	6	had	have	VBD
cord-303447-3a7jxl34	224	7	85	85	CD
cord-303447-3a7jxl34	224	8	%	%	NN
cord-303447-3a7jxl34	224	9	coverage	coverage	NN
cord-303447-3a7jxl34	224	10	levels	level	NNS
cord-303447-3a7jxl34	224	11	,	,	,
cord-303447-3a7jxl34	224	12	resulting	result	VBG
cord-303447-3a7jxl34	224	13	in	in	IN
cord-303447-3a7jxl34	224	14	a	a	DT
cord-303447-3a7jxl34	224	15	significant	significant	JJ
cord-303447-3a7jxl34	224	16	decrease	decrease	NN
cord-303447-3a7jxl34	224	17	in	in	IN
cord-303447-3a7jxl34	224	18	mortality	mortality	NN
cord-303447-3a7jxl34	224	19	,	,	,
cord-303447-3a7jxl34	224	20	morbidity	morbidity	NN
cord-303447-3a7jxl34	224	21	,	,	,
cord-303447-3a7jxl34	224	22	and	and	CC
cord-303447-3a7jxl34	224	23	hospitalizations	hospitalization	NNS
cord-303447-3a7jxl34	224	24	attributable	attributable	JJ
cord-303447-3a7jxl34	224	25	to	to	IN
cord-303447-3a7jxl34	224	26	varicella	varicella	NN
cord-303447-3a7jxl34	224	27	[	[	-LRB-
cord-303447-3a7jxl34	224	28	68	68	CD
cord-303447-3a7jxl34	224	29	]	]	-RRB-
cord-303447-3a7jxl34	224	30	.	.	.
cord-303447-3a7jxl34	225	1	Breakthrough	Breakthrough	NNP
cord-303447-3a7jxl34	225	2	varicella	varicella	NN
cord-303447-3a7jxl34	225	3	infections	infection	NNS
cord-303447-3a7jxl34	225	4	in	in	IN
cord-303447-3a7jxl34	225	5	vaccinated	vaccinated	JJ
cord-303447-3a7jxl34	225	6	children	child	NNS
cord-303447-3a7jxl34	225	7	occur	occur	VBP
cord-303447-3a7jxl34	225	8	in	in	IN
cord-303447-3a7jxl34	225	9	15	15	CD
cord-303447-3a7jxl34	225	10	%	%	NN
cord-303447-3a7jxl34	225	11	of	of	IN
cord-303447-3a7jxl34	225	12	children	child	NNS
cord-303447-3a7jxl34	225	13	exposed	expose	VBN
cord-303447-3a7jxl34	225	14	to	to	IN
cord-303447-3a7jxl34	225	15	varicella	varicella	NN
cord-303447-3a7jxl34	225	16	.	.	.
cord-303447-3a7jxl34	226	1	Breakthrough	Breakthrough	NNP
cord-303447-3a7jxl34	226	2	infections	infection	NNS
cord-303447-3a7jxl34	226	3	usually	usually	RB
cord-303447-3a7jxl34	226	4	are	be	VBP
cord-303447-3a7jxl34	226	5	mild	mild	JJ
cord-303447-3a7jxl34	226	6	(	(	-LRB-
cord-303447-3a7jxl34	226	7	b	b	NN
cord-303447-3a7jxl34	226	8	50	50	CD
cord-303447-3a7jxl34	226	9	lesions	lesion	NNS
cord-303447-3a7jxl34	226	10	)	)	-RRB-
cord-303447-3a7jxl34	226	11	,	,	,
cord-303447-3a7jxl34	226	12	however	however	RB
cord-303447-3a7jxl34	226	13	,	,	,
cord-303447-3a7jxl34	226	14	with	with	IN
cord-303447-3a7jxl34	226	15	few	few	JJ
cord-303447-3a7jxl34	226	16	complications	complication	NNS
cord-303447-3a7jxl34	226	17	[	[	-LRB-
cord-303447-3a7jxl34	226	18	69	69	CD
cord-303447-3a7jxl34	226	19	]	]	-RRB-
cord-303447-3a7jxl34	226	20	.	.	.
cord-303447-3a7jxl34	227	1	Vaccinated	vaccinated	JJ
cord-303447-3a7jxl34	227	2	children	child	NNS
cord-303447-3a7jxl34	227	3	with	with	IN
cord-303447-3a7jxl34	227	4	mild	mild	JJ
cord-303447-3a7jxl34	227	5	disease	disease	NN
cord-303447-3a7jxl34	227	6	were	be	VBD
cord-303447-3a7jxl34	227	7	only	only	RB
cord-303447-3a7jxl34	227	8	one	one	CD
cord-303447-3a7jxl34	227	9	third	third	NN
cord-303447-3a7jxl34	227	10	as	as	RB
cord-303447-3a7jxl34	227	11	contagious	contagious	JJ
cord-303447-3a7jxl34	227	12	as	as	IN
cord-303447-3a7jxl34	227	13	children	child	NNS
cord-303447-3a7jxl34	227	14	with	with	IN
cord-303447-3a7jxl34	227	15	moderate	moderate	JJ
cord-303447-3a7jxl34	227	16	-	-	HYPH
cord-303447-3a7jxl34	227	17	to	to	IN
cord-303447-3a7jxl34	227	18	-	-	HYPH
cord-303447-3a7jxl34	227	19	severe	severe	JJ
cord-303447-3a7jxl34	227	20	disease	disease	NN
cord-303447-3a7jxl34	227	21	,	,	,
cord-303447-3a7jxl34	227	22	whether	whether	IN
cord-303447-3a7jxl34	227	23	they	-PRON-	PRP
cord-303447-3a7jxl34	227	24	were	be	VBD
cord-303447-3a7jxl34	227	25	vaccinated	vaccinate	VBN
cord-303447-3a7jxl34	227	26	or	or	CC
cord-303447-3a7jxl34	227	27	unvaccinated	unvaccinated	JJ
cord-303447-3a7jxl34	227	28	.	.	.
cord-303447-3a7jxl34	228	1	Vaccine	vaccine	NN
cord-303447-3a7jxl34	228	2	effectiveness	effectiveness	NN
cord-303447-3a7jxl34	228	3	for	for	IN
cord-303447-3a7jxl34	228	4	prevention	prevention	NN
cord-303447-3a7jxl34	228	5	of	of	IN
cord-303447-3a7jxl34	228	6	moderate	moderate	JJ
cord-303447-3a7jxl34	228	7	disease	disease	NN
cord-303447-3a7jxl34	228	8	(	(	-LRB-
cord-303447-3a7jxl34	228	9	N	n	CD
cord-303447-3a7jxl34	228	10	50	50	CD
cord-303447-3a7jxl34	228	11	lesions	lesion	NNS
cord-303447-3a7jxl34	228	12	and	and	CC
cord-303447-3a7jxl34	228	13	complications	complication	NNS
cord-303447-3a7jxl34	228	14	requiring	require	VBG
cord-303447-3a7jxl34	228	15	a	a	DT
cord-303447-3a7jxl34	228	16	visit	visit	NN
cord-303447-3a7jxl34	228	17	to	to	IN
cord-303447-3a7jxl34	228	18	a	a	DT
cord-303447-3a7jxl34	228	19	clinician	clinician	NN
cord-303447-3a7jxl34	228	20	)	)	-RRB-
cord-303447-3a7jxl34	228	21	was	be	VBD
cord-303447-3a7jxl34	228	22	92	92	CD
cord-303447-3a7jxl34	228	23	%	%	NN
cord-303447-3a7jxl34	228	24	[	[	-LRB-
cord-303447-3a7jxl34	228	25	69	69	CD
cord-303447-3a7jxl34	228	26	]	]	-RRB-
cord-303447-3a7jxl34	228	27	.	.	.
cord-303447-3a7jxl34	229	1	A	a	DT
cord-303447-3a7jxl34	229	2	second	second	JJ
cord-303447-3a7jxl34	229	3	dose	dose	NN
cord-303447-3a7jxl34	229	4	of	of	IN
cord-303447-3a7jxl34	229	5	varicella	varicella	NN
cord-303447-3a7jxl34	229	6	vaccine	vaccine	NN
cord-303447-3a7jxl34	229	7	has	have	VBZ
cord-303447-3a7jxl34	229	8	been	be	VBN
cord-303447-3a7jxl34	229	9	approved	approve	VBN
cord-303447-3a7jxl34	229	10	by	by	IN
cord-303447-3a7jxl34	229	11	the	the	DT
cord-303447-3a7jxl34	229	12	FDA	FDA	NNP
cord-303447-3a7jxl34	229	13	and	and	CC
cord-303447-3a7jxl34	229	14	is	be	VBZ
cord-303447-3a7jxl34	229	15	being	be	VBG
cord-303447-3a7jxl34	229	16	considered	consider	VBN
cord-303447-3a7jxl34	229	17	for	for	IN
cord-303447-3a7jxl34	229	18	the	the	DT
cord-303447-3a7jxl34	229	19	routine	routine	JJ
cord-303447-3a7jxl34	229	20	childhood	childhood	NN
cord-303447-3a7jxl34	229	21	vaccination	vaccination	NN
cord-303447-3a7jxl34	229	22	schedule	schedule	NN
cord-303447-3a7jxl34	229	23	.	.	.
cord-303447-3a7jxl34	230	1	The	the	DT
cord-303447-3a7jxl34	230	2	impact	impact	NN
cord-303447-3a7jxl34	230	3	of	of	IN
cord-303447-3a7jxl34	230	4	varicella	varicella	NN
cord-303447-3a7jxl34	230	5	vaccine	vaccine	NN
cord-303447-3a7jxl34	230	6	on	on	IN
cord-303447-3a7jxl34	230	7	the	the	DT
cord-303447-3a7jxl34	230	8	incidence	incidence	NN
cord-303447-3a7jxl34	230	9	of	of	IN
cord-303447-3a7jxl34	230	10	zoster	zoster	NN
cord-303447-3a7jxl34	230	11	infections	infection	NNS
cord-303447-3a7jxl34	230	12	in	in	IN
cord-303447-3a7jxl34	230	13	adults	adult	NNS
cord-303447-3a7jxl34	230	14	in	in	IN
cord-303447-3a7jxl34	230	15	the	the	DT
cord-303447-3a7jxl34	230	16	United	United	NNP
cord-303447-3a7jxl34	230	17	States	States	NNP
cord-303447-3a7jxl34	230	18	is	be	VBZ
cord-303447-3a7jxl34	230	19	unknown	unknown	JJ
cord-303447-3a7jxl34	230	20	.	.	.
cord-303447-3a7jxl34	231	1	Varicella	varicella	NN
cord-303447-3a7jxl34	231	2	vaccine	vaccine	NN
cord-303447-3a7jxl34	231	3	may	may	MD
cord-303447-3a7jxl34	231	4	protect	protect	VB
cord-303447-3a7jxl34	231	5	children	child	NNS
cord-303447-3a7jxl34	231	6	receiving	receive	VBG
cord-303447-3a7jxl34	231	7	the	the	DT
cord-303447-3a7jxl34	231	8	vaccine	vaccine	NN
cord-303447-3a7jxl34	231	9	from	from	IN
cord-303447-3a7jxl34	231	10	zoster	zoster	NNP
cord-303447-3a7jxl34	231	11	when	when	WRB
cord-303447-3a7jxl34	231	12	they	-PRON-	PRP
cord-303447-3a7jxl34	231	13	become	become	VBP
cord-303447-3a7jxl34	231	14	adults	adult	NNS
cord-303447-3a7jxl34	231	15	.	.	.
cord-303447-3a7jxl34	232	1	Studies	study	NNS
cord-303447-3a7jxl34	232	2	suggest	suggest	VBP
cord-303447-3a7jxl34	232	3	,	,	,
cord-303447-3a7jxl34	232	4	however	however	RB
cord-303447-3a7jxl34	232	5	,	,	,
cord-303447-3a7jxl34	232	6	that	that	IN
cord-303447-3a7jxl34	232	7	continued	continue	VBD
cord-303447-3a7jxl34	232	8	exposure	exposure	NN
cord-303447-3a7jxl34	232	9	to	to	IN
cord-303447-3a7jxl34	232	10	varicella	varicella	NN
cord-303447-3a7jxl34	232	11	protects	protect	VBZ
cord-303447-3a7jxl34	232	12	latently	latently	RB
cord-303447-3a7jxl34	232	13	infected	infect	VBN
cord-303447-3a7jxl34	232	14	adults	adult	NNS
cord-303447-3a7jxl34	232	15	[	[	-LRB-
cord-303447-3a7jxl34	232	16	70	70	CD
cord-303447-3a7jxl34	232	17	]	]	-RRB-
cord-303447-3a7jxl34	232	18	.	.	.
cord-303447-3a7jxl34	233	1	Vaccination	vaccination	NN
cord-303447-3a7jxl34	233	2	in	in	IN
cord-303447-3a7jxl34	233	3	children	child	NNS
cord-303447-3a7jxl34	233	4	could	could	MD
cord-303447-3a7jxl34	233	5	lead	lead	VB
cord-303447-3a7jxl34	233	6	to	to	IN
cord-303447-3a7jxl34	233	7	an	an	DT
cord-303447-3a7jxl34	233	8	increase	increase	NN
cord-303447-3a7jxl34	233	9	in	in	IN
cord-303447-3a7jxl34	233	10	zoster	zoster	NN
cord-303447-3a7jxl34	233	11	incidence	incidence	NN
cord-303447-3a7jxl34	233	12	in	in	IN
cord-303447-3a7jxl34	233	13	unvaccinated	unvaccinated	JJ
cord-303447-3a7jxl34	233	14	adults	adult	NNS
cord-303447-3a7jxl34	233	15	because	because	IN
cord-303447-3a7jxl34	233	16	exposure	exposure	NN
cord-303447-3a7jxl34	233	17	to	to	IN
cord-303447-3a7jxl34	233	18	varicella	varicella	NN
cord-303447-3a7jxl34	233	19	-	-	HYPH
cord-303447-3a7jxl34	233	20	infected	infect	VBN
cord-303447-3a7jxl34	233	21	children	child	NNS
cord-303447-3a7jxl34	233	22	has	have	VBZ
cord-303447-3a7jxl34	233	23	declined	decline	VBN
cord-303447-3a7jxl34	233	24	,	,	,
cord-303447-3a7jxl34	233	25	but	but	CC
cord-303447-3a7jxl34	233	26	zoster	zoster	NN
cord-303447-3a7jxl34	233	27	surveillance	surveillance	NN
cord-303447-3a7jxl34	233	28	is	be	VBZ
cord-303447-3a7jxl34	233	29	limited	limit	VBN
cord-303447-3a7jxl34	233	30	.	.	.
cord-303447-3a7jxl34	234	1	A	a	DT
cord-303447-3a7jxl34	234	2	vaccine	vaccine	NN
cord-303447-3a7jxl34	234	3	to	to	TO
cord-303447-3a7jxl34	234	4	prevent	prevent	VB
cord-303447-3a7jxl34	234	5	herpes	herpes	NN
cord-303447-3a7jxl34	234	6	zoster	zoster	NN
cord-303447-3a7jxl34	234	7	in	in	IN
cord-303447-3a7jxl34	234	8	adults	adult	NNS
cord-303447-3a7jxl34	234	9	is	be	VBZ
cord-303447-3a7jxl34	234	10	under	under	IN
cord-303447-3a7jxl34	234	11	investigation	investigation	NN
cord-303447-3a7jxl34	234	12	.	.	.
cord-303447-3a7jxl34	235	1	Since	since	IN
cord-303447-3a7jxl34	235	2	the	the	DT
cord-303447-3a7jxl34	235	3	worldwide	worldwide	JJ
cord-303447-3a7jxl34	235	4	influenza	influenza	NN
cord-303447-3a7jxl34	235	5	pandemic	pandemic	NN
cord-303447-3a7jxl34	235	6	of	of	IN
cord-303447-3a7jxl34	235	7	1918	1918	CD
cord-303447-3a7jxl34	235	8	that	that	WDT
cord-303447-3a7jxl34	235	9	caused	cause	VBD
cord-303447-3a7jxl34	235	10	an	an	DT
cord-303447-3a7jxl34	235	11	estimated	estimate	VBN
cord-303447-3a7jxl34	235	12	25	25	CD
cord-303447-3a7jxl34	235	13	to	to	TO
cord-303447-3a7jxl34	235	14	50	50	CD
cord-303447-3a7jxl34	235	15	million	million	CD
cord-303447-3a7jxl34	235	16	deaths	death	NNS
cord-303447-3a7jxl34	235	17	,	,	,
cord-303447-3a7jxl34	235	18	the	the	DT
cord-303447-3a7jxl34	235	19	control	control	NN
cord-303447-3a7jxl34	235	20	of	of	IN
cord-303447-3a7jxl34	235	21	influenza	influenza	NN
cord-303447-3a7jxl34	235	22	circulation	circulation	NN
cord-303447-3a7jxl34	235	23	has	have	VBZ
cord-303447-3a7jxl34	235	24	been	be	VBN
cord-303447-3a7jxl34	235	25	a	a	DT
cord-303447-3a7jxl34	235	26	major	major	JJ
cord-303447-3a7jxl34	235	27	challenge	challenge	NN
cord-303447-3a7jxl34	235	28	to	to	IN
cord-303447-3a7jxl34	235	29	clinicians	clinician	NNS
cord-303447-3a7jxl34	235	30	and	and	CC
cord-303447-3a7jxl34	235	31	public	public	JJ
cord-303447-3a7jxl34	235	32	health	health	NN
cord-303447-3a7jxl34	235	33	experts	expert	NNS
cord-303447-3a7jxl34	235	34	.	.	.
cord-303447-3a7jxl34	236	1	The	the	DT
cord-303447-3a7jxl34	236	2	threat	threat	NN
cord-303447-3a7jxl34	236	3	of	of	IN
cord-303447-3a7jxl34	236	4	an	an	DT
cord-303447-3a7jxl34	236	5	unpredictable	unpredictable	JJ
cord-303447-3a7jxl34	236	6	influenza	influenza	NN
cord-303447-3a7jxl34	236	7	pandemic	pandemic	NN
cord-303447-3a7jxl34	236	8	and	and	CC
cord-303447-3a7jxl34	236	9	the	the	DT
cord-303447-3a7jxl34	236	10	concern	concern	NN
cord-303447-3a7jxl34	236	11	about	about	IN
cord-303447-3a7jxl34	236	12	avian	avian	JJ
cord-303447-3a7jxl34	236	13	influenza	influenza	NN
cord-303447-3a7jxl34	236	14	heighten	heighten	VB
cord-303447-3a7jxl34	236	15	the	the	DT
cord-303447-3a7jxl34	236	16	importance	importance	NN
cord-303447-3a7jxl34	236	17	of	of	IN
cord-303447-3a7jxl34	236	18	preventing	prevent	VBG
cord-303447-3a7jxl34	236	19	morbidity	morbidity	NN
cord-303447-3a7jxl34	236	20	and	and	CC
cord-303447-3a7jxl34	236	21	mortality	mortality	NN
cord-303447-3a7jxl34	236	22	caused	cause	VBN
cord-303447-3a7jxl34	236	23	by	by	IN
cord-303447-3a7jxl34	236	24	epidemics	epidemic	NNS
cord-303447-3a7jxl34	236	25	of	of	IN
cord-303447-3a7jxl34	236	26	influenza	influenza	NN
cord-303447-3a7jxl34	236	27	disease	disease	NN
cord-303447-3a7jxl34	236	28	in	in	IN
cord-303447-3a7jxl34	236	29	the	the	DT
cord-303447-3a7jxl34	236	30	United	United	NNP
cord-303447-3a7jxl34	236	31	States	States	NNP
cord-303447-3a7jxl34	236	32	,	,	,
cord-303447-3a7jxl34	236	33	which	which	WDT
cord-303447-3a7jxl34	236	34	cause	cause	VBP
cord-303447-3a7jxl34	236	35	more	more	JJR
cord-303447-3a7jxl34	236	36	than	than	IN
cord-303447-3a7jxl34	236	37	250,000	250,000	CD
cord-303447-3a7jxl34	236	38	hospitalizations	hospitalization	NNS
cord-303447-3a7jxl34	236	39	and	and	CC
cord-303447-3a7jxl34	236	40	more	more	JJR
cord-303447-3a7jxl34	236	41	than	than	IN
cord-303447-3a7jxl34	236	42	36,000	36,000	CD
cord-303447-3a7jxl34	236	43	deaths	death	NNS
cord-303447-3a7jxl34	236	44	annually	annually	RB
cord-303447-3a7jxl34	236	45	[	[	-LRB-
cord-303447-3a7jxl34	236	46	71	71	CD
cord-303447-3a7jxl34	236	47	]	]	-RRB-
cord-303447-3a7jxl34	236	48	.	.	.
cord-303447-3a7jxl34	237	1	Implementing	implement	VBG
cord-303447-3a7jxl34	237	2	the	the	DT
cord-303447-3a7jxl34	237	3	expansion	expansion	NN
cord-303447-3a7jxl34	237	4	of	of	IN
cord-303447-3a7jxl34	237	5	influenza	influenza	NN
cord-303447-3a7jxl34	237	6	vaccine	vaccine	NN
cord-303447-3a7jxl34	237	7	recommendations	recommendation	NNS
cord-303447-3a7jxl34	237	8	to	to	IN
cord-303447-3a7jxl34	237	9	6-to	6-to	CD
cord-303447-3a7jxl34	237	10	23-month	23-month	JJ
cord-303447-3a7jxl34	237	11	-	-	HYPH
cord-303447-3a7jxl34	237	12	old	old	JJ
cord-303447-3a7jxl34	237	13	children	child	NNS
cord-303447-3a7jxl34	237	14	and	and	CC
cord-303447-3a7jxl34	237	15	prioritizing	prioritize	VBG
cord-303447-3a7jxl34	237	16	vaccine	vaccine	NN
cord-303447-3a7jxl34	237	17	during	during	IN
cord-303447-3a7jxl34	237	18	influenza	influenza	NN
cord-303447-3a7jxl34	237	19	vaccine	vaccine	NN
cord-303447-3a7jxl34	237	20	shortages	shortage	NNS
cord-303447-3a7jxl34	237	21	are	be	VBP
cord-303447-3a7jxl34	237	22	important	important	JJ
cord-303447-3a7jxl34	237	23	issues	issue	NNS
cord-303447-3a7jxl34	237	24	the	the	DT
cord-303447-3a7jxl34	237	25	US	US	NNP
cord-303447-3a7jxl34	237	26	immunization	immunization	NN
cord-303447-3a7jxl34	237	27	program	program	NN
cord-303447-3a7jxl34	237	28	faces	face	VBZ
cord-303447-3a7jxl34	237	29	regarding	regard	VBG
cord-303447-3a7jxl34	237	30	influenza	influenza	NN
cord-303447-3a7jxl34	237	31	prevention	prevention	NN
cord-303447-3a7jxl34	237	32	.	.	.
cord-303447-3a7jxl34	238	1	Influenza	influenza	NN
cord-303447-3a7jxl34	238	2	virus	virus	NN
cord-303447-3a7jxl34	238	3	contains	contain	VBZ
cord-303447-3a7jxl34	238	4	eight	eight	CD
cord-303447-3a7jxl34	238	5	major	major	JJ
cord-303447-3a7jxl34	238	6	proteins	protein	NNS
cord-303447-3a7jxl34	238	7	,	,	,
cord-303447-3a7jxl34	238	8	including	include	VBG
cord-303447-3a7jxl34	238	9	hemagglutinin	hemagglutinin	NN
cord-303447-3a7jxl34	238	10	(	(	-LRB-
cord-303447-3a7jxl34	238	11	HA	HA	NNP
cord-303447-3a7jxl34	238	12	)	)	-RRB-
cord-303447-3a7jxl34	238	13	,	,	,
cord-303447-3a7jxl34	238	14	which	which	WDT
cord-303447-3a7jxl34	238	15	controls	control	VBZ
cord-303447-3a7jxl34	238	16	viral	viral	JJ
cord-303447-3a7jxl34	238	17	penetration	penetration	NN
cord-303447-3a7jxl34	238	18	and	and	CC
cord-303447-3a7jxl34	238	19	attachment	attachment	NN
cord-303447-3a7jxl34	238	20	,	,	,
cord-303447-3a7jxl34	238	21	and	and	CC
cord-303447-3a7jxl34	238	22	neuraminidase	neuraminidase	NN
cord-303447-3a7jxl34	238	23	(	(	-LRB-
cord-303447-3a7jxl34	238	24	NA	NA	NNP
cord-303447-3a7jxl34	238	25	)	)	-RRB-
cord-303447-3a7jxl34	238	26	,	,	,
cord-303447-3a7jxl34	238	27	which	which	WDT
cord-303447-3a7jxl34	238	28	controls	control	VBZ
cord-303447-3a7jxl34	238	29	viral	viral	JJ
cord-303447-3a7jxl34	238	30	particle	particle	NN
cord-303447-3a7jxl34	238	31	release	release	NN
cord-303447-3a7jxl34	238	32	and	and	CC
cord-303447-3a7jxl34	238	33	spread	spread	VB
cord-303447-3a7jxl34	238	34	.	.	.
cord-303447-3a7jxl34	239	1	Influenza	influenza	NN
cord-303447-3a7jxl34	239	2	strains	strain	NNS
cord-303447-3a7jxl34	239	3	are	be	VBP
cord-303447-3a7jxl34	239	4	identified	identify	VBN
cord-303447-3a7jxl34	239	5	by	by	IN
cord-303447-3a7jxl34	239	6	type	type	NN
cord-303447-3a7jxl34	239	7	(	(	-LRB-
cord-303447-3a7jxl34	239	8	A	A	NNP
cord-303447-3a7jxl34	239	9	,	,	,
cord-303447-3a7jxl34	239	10	B	b	NN
cord-303447-3a7jxl34	239	11	,	,	,
cord-303447-3a7jxl34	239	12	and	and	CC
cord-303447-3a7jxl34	239	13	C	C	NNP
cord-303447-3a7jxl34	239	14	)	)	-RRB-
cord-303447-3a7jxl34	239	15	and	and	CC
cord-303447-3a7jxl34	239	16	by	by	IN
cord-303447-3a7jxl34	239	17	subtype	subtype	NN
cord-303447-3a7jxl34	239	18	categorized	categorize	VBN
cord-303447-3a7jxl34	239	19	by	by	IN
cord-303447-3a7jxl34	239	20	HA	HA	NNP
cord-303447-3a7jxl34	239	21	and	and	CC
cord-303447-3a7jxl34	239	22	NA	NA	NNP
cord-303447-3a7jxl34	239	23	.	.	.
cord-303447-3a7jxl34	240	1	There	there	EX
cord-303447-3a7jxl34	240	2	are	be	VBP
cord-303447-3a7jxl34	240	3	15	15	CD
cord-303447-3a7jxl34	240	4	different	different	JJ
cord-303447-3a7jxl34	240	5	HA	HA	NNP
cord-303447-3a7jxl34	240	6	and	and	CC
cord-303447-3a7jxl34	240	7	9	9	CD
cord-303447-3a7jxl34	240	8	different	different	JJ
cord-303447-3a7jxl34	240	9	NA	NA	NNP
cord-303447-3a7jxl34	240	10	subtypes	subtype	NNS
cord-303447-3a7jxl34	240	11	.	.	.
cord-303447-3a7jxl34	241	1	Major	major	JJ
cord-303447-3a7jxl34	241	2	changes	change	NNS
cord-303447-3a7jxl34	241	3	in	in	IN
cord-303447-3a7jxl34	241	4	HA	HA	NNP
cord-303447-3a7jxl34	241	5	and	and	CC
cord-303447-3a7jxl34	241	6	NA	NA	NNP
cord-303447-3a7jxl34	241	7	,	,	,
cord-303447-3a7jxl34	241	8	called	call	VBN
cord-303447-3a7jxl34	241	9	antigenic	antigenic	JJ
cord-303447-3a7jxl34	241	10	shifts	shift	NNS
cord-303447-3a7jxl34	241	11	,	,	,
cord-303447-3a7jxl34	241	12	are	be	VBP
cord-303447-3a7jxl34	241	13	associated	associate	VBN
cord-303447-3a7jxl34	241	14	with	with	IN
cord-303447-3a7jxl34	241	15	emergence	emergence	NN
cord-303447-3a7jxl34	241	16	of	of	IN
cord-303447-3a7jxl34	241	17	novel	novel	JJ
cord-303447-3a7jxl34	241	18	influenza	influenza	NN
cord-303447-3a7jxl34	241	19	viruses	virus	NNS
cord-303447-3a7jxl34	241	20	to	to	IN
cord-303447-3a7jxl34	241	21	which	which	WDT
cord-303447-3a7jxl34	241	22	little	little	JJ
cord-303447-3a7jxl34	241	23	or	or	CC
cord-303447-3a7jxl34	241	24	no	no	DT
cord-303447-3a7jxl34	241	25	immunity	immunity	NN
cord-303447-3a7jxl34	241	26	exists	exist	VBZ
cord-303447-3a7jxl34	241	27	in	in	IN
cord-303447-3a7jxl34	241	28	the	the	DT
cord-303447-3a7jxl34	241	29	exposed	expose	VBN
cord-303447-3a7jxl34	241	30	population	population	NN
cord-303447-3a7jxl34	241	31	.	.	.
cord-303447-3a7jxl34	242	1	Antigenic	antigenic	JJ
cord-303447-3a7jxl34	242	2	shifts	shift	NNS
cord-303447-3a7jxl34	242	3	were	be	VBD
cord-303447-3a7jxl34	242	4	the	the	DT
cord-303447-3a7jxl34	242	5	cause	cause	NN
cord-303447-3a7jxl34	242	6	of	of	IN
cord-303447-3a7jxl34	242	7	the	the	DT
cord-303447-3a7jxl34	242	8	three	three	CD
cord-303447-3a7jxl34	242	9	influenza	influenza	NN
cord-303447-3a7jxl34	242	10	pandemics	pandemic	NNS
cord-303447-3a7jxl34	242	11	in	in	IN
cord-303447-3a7jxl34	242	12	the	the	DT
cord-303447-3a7jxl34	242	13	twentieth	twentieth	JJ
cord-303447-3a7jxl34	242	14	century	century	NN
cord-303447-3a7jxl34	242	15	(	(	-LRB-
cord-303447-3a7jxl34	242	16	Table	Table	NNP
cord-303447-3a7jxl34	242	17	7	7	CD
cord-303447-3a7jxl34	242	18	)	)	-RRB-
cord-303447-3a7jxl34	242	19	[	[	-LRB-
cord-303447-3a7jxl34	242	20	72	72	CD
cord-303447-3a7jxl34	242	21	]	]	-RRB-
cord-303447-3a7jxl34	242	22	.	.	.
cord-303447-3a7jxl34	243	1	Minor	minor	JJ
cord-303447-3a7jxl34	243	2	changes	change	NNS
cord-303447-3a7jxl34	243	3	in	in	IN
cord-303447-3a7jxl34	243	4	HA	HA	NNP
cord-303447-3a7jxl34	243	5	and	and	CC
cord-303447-3a7jxl34	243	6	NA	NA	NNP
cord-303447-3a7jxl34	243	7	,	,	,
cord-303447-3a7jxl34	243	8	called	call	VBN
cord-303447-3a7jxl34	243	9	antigenic	antigenic	JJ
cord-303447-3a7jxl34	243	10	drifts	drift	NNS
cord-303447-3a7jxl34	243	11	,	,	,
cord-303447-3a7jxl34	243	12	define	define	VB
cord-303447-3a7jxl34	243	13	the	the	DT
cord-303447-3a7jxl34	243	14	influenza	influenza	NN
cord-303447-3a7jxl34	243	15	viruses	virus	NNS
cord-303447-3a7jxl34	243	16	that	that	WDT
cord-303447-3a7jxl34	243	17	circulate	circulate	VBP
cord-303447-3a7jxl34	243	18	each	each	DT
cord-303447-3a7jxl34	243	19	year	year	NN
cord-303447-3a7jxl34	243	20	.	.	.
cord-303447-3a7jxl34	244	1	Influenza	influenza	NN
cord-303447-3a7jxl34	244	2	vaccines	vaccine	NNS
cord-303447-3a7jxl34	244	3	are	be	VBP
cord-303447-3a7jxl34	244	4	developed	develop	VBN
cord-303447-3a7jxl34	244	5	yearly	yearly	RB
cord-303447-3a7jxl34	244	6	based	base	VBN
cord-303447-3a7jxl34	244	7	on	on	IN
cord-303447-3a7jxl34	244	8	antigenic	antigenic	JJ
cord-303447-3a7jxl34	244	9	drifts	drift	NNS
cord-303447-3a7jxl34	244	10	.	.	.
cord-303447-3a7jxl34	245	1	Worldwide	worldwide	JJ
cord-303447-3a7jxl34	245	2	surveillance	surveillance	NN
cord-303447-3a7jxl34	245	3	established	establish	VBN
cord-303447-3a7jxl34	245	4	by	by	IN
cord-303447-3a7jxl34	245	5	the	the	DT
cord-303447-3a7jxl34	245	6	World	World	NNP
cord-303447-3a7jxl34	245	7	Health	Health	NNP
cord-303447-3a7jxl34	245	8	Organization	Organization	NNP
cord-303447-3a7jxl34	245	9	allows	allow	VBZ
cord-303447-3a7jxl34	245	10	predictions	prediction	NNS
cord-303447-3a7jxl34	245	11	to	to	TO
cord-303447-3a7jxl34	245	12	be	be	VB
cord-303447-3a7jxl34	245	13	made	make	VBN
cord-303447-3a7jxl34	245	14	regarding	regard	VBG
cord-303447-3a7jxl34	245	15	antigenic	antigenic	JJ
cord-303447-3a7jxl34	245	16	drifts	drift	NNS
cord-303447-3a7jxl34	245	17	,	,	,
cord-303447-3a7jxl34	245	18	which	which	WDT
cord-303447-3a7jxl34	245	19	enables	enable	VBZ
cord-303447-3a7jxl34	245	20	vaccine	vaccine	NN
cord-303447-3a7jxl34	245	21	to	to	TO
cord-303447-3a7jxl34	245	22	be	be	VB
cord-303447-3a7jxl34	245	23	updated	update	VBN
cord-303447-3a7jxl34	245	24	before	before	IN
cord-303447-3a7jxl34	245	25	the	the	DT
cord-303447-3a7jxl34	245	26	start	start	NN
cord-303447-3a7jxl34	245	27	of	of	IN
cord-303447-3a7jxl34	245	28	an	an	DT
cord-303447-3a7jxl34	245	29	influenza	influenza	NN
cord-303447-3a7jxl34	245	30	season	season	NN
cord-303447-3a7jxl34	245	31	.	.	.
cord-303447-3a7jxl34	246	1	Recommendations	recommendation	NNS
cord-303447-3a7jxl34	246	2	for	for	IN
cord-303447-3a7jxl34	246	3	which	which	WDT
cord-303447-3a7jxl34	246	4	influenza	influenza	NN
cord-303447-3a7jxl34	246	5	strains	strain	NNS
cord-303447-3a7jxl34	246	6	should	should	MD
cord-303447-3a7jxl34	246	7	be	be	VB
cord-303447-3a7jxl34	246	8	included	include	VBN
cord-303447-3a7jxl34	246	9	in	in	IN
cord-303447-3a7jxl34	246	10	the	the	DT
cord-303447-3a7jxl34	246	11	vaccine	vaccine	NN
cord-303447-3a7jxl34	246	12	are	be	VBP
cord-303447-3a7jxl34	246	13	made	make	VBN
cord-303447-3a7jxl34	246	14	in	in	IN
cord-303447-3a7jxl34	246	15	early	early	JJ
cord-303447-3a7jxl34	246	16	spring	spring	NN
cord-303447-3a7jxl34	246	17	before	before	IN
cord-303447-3a7jxl34	246	18	influenza	influenza	NN
cord-303447-3a7jxl34	246	19	season	season	NN
cord-303447-3a7jxl34	246	20	.	.	.
cord-303447-3a7jxl34	247	1	Three	three	CD
cord-303447-3a7jxl34	247	2	influenza	influenza	NN
cord-303447-3a7jxl34	247	3	types	type	NNS
cord-303447-3a7jxl34	247	4	are	be	VBP
cord-303447-3a7jxl34	247	5	formulated	formulate	VBN
cord-303447-3a7jxl34	247	6	and	and	CC
cord-303447-3a7jxl34	247	7	combined	combine	VBN
cord-303447-3a7jxl34	247	8	to	to	TO
cord-303447-3a7jxl34	247	9	make	make	VB
cord-303447-3a7jxl34	247	10	a	a	DT
cord-303447-3a7jxl34	247	11	new	new	JJ
cord-303447-3a7jxl34	247	12	trivalent	trivalent	JJ
cord-303447-3a7jxl34	247	13	vaccine	vaccine	NN
cord-303447-3a7jxl34	247	14	each	each	DT
cord-303447-3a7jxl34	247	15	year	year	NN
cord-303447-3a7jxl34	247	16	.	.	.
cord-303447-3a7jxl34	248	1	Two	two	CD
cord-303447-3a7jxl34	248	2	types	type	NNS
cord-303447-3a7jxl34	248	3	of	of	IN
cord-303447-3a7jxl34	248	4	influenza	influenza	NN
cord-303447-3a7jxl34	248	5	vaccines	vaccine	NNS
cord-303447-3a7jxl34	248	6	are	be	VBP
cord-303447-3a7jxl34	248	7	licensed	license	VBN
cord-303447-3a7jxl34	248	8	for	for	IN
cord-303447-3a7jxl34	248	9	use	use	NN
cord-303447-3a7jxl34	248	10	in	in	IN
cord-303447-3a7jxl34	248	11	the	the	DT
cord-303447-3a7jxl34	248	12	United	United	NNP
cord-303447-3a7jxl34	248	13	States	States	NNP
cord-303447-3a7jxl34	248	14	.	.	.
cord-303447-3a7jxl34	249	1	One	one	CD
cord-303447-3a7jxl34	249	2	is	be	VBZ
cord-303447-3a7jxl34	249	3	an	an	DT
cord-303447-3a7jxl34	249	4	inactivated	inactivated	JJ
cord-303447-3a7jxl34	249	5	vaccine	vaccine	NN
cord-303447-3a7jxl34	249	6	recommended	recommend	VBN
cord-303447-3a7jxl34	249	7	for	for	IN
cord-303447-3a7jxl34	249	8	persons	person	NNS
cord-303447-3a7jxl34	249	9	6	6	CD
cord-303447-3a7jxl34	249	10	months	month	NNS
cord-303447-3a7jxl34	249	11	of	of	IN
cord-303447-3a7jxl34	249	12	age	age	NN
cord-303447-3a7jxl34	249	13	in	in	IN
cord-303447-3a7jxl34	249	14	highrisk	highrisk	JJ
cord-303447-3a7jxl34	249	15	groups	group	NNS
cord-303447-3a7jxl34	249	16	and	and	CC
cord-303447-3a7jxl34	249	17	their	-PRON-	PRP$
cord-303447-3a7jxl34	249	18	close	close	JJ
cord-303447-3a7jxl34	249	19	contacts	contact	NNS
cord-303447-3a7jxl34	249	20	.	.	.
cord-303447-3a7jxl34	250	1	The	the	DT
cord-303447-3a7jxl34	250	2	second	second	JJ
cord-303447-3a7jxl34	250	3	is	be	VBZ
cord-303447-3a7jxl34	250	4	a	a	DT
cord-303447-3a7jxl34	250	5	cold	cold	NN
cord-303447-3a7jxl34	250	6	adapted	adapt	VBN
cord-303447-3a7jxl34	250	7	,	,	,
cord-303447-3a7jxl34	250	8	live	live	VBP
cord-303447-3a7jxl34	250	9	,	,	,
cord-303447-3a7jxl34	250	10	nasally	nasally	RB
cord-303447-3a7jxl34	250	11	administered	administer	VBN
cord-303447-3a7jxl34	250	12	vaccine	vaccine	NN
cord-303447-3a7jxl34	250	13	licensed	license	VBN
cord-303447-3a7jxl34	250	14	for	for	IN
cord-303447-3a7jxl34	250	15	healthy	healthy	JJ
cord-303447-3a7jxl34	250	16	people	people	NNS
cord-303447-3a7jxl34	250	17	5	5	CD
cord-303447-3a7jxl34	250	18	to	to	TO
cord-303447-3a7jxl34	250	19	49	49	CD
cord-303447-3a7jxl34	250	20	years	year	NNS
cord-303447-3a7jxl34	250	21	of	of	IN
cord-303447-3a7jxl34	250	22	age	age	NN
cord-303447-3a7jxl34	250	23	,	,	,
cord-303447-3a7jxl34	250	24	including	include	VBG
cord-303447-3a7jxl34	250	25	close	close	JJ
cord-303447-3a7jxl34	250	26	contacts	contact	NNS
cord-303447-3a7jxl34	250	27	of	of	IN
cord-303447-3a7jxl34	250	28	high	high	JJ
cord-303447-3a7jxl34	250	29	-	-	HYPH
cord-303447-3a7jxl34	250	30	risk	risk	NN
cord-303447-3a7jxl34	250	31	persons	person	NNS
cord-303447-3a7jxl34	250	32	.	.	.
cord-303447-3a7jxl34	251	1	The	the	DT
cord-303447-3a7jxl34	251	2	ACIP	ACIP	NNP
cord-303447-3a7jxl34	251	3	and	and	CC
cord-303447-3a7jxl34	251	4	AAP	AAP	NNP
cord-303447-3a7jxl34	251	5	recommended	recommend	VBD
cord-303447-3a7jxl34	251	6	in	in	IN
cord-303447-3a7jxl34	251	7	2004	2004	CD
cord-303447-3a7jxl34	251	8	to	to	TO
cord-303447-3a7jxl34	251	9	expand	expand	VB
cord-303447-3a7jxl34	251	10	influenza	influenza	NN
cord-303447-3a7jxl34	251	11	vaccine	vaccine	NN
cord-303447-3a7jxl34	251	12	recommendations	recommendation	NNS
cord-303447-3a7jxl34	251	13	to	to	TO
cord-303447-3a7jxl34	251	14	include	include	VB
cord-303447-3a7jxl34	251	15	all	all	DT
cord-303447-3a7jxl34	251	16	children	child	NNS
cord-303447-3a7jxl34	251	17	6	6	CD
cord-303447-3a7jxl34	251	18	to	to	TO
cord-303447-3a7jxl34	251	19	23	23	CD
cord-303447-3a7jxl34	251	20	months	month	NNS
cord-303447-3a7jxl34	251	21	old	old	JJ
cord-303447-3a7jxl34	251	22	and	and	CC
cord-303447-3a7jxl34	251	23	household	household	NN
cord-303447-3a7jxl34	251	24	contacts	contact	NNS
cord-303447-3a7jxl34	251	25	of	of	IN
cord-303447-3a7jxl34	251	26	children	child	NNS
cord-303447-3a7jxl34	251	27	up	up	IN
cord-303447-3a7jxl34	251	28	to	to	TO
cord-303447-3a7jxl34	251	29	23	23	CD
cord-303447-3a7jxl34	251	30	months	month	NNS
cord-303447-3a7jxl34	251	31	old	old	JJ
cord-303447-3a7jxl34	251	32	as	as	RB
cord-303447-3a7jxl34	251	33	well	well	RB
cord-303447-3a7jxl34	251	34	as	as	IN
cord-303447-3a7jxl34	251	35	to	to	TO
cord-303447-3a7jxl34	251	36	continue	continue	VB
cord-303447-3a7jxl34	251	37	immunization	immunization	NN
cord-303447-3a7jxl34	251	38	of	of	IN
cord-303447-3a7jxl34	251	39	all	all	DT
cord-303447-3a7jxl34	251	40	children	child	NNS
cord-303447-3a7jxl34	251	41	in	in	IN
cord-303447-3a7jxl34	251	42	high	high	JJ
cord-303447-3a7jxl34	251	43	-	-	HYPH
cord-303447-3a7jxl34	251	44	risk	risk	NN
cord-303447-3a7jxl34	251	45	groups	group	NNS
cord-303447-3a7jxl34	251	46	.	.	.
cord-303447-3a7jxl34	252	1	This	this	DT
cord-303447-3a7jxl34	252	2	recommendation	recommendation	NN
cord-303447-3a7jxl34	252	3	was	be	VBD
cord-303447-3a7jxl34	252	4	made	make	VBN
cord-303447-3a7jxl34	252	5	based	base	VBN
cord-303447-3a7jxl34	252	6	on	on	IN
cord-303447-3a7jxl34	252	7	epidemiologic	epidemiologic	JJ
cord-303447-3a7jxl34	252	8	data	datum	NNS
cord-303447-3a7jxl34	252	9	showing	show	VBG
cord-303447-3a7jxl34	252	10	that	that	IN
cord-303447-3a7jxl34	252	11	healthy	healthy	JJ
cord-303447-3a7jxl34	252	12	children	child	NNS
cord-303447-3a7jxl34	252	13	in	in	IN
cord-303447-3a7jxl34	252	14	this	this	DT
cord-303447-3a7jxl34	252	15	age	age	NN
cord-303447-3a7jxl34	252	16	group	group	NN
cord-303447-3a7jxl34	252	17	are	be	VBP
cord-303447-3a7jxl34	252	18	at	at	IN
cord-303447-3a7jxl34	252	19	high	high	JJ
cord-303447-3a7jxl34	252	20	risk	risk	NN
cord-303447-3a7jxl34	252	21	of	of	IN
cord-303447-3a7jxl34	252	22	hospitalization	hospitalization	NN
cord-303447-3a7jxl34	252	23	from	from	IN
cord-303447-3a7jxl34	252	24	influenza	influenza	NN
cord-303447-3a7jxl34	252	25	,	,	,
cord-303447-3a7jxl34	252	26	and	and	CC
cord-303447-3a7jxl34	252	27	that	that	IN
cord-303447-3a7jxl34	252	28	deaths	death	NNS
cord-303447-3a7jxl34	252	29	in	in	IN
cord-303447-3a7jxl34	252	30	this	this	DT
cord-303447-3a7jxl34	252	31	age	age	NN
cord-303447-3a7jxl34	252	32	group	group	NN
cord-303447-3a7jxl34	252	33	occur	occur	VBP
cord-303447-3a7jxl34	252	34	[	[	-LRB-
cord-303447-3a7jxl34	252	35	73	73	CD
cord-303447-3a7jxl34	252	36	]	]	-RRB-
cord-303447-3a7jxl34	252	37	[	[	-LRB-
cord-303447-3a7jxl34	252	38	74	74	CD
cord-303447-3a7jxl34	252	39	]	]	-RRB-
cord-303447-3a7jxl34	252	40	[	[	-LRB-
cord-303447-3a7jxl34	252	41	75	75	CD
cord-303447-3a7jxl34	252	42	]	]	-RRB-
cord-303447-3a7jxl34	252	43	[	[	-LRB-
cord-303447-3a7jxl34	252	44	76	76	CD
cord-303447-3a7jxl34	252	45	]	]	-RRB-
cord-303447-3a7jxl34	252	46	.	.	.
cord-303447-3a7jxl34	253	1	More	More	JJR
cord-303447-3a7jxl34	253	2	than	than	IN
cord-303447-3a7jxl34	253	3	150	150	CD
cord-303447-3a7jxl34	253	4	reports	report	NNS
cord-303447-3a7jxl34	253	5	of	of	IN
cord-303447-3a7jxl34	253	6	pediatric	pediatric	JJ
cord-303447-3a7jxl34	253	7	influenzaassociated	influenzaassociate	VBN
cord-303447-3a7jxl34	253	8	deaths	death	NNS
cord-303447-3a7jxl34	253	9	during	during	IN
cord-303447-3a7jxl34	253	10	the	the	DT
cord-303447-3a7jxl34	253	11	2003	2003	CD
cord-303447-3a7jxl34	253	12	-	-	SYM
cord-303447-3a7jxl34	253	13	04	04	CD
cord-303447-3a7jxl34	253	14	influenza	influenza	NN
cord-303447-3a7jxl34	253	15	season	season	NN
cord-303447-3a7jxl34	253	16	stimulated	stimulate	VBD
cord-303447-3a7jxl34	253	17	the	the	DT
cord-303447-3a7jxl34	253	18	addition	addition	NN
cord-303447-3a7jxl34	253	19	[	[	-LRB-
cord-303447-3a7jxl34	253	20	77	77	CD
cord-303447-3a7jxl34	253	21	]	]	-RRB-
cord-303447-3a7jxl34	253	22	.	.	.
cord-303447-3a7jxl34	254	1	The	the	DT
cord-303447-3a7jxl34	254	2	influenza	influenza	NN
cord-303447-3a7jxl34	254	3	vaccine	vaccine	NN
cord-303447-3a7jxl34	254	4	is	be	VBZ
cord-303447-3a7jxl34	254	5	unique	unique	JJ
cord-303447-3a7jxl34	254	6	to	to	IN
cord-303447-3a7jxl34	254	7	the	the	DT
cord-303447-3a7jxl34	254	8	recommended	recommend	VBN
cord-303447-3a7jxl34	254	9	childhood	childhood	NN
cord-303447-3a7jxl34	254	10	and	and	CC
cord-303447-3a7jxl34	254	11	adolescent	adolescent	JJ
cord-303447-3a7jxl34	254	12	immunization	immunization	NN
cord-303447-3a7jxl34	254	13	schedule	schedule	NN
cord-303447-3a7jxl34	254	14	because	because	IN
cord-303447-3a7jxl34	254	15	it	-PRON-	PRP
cord-303447-3a7jxl34	254	16	is	be	VBZ
cord-303447-3a7jxl34	254	17	the	the	DT
cord-303447-3a7jxl34	254	18	only	only	JJ
cord-303447-3a7jxl34	254	19	vaccine	vaccine	NN
cord-303447-3a7jxl34	254	20	that	that	WDT
cord-303447-3a7jxl34	254	21	requires	require	VBZ
cord-303447-3a7jxl34	254	22	a	a	DT
cord-303447-3a7jxl34	254	23	visit	visit	NN
cord-303447-3a7jxl34	254	24	during	during	IN
cord-303447-3a7jxl34	254	25	a	a	DT
cord-303447-3a7jxl34	254	26	certain	certain	JJ
cord-303447-3a7jxl34	254	27	time	time	NN
cord-303447-3a7jxl34	254	28	of	of	IN
cord-303447-3a7jxl34	254	29	year	year	NN
cord-303447-3a7jxl34	254	30	and	and	CC
cord-303447-3a7jxl34	254	31	that	that	DT
cord-303447-3a7jxl34	254	32	requires	require	VBZ
cord-303447-3a7jxl34	254	33	annual	annual	JJ
cord-303447-3a7jxl34	254	34	immunization	immunization	NN
cord-303447-3a7jxl34	254	35	.	.	.
cord-303447-3a7jxl34	255	1	Even	even	RB
cord-303447-3a7jxl34	255	2	if	if	IN
cord-303447-3a7jxl34	255	3	the	the	DT
cord-303447-3a7jxl34	255	4	circulating	circulate	VBG
cord-303447-3a7jxl34	255	5	strains	strain	NNS
cord-303447-3a7jxl34	255	6	of	of	IN
cord-303447-3a7jxl34	255	7	virus	virus	NN
cord-303447-3a7jxl34	255	8	are	be	VBP
cord-303447-3a7jxl34	255	9	the	the	DT
cord-303447-3a7jxl34	255	10	same	same	JJ
cord-303447-3a7jxl34	255	11	as	as	IN
cord-303447-3a7jxl34	255	12	the	the	DT
cord-303447-3a7jxl34	255	13	year	year	NN
cord-303447-3a7jxl34	255	14	before	before	RB
cord-303447-3a7jxl34	255	15	,	,	,
cord-303447-3a7jxl34	255	16	an	an	DT
cord-303447-3a7jxl34	255	17	annual	annual	JJ
cord-303447-3a7jxl34	255	18	booster	booster	NN
cord-303447-3a7jxl34	255	19	is	be	VBZ
cord-303447-3a7jxl34	255	20	necessary	necessary	JJ
cord-303447-3a7jxl34	255	21	to	to	TO
cord-303447-3a7jxl34	255	22	retain	retain	VB
cord-303447-3a7jxl34	255	23	immunity	immunity	NN
cord-303447-3a7jxl34	255	24	.	.	.
cord-303447-3a7jxl34	256	1	In	in	IN
cord-303447-3a7jxl34	256	2	addition	addition	NN
cord-303447-3a7jxl34	256	3	,	,	,
cord-303447-3a7jxl34	256	4	children	child	NNS
cord-303447-3a7jxl34	256	5	6	6	CD
cord-303447-3a7jxl34	256	6	months	month	NNS
cord-303447-3a7jxl34	256	7	to	to	IN
cord-303447-3a7jxl34	256	8	8	8	CD
cord-303447-3a7jxl34	256	9	years	year	NNS
cord-303447-3a7jxl34	256	10	old	old	JJ
cord-303447-3a7jxl34	256	11	are	be	VBP
cord-303447-3a7jxl34	256	12	recommended	recommend	VBN
cord-303447-3a7jxl34	256	13	to	to	TO
cord-303447-3a7jxl34	256	14	have	have	VB
cord-303447-3a7jxl34	256	15	two	two	CD
cord-303447-3a7jxl34	256	16	doses	dose	NNS
cord-303447-3a7jxl34	256	17	of	of	IN
cord-303447-3a7jxl34	256	18	influenza	influenza	NN
cord-303447-3a7jxl34	256	19	vaccine	vaccine	NN
cord-303447-3a7jxl34	256	20	administered	administer	VBD
cord-303447-3a7jxl34	256	21	1	1	CD
cord-303447-3a7jxl34	256	22	month	month	NN
cord-303447-3a7jxl34	256	23	apart	apart	RB
cord-303447-3a7jxl34	256	24	if	if	IN
cord-303447-3a7jxl34	256	25	they	-PRON-	PRP
cord-303447-3a7jxl34	256	26	previously	previously	RB
cord-303447-3a7jxl34	256	27	have	have	VBP
cord-303447-3a7jxl34	256	28	never	never	RB
cord-303447-3a7jxl34	256	29	been	be	VBN
cord-303447-3a7jxl34	256	30	vaccinated	vaccinate	VBN
cord-303447-3a7jxl34	256	31	for	for	IN
cord-303447-3a7jxl34	256	32	influenza	influenza	NN
cord-303447-3a7jxl34	256	33	[	[	-LRB-
cord-303447-3a7jxl34	256	34	76	76	CD
cord-303447-3a7jxl34	256	35	]	]	-RRB-
cord-303447-3a7jxl34	256	36	.	.	.
cord-303447-3a7jxl34	257	1	Adding	add	VBG
cord-303447-3a7jxl34	257	2	influenza	influenza	NN
cord-303447-3a7jxl34	257	3	into	into	IN
cord-303447-3a7jxl34	257	4	the	the	DT
cord-303447-3a7jxl34	257	5	childhood	childhood	NN
cord-303447-3a7jxl34	257	6	schedule	schedule	NN
cord-303447-3a7jxl34	257	7	is	be	VBZ
cord-303447-3a7jxl34	257	8	challenging	challenging	JJ
cord-303447-3a7jxl34	257	9	for	for	IN
cord-303447-3a7jxl34	257	10	public	public	JJ
cord-303447-3a7jxl34	257	11	health	health	NN
cord-303447-3a7jxl34	257	12	officials	official	NNS
cord-303447-3a7jxl34	257	13	and	and	CC
cord-303447-3a7jxl34	257	14	primary	primary	JJ
cord-303447-3a7jxl34	257	15	care	care	NN
cord-303447-3a7jxl34	257	16	physicians	physician	NNS
cord-303447-3a7jxl34	257	17	developing	develop	VBG
cord-303447-3a7jxl34	257	18	programs	program	NNS
cord-303447-3a7jxl34	257	19	to	to	TO
cord-303447-3a7jxl34	257	20	attain	attain	VB
cord-303447-3a7jxl34	257	21	high	high	JJ
cord-303447-3a7jxl34	257	22	coverage	coverage	NN
cord-303447-3a7jxl34	257	23	rates	rate	NNS
cord-303447-3a7jxl34	257	24	in	in	IN
cord-303447-3a7jxl34	257	25	children	child	NNS
cord-303447-3a7jxl34	257	26	6	6	CD
cord-303447-3a7jxl34	257	27	to	to	TO
cord-303447-3a7jxl34	257	28	23	23	CD
cord-303447-3a7jxl34	257	29	months	month	NNS
cord-303447-3a7jxl34	257	30	old	old	JJ
cord-303447-3a7jxl34	257	31	.	.	.
cord-303447-3a7jxl34	258	1	Vaccine	vaccine	NN
cord-303447-3a7jxl34	258	2	development	development	NN
cord-303447-3a7jxl34	258	3	is	be	VBZ
cord-303447-3a7jxl34	258	4	expanding	expand	VBG
cord-303447-3a7jxl34	258	5	to	to	TO
cord-303447-3a7jxl34	258	6	include	include	VB
cord-303447-3a7jxl34	258	7	products	product	NNS
cord-303447-3a7jxl34	258	8	against	against	IN
cord-303447-3a7jxl34	258	9	cancers	cancer	NNS
cord-303447-3a7jxl34	258	10	,	,	,
cord-303447-3a7jxl34	258	11	chronic	chronic	JJ
cord-303447-3a7jxl34	258	12	diseases	disease	NNS
cord-303447-3a7jxl34	258	13	,	,	,
cord-303447-3a7jxl34	258	14	and	and	CC
cord-303447-3a7jxl34	258	15	other	other	JJ
cord-303447-3a7jxl34	258	16	infectious	infectious	JJ
cord-303447-3a7jxl34	258	17	diseases	disease	NNS
cord-303447-3a7jxl34	258	18	.	.	.
cord-303447-3a7jxl34	259	1	Vaccines	vaccine	NNS
cord-303447-3a7jxl34	259	2	against	against	IN
cord-303447-3a7jxl34	259	3	inflammatory	inflammatory	JJ
cord-303447-3a7jxl34	259	4	diseases	disease	NNS
cord-303447-3a7jxl34	259	5	for	for	IN
cord-303447-3a7jxl34	259	6	which	which	WDT
cord-303447-3a7jxl34	259	7	an	an	DT
cord-303447-3a7jxl34	259	8	infectious	infectious	JJ
cord-303447-3a7jxl34	259	9	cause	cause	NN
cord-303447-3a7jxl34	259	10	has	have	VBZ
cord-303447-3a7jxl34	259	11	not	not	RB
cord-303447-3a7jxl34	259	12	been	be	VBN
cord-303447-3a7jxl34	259	13	identified	identify	VBN
cord-303447-3a7jxl34	259	14	,	,	,
cord-303447-3a7jxl34	259	15	such	such	JJ
cord-303447-3a7jxl34	259	16	as	as	IN
cord-303447-3a7jxl34	259	17	multiple	multiple	JJ
cord-303447-3a7jxl34	259	18	sclerosis	sclerosis	NN
cord-303447-3a7jxl34	259	19	and	and	CC
cord-303447-3a7jxl34	259	20	rheumatoid	rheumatoid	NN
cord-303447-3a7jxl34	259	21	arthritis	arthritis	NN
cord-303447-3a7jxl34	259	22	,	,	,
cord-303447-3a7jxl34	259	23	are	be	VBP
cord-303447-3a7jxl34	259	24	being	be	VBG
cord-303447-3a7jxl34	259	25	developed	develop	VBN
cord-303447-3a7jxl34	259	26	as	as	IN
cord-303447-3a7jxl34	259	27	therapeutic	therapeutic	JJ
cord-303447-3a7jxl34	259	28	vaccines	vaccine	NNS
cord-303447-3a7jxl34	259	29	.	.	.
cord-303447-3a7jxl34	260	1	Scientists	scientist	NNS
cord-303447-3a7jxl34	260	2	effectively	effectively	RB
cord-303447-3a7jxl34	260	3	are	be	VBP
cord-303447-3a7jxl34	260	4	using	use	VBG
cord-303447-3a7jxl34	260	5	new	new	JJ
cord-303447-3a7jxl34	260	6	biologic	biologic	JJ
cord-303447-3a7jxl34	260	7	tools	tool	NNS
cord-303447-3a7jxl34	260	8	to	to	TO
cord-303447-3a7jxl34	260	9	improve	improve	VB
cord-303447-3a7jxl34	260	10	existing	exist	VBG
cord-303447-3a7jxl34	260	11	vaccines	vaccine	NNS
cord-303447-3a7jxl34	260	12	.	.	.
cord-303447-3a7jxl34	261	1	New	new	JJ
cord-303447-3a7jxl34	261	2	technologies	technology	NNS
cord-303447-3a7jxl34	261	3	also	also	RB
cord-303447-3a7jxl34	261	4	are	be	VBP
cord-303447-3a7jxl34	261	5	being	be	VBG
cord-303447-3a7jxl34	261	6	used	use	VBN
cord-303447-3a7jxl34	261	7	to	to	TO
cord-303447-3a7jxl34	261	8	improve	improve	VB
cord-303447-3a7jxl34	261	9	vaccine	vaccine	NN
cord-303447-3a7jxl34	261	10	delivery	delivery	NN
cord-303447-3a7jxl34	261	11	systems	system	NNS
cord-303447-3a7jxl34	261	12	,	,	,
cord-303447-3a7jxl34	261	13	producing	produce	VBG
cord-303447-3a7jxl34	261	14	better	well	JJR
cord-303447-3a7jxl34	261	15	combination	combination	NN
cord-303447-3a7jxl34	261	16	,	,	,
cord-303447-3a7jxl34	261	17	oral	oral	JJ
cord-303447-3a7jxl34	261	18	,	,	,
cord-303447-3a7jxl34	261	19	and	and	CC
cord-303447-3a7jxl34	261	20	intranasal	intranasal	NN
cord-303447-3a7jxl34	261	21	vaccines	vaccine	NNS
cord-303447-3a7jxl34	261	22	.	.	.
cord-303447-3a7jxl34	262	1	The	the	DT
cord-303447-3a7jxl34	262	2	science	science	NN
cord-303447-3a7jxl34	262	3	behind	behind	IN
cord-303447-3a7jxl34	262	4	new	new	JJ
cord-303447-3a7jxl34	262	5	vaccines	vaccine	NNS
cord-303447-3a7jxl34	262	6	continues	continue	VBZ
cord-303447-3a7jxl34	262	7	to	to	TO
cord-303447-3a7jxl34	262	8	advance	advance	VB
cord-303447-3a7jxl34	262	9	at	at	IN
cord-303447-3a7jxl34	262	10	a	a	DT
cord-303447-3a7jxl34	262	11	remarkable	remarkable	JJ
cord-303447-3a7jxl34	262	12	pace	pace	NN
cord-303447-3a7jxl34	262	13	,	,	,
cord-303447-3a7jxl34	262	14	driven	drive	VBN
cord-303447-3a7jxl34	262	15	by	by	IN
cord-303447-3a7jxl34	262	16	an	an	DT
cord-303447-3a7jxl34	262	17	evolving	evolve	VBG
cord-303447-3a7jxl34	262	18	understanding	understanding	NN
cord-303447-3a7jxl34	262	19	of	of	IN
cord-303447-3a7jxl34	262	20	the	the	DT
cord-303447-3a7jxl34	262	21	cellular	cellular	JJ
cord-303447-3a7jxl34	262	22	and	and	CC
cord-303447-3a7jxl34	262	23	molecular	molecular	JJ
cord-303447-3a7jxl34	262	24	processes	process	NNS
cord-303447-3a7jxl34	262	25	involved	involve	VBN
cord-303447-3a7jxl34	262	26	in	in	IN
cord-303447-3a7jxl34	262	27	different	different	JJ
cord-303447-3a7jxl34	262	28	responses	response	NNS
cord-303447-3a7jxl34	262	29	of	of	IN
cord-303447-3a7jxl34	262	30	the	the	DT
cord-303447-3a7jxl34	262	31	immune	immune	JJ
cord-303447-3a7jxl34	262	32	system	system	NN
cord-303447-3a7jxl34	262	33	[	[	-LRB-
cord-303447-3a7jxl34	262	34	78	78	CD
cord-303447-3a7jxl34	262	35	]	]	-RRB-
cord-303447-3a7jxl34	262	36	.	.	.
cord-303447-3a7jxl34	263	1	Many	many	JJ
cord-303447-3a7jxl34	263	2	infectious	infectious	JJ
cord-303447-3a7jxl34	263	3	organisms	organism	NNS
cord-303447-3a7jxl34	263	4	have	have	VBP
cord-303447-3a7jxl34	263	5	evolved	evolve	VBN
cord-303447-3a7jxl34	263	6	over	over	IN
cord-303447-3a7jxl34	263	7	thousands	thousand	NNS
cord-303447-3a7jxl34	263	8	of	of	IN
cord-303447-3a7jxl34	263	9	years	year	NNS
cord-303447-3a7jxl34	263	10	to	to	TO
cord-303447-3a7jxl34	263	11	evade	evade	VB
cord-303447-3a7jxl34	263	12	this	this	DT
cord-303447-3a7jxl34	263	13	immune	immune	JJ
cord-303447-3a7jxl34	263	14	response	response	NN
cord-303447-3a7jxl34	263	15	.	.	.
cord-303447-3a7jxl34	264	1	Adjuvants	adjuvant	NNS
cord-303447-3a7jxl34	264	2	to	to	IN
cord-303447-3a7jxl34	264	3	vaccines	vaccine	NNS
cord-303447-3a7jxl34	264	4	are	be	VBP
cord-303447-3a7jxl34	264	5	now	now	RB
cord-303447-3a7jxl34	264	6	being	be	VBG
cord-303447-3a7jxl34	264	7	used	use	VBN
cord-303447-3a7jxl34	264	8	not	not	RB
cord-303447-3a7jxl34	264	9	only	only	RB
cord-303447-3a7jxl34	264	10	to	to	TO
cord-303447-3a7jxl34	264	11	create	create	VB
cord-303447-3a7jxl34	264	12	an	an	DT
cord-303447-3a7jxl34	264	13	immune	immune	JJ
cord-303447-3a7jxl34	264	14	response	response	NN
cord-303447-3a7jxl34	264	15	,	,	,
cord-303447-3a7jxl34	264	16	but	but	CC
cord-303447-3a7jxl34	264	17	also	also	RB
cord-303447-3a7jxl34	264	18	to	to	TO
cord-303447-3a7jxl34	264	19	focus	focus	VB
cord-303447-3a7jxl34	264	20	the	the	DT
cord-303447-3a7jxl34	264	21	immune	immune	JJ
cord-303447-3a7jxl34	264	22	response	response	NN
cord-303447-3a7jxl34	264	23	down	down	IN
cord-303447-3a7jxl34	264	24	a	a	DT
cord-303447-3a7jxl34	264	25	desired	desire	VBN
cord-303447-3a7jxl34	264	26	path	path	NN
cord-303447-3a7jxl34	264	27	[	[	-LRB-
cord-303447-3a7jxl34	264	28	79	79	CD
cord-303447-3a7jxl34	264	29	]	]	-RRB-
cord-303447-3a7jxl34	264	30	.	.	.
cord-303447-3a7jxl34	265	1	DNA	DNA	NNP
cord-303447-3a7jxl34	265	2	vaccines	vaccine	NNS
cord-303447-3a7jxl34	265	3	,	,	,
cord-303447-3a7jxl34	265	4	plasmids	plasmid	NNS
cord-303447-3a7jxl34	265	5	of	of	IN
cord-303447-3a7jxl34	265	6	DNA	dna	NN
cord-303447-3a7jxl34	265	7	encoding	encode	VBG
cord-303447-3a7jxl34	265	8	the	the	DT
cord-303447-3a7jxl34	265	9	desired	desire	VBN
cord-303447-3a7jxl34	265	10	antigen	antigen	NN
cord-303447-3a7jxl34	265	11	,	,	,
cord-303447-3a7jxl34	265	12	also	also	RB
cord-303447-3a7jxl34	265	13	are	be	VBP
cord-303447-3a7jxl34	265	14	being	be	VBG
cord-303447-3a7jxl34	265	15	developed	develop	VBN
cord-303447-3a7jxl34	265	16	with	with	IN
cord-303447-3a7jxl34	265	17	the	the	DT
cord-303447-3a7jxl34	265	18	intention	intention	NN
cord-303447-3a7jxl34	265	19	of	of	IN
cord-303447-3a7jxl34	265	20	simplifying	simplify	VBG
cord-303447-3a7jxl34	265	21	vaccine	vaccine	NN
cord-303447-3a7jxl34	265	22	production	production	NN
cord-303447-3a7jxl34	265	23	and	and	CC
cord-303447-3a7jxl34	265	24	eliminating	eliminate	VBG
cord-303447-3a7jxl34	265	25	the	the	DT
cord-303447-3a7jxl34	265	26	possible	possible	JJ
cord-303447-3a7jxl34	265	27	risk	risk	NN
cord-303447-3a7jxl34	265	28	of	of	IN
cord-303447-3a7jxl34	265	29	organism	organism	NN
cord-303447-3a7jxl34	265	30	reversion	reversion	NN
cord-303447-3a7jxl34	265	31	[	[	-LRB-
cord-303447-3a7jxl34	265	32	78	78	CD
cord-303447-3a7jxl34	265	33	]	]	-RRB-
cord-303447-3a7jxl34	265	34	.	.	.
cord-303447-3a7jxl34	266	1	As	as	IN
cord-303447-3a7jxl34	266	2	was	be	VBD
cord-303447-3a7jxl34	266	3	true	true	JJ
cord-303447-3a7jxl34	266	4	during	during	IN
cord-303447-3a7jxl34	266	5	the	the	DT
cord-303447-3a7jxl34	266	6	time	time	NN
cord-303447-3a7jxl34	266	7	of	of	IN
cord-303447-3a7jxl34	266	8	Jenner	Jenner	NNP
cord-303447-3a7jxl34	266	9	,	,	,
cord-303447-3a7jxl34	266	10	vaccines	vaccine	NNS
cord-303447-3a7jxl34	266	11	continue	continue	VBP
cord-303447-3a7jxl34	266	12	to	to	TO
cord-303447-3a7jxl34	266	13	push	push	VB
cord-303447-3a7jxl34	266	14	the	the	DT
cord-303447-3a7jxl34	266	15	frontiers	frontier	NNS
cord-303447-3a7jxl34	266	16	of	of	IN
cord-303447-3a7jxl34	266	17	science	science	NN
cord-303447-3a7jxl34	266	18	and	and	CC
cord-303447-3a7jxl34	266	19	medicine	medicine	NN
cord-303447-3a7jxl34	266	20	.	.	.
cord-303447-3a7jxl34	267	1	In	in	IN
cord-303447-3a7jxl34	267	2	2000	2000	CD
cord-303447-3a7jxl34	267	3	,	,	,
cord-303447-3a7jxl34	267	4	the	the	DT
cord-303447-3a7jxl34	267	5	IOM	IOM	NNP
cord-303447-3a7jxl34	267	6	published	publish	VBD
cord-303447-3a7jxl34	267	7	a	a	DT
cord-303447-3a7jxl34	267	8	report	report	NN
cord-303447-3a7jxl34	267	9	prioritizing	prioritize	VBG
cord-303447-3a7jxl34	267	10	development	development	NN
cord-303447-3a7jxl34	267	11	of	of	IN
cord-303447-3a7jxl34	267	12	vaccines	vaccine	NNS
cord-303447-3a7jxl34	267	13	to	to	TO
cord-303447-3a7jxl34	267	14	be	be	VB
cord-303447-3a7jxl34	267	15	used	use	VBN
cord-303447-3a7jxl34	267	16	in	in	IN
cord-303447-3a7jxl34	267	17	the	the	DT
cord-303447-3a7jxl34	267	18	United	United	NNP
cord-303447-3a7jxl34	267	19	States	States	NNP
cord-303447-3a7jxl34	267	20	.	.	.
cord-303447-3a7jxl34	268	1	The	the	DT
cord-303447-3a7jxl34	268	2	IOM	IOM	NNP
cord-303447-3a7jxl34	268	3	committee	committee	NN
cord-303447-3a7jxl34	268	4	considered	consider	VBD
cord-303447-3a7jxl34	268	5	vaccines	vaccine	NNS
cord-303447-3a7jxl34	268	6	that	that	WDT
cord-303447-3a7jxl34	268	7	could	could	MD
cord-303447-3a7jxl34	268	8	be	be	VB
cord-303447-3a7jxl34	268	9	licensed	license	VBN
cord-303447-3a7jxl34	268	10	within	within	IN
cord-303447-3a7jxl34	268	11	20	20	CD
cord-303447-3a7jxl34	268	12	years	year	NNS
cord-303447-3a7jxl34	268	13	directed	direct	VBN
cord-303447-3a7jxl34	268	14	against	against	IN
cord-303447-3a7jxl34	268	15	conditions	condition	NNS
cord-303447-3a7jxl34	268	16	of	of	IN
cord-303447-3a7jxl34	268	17	domestic	domestic	JJ
cord-303447-3a7jxl34	268	18	health	health	NN
cord-303447-3a7jxl34	268	19	importance	importance	NN
cord-303447-3a7jxl34	268	20	[	[	-LRB-
cord-303447-3a7jxl34	268	21	80	80	CD
cord-303447-3a7jxl34	268	22	]	]	-RRB-
cord-303447-3a7jxl34	268	23	.	.	.
cord-303447-3a7jxl34	269	1	Health	health	NN
cord-303447-3a7jxl34	269	2	benefits	benefit	NNS
cord-303447-3a7jxl34	269	3	of	of	IN
cord-303447-3a7jxl34	269	4	these	these	DT
cord-303447-3a7jxl34	269	5	vaccines	vaccine	NNS
cord-303447-3a7jxl34	269	6	were	be	VBD
cord-303447-3a7jxl34	269	7	measured	measure	VBN
cord-303447-3a7jxl34	269	8	by	by	IN
cord-303447-3a7jxl34	269	9	a	a	DT
cord-303447-3a7jxl34	269	10	standard	standard	JJ
cord-303447-3a7jxl34	269	11	health	health	NN
cord-303447-3a7jxl34	269	12	outcome	outcome	NN
cord-303447-3a7jxl34	269	13	measure	measure	NN
cord-303447-3a7jxl34	269	14	,	,	,
cord-303447-3a7jxl34	269	15	quality	quality	NN
cord-303447-3a7jxl34	269	16	-	-	HYPH
cord-303447-3a7jxl34	269	17	adjusted	adjust	VBN
cord-303447-3a7jxl34	269	18	life	life	NN
cord-303447-3a7jxl34	269	19	years	year	NNS
cord-303447-3a7jxl34	269	20	gained	gain	VBD
cord-303447-3a7jxl34	269	21	.	.	.
cord-303447-3a7jxl34	270	1	These	these	DT
cord-303447-3a7jxl34	270	2	vaccines	vaccine	NNS
cord-303447-3a7jxl34	270	3	were	be	VBD
cord-303447-3a7jxl34	270	4	placed	place	VBN
cord-303447-3a7jxl34	270	5	into	into	IN
cord-303447-3a7jxl34	270	6	categories	category	NNS
cord-303447-3a7jxl34	270	7	of	of	IN
cord-303447-3a7jxl34	270	8	most	most	RBS
cord-303447-3a7jxl34	270	9	favorable	favorable	JJ
cord-303447-3a7jxl34	270	10	to	to	IN
cord-303447-3a7jxl34	270	11	least	least	JJS
cord-303447-3a7jxl34	270	12	favorable	favorable	JJ
cord-303447-3a7jxl34	270	13	(	(	-LRB-
cord-303447-3a7jxl34	270	14	Box	Box	NNP
cord-303447-3a7jxl34	270	15	2	2	CD
cord-303447-3a7jxl34	270	16	)	)	-RRB-
cord-303447-3a7jxl34	270	17	.	.	.
cord-303447-3a7jxl34	271	1	Since	since	IN
cord-303447-3a7jxl34	271	2	publication	publication	NN
cord-303447-3a7jxl34	271	3	of	of	IN
cord-303447-3a7jxl34	271	4	this	this	DT
cord-303447-3a7jxl34	271	5	report	report	NN
cord-303447-3a7jxl34	271	6	,	,	,
cord-303447-3a7jxl34	271	7	PCV7	PCV7	NNP
cord-303447-3a7jxl34	271	8	has	have	VBZ
cord-303447-3a7jxl34	271	9	been	be	VBN
cord-303447-3a7jxl34	271	10	licensed	license	VBN
cord-303447-3a7jxl34	271	11	for	for	IN
cord-303447-3a7jxl34	271	12	infants	infant	NNS
cord-303447-3a7jxl34	271	13	beginning	begin	VBG
cord-303447-3a7jxl34	271	14	at	at	IN
cord-303447-3a7jxl34	271	15	2	2	CD
cord-303447-3a7jxl34	271	16	months	month	NNS
cord-303447-3a7jxl34	271	17	of	of	IN
cord-303447-3a7jxl34	271	18	age	age	NN
cord-303447-3a7jxl34	271	19	(	(	-LRB-
cord-303447-3a7jxl34	271	20	most	most	RBS
cord-303447-3a7jxl34	271	21	favorable	favorable	JJ
cord-303447-3a7jxl34	271	22	category	category	NN
cord-303447-3a7jxl34	271	23	)	)	-RRB-
cord-303447-3a7jxl34	271	24	,	,	,
cord-303447-3a7jxl34	271	25	and	and	CC
cord-303447-3a7jxl34	271	26	HPV	HPV	NNP
cord-303447-3a7jxl34	271	27	vaccine	vaccine	NN
cord-303447-3a7jxl34	271	28	(	(	-LRB-
cord-303447-3a7jxl34	271	29	more	more	RBR
cord-303447-3a7jxl34	271	30	favorable	favorable	JJ
cord-303447-3a7jxl34	271	31	category	category	NN
cord-303447-3a7jxl34	271	32	)	)	-RRB-
cord-303447-3a7jxl34	271	33	and	and	CC
cord-303447-3a7jxl34	271	34	rotavirus	rotavirus	JJ
cord-303447-3a7jxl34	271	35	vaccine	vaccine	NN
cord-303447-3a7jxl34	271	36	administered	administer	VBN
cord-303447-3a7jxl34	271	37	to	to	IN
cord-303447-3a7jxl34	271	38	infants	infant	NNS
cord-303447-3a7jxl34	271	39	(	(	-LRB-
cord-303447-3a7jxl34	271	40	favorable	favorable	JJ
cord-303447-3a7jxl34	271	41	category	category	NN
cord-303447-3a7jxl34	271	42	)	)	-RRB-
cord-303447-3a7jxl34	271	43	are	be	VBP
cord-303447-3a7jxl34	271	44	on	on	IN
cord-303447-3a7jxl34	271	45	the	the	DT
cord-303447-3a7jxl34	271	46	near	near	JJ
cord-303447-3a7jxl34	271	47	horizon	horizon	NN
cord-303447-3a7jxl34	271	48	as	as	IN
cord-303447-3a7jxl34	271	49	discussed	discuss	VBN
cord-303447-3a7jxl34	271	50	in	in	IN
cord-303447-3a7jxl34	271	51	this	this	DT
cord-303447-3a7jxl34	271	52	article	article	NN
cord-303447-3a7jxl34	271	53	.	.	.
cord-303447-3a7jxl34	272	1	Since	since	IN
cord-303447-3a7jxl34	272	2	release	release	NN
cord-303447-3a7jxl34	272	3	of	of	IN
cord-303447-3a7jxl34	272	4	this	this	DT
cord-303447-3a7jxl34	272	5	report	report	NN
cord-303447-3a7jxl34	272	6	,	,	,
cord-303447-3a7jxl34	272	7	several	several	JJ
cord-303447-3a7jxl34	272	8	organisms	organism	NNS
cord-303447-3a7jxl34	272	9	not	not	RB
cord-303447-3a7jxl34	272	10	included	include	VBN
cord-303447-3a7jxl34	272	11	on	on	IN
cord-303447-3a7jxl34	272	12	the	the	DT
cord-303447-3a7jxl34	272	13	IOM	IOM	NNP
cord-303447-3a7jxl34	272	14	list	list	NN
cord-303447-3a7jxl34	272	15	have	have	VBP
cord-303447-3a7jxl34	272	16	emerged	emerge	VBN
cord-303447-3a7jxl34	272	17	or	or	CC
cord-303447-3a7jxl34	272	18	became	become	VBD
cord-303447-3a7jxl34	272	19	larger	large	JJR
cord-303447-3a7jxl34	272	20	public	public	JJ
cord-303447-3a7jxl34	272	21	health	health	NN
cord-303447-3a7jxl34	272	22	threats	threat	NNS
cord-303447-3a7jxl34	272	23	,	,	,
cord-303447-3a7jxl34	272	24	including	include	VBG
cord-303447-3a7jxl34	272	25	West	West	NNP
cord-303447-3a7jxl34	272	26	Nile	Nile	NNP
cord-303447-3a7jxl34	272	27	virus	virus	NN
cord-303447-3a7jxl34	272	28	,	,	,
cord-303447-3a7jxl34	272	29	metapneumovirus	metapneumovirus	NNP
cord-303447-3a7jxl34	272	30	,	,	,
cord-303447-3a7jxl34	272	31	methicillin	methicillin	NN
cord-303447-3a7jxl34	272	32	-	-	HYPH
cord-303447-3a7jxl34	272	33	resistant	resistant	JJ
cord-303447-3a7jxl34	272	34	Staphylococcus	Staphylococcus	NNP
cord-303447-3a7jxl34	272	35	aureus	aureus	NN
cord-303447-3a7jxl34	272	36	,	,	,
cord-303447-3a7jxl34	272	37	the	the	DT
cord-303447-3a7jxl34	272	38	coronavirus	coronavirus	NN
cord-303447-3a7jxl34	272	39	associated	associate	VBN
cord-303447-3a7jxl34	272	40	with	with	IN
cord-303447-3a7jxl34	272	41	severe	severe	JJ
cord-303447-3a7jxl34	272	42	acute	acute	JJ
cord-303447-3a7jxl34	272	43	respiratory	respiratory	JJ
cord-303447-3a7jxl34	272	44	syndrome	syndrome	NN
cord-303447-3a7jxl34	272	45	Box	Box	NNP
cord-303447-3a7jxl34	272	46	2	2	CD
cord-303447-3a7jxl34	272	47	.	.	.
cord-303447-3a7jxl34	273	1	Institute	Institute	NNP
cord-303447-3a7jxl34	273	2	of	of	IN
cord-303447-3a7jxl34	273	3	Medicine	Medicine	NNP
cord-303447-3a7jxl34	273	4	report	report	VBP
cord-303447-3a7jxl34	273	5	on	on	IN
cord-303447-3a7jxl34	273	6	vaccines	vaccine	NNS
cord-303447-3a7jxl34	273	7	for	for	IN
cord-303447-3a7jxl34	273	8	the	the	DT
cord-303447-3a7jxl34	273	9	twenty	twenty	CD
cord-303447-3a7jxl34	273	10	-	-	HYPH
cord-303447-3a7jxl34	273	11	first	first	JJ
cord-303447-3a7jxl34	273	12	century	century	NN
cord-303447-3a7jxl34	273	13	Most	most	RBS
cord-303447-3a7jxl34	273	14	favorable	favorable	JJ
cord-303447-3a7jxl34	273	15	:	:	:
cord-303447-3a7jxl34	273	16	vaccination	vaccination	NN
cord-303447-3a7jxl34	273	17	strategy	strategy	NN
cord-303447-3a7jxl34	273	18	would	would	MD
cord-303447-3a7jxl34	273	19	save	save	VB
cord-303447-3a7jxl34	273	20	money	money	NN
cord-303447-3a7jxl34	273	21	Cytomegalovirus	Cytomegalovirus	NNP
cord-303447-3a7jxl34	273	22	vaccine	vaccine	NN
cord-303447-3a7jxl34	273	23	administered	administer	VBN
cord-303447-3a7jxl34	273	24	to	to	IN
cord-303447-3a7jxl34	273	25	12-year	12-year	JJ
cord-303447-3a7jxl34	273	26	-	-	HYPH
cord-303447-3a7jxl34	273	27	olds	old	NNS
cord-303447-3a7jxl34	273	28	Influenza	Influenza	NNP
cord-303447-3a7jxl34	273	29	virus	virus	NN
cord-303447-3a7jxl34	273	30	vaccine	vaccine	NN
cord-303447-3a7jxl34	273	31	administered	administer	VBN
cord-303447-3a7jxl34	273	32	to	to	IN
cord-303447-3a7jxl34	273	33	the	the	DT
cord-303447-3a7jxl34	273	34	general	general	JJ
cord-303447-3a7jxl34	273	35	population	population	NN
cord-303447-3a7jxl34	273	36	(	(	-LRB-
cord-303447-3a7jxl34	273	37	once	once	RB
cord-303447-3a7jxl34	273	38	per	per	IN
cord-303447-3a7jxl34	273	39	person	person	NN
cord-303447-3a7jxl34	273	40	every	every	DT
cord-303447-3a7jxl34	273	41	5	5	CD
cord-303447-3a7jxl34	273	42	years	year	NNS
cord-303447-3a7jxl34	273	43	)	)	-RRB-
cord-303447-3a7jxl34	273	44	Insulin	insulin	NN
cord-303447-3a7jxl34	273	45	-	-	HYPH
cord-303447-3a7jxl34	273	46	dependent	dependent	JJ
cord-303447-3a7jxl34	273	47	diabetes	diabetes	NN
cord-303447-3a7jxl34	273	48	mellitus	mellitus	NN
cord-303447-3a7jxl34	273	49	therapeutic	therapeutic	JJ
cord-303447-3a7jxl34	273	50	vaccine	vaccine	NN
cord-303447-3a7jxl34	273	51	Multiple	multiple	JJ
cord-303447-3a7jxl34	273	52	sclerosis	sclerosis	NN
cord-303447-3a7jxl34	273	53	therapeutic	therapeutic	JJ
cord-303447-3a7jxl34	273	54	vaccine	vaccine	NN
cord-303447-3a7jxl34	273	55	Rheumatoid	Rheumatoid	NNP
cord-303447-3a7jxl34	273	56	arthritis	arthritis	NN
cord-303447-3a7jxl34	273	57	therapeutic	therapeutic	JJ
cord-303447-3a7jxl34	273	58	vaccine	vaccine	NN
cord-303447-3a7jxl34	273	59	Group	Group	NNP
cord-303447-3a7jxl34	273	60	B	B	NNP
cord-303447-3a7jxl34	273	61	streptococcus	streptococcus	NN
cord-303447-3a7jxl34	273	62	vaccine	vaccine	NN
cord-303447-3a7jxl34	273	63	given	give	VBN
cord-303447-3a7jxl34	273	64	to	to	IN
cord-303447-3a7jxl34	273	65	women	woman	NNS
cord-303447-3a7jxl34	273	66	during	during	IN
cord-303447-3a7jxl34	273	67	first	first	JJ
cord-303447-3a7jxl34	273	68	pregnancy	pregnancy	NN
cord-303447-3a7jxl34	273	69	and	and	CC
cord-303447-3a7jxl34	273	70	to	to	IN
cord-303447-3a7jxl34	273	71	high	high	JJ
cord-303447-3a7jxl34	273	72	-	-	HYPH
cord-303447-3a7jxl34	273	73	risk	risk	NN
cord-303447-3a7jxl34	273	74	adults	adult	NNS
cord-303447-3a7jxl34	273	75	Streptococcus	Streptococcus	NNP
cord-303447-3a7jxl34	273	76	pneumoniae	pneumoniae	NN
cord-303447-3a7jxl34	273	77	vaccine	vaccine	NN
cord-303447-3a7jxl34	273	78	given	give	VBN
cord-303447-3a7jxl34	273	79	to	to	IN
cord-303447-3a7jxl34	273	80	infants	infant	NNS
cord-303447-3a7jxl34	273	81	and	and	CC
cord-303447-3a7jxl34	273	82	65-year	65-year	JJ
cord-303447-3a7jxl34	273	83	-	-	HYPH
cord-303447-3a7jxl34	273	84	olds	old	NNS
cord-303447-3a7jxl34	273	85	More	more	RBR
cord-303447-3a7jxl34	273	86	favorable	favorable	JJ
cord-303447-3a7jxl34	273	87	:	:	:
cord-303447-3a7jxl34	273	88	vaccination	vaccination	NN
cord-303447-3a7jxl34	273	89	strategy	strategy	NN
cord-303447-3a7jxl34	273	90	would	would	MD
cord-303447-3a7jxl34	273	91	incur	incur	VB
cord-303447-3a7jxl34	273	92	small	small	JJ
cord-303447-3a7jxl34	273	93	costs	cost	NNS
cord-303447-3a7jxl34	273	94	(	(	-LRB-
cord-303447-3a7jxl34	273	95	b$10,000	b$10,000	NNP
cord-303447-3a7jxl34	273	96	)	)	-RRB-
cord-303447-3a7jxl34	273	97	for	for	IN
cord-303447-3a7jxl34	273	98	each	each	DT
cord-303447-3a7jxl34	273	99	QALY	QALY	NNP
cord-303447-3a7jxl34	274	1	*	*	NFP
cord-303447-3a7jxl34	274	2	Chlamydia	Chlamydia	NNP
cord-303447-3a7jxl34	274	3	vaccine	vaccine	NN
cord-303447-3a7jxl34	274	4	administered	administer	VBN
cord-303447-3a7jxl34	274	5	to	to	IN
cord-303447-3a7jxl34	274	6	12-year	12-year	JJ
cord-303447-3a7jxl34	274	7	-	-	HYPH
cord-303447-3a7jxl34	274	8	olds	old	NNS
cord-303447-3a7jxl34	274	9	Helicobacter	Helicobacter	NNP
cord-303447-3a7jxl34	274	10	pylori	pylori	NN
cord-303447-3a7jxl34	274	11	vaccine	vaccine	NN
cord-303447-3a7jxl34	274	12	administered	administer	VBN
cord-303447-3a7jxl34	274	13	to	to	IN
cord-303447-3a7jxl34	274	14	infants	infant	NNS
cord-303447-3a7jxl34	274	15	Hepatitis	Hepatitis	NNP
cord-303447-3a7jxl34	274	16	C	C	NNP
cord-303447-3a7jxl34	274	17	vaccine	vaccine	NN
cord-303447-3a7jxl34	274	18	administered	administer	VBN
cord-303447-3a7jxl34	274	19	to	to	IN
cord-303447-3a7jxl34	274	20	infants	infant	NNS
cord-303447-3a7jxl34	274	21	Herpes	Herpes	NNP
cord-303447-3a7jxl34	274	22	simplex	simplex	NN
cord-303447-3a7jxl34	274	23	virus	virus	NN
cord-303447-3a7jxl34	274	24	vaccine	vaccine	NN
cord-303447-3a7jxl34	274	25	administered	administer	VBN
cord-303447-3a7jxl34	274	26	to	to	IN
cord-303447-3a7jxl34	274	27	12-year	12-year	JJ
cord-303447-3a7jxl34	274	28	-	-	HYPH
cord-303447-3a7jxl34	274	29	olds	old	NNS
cord-303447-3a7jxl34	274	30	HPV	HPV	NNP
cord-303447-3a7jxl34	274	31	vaccine	vaccine	NN
cord-303447-3a7jxl34	274	32	administered	administer	VBD
cord-303447-3a7jxl34	274	33	to	to	IN
cord-303447-3a7jxl34	274	34	12-year	12-year	JJ
cord-303447-3a7jxl34	274	35	-	-	HYPH
cord-303447-3a7jxl34	274	36	olds	old	NNS
cord-303447-3a7jxl34	274	37	Melanoma	Melanoma	NNP
cord-303447-3a7jxl34	274	38	therapeutic	therapeutic	JJ
cord-303447-3a7jxl34	274	39	vaccine	vaccine	NN
cord-303447-3a7jxl34	274	40	Mycobacterium	Mycobacterium	NNP
cord-303447-3a7jxl34	274	41	tuberculosis	tuberculosis	NN
cord-303447-3a7jxl34	274	42	vaccine	vaccine	NN
cord-303447-3a7jxl34	274	43	administered	administer	VBN
cord-303447-3a7jxl34	274	44	to	to	IN
cord-303447-3a7jxl34	274	45	highrisk	highrisk	JJ
cord-303447-3a7jxl34	274	46	populations	population	NNS
cord-303447-3a7jxl34	274	47	Neisseria	Neisseria	NNP
cord-303447-3a7jxl34	274	48	gonorrhoeae	gonorrhoeae	NNP
cord-303447-3a7jxl34	274	49	vaccine	vaccine	NN
cord-303447-3a7jxl34	274	50	administered	administer	VBN
cord-303447-3a7jxl34	274	51	to	to	IN
cord-303447-3a7jxl34	274	52	12-year	12-year	JJ
cord-303447-3a7jxl34	274	53	-	-	HYPH
cord-303447-3a7jxl34	274	54	olds	old	NNS
cord-303447-3a7jxl34	274	55	Respiratory	respiratory	JJ
cord-303447-3a7jxl34	274	56	syncytial	syncytial	JJ
cord-303447-3a7jxl34	274	57	virus	virus	NN
cord-303447-3a7jxl34	274	58	vaccine	vaccine	NN
cord-303447-3a7jxl34	274	59	administered	administer	VBN
cord-303447-3a7jxl34	274	60	to	to	IN
cord-303447-3a7jxl34	274	61	infants	infant	NNS
cord-303447-3a7jxl34	274	62	and	and	CC
cord-303447-3a7jxl34	274	63	12-year	12-year	JJ
cord-303447-3a7jxl34	274	64	-	-	HYPH
cord-303447-3a7jxl34	274	65	olds	old	NNS
cord-303447-3a7jxl34	275	1	Favorable	favorable	JJ
cord-303447-3a7jxl34	275	2	:	:	:
cord-303447-3a7jxl34	275	3	vaccination	vaccination	NN
cord-303447-3a7jxl34	275	4	strategy	strategy	NN
cord-303447-3a7jxl34	275	5	would	would	MD
cord-303447-3a7jxl34	275	6	incur	incur	VB
cord-303447-3a7jxl34	275	7	moderate	moderate	JJ
cord-303447-3a7jxl34	275	8	costs	cost	NNS
cord-303447-3a7jxl34	275	9	(	(	-LRB-
cord-303447-3a7jxl34	275	10	N$10,000	n$10,000	NN
cord-303447-3a7jxl34	275	11	but	but	CC
cord-303447-3a7jxl34	275	12	b$100,000	b$100,000	CD
cord-303447-3a7jxl34	275	13	)	)	-RRB-
cord-303447-3a7jxl34	275	14	per	per	IN
cord-303447-3a7jxl34	275	15	QALY	QALY	NNP
cord-303447-3a7jxl34	275	16	gained	gain	VBD
cord-303447-3a7jxl34	275	17	Parainfluenza	Parainfluenza	NNP
cord-303447-3a7jxl34	275	18	virus	virus	NN
cord-303447-3a7jxl34	275	19	vaccine	vaccine	NN
cord-303447-3a7jxl34	275	20	administered	administer	VBN
cord-303447-3a7jxl34	275	21	to	to	IN
cord-303447-3a7jxl34	275	22	infants	infant	NNS
cord-303447-3a7jxl34	275	23	and	and	CC
cord-303447-3a7jxl34	275	24	women	woman	NNS
cord-303447-3a7jxl34	275	25	during	during	IN
cord-303447-3a7jxl34	275	26	their	-PRON-	PRP$
cord-303447-3a7jxl34	275	27	first	first	JJ
cord-303447-3a7jxl34	275	28	pregnancy	pregnancy	NN
cord-303447-3a7jxl34	275	29	Rotavirus	Rotavirus	NNP
cord-303447-3a7jxl34	275	30	vaccine	vaccine	NN
cord-303447-3a7jxl34	275	31	administered	administer	VBN
cord-303447-3a7jxl34	275	32	to	to	IN
cord-303447-3a7jxl34	275	33	infants	infant	NNS
cord-303447-3a7jxl34	275	34	Group	Group	NNP
cord-303447-3a7jxl34	275	35	A	a	DT
cord-303447-3a7jxl34	275	36	streptococcus	streptococcus	NN
cord-303447-3a7jxl34	275	37	vaccine	vaccine	NN
cord-303447-3a7jxl34	275	38	administered	administer	VBN
cord-303447-3a7jxl34	275	39	to	to	IN
cord-303447-3a7jxl34	275	40	infants	infant	NNS
cord-303447-3a7jxl34	275	41	Group	Group	NNP
cord-303447-3a7jxl34	275	42	B	B	NNP
cord-303447-3a7jxl34	275	43	streptococcus	streptococcus	NN
cord-303447-3a7jxl34	275	44	vaccine	vaccine	NN
cord-303447-3a7jxl34	275	45	given	give	VBN
cord-303447-3a7jxl34	275	46	to	to	IN
cord-303447-3a7jxl34	275	47	high	high	JJ
cord-303447-3a7jxl34	275	48	-	-	HYPH
cord-303447-3a7jxl34	275	49	risk	risk	NN
cord-303447-3a7jxl34	275	50	adults	adult	NNS
cord-303447-3a7jxl34	275	51	and	and	CC
cord-303447-3a7jxl34	275	52	low	low	JJ
cord-303447-3a7jxl34	275	53	utilization	utilization	NN
cord-303447-3a7jxl34	275	54	in	in	IN
cord-303447-3a7jxl34	275	55	12-year	12-year	JJ
cord-303447-3a7jxl34	275	56	-	-	HYPH
cord-303447-3a7jxl34	275	57	olds	old	NNS
cord-303447-3a7jxl34	275	58	or	or	CC
cord-303447-3a7jxl34	275	59	women	woman	NNS
cord-303447-3a7jxl34	275	60	during	during	IN
cord-303447-3a7jxl34	275	61	their	-PRON-	PRP$
cord-303447-3a7jxl34	275	62	first	first	JJ
cord-303447-3a7jxl34	275	63	pregnancy	pregnancy	NN
cord-303447-3a7jxl34	275	64	(	(	-LRB-
cord-303447-3a7jxl34	275	65	SARS	SARS	NNP
cord-303447-3a7jxl34	275	66	)	)	-RRB-
cord-303447-3a7jxl34	275	67	,	,	,
cord-303447-3a7jxl34	275	68	and	and	CC
cord-303447-3a7jxl34	275	69	avian	avian	JJ
cord-303447-3a7jxl34	275	70	influenza	influenza	NN
cord-303447-3a7jxl34	275	71	virus	virus	NN
cord-303447-3a7jxl34	275	72	(	(	-LRB-
cord-303447-3a7jxl34	275	73	H5N1	H5N1	NNP
cord-303447-3a7jxl34	275	74	)	)	-RRB-
cord-303447-3a7jxl34	275	75	.	.	.
cord-303447-3a7jxl34	276	1	The	the	DT
cord-303447-3a7jxl34	276	2	ongoing	ongoing	JJ
cord-303447-3a7jxl34	276	3	outbreak	outbreak	NN
cord-303447-3a7jxl34	276	4	of	of	IN
cord-303447-3a7jxl34	276	5	H5N1	H5N1	NNP
cord-303447-3a7jxl34	276	6	influenza	influenza	NN
cord-303447-3a7jxl34	276	7	in	in	IN
cord-303447-3a7jxl34	276	8	Asia	Asia	NNP
cord-303447-3a7jxl34	276	9	,	,	,
cord-303447-3a7jxl34	276	10	associated	associate	VBN
cord-303447-3a7jxl34	276	11	with	with	IN
cord-303447-3a7jxl34	276	12	high	high	JJ
cord-303447-3a7jxl34	276	13	mortality	mortality	NN
cord-303447-3a7jxl34	276	14	rates	rate	NNS
cord-303447-3a7jxl34	276	15	,	,	,
cord-303447-3a7jxl34	276	16	has	have	VBZ
cord-303447-3a7jxl34	276	17	stimulated	stimulate	VBN
cord-303447-3a7jxl34	276	18	research	research	NN
cord-303447-3a7jxl34	276	19	of	of	IN
cord-303447-3a7jxl34	276	20	a	a	DT
cord-303447-3a7jxl34	276	21	vaccine	vaccine	NN
cord-303447-3a7jxl34	276	22	that	that	WDT
cord-303447-3a7jxl34	276	23	has	have	VBZ
cord-303447-3a7jxl34	276	24	the	the	DT
cord-303447-3a7jxl34	276	25	potential	potential	NN
cord-303447-3a7jxl34	276	26	to	to	TO
cord-303447-3a7jxl34	276	27	thwart	thwart	VB
cord-303447-3a7jxl34	276	28	a	a	DT
cord-303447-3a7jxl34	276	29	possible	possible	JJ
cord-303447-3a7jxl34	276	30	major	major	JJ
cord-303447-3a7jxl34	276	31	influenza	influenza	NN
cord-303447-3a7jxl34	276	32	pandemic	pandemic	NN
cord-303447-3a7jxl34	276	33	.	.	.
cord-303447-3a7jxl34	277	1	Circulating	circulate	VBG
cord-303447-3a7jxl34	277	2	H5N1	H5N1	NNP
cord-303447-3a7jxl34	277	3	viruses	virus	NNS
cord-303447-3a7jxl34	277	4	may	may	MD
cord-303447-3a7jxl34	277	5	adapt	adapt	VB
cord-303447-3a7jxl34	277	6	to	to	IN
cord-303447-3a7jxl34	277	7	humans	human	NNS
cord-303447-3a7jxl34	277	8	through	through	IN
cord-303447-3a7jxl34	277	9	genetic	genetic	JJ
cord-303447-3a7jxl34	277	10	mutation	mutation	NN
cord-303447-3a7jxl34	277	11	or	or	CC
cord-303447-3a7jxl34	277	12	reassortant	reassortant	JJ
cord-303447-3a7jxl34	277	13	with	with	IN
cord-303447-3a7jxl34	277	14	human	human	JJ
cord-303447-3a7jxl34	277	15	influenza	influenza	NN
cord-303447-3a7jxl34	277	16	strains	strain	NNS
cord-303447-3a7jxl34	277	17	,	,	,
cord-303447-3a7jxl34	277	18	allowing	allow	VBG
cord-303447-3a7jxl34	277	19	for	for	IN
cord-303447-3a7jxl34	277	20	human	human	NN
cord-303447-3a7jxl34	277	21	-	-	HYPH
cord-303447-3a7jxl34	277	22	to	to	IN
cord-303447-3a7jxl34	277	23	-	-	HYPH
cord-303447-3a7jxl34	277	24	human	human	JJ
cord-303447-3a7jxl34	277	25	transmission	transmission	NN
cord-303447-3a7jxl34	277	26	,	,	,
cord-303447-3a7jxl34	277	27	facilitated	facilitate	VBN
cord-303447-3a7jxl34	277	28	by	by	IN
cord-303447-3a7jxl34	277	29	the	the	DT
cord-303447-3a7jxl34	277	30	fact	fact	NN
cord-303447-3a7jxl34	277	31	that	that	IN
cord-303447-3a7jxl34	277	32	most	most	JJS
cord-303447-3a7jxl34	277	33	humans	human	NNS
cord-303447-3a7jxl34	277	34	lack	lack	VBP
cord-303447-3a7jxl34	277	35	preexisting	preexist	VBG
cord-303447-3a7jxl34	277	36	immunity	immunity	NN
cord-303447-3a7jxl34	277	37	owing	owe	VBG
cord-303447-3a7jxl34	277	38	to	to	IN
cord-303447-3a7jxl34	277	39	lack	lack	NN
cord-303447-3a7jxl34	277	40	of	of	IN
cord-303447-3a7jxl34	277	41	previous	previous	JJ
cord-303447-3a7jxl34	277	42	exposure	exposure	NN
cord-303447-3a7jxl34	277	43	[	[	-LRB-
cord-303447-3a7jxl34	277	44	81	81	CD
cord-303447-3a7jxl34	277	45	]	]	-RRB-
cord-303447-3a7jxl34	277	46	.	.	.
cord-303447-3a7jxl34	278	1	These	these	DT
cord-303447-3a7jxl34	278	2	emerging	emerge	VBG
cord-303447-3a7jxl34	278	3	infectious	infectious	JJ
cord-303447-3a7jxl34	278	4	diseases	disease	NNS
cord-303447-3a7jxl34	278	5	and	and	CC
cord-303447-3a7jxl34	278	6	the	the	DT
cord-303447-3a7jxl34	278	7	need	need	NN
cord-303447-3a7jxl34	278	8	to	to	TO
cord-303447-3a7jxl34	278	9	prevent	prevent	VB
cord-303447-3a7jxl34	278	10	them	-PRON-	PRP
cord-303447-3a7jxl34	278	11	add	add	VB
cord-303447-3a7jxl34	278	12	further	further	JJ
cord-303447-3a7jxl34	278	13	complexity	complexity	NN
cord-303447-3a7jxl34	278	14	to	to	IN
cord-303447-3a7jxl34	278	15	immunization	immunization	NN
cord-303447-3a7jxl34	278	16	schedules	schedule	NNS
cord-303447-3a7jxl34	278	17	of	of	IN
cord-303447-3a7jxl34	278	18	the	the	DT
cord-303447-3a7jxl34	278	19	future	future	NN
cord-303447-3a7jxl34	278	20	.	.	.
cord-303447-3a7jxl34	279	1	Until	until	IN
cord-303447-3a7jxl34	279	2	the	the	DT
cord-303447-3a7jxl34	279	3	twentieth	twentieth	JJ
cord-303447-3a7jxl34	279	4	century	century	NN
cord-303447-3a7jxl34	279	5	,	,	,
cord-303447-3a7jxl34	279	6	approximately	approximately	RB
cord-303447-3a7jxl34	279	7	half	half	NN
cord-303447-3a7jxl34	279	8	of	of	IN
cord-303447-3a7jxl34	279	9	children	child	NNS
cord-303447-3a7jxl34	279	10	in	in	IN
cord-303447-3a7jxl34	279	11	the	the	DT
cord-303447-3a7jxl34	279	12	United	United	NNP
cord-303447-3a7jxl34	279	13	States	States	NNP
cord-303447-3a7jxl34	279	14	died	die	VBD
cord-303447-3a7jxl34	279	15	as	as	IN
cord-303447-3a7jxl34	279	16	a	a	DT
cord-303447-3a7jxl34	279	17	result	result	NN
cord-303447-3a7jxl34	279	18	of	of	IN
cord-303447-3a7jxl34	279	19	childhood	childhood	NN
cord-303447-3a7jxl34	279	20	illness	illness	NN
cord-303447-3a7jxl34	279	21	.	.	.
cord-303447-3a7jxl34	280	1	Until	until	IN
cord-303447-3a7jxl34	280	2	the	the	DT
cord-303447-3a7jxl34	280	3	1920s	1920s	CD
cord-303447-3a7jxl34	280	4	,	,	,
cord-303447-3a7jxl34	280	5	infectious	infectious	JJ
cord-303447-3a7jxl34	280	6	diseases	disease	NNS
cord-303447-3a7jxl34	280	7	were	be	VBD
cord-303447-3a7jxl34	280	8	the	the	DT
cord-303447-3a7jxl34	280	9	leading	leading	JJ
cord-303447-3a7jxl34	280	10	cause	cause	NN
cord-303447-3a7jxl34	280	11	of	of	IN
cord-303447-3a7jxl34	280	12	death	death	NN
cord-303447-3a7jxl34	280	13	in	in	IN
cord-303447-3a7jxl34	280	14	the	the	DT
cord-303447-3a7jxl34	280	15	United	United	NNP
cord-303447-3a7jxl34	280	16	States	States	NNP
cord-303447-3a7jxl34	280	17	.	.	.
cord-303447-3a7jxl34	281	1	In	in	IN
cord-303447-3a7jxl34	281	2	the	the	DT
cord-303447-3a7jxl34	281	3	first	first	JJ
cord-303447-3a7jxl34	281	4	edition	edition	NN
cord-303447-3a7jxl34	281	5	of	of	IN
cord-303447-3a7jxl34	281	6	the	the	DT
cord-303447-3a7jxl34	281	7	Red	Red	NNP
cord-303447-3a7jxl34	281	8	Book	Book	NNP
cord-303447-3a7jxl34	281	9	published	publish	VBN
cord-303447-3a7jxl34	281	10	by	by	IN
cord-303447-3a7jxl34	281	11	the	the	DT
cord-303447-3a7jxl34	281	12	AAP	AAP	NNP
cord-303447-3a7jxl34	281	13	in	in	IN
cord-303447-3a7jxl34	281	14	January	January	NNP
cord-303447-3a7jxl34	281	15	1938	1938	CD
cord-303447-3a7jxl34	281	16	,	,	,
cord-303447-3a7jxl34	281	17	18	18	CD
cord-303447-3a7jxl34	281	18	chapters	chapter	NNS
cord-303447-3a7jxl34	281	19	dealt	deal	VBD
cord-303447-3a7jxl34	281	20	with	with	IN
cord-303447-3a7jxl34	281	21	infectious	infectious	JJ
cord-303447-3a7jxl34	281	22	diseases	disease	NNS
cord-303447-3a7jxl34	281	23	,	,	,
cord-303447-3a7jxl34	281	24	ranging	range	VBG
cord-303447-3a7jxl34	281	25	from	from	IN
cord-303447-3a7jxl34	281	26	the	the	DT
cord-303447-3a7jxl34	281	27	common	common	JJ
cord-303447-3a7jxl34	281	28	cold	cold	NN
cord-303447-3a7jxl34	281	29	to	to	IN
cord-303447-3a7jxl34	281	30	smallpox	smallpox	NN
cord-303447-3a7jxl34	281	31	.	.	.
cord-303447-3a7jxl34	282	1	Except	except	IN
cord-303447-3a7jxl34	282	2	for	for	IN
cord-303447-3a7jxl34	282	3	pertussis	pertussis	NN
cord-303447-3a7jxl34	282	4	,	,	,
cord-303447-3a7jxl34	282	5	diphtheria	diphtheria	NN
cord-303447-3a7jxl34	282	6	,	,	,
cord-303447-3a7jxl34	282	7	and	and	CC
cord-303447-3a7jxl34	282	8	Less	less	RBR
cord-303447-3a7jxl34	282	9	favorable	favorable	JJ
cord-303447-3a7jxl34	282	10	:	:	:
cord-303447-3a7jxl34	282	11	vaccination	vaccination	NN
cord-303447-3a7jxl34	282	12	strategy	strategy	NN
cord-303447-3a7jxl34	282	13	would	would	MD
cord-303447-3a7jxl34	282	14	incur	incur	VB
cord-303447-3a7jxl34	282	15	significant	significant	JJ
cord-303447-3a7jxl34	282	16	costs	cost	NNS
cord-303447-3a7jxl34	282	17	(	(	-LRB-
cord-303447-3a7jxl34	282	18	N$100,000-N$1	n$100,000-n$1	JJ
cord-303447-3a7jxl34	282	19	million	million	CD
cord-303447-3a7jxl34	282	20	per	per	IN
cord-303447-3a7jxl34	282	21	QALY	QALY	NNP
cord-303447-3a7jxl34	282	22	gained	gain	VBD
cord-303447-3a7jxl34	282	23	)	)	-RRB-
cord-303447-3a7jxl34	283	1	Borrelia	Borrelia	NNP
cord-303447-3a7jxl34	283	2	burgdorferi	burgdorferi	NN
cord-303447-3a7jxl34	283	3	vaccine	vaccine	NN
cord-303447-3a7jxl34	283	4	given	give	VBN
cord-303447-3a7jxl34	283	5	to	to	IN
cord-303447-3a7jxl34	283	6	resident	resident	JJ
cord-303447-3a7jxl34	283	7	infants	infant	NNS
cord-303447-3a7jxl34	283	8	born	bear	VBN
cord-303447-3a7jxl34	283	9	in	in	IN
cord-303447-3a7jxl34	283	10	and	and	CC
cord-303447-3a7jxl34	283	11	immigrants	immigrant	NNS
cord-303447-3a7jxl34	283	12	of	of	IN
cord-303447-3a7jxl34	283	13	any	any	DT
cord-303447-3a7jxl34	283	14	age	age	NN
cord-303447-3a7jxl34	283	15	to	to	TO
cord-303447-3a7jxl34	283	16	geographically	geographically	RB
cord-303447-3a7jxl34	283	17	defined	define	VBN
cord-303447-3a7jxl34	283	18	highrisk	highrisk	NN
cord-303447-3a7jxl34	283	19	areas	area	NNS
cord-303447-3a7jxl34	284	1	Coccidioides	Coccidioides	NNP
cord-303447-3a7jxl34	284	2	immitis	immitis	JJ
cord-303447-3a7jxl34	284	3	vaccine	vaccine	NN
cord-303447-3a7jxl34	284	4	given	give	VBN
cord-303447-3a7jxl34	284	5	to	to	IN
cord-303447-3a7jxl34	284	6	resident	resident	JJ
cord-303447-3a7jxl34	284	7	infants	infant	NNS
cord-303447-3a7jxl34	284	8	born	bear	VBN
cord-303447-3a7jxl34	284	9	in	in	IN
cord-303447-3a7jxl34	284	10	and	and	CC
cord-303447-3a7jxl34	284	11	immigrants	immigrant	NNS
cord-303447-3a7jxl34	284	12	of	of	IN
cord-303447-3a7jxl34	284	13	any	any	DT
cord-303447-3a7jxl34	284	14	age	age	NN
cord-303447-3a7jxl34	284	15	to	to	TO
cord-303447-3a7jxl34	284	16	geographically	geographically	RB
cord-303447-3a7jxl34	284	17	defined	define	VBN
cord-303447-3a7jxl34	284	18	highrisk	highrisk	NN
cord-303447-3a7jxl34	284	19	areas	area	NNS
cord-303447-3a7jxl34	284	20	Enterotoxigenic	Enterotoxigenic	NNP
cord-303447-3a7jxl34	284	21	Escherichia	Escherichia	NNP
cord-303447-3a7jxl34	284	22	coli	coli	VBZ
cord-303447-3a7jxl34	284	23	vaccine	vaccine	NN
cord-303447-3a7jxl34	284	24	administered	administer	VBN
cord-303447-3a7jxl34	284	25	to	to	IN
cord-303447-3a7jxl34	284	26	infants	infant	NNS
cord-303447-3a7jxl34	284	27	and	and	CC
cord-303447-3a7jxl34	284	28	travelers	traveler	NNS
cord-303447-3a7jxl34	284	29	Epstein	Epstein	NNP
cord-303447-3a7jxl34	284	30	-	-	HYPH
cord-303447-3a7jxl34	284	31	Barr	Barr	NNP
cord-303447-3a7jxl34	284	32	virus	virus	NN
cord-303447-3a7jxl34	284	33	vaccine	vaccine	NN
cord-303447-3a7jxl34	284	34	administered	administer	VBN
cord-303447-3a7jxl34	284	35	to	to	IN
cord-303447-3a7jxl34	284	36	12-year	12-year	JJ
cord-303447-3a7jxl34	284	37	-	-	HYPH
cord-303447-3a7jxl34	284	38	olds	old	NNS
cord-303447-3a7jxl34	284	39	Histoplasma	Histoplasma	NNP
cord-303447-3a7jxl34	284	40	capsulatum	capsulatum	NN
cord-303447-3a7jxl34	284	41	vaccine	vaccine	NN
cord-303447-3a7jxl34	284	42	given	give	VBN
cord-303447-3a7jxl34	284	43	to	to	IN
cord-303447-3a7jxl34	284	44	resident	resident	JJ
cord-303447-3a7jxl34	284	45	infants	infant	NNS
cord-303447-3a7jxl34	284	46	born	bear	VBN
cord-303447-3a7jxl34	284	47	in	in	IN
cord-303447-3a7jxl34	284	48	and	and	CC
cord-303447-3a7jxl34	284	49	immigrants	immigrant	NNS
cord-303447-3a7jxl34	284	50	of	of	IN
cord-303447-3a7jxl34	284	51	any	any	DT
cord-303447-3a7jxl34	284	52	age	age	NN
cord-303447-3a7jxl34	284	53	to	to	TO
cord-303447-3a7jxl34	284	54	geographically	geographically	RB
cord-303447-3a7jxl34	284	55	defined	define	VBN
cord-303447-3a7jxl34	284	56	highrisk	highrisk	NN
cord-303447-3a7jxl34	284	57	areas	area	NNS
cord-303447-3a7jxl34	285	1	Neisseria	Neisseria	NNP
cord-303447-3a7jxl34	285	2	meningitidis	meningitidis	NNP
cord-303447-3a7jxl34	285	3	type	type	NN
cord-303447-3a7jxl34	285	4	b	b	NNP
cord-303447-3a7jxl34	285	5	vaccine	vaccine	NN
cord-303447-3a7jxl34	285	6	given	give	VBN
cord-303447-3a7jxl34	285	7	to	to	IN
cord-303447-3a7jxl34	285	8	infants	infant	NNS
cord-303447-3a7jxl34	285	9	Shigella	Shigella	NNP
cord-303447-3a7jxl34	285	10	vaccine	vaccine	NN
cord-303447-3a7jxl34	285	11	given	give	VBN
cord-303447-3a7jxl34	285	12	to	to	IN
cord-303447-3a7jxl34	285	13	infants	infant	NNS
cord-303447-3a7jxl34	285	14	and	and	CC
cord-303447-3a7jxl34	285	15	travelers	traveler	NNS
cord-303447-3a7jxl34	285	16	or	or	CC
cord-303447-3a7jxl34	285	17	travelers	traveler	NNS
cord-303447-3a7jxl34	285	18	only	only	RB
cord-303447-3a7jxl34	285	19	*	*	NFP
cord-303447-3a7jxl34	285	20	Quality	quality	NN
cord-303447-3a7jxl34	285	21	-	-	HYPH
cord-303447-3a7jxl34	285	22	adjusted	adjust	VBN
cord-303447-3a7jxl34	285	23	life	life	NN
cord-303447-3a7jxl34	285	24	year	year	NN
cord-303447-3a7jxl34	286	1	(	(	-LRB-
cord-303447-3a7jxl34	286	2	QALY	QALY	NNP
cord-303447-3a7jxl34	286	3	)	)	-RRB-
cord-303447-3a7jxl34	286	4	takes	take	VBZ
cord-303447-3a7jxl34	286	5	into	into	IN
cord-303447-3a7jxl34	286	6	account	account	NN
cord-303447-3a7jxl34	286	7	quantity	quantity	NN
cord-303447-3a7jxl34	286	8	and	and	CC
cord-303447-3a7jxl34	286	9	quality	quality	NN
cord-303447-3a7jxl34	286	10	of	of	IN
cord-303447-3a7jxl34	286	11	life	life	NN
cord-303447-3a7jxl34	286	12	generated	generate	VBN
cord-303447-3a7jxl34	286	13	by	by	IN
cord-303447-3a7jxl34	286	14	health	health	NN
cord-303447-3a7jxl34	286	15	care	care	NN
cord-303447-3a7jxl34	286	16	interventions	intervention	NNS
cord-303447-3a7jxl34	286	17	.	.	.
cord-303447-3a7jxl34	287	1	QALY	QALY	NNP
cord-303447-3a7jxl34	287	2	is	be	VBZ
cord-303447-3a7jxl34	287	3	calculated	calculate	VBN
cord-303447-3a7jxl34	287	4	by	by	IN
cord-303447-3a7jxl34	287	5	placing	place	VBG
cord-303447-3a7jxl34	287	6	a	a	DT
cord-303447-3a7jxl34	287	7	weight	weight	NN
cord-303447-3a7jxl34	287	8	on	on	IN
cord-303447-3a7jxl34	287	9	time	time	NN
cord-303447-3a7jxl34	287	10	in	in	IN
cord-303447-3a7jxl34	287	11	different	different	JJ
cord-303447-3a7jxl34	287	12	health	health	NN
cord-303447-3a7jxl34	287	13	states	state	NNS
cord-303447-3a7jxl34	287	14	.	.	.
cord-303447-3a7jxl34	288	1	The	the	DT
cord-303447-3a7jxl34	288	2	cost	cost	NN
cord-303447-3a7jxl34	288	3	per	per	IN
cord-303447-3a7jxl34	288	4	QALY	QALY	NNP
cord-303447-3a7jxl34	288	5	is	be	VBZ
cord-303447-3a7jxl34	288	6	the	the	DT
cord-303447-3a7jxl34	288	7	cost	cost	NN
cord-303447-3a7jxl34	288	8	required	require	VBN
cord-303447-3a7jxl34	288	9	to	to	TO
cord-303447-3a7jxl34	288	10	generate	generate	VB
cord-303447-3a7jxl34	288	11	1	1	CD
cord-303447-3a7jxl34	288	12	year	year	NN
cord-303447-3a7jxl34	288	13	of	of	IN
cord-303447-3a7jxl34	288	14	perfect	perfect	JJ
cord-303447-3a7jxl34	288	15	health	health	NN
cord-303447-3a7jxl34	288	16	.	.	.
cord-303447-3a7jxl34	289	1	Data	datum	NNS
cord-303447-3a7jxl34	289	2	from	from	IN
cord-303447-3a7jxl34	289	3	www.iom.edu/vaccinepriorities	www.iom.edu/vaccineprioritie	NNS
cord-303447-3a7jxl34	289	4	.	.	.
cord-303447-3a7jxl34	289	5	tetanus	tetanus	NN
cord-303447-3a7jxl34	289	6	,	,	,
cord-303447-3a7jxl34	289	7	and	and	CC
cord-303447-3a7jxl34	289	8	smallpox	smallpox	NN
cord-303447-3a7jxl34	289	9	,	,	,
cord-303447-3a7jxl34	289	10	active	active	JJ
cord-303447-3a7jxl34	289	11	immunization	immunization	NN
cord-303447-3a7jxl34	289	12	was	be	VBD
cord-303447-3a7jxl34	289	13	not	not	RB
cord-303447-3a7jxl34	289	14	available	available	JJ
cord-303447-3a7jxl34	289	15	for	for	IN
cord-303447-3a7jxl34	289	16	the	the	DT
cord-303447-3a7jxl34	289	17	other	other	JJ
cord-303447-3a7jxl34	289	18	14	14	CD
cord-303447-3a7jxl34	289	19	conditions	condition	NNS
cord-303447-3a7jxl34	289	20	in	in	IN
cord-303447-3a7jxl34	289	21	this	this	DT
cord-303447-3a7jxl34	289	22	edition	edition	NN
cord-303447-3a7jxl34	289	23	.	.	.
cord-303447-3a7jxl34	290	1	Currently	currently	RB
cord-303447-3a7jxl34	290	2	,	,	,
cord-303447-3a7jxl34	290	3	active	active	JJ
cord-303447-3a7jxl34	290	4	immunization	immunization	NN
cord-303447-3a7jxl34	290	5	exists	exist	VBZ
cord-303447-3a7jxl34	290	6	for	for	IN
cord-303447-3a7jxl34	290	7	12	12	CD
cord-303447-3a7jxl34	290	8	of	of	IN
cord-303447-3a7jxl34	290	9	the	the	DT
cord-303447-3a7jxl34	290	10	18	18	CD
cord-303447-3a7jxl34	290	11	diseases	disease	NNS
cord-303447-3a7jxl34	290	12	contained	contain	VBN
cord-303447-3a7jxl34	290	13	in	in	IN
cord-303447-3a7jxl34	290	14	the	the	DT
cord-303447-3a7jxl34	290	15	eight	eight	CD
cord-303447-3a7jxl34	290	16	pages	page	NNS
cord-303447-3a7jxl34	290	17	of	of	IN
cord-303447-3a7jxl34	290	18	the	the	DT
cord-303447-3a7jxl34	290	19	1938	1938	CD
cord-303447-3a7jxl34	290	20	Red	Red	NNP
cord-303447-3a7jxl34	290	21	Book	Book	NNP
cord-303447-3a7jxl34	290	22	,	,	,
cord-303447-3a7jxl34	290	23	and	and	CC
cord-303447-3a7jxl34	290	24	one	one	CD
cord-303447-3a7jxl34	290	25	disease	disease	NN
cord-303447-3a7jxl34	290	26	,	,	,
cord-303447-3a7jxl34	290	27	smallpox	smallpox	NN
cord-303447-3a7jxl34	290	28	,	,	,
cord-303447-3a7jxl34	290	29	has	have	VBZ
cord-303447-3a7jxl34	290	30	been	be	VBN
cord-303447-3a7jxl34	290	31	eradicated	eradicate	VBN
cord-303447-3a7jxl34	290	32	.	.	.
cord-303447-3a7jxl34	291	1	Since	since	IN
cord-303447-3a7jxl34	291	2	then	then	RB
cord-303447-3a7jxl34	291	3	,	,	,
cord-303447-3a7jxl34	291	4	many	many	JJ
cord-303447-3a7jxl34	291	5	other	other	JJ
cord-303447-3a7jxl34	291	6	infectious	infectious	JJ
cord-303447-3a7jxl34	291	7	disease	disease	NN
cord-303447-3a7jxl34	291	8	have	have	VBP
cord-303447-3a7jxl34	291	9	emerged	emerge	VBN
cord-303447-3a7jxl34	291	10	or	or	CC
cord-303447-3a7jxl34	291	11	reemerged	reemerge	VBN
cord-303447-3a7jxl34	291	12	,	,	,
cord-303447-3a7jxl34	291	13	including	include	VBG
cord-303447-3a7jxl34	291	14	SARS	SARS	NNP
cord-303447-3a7jxl34	291	15	,	,	,
cord-303447-3a7jxl34	291	16	HIV	HIV	NNP
cord-303447-3a7jxl34	291	17	,	,	,
cord-303447-3a7jxl34	291	18	West	West	NNP
cord-303447-3a7jxl34	291	19	Nile	Nile	NNP
cord-303447-3a7jxl34	291	20	virus	virus	NN
cord-303447-3a7jxl34	291	21	,	,	,
cord-303447-3a7jxl34	291	22	metapneumovirus	metapneumovirus	NNP
cord-303447-3a7jxl34	291	23	,	,	,
cord-303447-3a7jxl34	291	24	avian	avian	JJ
cord-303447-3a7jxl34	291	25	influenza	influenza	NN
cord-303447-3a7jxl34	291	26	,	,	,
cord-303447-3a7jxl34	291	27	and	and	CC
cord-303447-3a7jxl34	291	28	methicillin	methicillin	NN
cord-303447-3a7jxl34	291	29	-	-	HYPH
cord-303447-3a7jxl34	291	30	resistant	resistant	JJ
cord-303447-3a7jxl34	291	31	S.	S.	NNP
cord-303447-3a7jxl34	291	32	aureus	aureus	NN
cord-303447-3a7jxl34	291	33	.	.	.
cord-303447-3a7jxl34	292	1	Many	many	JJ
cord-303447-3a7jxl34	292	2	of	of	IN
cord-303447-3a7jxl34	292	3	these	these	DT
cord-303447-3a7jxl34	292	4	conditions	condition	NNS
cord-303447-3a7jxl34	292	5	are	be	VBP
cord-303447-3a7jxl34	292	6	expected	expect	VBN
cord-303447-3a7jxl34	292	7	to	to	TO
cord-303447-3a7jxl34	292	8	be	be	VB
cord-303447-3a7jxl34	292	9	controlled	control	VBN
cord-303447-3a7jxl34	292	10	in	in	IN
cord-303447-3a7jxl34	292	11	the	the	DT
cord-303447-3a7jxl34	292	12	future	future	NN
cord-303447-3a7jxl34	292	13	by	by	IN
cord-303447-3a7jxl34	292	14	immunizations	immunization	NNS
cord-303447-3a7jxl34	292	15	.	.	.
cord-303447-3a7jxl34	293	1	As	as	IN
cord-303447-3a7jxl34	293	2	the	the	DT
cord-303447-3a7jxl34	293	3	recommended	recommend	VBN
cord-303447-3a7jxl34	293	4	childhood	childhood	NN
cord-303447-3a7jxl34	293	5	and	and	CC
cord-303447-3a7jxl34	293	6	adolescent	adolescent	JJ
cord-303447-3a7jxl34	293	7	immunization	immunization	NN
cord-303447-3a7jxl34	293	8	schedule	schedule	NN
cord-303447-3a7jxl34	293	9	continues	continue	VBZ
cord-303447-3a7jxl34	293	10	to	to	TO
cord-303447-3a7jxl34	293	11	expand	expand	VB
cord-303447-3a7jxl34	293	12	,	,	,
cord-303447-3a7jxl34	293	13	the	the	DT
cord-303447-3a7jxl34	293	14	US	US	NNP
cord-303447-3a7jxl34	293	15	immunization	immunization	NN
cord-303447-3a7jxl34	293	16	program	program	NN
cord-303447-3a7jxl34	293	17	will	will	MD
cord-303447-3a7jxl34	293	18	be	be	VB
cord-303447-3a7jxl34	293	19	challenged	challenge	VBN
cord-303447-3a7jxl34	293	20	to	to	TO
cord-303447-3a7jxl34	293	21	integrate	integrate	VB
cord-303447-3a7jxl34	293	22	novel	novel	JJ
cord-303447-3a7jxl34	293	23	immunization	immunization	NN
cord-303447-3a7jxl34	293	24	strategies	strategy	NNS
cord-303447-3a7jxl34	293	25	into	into	IN
cord-303447-3a7jxl34	293	26	the	the	DT
cord-303447-3a7jxl34	293	27	current	current	JJ
cord-303447-3a7jxl34	293	28	immunization	immunization	NN
cord-303447-3a7jxl34	293	29	infrastructure	infrastructure	NN
cord-303447-3a7jxl34	293	30	.	.	.
cord-303447-3a7jxl34	294	1	The	the	DT
cord-303447-3a7jxl34	294	2	impact	impact	NN
cord-303447-3a7jxl34	294	3	of	of	IN
cord-303447-3a7jxl34	294	4	future	future	JJ
cord-303447-3a7jxl34	294	5	vaccines	vaccine	NNS
cord-303447-3a7jxl34	294	6	in	in	IN
cord-303447-3a7jxl34	294	7	the	the	DT
cord-303447-3a7jxl34	294	8	United	United	NNP
cord-303447-3a7jxl34	294	9	States	States	NNP
cord-303447-3a7jxl34	294	10	will	will	MD
cord-303447-3a7jxl34	294	11	be	be	VB
cord-303447-3a7jxl34	294	12	more	more	RBR
cord-303447-3a7jxl34	294	13	difficult	difficult	JJ
cord-303447-3a7jxl34	294	14	to	to	TO
cord-303447-3a7jxl34	294	15	calculate	calculate	VB
cord-303447-3a7jxl34	294	16	because	because	IN
cord-303447-3a7jxl34	294	17	they	-PRON-	PRP
cord-303447-3a7jxl34	294	18	will	will	MD
cord-303447-3a7jxl34	294	19	prevent	prevent	VB
cord-303447-3a7jxl34	294	20	fewer	few	JJR
cord-303447-3a7jxl34	294	21	deaths	death	NNS
cord-303447-3a7jxl34	294	22	than	than	IN
cord-303447-3a7jxl34	294	23	vaccines	vaccine	NNS
cord-303447-3a7jxl34	294	24	in	in	IN
cord-303447-3a7jxl34	294	25	the	the	DT
cord-303447-3a7jxl34	294	26	past	past	NN
cord-303447-3a7jxl34	294	27	.	.	.
cord-303447-3a7jxl34	295	1	The	the	DT
cord-303447-3a7jxl34	295	2	cost	cost	NN
cord-303447-3a7jxl34	295	3	of	of	IN
cord-303447-3a7jxl34	295	4	these	these	DT
cord-303447-3a7jxl34	295	5	vaccines	vaccine	NNS
cord-303447-3a7jxl34	295	6	will	will	MD
cord-303447-3a7jxl34	295	7	continue	continue	VB
cord-303447-3a7jxl34	295	8	to	to	TO
cord-303447-3a7jxl34	295	9	increase	increase	VB
cord-303447-3a7jxl34	295	10	,	,	,
cord-303447-3a7jxl34	295	11	and	and	CC
cord-303447-3a7jxl34	295	12	funding	funding	NN
cord-303447-3a7jxl34	295	13	support	support	NN
cord-303447-3a7jxl34	295	14	will	will	MD
cord-303447-3a7jxl34	295	15	be	be	VB
cord-303447-3a7jxl34	295	16	challenged	challenge	VBN
cord-303447-3a7jxl34	295	17	.	.	.
cord-303447-3a7jxl34	296	1	The	the	DT
cord-303447-3a7jxl34	296	2	risk	risk	NN
cord-303447-3a7jxl34	296	3	of	of	IN
cord-303447-3a7jxl34	296	4	adverse	adverse	JJ
cord-303447-3a7jxl34	296	5	vaccine	vaccine	NN
cord-303447-3a7jxl34	296	6	events	event	NNS
cord-303447-3a7jxl34	296	7	will	will	MD
cord-303447-3a7jxl34	296	8	have	have	VB
cord-303447-3a7jxl34	296	9	to	to	TO
cord-303447-3a7jxl34	296	10	be	be	VB
cord-303447-3a7jxl34	296	11	weighed	weigh	VBN
cord-303447-3a7jxl34	296	12	against	against	IN
cord-303447-3a7jxl34	296	13	the	the	DT
cord-303447-3a7jxl34	296	14	risk	risk	NN
cord-303447-3a7jxl34	296	15	of	of	IN
cord-303447-3a7jxl34	296	16	the	the	DT
cord-303447-3a7jxl34	296	17	disease	disease	NN
cord-303447-3a7jxl34	296	18	if	if	IN
cord-303447-3a7jxl34	296	19	not	not	RB
cord-303447-3a7jxl34	296	20	vaccinated	vaccinate	VBN
cord-303447-3a7jxl34	296	21	.	.	.
cord-303447-3a7jxl34	297	1	Pediatric	pediatric	JJ
cord-303447-3a7jxl34	297	2	health	health	NN
cord-303447-3a7jxl34	297	3	care	care	NN
cord-303447-3a7jxl34	297	4	providers	provider	NNS
cord-303447-3a7jxl34	297	5	face	face	VBP
cord-303447-3a7jxl34	297	6	a	a	DT
cord-303447-3a7jxl34	297	7	growing	grow	VBG
cord-303447-3a7jxl34	297	8	complexity	complexity	NN
cord-303447-3a7jxl34	297	9	of	of	IN
cord-303447-3a7jxl34	297	10	problems	problem	NNS
cord-303447-3a7jxl34	297	11	in	in	IN
cord-303447-3a7jxl34	297	12	children	child	NNS
cord-303447-3a7jxl34	297	13	,	,	,
cord-303447-3a7jxl34	297	14	including	include	VBG
cord-303447-3a7jxl34	297	15	injury	injury	NN
cord-303447-3a7jxl34	297	16	,	,	,
cord-303447-3a7jxl34	297	17	obesity	obesity	NN
cord-303447-3a7jxl34	297	18	,	,	,
cord-303447-3a7jxl34	297	19	asthma	asthma	NN
cord-303447-3a7jxl34	297	20	,	,	,
cord-303447-3a7jxl34	297	21	and	and	CC
cord-303447-3a7jxl34	297	22	mental	mental	JJ
cord-303447-3a7jxl34	297	23	health	health	NN
cord-303447-3a7jxl34	297	24	and	and	CC
cord-303447-3a7jxl34	297	25	behavioral	behavioral	JJ
cord-303447-3a7jxl34	297	26	disorders	disorder	NNS
cord-303447-3a7jxl34	297	27	.	.	.
cord-303447-3a7jxl34	298	1	As	as	IN
cord-303447-3a7jxl34	298	2	the	the	DT
cord-303447-3a7jxl34	298	3	cost	cost	NN
cord-303447-3a7jxl34	298	4	and	and	CC
cord-303447-3a7jxl34	298	5	complexity	complexity	NN
cord-303447-3a7jxl34	298	6	of	of	IN
cord-303447-3a7jxl34	298	7	the	the	DT
cord-303447-3a7jxl34	298	8	childhood	childhood	NN
cord-303447-3a7jxl34	298	9	and	and	CC
cord-303447-3a7jxl34	298	10	adolescent	adolescent	JJ
cord-303447-3a7jxl34	298	11	immunization	immunization	NN
cord-303447-3a7jxl34	298	12	schedule	schedule	NN
cord-303447-3a7jxl34	298	13	increase	increase	NN
cord-303447-3a7jxl34	298	14	,	,	,
cord-303447-3a7jxl34	298	15	considering	consider	VBG
cord-303447-3a7jxl34	298	16	the	the	DT
cord-303447-3a7jxl34	298	17	role	role	NN
cord-303447-3a7jxl34	298	18	of	of	IN
cord-303447-3a7jxl34	298	19	immunizations	immunization	NNS
cord-303447-3a7jxl34	298	20	within	within	IN
cord-303447-3a7jxl34	298	21	the	the	DT
cord-303447-3a7jxl34	298	22	context	context	NN
cord-303447-3a7jxl34	298	23	of	of	IN
cord-303447-3a7jxl34	298	24	other	other	JJ
cord-303447-3a7jxl34	298	25	preventive	preventive	JJ
cord-303447-3a7jxl34	298	26	health	health	NN
cord-303447-3a7jxl34	298	27	interventions	intervention	NNS
cord-303447-3a7jxl34	298	28	and	and	CC
cord-303447-3a7jxl34	298	29	overall	overall	JJ
cord-303447-3a7jxl34	298	30	societal	societal	JJ
cord-303447-3a7jxl34	298	31	values	value	NNS
cord-303447-3a7jxl34	298	32	becomes	become	VBZ
cord-303447-3a7jxl34	298	33	increasingly	increasingly	RB
cord-303447-3a7jxl34	298	34	important	important	JJ
cord-303447-3a7jxl34	298	35	.	.	.
cord-303447-3a7jxl34	299	1	Immunizations	immunization	NNS
cord-303447-3a7jxl34	299	2	are	be	VBP
cord-303447-3a7jxl34	299	3	one	one	CD
cord-303447-3a7jxl34	299	4	of	of	IN
cord-303447-3a7jxl34	299	5	the	the	DT
cord-303447-3a7jxl34	299	6	most	most	RBS
cord-303447-3a7jxl34	299	7	effective	effective	JJ
cord-303447-3a7jxl34	299	8	clinical	clinical	JJ
cord-303447-3a7jxl34	299	9	preventive	preventive	JJ
cord-303447-3a7jxl34	299	10	services	service	NNS
cord-303447-3a7jxl34	299	11	in	in	IN
cord-303447-3a7jxl34	299	12	pediatric	pediatric	JJ
cord-303447-3a7jxl34	299	13	practice	practice	NN
cord-303447-3a7jxl34	299	14	[	[	-LRB-
cord-303447-3a7jxl34	299	15	15	15	CD
cord-303447-3a7jxl34	299	16	]	]	-RRB-
cord-303447-3a7jxl34	299	17	.	.	.
cord-303447-3a7jxl34	300	1	Despite	despite	IN
cord-303447-3a7jxl34	300	2	the	the	DT
cord-303447-3a7jxl34	300	3	challenges	challenge	NNS
cord-303447-3a7jxl34	300	4	facing	face	VBG
cord-303447-3a7jxl34	300	5	the	the	DT
cord-303447-3a7jxl34	300	6	US	US	NNP
cord-303447-3a7jxl34	300	7	immunization	immunization	NN
cord-303447-3a7jxl34	300	8	program	program	NN
cord-303447-3a7jxl34	300	9	,	,	,
cord-303447-3a7jxl34	300	10	immunizations	immunization	NNS
cord-303447-3a7jxl34	300	11	will	will	MD
cord-303447-3a7jxl34	300	12	likely	likely	RB
cord-303447-3a7jxl34	300	13	remain	remain	VB
cord-303447-3a7jxl34	300	14	on	on	IN
cord-303447-3a7jxl34	300	15	the	the	DT
cord-303447-3a7jxl34	300	16	list	list	NN
cord-303447-3a7jxl34	300	17	of	of	IN
cord-303447-3a7jxl34	300	18	great	great	JJ
cord-303447-3a7jxl34	300	19	public	public	JJ
cord-303447-3a7jxl34	300	20	health	health	NN
cord-303447-3a7jxl34	300	21	accomplishments	accomplishment	NNS
cord-303447-3a7jxl34	300	22	of	of	IN
cord-303447-3a7jxl34	300	23	the	the	DT
cord-303447-3a7jxl34	300	24	twenty	twenty	CD
cord-303447-3a7jxl34	300	25	-	-	HYPH
cord-303447-3a7jxl34	300	26	first	first	JJ
cord-303447-3a7jxl34	300	27	century	century	NN
cord-303447-3a7jxl34	300	28	,	,	,
cord-303447-3a7jxl34	300	29	and	and	CC
cord-303447-3a7jxl34	300	30	the	the	DT
cord-303447-3a7jxl34	300	31	legacy	legacy	NN
cord-303447-3a7jxl34	300	32	of	of	IN
cord-303447-3a7jxl34	300	33	Jenner	Jenner	NNP
cord-303447-3a7jxl34	300	34	will	will	MD
cord-303447-3a7jxl34	300	35	continue	continue	VB
cord-303447-3a7jxl34	300	36	.	.	.
cord-303447-3a7jxl34	301	1	Smallpox	smallpox	NN
cord-303447-3a7jxl34	301	2	and	and	CC
cord-303447-3a7jxl34	301	3	its	-PRON-	PRP$
cord-303447-3a7jxl34	301	4	eradication	eradication	NN
cord-303447-3a7jxl34	301	5	.	.	.
cord-303447-3a7jxl34	302	1	Geneva7	Geneva7	NNP
cord-303447-3a7jxl34	303	1	WHO	who	WP
cord-303447-3a7jxl34	303	2	Ten	ten	CD
cord-303447-3a7jxl34	303	3	great	great	JJ
cord-303447-3a7jxl34	303	4	public	public	JJ
cord-303447-3a7jxl34	303	5	health	health	NN
cord-303447-3a7jxl34	303	6	achievements	achievement	NNS
cord-303447-3a7jxl34	303	7	,	,	,
cord-303447-3a7jxl34	303	8	United	United	NNP
cord-303447-3a7jxl34	303	9	States	States	NNP
cord-303447-3a7jxl34	303	10	Impact	Impact	NNP
cord-303447-3a7jxl34	303	11	of	of	IN
cord-303447-3a7jxl34	303	12	vaccines	vaccine	NNS
cord-303447-3a7jxl34	303	13	universally	universally	RB
cord-303447-3a7jxl34	303	14	recommended	recommend	VBN
cord-303447-3a7jxl34	303	15	for	for	IN
cord-303447-3a7jxl34	303	16	children	child	NNS
cord-303447-3a7jxl34	303	17	-	-	:
cord-303447-3a7jxl34	303	18	United	United	NNP
cord-303447-3a7jxl34	303	19	States	States	NNP
cord-303447-3a7jxl34	303	20	Measles	Measles	NNP
cord-303447-3a7jxl34	303	21	elimination	elimination	NN
cord-303447-3a7jxl34	303	22	in	in	IN
cord-303447-3a7jxl34	303	23	the	the	DT
cord-303447-3a7jxl34	303	24	United	United	NNP
cord-303447-3a7jxl34	303	25	States	States	NNP
cord-303447-3a7jxl34	303	26	Epidemiology	Epidemiology	NNP
cord-303447-3a7jxl34	303	27	of	of	IN
cord-303447-3a7jxl34	303	28	poliomyelitis	poliomyelitis	NN
cord-303447-3a7jxl34	303	29	in	in	IN
cord-303447-3a7jxl34	303	30	the	the	DT
cord-303447-3a7jxl34	303	31	United	United	NNP
cord-303447-3a7jxl34	303	32	States	States	NNP
cord-303447-3a7jxl34	304	1	one	one	CD
cord-303447-3a7jxl34	304	2	decade	decade	NN
cord-303447-3a7jxl34	304	3	after	after	IN
cord-303447-3a7jxl34	304	4	the	the	DT
cord-303447-3a7jxl34	304	5	last	last	JJ
cord-303447-3a7jxl34	304	6	reported	report	VBN
cord-303447-3a7jxl34	304	7	case	case	NN
cord-303447-3a7jxl34	304	8	of	of	IN
cord-303447-3a7jxl34	304	9	indigenous	indigenous	JJ
cord-303447-3a7jxl34	304	10	wild	wild	JJ
cord-303447-3a7jxl34	304	11	virus	virus	NN
cord-303447-3a7jxl34	304	12	-	-	HYPH
cord-303447-3a7jxl34	304	13	associated	associate	VBN
cord-303447-3a7jxl34	304	14	disease	disease	NN
cord-303447-3a7jxl34	304	15	Healthy	healthy	JJ
cord-303447-3a7jxl34	304	16	people	people	NNS
cord-303447-3a7jxl34	304	17	2010	2010	CD
cord-303447-3a7jxl34	304	18	:	:	:
cord-303447-3a7jxl34	304	19	national	national	JJ
cord-303447-3a7jxl34	304	20	health	health	NN
cord-303447-3a7jxl34	304	21	promotion	promotion	NN
cord-303447-3a7jxl34	304	22	and	and	CC
cord-303447-3a7jxl34	304	23	disease	disease	NN
cord-303447-3a7jxl34	304	24	prevention	prevention	NN
cord-303447-3a7jxl34	304	25	objectives	objective	NNS
cord-303447-3a7jxl34	304	26	Haemophilus	haemophilus	JJ
cord-303447-3a7jxl34	304	27	influenzae	influenzae	NN
cord-303447-3a7jxl34	304	28	invasive	invasive	JJ
cord-303447-3a7jxl34	304	29	disease	disease	NN
cord-303447-3a7jxl34	304	30	in	in	IN
cord-303447-3a7jxl34	304	31	the	the	DT
cord-303447-3a7jxl34	304	32	United	United	NNP
cord-303447-3a7jxl34	304	33	States	States	NNP
cord-303447-3a7jxl34	304	34	,	,	,
cord-303447-3a7jxl34	304	35	1994	1994	CD
cord-303447-3a7jxl34	304	36	-	-	SYM
cord-303447-3a7jxl34	304	37	1995	1995	CD
cord-303447-3a7jxl34	304	38	:	:	:
cord-303447-3a7jxl34	304	39	near	near	IN
cord-303447-3a7jxl34	304	40	disappearance	disappearance	NN
cord-303447-3a7jxl34	304	41	of	of	IN
cord-303447-3a7jxl34	304	42	a	a	DT
cord-303447-3a7jxl34	304	43	vaccine	vaccine	NN
cord-303447-3a7jxl34	304	44	-	-	HYPH
cord-303447-3a7jxl34	304	45	preventable	preventable	JJ
cord-303447-3a7jxl34	304	46	childhood	childhood	NN
cord-303447-3a7jxl34	304	47	disease	disease	NN
cord-303447-3a7jxl34	304	48	Recommended	recommend	VBD
cord-303447-3a7jxl34	304	49	childhood	childhood	NN
cord-303447-3a7jxl34	304	50	and	and	CC
cord-303447-3a7jxl34	304	51	adolescent	adolescent	JJ
cord-303447-3a7jxl34	304	52	immunization	immunization	NN
cord-303447-3a7jxl34	304	53	schedule	schedule	NN
cord-303447-3a7jxl34	304	54	-	-	:
cord-303447-3a7jxl34	304	55	United	United	NNP
cord-303447-3a7jxl34	304	56	States	States	NNP
cord-303447-3a7jxl34	304	57	Advisory	Advisory	NNP
cord-303447-3a7jxl34	304	58	Committee	Committee	NNP
cord-303447-3a7jxl34	304	59	on	on	IN
cord-303447-3a7jxl34	304	60	Immunization	Immunization	NNP
cord-303447-3a7jxl34	304	61	Practices	Practices	NNPS
cord-303447-3a7jxl34	304	62	,	,	,
cord-303447-3a7jxl34	304	63	American	American	NNP
cord-303447-3a7jxl34	304	64	Academy	Academy	NNP
cord-303447-3a7jxl34	304	65	of	of	IN
cord-303447-3a7jxl34	304	66	Pediatrics	Pediatrics	NNP
cord-303447-3a7jxl34	304	67	,	,	,
cord-303447-3a7jxl34	304	68	American	American	NNP
cord-303447-3a7jxl34	304	69	Academy	Academy	NNP
cord-303447-3a7jxl34	304	70	of	of	IN
cord-303447-3a7jxl34	304	71	Family	Family	NNP
cord-303447-3a7jxl34	304	72	Physicians	Physicians	NNPS
cord-303447-3a7jxl34	304	73	,	,	,
cord-303447-3a7jxl34	304	74	National	National	NNP
cord-303447-3a7jxl34	304	75	Immunization	Immunization	NNP
cord-303447-3a7jxl34	304	76	Program	Program	NNP
cord-303447-3a7jxl34	304	77	Development	Development	NNP
cord-303447-3a7jxl34	304	78	of	of	IN
cord-303447-3a7jxl34	304	79	pediatric	pediatric	JJ
cord-303447-3a7jxl34	304	80	vaccine	vaccine	NN
cord-303447-3a7jxl34	304	81	recommendations	recommendation	NNS
cord-303447-3a7jxl34	304	82	and	and	CC
cord-303447-3a7jxl34	304	83	policies	policy	NNS
cord-303447-3a7jxl34	304	84	Vaccination	vaccination	NN
cord-303447-3a7jxl34	304	85	policies	policy	NNS
cord-303447-3a7jxl34	304	86	and	and	CC
cord-303447-3a7jxl34	304	87	programs	program	NNS
cord-303447-3a7jxl34	304	88	:	:	:
cord-303447-3a7jxl34	304	89	the	the	DT
cord-303447-3a7jxl34	304	90	federal	federal	JJ
cord-303447-3a7jxl34	304	91	government	government	NN
cord-303447-3a7jxl34	304	92	's	's	POS
cord-303447-3a7jxl34	304	93	role	role	NN
cord-303447-3a7jxl34	304	94	in	in	IN
cord-303447-3a7jxl34	304	95	making	make	VBG
cord-303447-3a7jxl34	304	96	the	the	DT
cord-303447-3a7jxl34	304	97	system	system	NN
cord-303447-3a7jxl34	304	98	work	work	NN
cord-303447-3a7jxl34	304	99	Financing	financing	NN
cord-303447-3a7jxl34	304	100	immunizations	immunization	NNS
cord-303447-3a7jxl34	304	101	in	in	IN
cord-303447-3a7jxl34	304	102	the	the	DT
cord-303447-3a7jxl34	304	103	United	United	NNP
cord-303447-3a7jxl34	304	104	States	States	NNP
cord-303447-3a7jxl34	304	105	Cost	cost	NN
cord-303447-3a7jxl34	304	106	-	-	HYPH
cord-303447-3a7jxl34	304	107	effectiveness	effectiveness	NN
cord-303447-3a7jxl34	304	108	of	of	IN
cord-303447-3a7jxl34	304	109	a	a	DT
cord-303447-3a7jxl34	304	110	routine	routine	JJ
cord-303447-3a7jxl34	304	111	varicella	varicella	NN
cord-303447-3a7jxl34	304	112	vaccination	vaccination	NN
cord-303447-3a7jxl34	304	113	program	program	NN
cord-303447-3a7jxl34	304	114	for	for	IN
cord-303447-3a7jxl34	304	115	US	US	NNP
cord-303447-3a7jxl34	304	116	children	child	NNS
cord-303447-3a7jxl34	305	1	Projected	project	VBN
cord-303447-3a7jxl34	305	2	cost	cost	NN
cord-303447-3a7jxl34	305	3	-	-	HYPH
cord-303447-3a7jxl34	305	4	effectiveness	effectiveness	NN
cord-303447-3a7jxl34	305	5	of	of	IN
cord-303447-3a7jxl34	305	6	pneumococcal	pneumococcal	JJ
cord-303447-3a7jxl34	305	7	conjugate	conjugate	NN
cord-303447-3a7jxl34	305	8	vaccination	vaccination	NN
cord-303447-3a7jxl34	305	9	of	of	IN
cord-303447-3a7jxl34	305	10	healthy	healthy	JJ
cord-303447-3a7jxl34	305	11	infants	infant	NNS
cord-303447-3a7jxl34	305	12	and	and	CC
cord-303447-3a7jxl34	305	13	young	young	JJ
cord-303447-3a7jxl34	305	14	children	child	NNS
cord-303447-3a7jxl34	305	15	Priorities	Priorities	NNPS
cord-303447-3a7jxl34	305	16	among	among	IN
cord-303447-3a7jxl34	305	17	recommended	recommend	VBN
cord-303447-3a7jxl34	305	18	clinical	clinical	JJ
cord-303447-3a7jxl34	305	19	preventive	preventive	JJ
cord-303447-3a7jxl34	305	20	services	service	NNS
cord-303447-3a7jxl34	305	21	Cost	cost	NN
cord-303447-3a7jxl34	305	22	-	-	HYPH
cord-303447-3a7jxl34	305	23	effectiveness	effectiveness	NN
cord-303447-3a7jxl34	305	24	of	of	IN
cord-303447-3a7jxl34	305	25	hepatitis	hepatitis	NN
cord-303447-3a7jxl34	305	26	B	B	NNP
cord-303447-3a7jxl34	305	27	virus	virus	NN
cord-303447-3a7jxl34	305	28	immunization	immunization	NN
cord-303447-3a7jxl34	305	29	Strengthening	strengthen	VBG
cord-303447-3a7jxl34	305	30	the	the	DT
cord-303447-3a7jxl34	305	31	supply	supply	NN
cord-303447-3a7jxl34	305	32	of	of	IN
cord-303447-3a7jxl34	305	33	routinely	routinely	RB
cord-303447-3a7jxl34	305	34	recommended	recommend	VBN
cord-303447-3a7jxl34	305	35	vaccines	vaccine	NNS
cord-303447-3a7jxl34	305	36	in	in	IN
cord-303447-3a7jxl34	305	37	the	the	DT
cord-303447-3a7jxl34	305	38	United	United	NNP
cord-303447-3a7jxl34	305	39	States	States	NNP
cord-303447-3a7jxl34	305	40	:	:	:
cord-303447-3a7jxl34	306	1	recommendations	recommendation	NNS
cord-303447-3a7jxl34	306	2	from	from	IN
cord-303447-3a7jxl34	306	3	the	the	DT
cord-303447-3a7jxl34	306	4	National	National	NNP
cord-303447-3a7jxl34	306	5	Vaccine	Vaccine	NNP
cord-303447-3a7jxl34	306	6	Advisory	Advisory	NNP
cord-303447-3a7jxl34	306	7	Committee	Committee	NNP
cord-303447-3a7jxl34	306	8	Centers	Centers	NNPS
cord-303447-3a7jxl34	306	9	for	for	IN
cord-303447-3a7jxl34	306	10	Disease	Disease	NNP
cord-303447-3a7jxl34	306	11	Control	Control	NNP
cord-303447-3a7jxl34	306	12	and	and	CC
cord-303447-3a7jxl34	306	13	Prevention	Prevention	NNP
cord-303447-3a7jxl34	306	14	.	.	.
cord-303447-3a7jxl34	307	1	Shortage	shortage	NN
cord-303447-3a7jxl34	307	2	of	of	IN
cord-303447-3a7jxl34	307	3	tetanus	tetanus	NN
cord-303447-3a7jxl34	307	4	and	and	CC
cord-303447-3a7jxl34	307	5	diphtheria	diphtheria	NN
cord-303447-3a7jxl34	307	6	toxoids	toxoid	NNS
cord-303447-3a7jxl34	307	7	Update	Update	NNP
cord-303447-3a7jxl34	307	8	on	on	IN
cord-303447-3a7jxl34	307	9	the	the	DT
cord-303447-3a7jxl34	307	10	supply	supply	NN
cord-303447-3a7jxl34	307	11	of	of	IN
cord-303447-3a7jxl34	307	12	tetanus	tetanus	NN
cord-303447-3a7jxl34	307	13	and	and	CC
cord-303447-3a7jxl34	307	14	diphtheria	diphtheria	NN
cord-303447-3a7jxl34	307	15	toxoids	toxoid	NNS
cord-303447-3a7jxl34	307	16	and	and	CC
cord-303447-3a7jxl34	307	17	of	of	IN
cord-303447-3a7jxl34	307	18	diphtheria	diphtheria	NN
cord-303447-3a7jxl34	307	19	and	and	CC
cord-303447-3a7jxl34	307	20	tetanus	tetanus	NN
cord-303447-3a7jxl34	307	21	toxoids	toxoid	NNS
cord-303447-3a7jxl34	307	22	and	and	CC
cord-303447-3a7jxl34	307	23	acellular	acellular	JJ
cord-303447-3a7jxl34	307	24	pertussis	pertussis	NN
cord-303447-3a7jxl34	307	25	vaccine	vaccine	NN
cord-303447-3a7jxl34	307	26	Notice	notice	NN
cord-303447-3a7jxl34	307	27	to	to	IN
cord-303447-3a7jxl34	307	28	readers	reader	NNS
cord-303447-3a7jxl34	307	29	:	:	:
cord-303447-3a7jxl34	307	30	decreased	decrease	VBN
cord-303447-3a7jxl34	307	31	availability	availability	NN
cord-303447-3a7jxl34	307	32	of	of	IN
cord-303447-3a7jxl34	307	33	pneumococcal	pneumococcal	JJ
cord-303447-3a7jxl34	307	34	conjugate	conjugate	JJ
cord-303447-3a7jxl34	307	35	vaccine	vaccine	NN
cord-303447-3a7jxl34	307	36	Shortage	shortage	NN
cord-303447-3a7jxl34	307	37	of	of	IN
cord-303447-3a7jxl34	307	38	varicella	varicella	NN
cord-303447-3a7jxl34	307	39	and	and	CC
cord-303447-3a7jxl34	307	40	measles	measle	NNS
cord-303447-3a7jxl34	307	41	,	,	,
cord-303447-3a7jxl34	307	42	mumps	mumps	NN
cord-303447-3a7jxl34	307	43	and	and	CC
cord-303447-3a7jxl34	307	44	rubella	rubella	NN
cord-303447-3a7jxl34	307	45	vaccines	vaccine	NNS
cord-303447-3a7jxl34	307	46	and	and	CC
cord-303447-3a7jxl34	307	47	interim	interim	JJ
cord-303447-3a7jxl34	307	48	recommendations	recommendation	NNS
cord-303447-3a7jxl34	307	49	from	from	IN
cord-303447-3a7jxl34	307	50	the	the	DT
cord-303447-3a7jxl34	307	51	Advisory	Advisory	NNP
cord-303447-3a7jxl34	307	52	Committee	Committee	NNP
cord-303447-3a7jxl34	307	53	on	on	IN
cord-303447-3a7jxl34	307	54	Immunization	Immunization	NNP
cord-303447-3a7jxl34	307	55	Practices	Practices	NNPS
cord-303447-3a7jxl34	307	56	Experiences	experience	NNS
cord-303447-3a7jxl34	307	57	with	with	IN
cord-303447-3a7jxl34	307	58	obtaining	obtain	VBG
cord-303447-3a7jxl34	307	59	influenza	influenza	NN
cord-303447-3a7jxl34	307	60	vaccination	vaccination	NN
cord-303447-3a7jxl34	307	61	among	among	IN
cord-303447-3a7jxl34	307	62	persons	person	NNS
cord-303447-3a7jxl34	307	63	in	in	IN
cord-303447-3a7jxl34	307	64	priority	priority	NN
cord-303447-3a7jxl34	307	65	groups	group	NNS
cord-303447-3a7jxl34	307	66	during	during	IN
cord-303447-3a7jxl34	307	67	a	a	DT
cord-303447-3a7jxl34	307	68	vaccine	vaccine	NN
cord-303447-3a7jxl34	307	69	shortage	shortage	NN
cord-303447-3a7jxl34	307	70	-	-	:
cord-303447-3a7jxl34	307	71	United	United	NNP
cord-303447-3a7jxl34	307	72	States	States	NNP
cord-303447-3a7jxl34	307	73	Notice	Notice	NNP
cord-303447-3a7jxl34	307	74	to	to	IN
cord-303447-3a7jxl34	307	75	readers	reader	NNS
cord-303447-3a7jxl34	307	76	:	:	:
cord-303447-3a7jxl34	307	77	pneumococcal	pneumococcal	JJ
cord-303447-3a7jxl34	307	78	conjugate	conjugate	JJ
cord-303447-3a7jxl34	307	79	vaccine	vaccine	NN
cord-303447-3a7jxl34	307	80	shortage	shortage	NN
cord-303447-3a7jxl34	307	81	resolved	resolve	VBD
cord-303447-3a7jxl34	307	82	Impact	Impact	NNP
cord-303447-3a7jxl34	307	83	of	of	IN
cord-303447-3a7jxl34	307	84	vaccine	vaccine	NN
cord-303447-3a7jxl34	307	85	shortages	shortage	NNS
cord-303447-3a7jxl34	307	86	on	on	IN
cord-303447-3a7jxl34	307	87	immunization	immunization	NN
cord-303447-3a7jxl34	307	88	programs	program	NNS
cord-303447-3a7jxl34	307	89	and	and	CC
cord-303447-3a7jxl34	307	90	providers	provider	NNS
cord-303447-3a7jxl34	307	91	Variation	Variation	NNP
cord-303447-3a7jxl34	307	92	in	in	IN
cord-303447-3a7jxl34	307	93	public	public	JJ
cord-303447-3a7jxl34	307	94	and	and	CC
cord-303447-3a7jxl34	307	95	private	private	JJ
cord-303447-3a7jxl34	307	96	supply	supply	NN
cord-303447-3a7jxl34	307	97	of	of	IN
cord-303447-3a7jxl34	307	98	pneumococcal	pneumococcal	JJ
cord-303447-3a7jxl34	307	99	conjugate	conjugate	JJ
cord-303447-3a7jxl34	307	100	vaccine	vaccine	NN
cord-303447-3a7jxl34	307	101	during	during	IN
cord-303447-3a7jxl34	307	102	a	a	DT
cord-303447-3a7jxl34	307	103	shortage	shortage	NN
cord-303447-3a7jxl34	307	104	Limited	limited	JJ
cord-303447-3a7jxl34	307	105	supply	supply	NN
cord-303447-3a7jxl34	307	106	of	of	IN
cord-303447-3a7jxl34	307	107	pneumococcal	pneumococcal	JJ
cord-303447-3a7jxl34	307	108	conjugate	conjugate	NN
cord-303447-3a7jxl34	307	109	vaccine	vaccine	NN
cord-303447-3a7jxl34	307	110	:	:	:
cord-303447-3a7jxl34	307	111	suspension	suspension	NN
cord-303447-3a7jxl34	307	112	of	of	IN
cord-303447-3a7jxl34	307	113	recommendation	recommendation	NN
cord-303447-3a7jxl34	307	114	for	for	IN
cord-303447-3a7jxl34	307	115	fourth	fourth	JJ
cord-303447-3a7jxl34	307	116	dose	dose	NN
cord-303447-3a7jxl34	307	117	Report	Report	NNP
cord-303447-3a7jxl34	307	118	to	to	IN
cord-303447-3a7jxl34	307	119	congressional	congressional	JJ
cord-303447-3a7jxl34	307	120	requesters	requester	NNS
cord-303447-3a7jxl34	307	121	:	:	:
cord-303447-3a7jxl34	307	122	childhood	childhood	NN
cord-303447-3a7jxl34	307	123	vaccines	vaccine	NNS
cord-303447-3a7jxl34	307	124	:	:	:
cord-303447-3a7jxl34	307	125	ensuring	ensure	VBG
cord-303447-3a7jxl34	307	126	an	an	DT
cord-303447-3a7jxl34	307	127	adequate	adequate	JJ
cord-303447-3a7jxl34	307	128	supply	supply	NN
cord-303447-3a7jxl34	307	129	poses	pose	VBZ
cord-303447-3a7jxl34	307	130	continuing	continue	VBG
cord-303447-3a7jxl34	307	131	challenges	challenge	NNS
cord-303447-3a7jxl34	307	132	Safety	safety	NN
cord-303447-3a7jxl34	307	133	of	of	IN
cord-303447-3a7jxl34	307	134	immunizations	immunization	NNS
cord-303447-3a7jxl34	307	135	:	:	:
cord-303447-3a7jxl34	307	136	vaccine	vaccine	NN
cord-303447-3a7jxl34	307	137	Centers	Centers	NNPS
cord-303447-3a7jxl34	307	138	for	for	IN
cord-303447-3a7jxl34	307	139	Disease	Disease	NNP
cord-303447-3a7jxl34	307	140	Control	Control	NNP
cord-303447-3a7jxl34	307	141	and	and	CC
cord-303447-3a7jxl34	307	142	Prevention	Prevention	NNP
cord-303447-3a7jxl34	307	143	.	.	.
cord-303447-3a7jxl34	308	1	Poliomyelitis	poliomyelitis	NN
cord-303447-3a7jxl34	308	2	prevention	prevention	NN
cord-303447-3a7jxl34	308	3	in	in	IN
cord-303447-3a7jxl34	308	4	the	the	DT
cord-303447-3a7jxl34	308	5	United	United	NNP
cord-303447-3a7jxl34	308	6	States	States	NNP
cord-303447-3a7jxl34	308	7	:	:	:
cord-303447-3a7jxl34	308	8	updated	update	VBN
cord-303447-3a7jxl34	308	9	recommendations	recommendation	NNS
cord-303447-3a7jxl34	308	10	of	of	IN
cord-303447-3a7jxl34	308	11	the	the	DT
cord-303447-3a7jxl34	308	12	Advisory	Advisory	NNP
cord-303447-3a7jxl34	308	13	Committee	Committee	NNP
cord-303447-3a7jxl34	308	14	on	on	IN
cord-303447-3a7jxl34	308	15	Immunization	Immunization	NNP
cord-303447-3a7jxl34	308	16	Practices	Practices	NNPS
cord-303447-3a7jxl34	308	17	(	(	-LRB-
cord-303447-3a7jxl34	308	18	ACIP	ACIP	NNP
cord-303447-3a7jxl34	308	19	)	)	-RRB-
cord-303447-3a7jxl34	308	20	Immunization	Immunization	NNP
cord-303447-3a7jxl34	308	21	safety	safety	NN
cord-303447-3a7jxl34	308	22	review	review	NN
cord-303447-3a7jxl34	308	23	:	:	:
cord-303447-3a7jxl34	308	24	committee	committee	NN
cord-303447-3a7jxl34	308	25	reports	report	NNS
cord-303447-3a7jxl34	308	26	.	.	.
cord-303447-3a7jxl34	309	1	Washington	Washington	NNP
cord-303447-3a7jxl34	309	2	,	,	,
cord-303447-3a7jxl34	309	3	DC7	DC7	NNP
cord-303447-3a7jxl34	309	4	National	National	NNP
cord-303447-3a7jxl34	309	5	Academy	Academy	NNP
cord-303447-3a7jxl34	309	6	of	of	IN
cord-303447-3a7jxl34	309	7	Sciences	Sciences	NNPS
cord-303447-3a7jxl34	309	8	Understanding	Understanding	NNP
cord-303447-3a7jxl34	309	9	vaccine	vaccine	NN
cord-303447-3a7jxl34	309	10	safety	safety	NN
cord-303447-3a7jxl34	309	11	information	information	NN
cord-303447-3a7jxl34	309	12	from	from	IN
cord-303447-3a7jxl34	309	13	the	the	DT
cord-303447-3a7jxl34	309	14	Vaccine	Vaccine	NNP
cord-303447-3a7jxl34	309	15	Adverse	Adverse	NNP
cord-303447-3a7jxl34	309	16	Event	Event	NNP
cord-303447-3a7jxl34	309	17	Reporting	Reporting	NNP
cord-303447-3a7jxl34	309	18	System	System	NNP
cord-303447-3a7jxl34	309	19	Withdrawal	Withdrawal	NNP
cord-303447-3a7jxl34	309	20	of	of	IN
cord-303447-3a7jxl34	309	21	rotavirus	rotavirus	JJ
cord-303447-3a7jxl34	309	22	vaccine	vaccine	NN
cord-303447-3a7jxl34	309	23	recommendation	recommendation	NN
cord-303447-3a7jxl34	309	24	Rotavirus	Rotavirus	NNP
cord-303447-3a7jxl34	309	25	vaccine	vaccine	NN
cord-303447-3a7jxl34	309	26	for	for	IN
cord-303447-3a7jxl34	309	27	the	the	DT
cord-303447-3a7jxl34	309	28	prevention	prevention	NN
cord-303447-3a7jxl34	309	29	of	of	IN
cord-303447-3a7jxl34	309	30	rotavirus	rotavirus	JJ
cord-303447-3a7jxl34	309	31	gastroenteritis	gastroenteritis	NN
cord-303447-3a7jxl34	309	32	among	among	IN
cord-303447-3a7jxl34	309	33	children	child	NNS
cord-303447-3a7jxl34	309	34	:	:	:
cord-303447-3a7jxl34	309	35	recommendations	recommendation	NNS
cord-303447-3a7jxl34	309	36	of	of	IN
cord-303447-3a7jxl34	309	37	the	the	DT
cord-303447-3a7jxl34	309	38	Advisory	Advisory	NNP
cord-303447-3a7jxl34	309	39	Committee	Committee	NNP
cord-303447-3a7jxl34	309	40	on	on	IN
cord-303447-3a7jxl34	309	41	Immunization	Immunization	NNP
cord-303447-3a7jxl34	309	42	Practices	Practices	NNPS
cord-303447-3a7jxl34	309	43	(	(	-LRB-
cord-303447-3a7jxl34	309	44	ACIP	ACIP	NNP
cord-303447-3a7jxl34	309	45	)	)	-RRB-
cord-303447-3a7jxl34	309	46	Safety	safety	NN
cord-303447-3a7jxl34	309	47	of	of	IN
cord-303447-3a7jxl34	309	48	immunizations	immunization	NNS
cord-303447-3a7jxl34	309	49	Centers	Centers	NNPS
cord-303447-3a7jxl34	309	50	for	for	IN
cord-303447-3a7jxl34	309	51	Disease	Disease	NNP
cord-303447-3a7jxl34	309	52	Control	Control	NNP
cord-303447-3a7jxl34	309	53	and	and	CC
cord-303447-3a7jxl34	309	54	Prevention	Prevention	NNP
cord-303447-3a7jxl34	309	55	.	.	.
cord-303447-3a7jxl34	310	1	Immunization	immunization	NN
cord-303447-3a7jxl34	310	2	of	of	IN
cord-303447-3a7jxl34	310	3	adolescents	adolescent	NNS
cord-303447-3a7jxl34	310	4	:	:	:
cord-303447-3a7jxl34	310	5	recommendations	recommendation	NNS
cord-303447-3a7jxl34	310	6	of	of	IN
cord-303447-3a7jxl34	310	7	the	the	DT
cord-303447-3a7jxl34	310	8	Advisory	Advisory	NNP
cord-303447-3a7jxl34	310	9	Committee	Committee	NNP
cord-303447-3a7jxl34	310	10	on	on	IN
cord-303447-3a7jxl34	310	11	Immunization	Immunization	NNP
cord-303447-3a7jxl34	310	12	Practices	Practices	NNPS
cord-303447-3a7jxl34	310	13	,	,	,
cord-303447-3a7jxl34	310	14	the	the	DT
cord-303447-3a7jxl34	310	15	American	American	NNP
cord-303447-3a7jxl34	310	16	Academy	Academy	NNP
cord-303447-3a7jxl34	310	17	of	of	IN
cord-303447-3a7jxl34	310	18	Pediatrics	Pediatrics	NNP
cord-303447-3a7jxl34	310	19	,	,	,
cord-303447-3a7jxl34	310	20	the	the	DT
cord-303447-3a7jxl34	310	21	American	American	NNP
cord-303447-3a7jxl34	310	22	Academy	Academy	NNP
cord-303447-3a7jxl34	310	23	of	of	IN
cord-303447-3a7jxl34	310	24	Family	Family	NNP
cord-303447-3a7jxl34	310	25	Physicians	Physicians	NNPS
cord-303447-3a7jxl34	310	26	,	,	,
cord-303447-3a7jxl34	310	27	and	and	CC
cord-303447-3a7jxl34	310	28	the	the	DT
cord-303447-3a7jxl34	310	29	American	American	NNP
cord-303447-3a7jxl34	310	30	Medical	Medical	NNP
cord-303447-3a7jxl34	310	31	Association	Association	NNP
cord-303447-3a7jxl34	310	32	Preventing	prevent	VBG
cord-303447-3a7jxl34	310	33	pneumococcal	pneumococcal	JJ
cord-303447-3a7jxl34	310	34	disease	disease	NN
cord-303447-3a7jxl34	310	35	among	among	IN
cord-303447-3a7jxl34	310	36	infants	infant	NNS
cord-303447-3a7jxl34	310	37	and	and	CC
cord-303447-3a7jxl34	310	38	young	young	JJ
cord-303447-3a7jxl34	310	39	children	child	NNS
cord-303447-3a7jxl34	310	40	:	:	:
cord-303447-3a7jxl34	310	41	recommendations	recommendation	NNS
cord-303447-3a7jxl34	310	42	of	of	IN
cord-303447-3a7jxl34	310	43	the	the	DT
cord-303447-3a7jxl34	310	44	Advisory	Advisory	NNP
cord-303447-3a7jxl34	310	45	Committee	Committee	NNP
cord-303447-3a7jxl34	310	46	on	on	IN
cord-303447-3a7jxl34	310	47	Immunization	Immunization	NNP
cord-303447-3a7jxl34	310	48	Practices	Practices	NNPS
cord-303447-3a7jxl34	310	49	(	(	-LRB-
cord-303447-3a7jxl34	311	1	ACIP	ACIP	NNP
cord-303447-3a7jxl34	311	2	)	)	-RRB-
cord-303447-3a7jxl34	311	3	Postlicensure	postlicensure	NN
cord-303447-3a7jxl34	311	4	surveillance	surveillance	NN
cord-303447-3a7jxl34	311	5	for	for	IN
cord-303447-3a7jxl34	311	6	pneumococcal	pneumococcal	JJ
cord-303447-3a7jxl34	311	7	invasive	invasive	JJ
cord-303447-3a7jxl34	311	8	disease	disease	NN
cord-303447-3a7jxl34	311	9	after	after	IN
cord-303447-3a7jxl34	311	10	use	use	NN
cord-303447-3a7jxl34	311	11	of	of	IN
cord-303447-3a7jxl34	311	12	heptavalent	heptavalent	NN
cord-303447-3a7jxl34	311	13	pneumococcal	pneumococcal	JJ
cord-303447-3a7jxl34	311	14	conjugate	conjugate	JJ
cord-303447-3a7jxl34	311	15	vaccine	vaccine	NN
cord-303447-3a7jxl34	311	16	in	in	IN
cord-303447-3a7jxl34	311	17	Northern	Northern	NNP
cord-303447-3a7jxl34	311	18	California	California	NNP
cord-303447-3a7jxl34	311	19	Kaiser	Kaiser	NNP
cord-303447-3a7jxl34	311	20	Permanente	Permanente	NNP
cord-303447-3a7jxl34	311	21	Decrease	Decrease	NNP
cord-303447-3a7jxl34	311	22	of	of	IN
cord-303447-3a7jxl34	311	23	invasive	invasive	JJ
cord-303447-3a7jxl34	311	24	pneumococcal	pneumococcal	JJ
cord-303447-3a7jxl34	311	25	infections	infection	NNS
cord-303447-3a7jxl34	311	26	in	in	IN
cord-303447-3a7jxl34	311	27	children	child	NNS
cord-303447-3a7jxl34	311	28	among	among	IN
cord-303447-3a7jxl34	311	29	8	8	CD
cord-303447-3a7jxl34	311	30	children	child	NNS
cord-303447-3a7jxl34	311	31	's	's	POS
cord-303447-3a7jxl34	311	32	hospitals	hospital	NNS
cord-303447-3a7jxl34	311	33	in	in	IN
cord-303447-3a7jxl34	311	34	the	the	DT
cord-303447-3a7jxl34	311	35	United	United	NNP
cord-303447-3a7jxl34	311	36	States	States	NNP
cord-303447-3a7jxl34	311	37	after	after	IN
cord-303447-3a7jxl34	311	38	the	the	DT
cord-303447-3a7jxl34	311	39	introduction	introduction	NN
cord-303447-3a7jxl34	311	40	of	of	IN
cord-303447-3a7jxl34	311	41	the	the	DT
cord-303447-3a7jxl34	311	42	7-valent	7-valent	CD
cord-303447-3a7jxl34	311	43	pneumococcal	pneumococcal	JJ
cord-303447-3a7jxl34	311	44	conjugate	conjugate	NN
cord-303447-3a7jxl34	311	45	vaccine	vaccine	NN
cord-303447-3a7jxl34	311	46	Decline	decline	VB
cord-303447-3a7jxl34	311	47	in	in	IN
cord-303447-3a7jxl34	311	48	invasive	invasive	JJ
cord-303447-3a7jxl34	311	49	pneumococcal	pneumococcal	JJ
cord-303447-3a7jxl34	311	50	disease	disease	NN
cord-303447-3a7jxl34	311	51	after	after	IN
cord-303447-3a7jxl34	311	52	the	the	DT
cord-303447-3a7jxl34	311	53	introduction	introduction	NN
cord-303447-3a7jxl34	311	54	of	of	IN
cord-303447-3a7jxl34	311	55	protein	protein	NN
cord-303447-3a7jxl34	311	56	-	-	HYPH
cord-303447-3a7jxl34	311	57	polysaccharide	polysaccharide	NN
cord-303447-3a7jxl34	311	58	conjugate	conjugate	NN
cord-303447-3a7jxl34	311	59	vaccine	vaccine	NN
cord-303447-3a7jxl34	311	60	Population	population	NN
cord-303447-3a7jxl34	311	61	-	-	HYPH
cord-303447-3a7jxl34	311	62	based	base	VBN
cord-303447-3a7jxl34	311	63	impact	impact	NN
cord-303447-3a7jxl34	311	64	of	of	IN
cord-303447-3a7jxl34	311	65	pneumococcal	pneumococcal	JJ
cord-303447-3a7jxl34	311	66	conjugate	conjugate	JJ
cord-303447-3a7jxl34	311	67	vaccine	vaccine	NN
cord-303447-3a7jxl34	311	68	in	in	IN
cord-303447-3a7jxl34	311	69	young	young	JJ
cord-303447-3a7jxl34	311	70	children	child	NNS
cord-303447-3a7jxl34	311	71	Impact	Impact	NNP
cord-303447-3a7jxl34	311	72	of	of	IN
cord-303447-3a7jxl34	311	73	the	the	DT
cord-303447-3a7jxl34	311	74	pneumococcal	pneumococcal	JJ
cord-303447-3a7jxl34	311	75	conjugate	conjugate	NN
cord-303447-3a7jxl34	311	76	vaccine	vaccine	NN
cord-303447-3a7jxl34	311	77	on	on	IN
cord-303447-3a7jxl34	311	78	otitis	otitis	NN
cord-303447-3a7jxl34	311	79	media	medium	NNS
cord-303447-3a7jxl34	311	80	Pediatricians	pediatrician	NNS
cord-303447-3a7jxl34	311	81	'	'	POS
cord-303447-3a7jxl34	311	82	self	self	NN
cord-303447-3a7jxl34	311	83	-	-	HYPH
cord-303447-3a7jxl34	311	84	reported	report	VBN
cord-303447-3a7jxl34	311	85	clinical	clinical	JJ
cord-303447-3a7jxl34	311	86	practices	practice	NNS
cord-303447-3a7jxl34	311	87	and	and	CC
cord-303447-3a7jxl34	311	88	adherence	adherence	NN
cord-303447-3a7jxl34	311	89	to	to	IN
cord-303447-3a7jxl34	311	90	national	national	JJ
cord-303447-3a7jxl34	311	91	immunization	immunization	NN
cord-303447-3a7jxl34	311	92	guidelines	guideline	NNS
cord-303447-3a7jxl34	311	93	after	after	IN
cord-303447-3a7jxl34	311	94	the	the	DT
cord-303447-3a7jxl34	311	95	introduction	introduction	NN
cord-303447-3a7jxl34	311	96	of	of	IN
cord-303447-3a7jxl34	311	97	pneumococcal	pneumococcal	JJ
cord-303447-3a7jxl34	311	98	conjugate	conjugate	NN
cord-303447-3a7jxl34	311	99	vaccine	vaccine	NN
cord-303447-3a7jxl34	311	100	Potential	potential	JJ
cord-303447-3a7jxl34	311	101	impact	impact	NN
cord-303447-3a7jxl34	311	102	of	of	IN
cord-303447-3a7jxl34	311	103	conjugate	conjugate	JJ
cord-303447-3a7jxl34	311	104	pneumococcal	pneumococcal	JJ
cord-303447-3a7jxl34	311	105	vaccines	vaccine	NNS
cord-303447-3a7jxl34	311	106	on	on	IN
cord-303447-3a7jxl34	311	107	pediatric	pediatric	JJ
cord-303447-3a7jxl34	311	108	pneumococcal	pneumococcal	JJ
cord-303447-3a7jxl34	311	109	diseases	disease	NNS
cord-303447-3a7jxl34	311	110	Childhood	Childhood	NNP
cord-303447-3a7jxl34	311	111	hepatitis	hepatitis	NN
cord-303447-3a7jxl34	311	112	B	B	NNP
cord-303447-3a7jxl34	311	113	virus	virus	NN
cord-303447-3a7jxl34	311	114	infections	infection	NNS
cord-303447-3a7jxl34	311	115	in	in	IN
cord-303447-3a7jxl34	311	116	the	the	DT
cord-303447-3a7jxl34	311	117	United	United	NNP
cord-303447-3a7jxl34	311	118	States	States	NNP
cord-303447-3a7jxl34	311	119	before	before	IN
cord-303447-3a7jxl34	311	120	hepatitis	hepatitis	NNP
cord-303447-3a7jxl34	311	121	B	B	NNP
cord-303447-3a7jxl34	311	122	immunization	immunization	NN
cord-303447-3a7jxl34	311	123	Clinical	clinical	JJ
cord-303447-3a7jxl34	311	124	practice	practice	NN
cord-303447-3a7jxl34	311	125	:	:	:
cord-303447-3a7jxl34	311	126	prevention	prevention	NN
cord-303447-3a7jxl34	311	127	of	of	IN
cord-303447-3a7jxl34	311	128	hepatitis	hepatitis	NNP
cord-303447-3a7jxl34	311	129	B	B	NNP
cord-303447-3a7jxl34	311	130	with	with	IN
cord-303447-3a7jxl34	311	131	the	the	DT
cord-303447-3a7jxl34	311	132	hepatitis	hepatitis	NN
cord-303447-3a7jxl34	311	133	B	B	NNP
cord-303447-3a7jxl34	311	134	vaccine	vaccine	NN
cord-303447-3a7jxl34	311	135	Centers	Centers	NNPS
cord-303447-3a7jxl34	311	136	for	for	IN
cord-303447-3a7jxl34	311	137	Disease	Disease	NNP
cord-303447-3a7jxl34	311	138	Control	Control	NNP
cord-303447-3a7jxl34	311	139	and	and	CC
cord-303447-3a7jxl34	311	140	Prevention	Prevention	NNP
cord-303447-3a7jxl34	311	141	.	.	.
cord-303447-3a7jxl34	312	1	Hepatitis	Hepatitis	NNP
cord-303447-3a7jxl34	312	2	B	B	NNP
cord-303447-3a7jxl34	312	3	vaccination	vaccination	NN
cord-303447-3a7jxl34	312	4	-	-	:
cord-303447-3a7jxl34	312	5	United	United	NNP
cord-303447-3a7jxl34	312	6	States	States	NNP
cord-303447-3a7jxl34	312	7	Acute	acute	JJ
cord-303447-3a7jxl34	312	8	hepatitis	hepatitis	NN
cord-303447-3a7jxl34	312	9	B	b	NN
cord-303447-3a7jxl34	312	10	among	among	IN
cord-303447-3a7jxl34	312	11	children	child	NNS
cord-303447-3a7jxl34	312	12	and	and	CC
cord-303447-3a7jxl34	312	13	adolescents	adolescent	NNS
cord-303447-3a7jxl34	312	14	-	-	:
cord-303447-3a7jxl34	312	15	United	United	NNP
cord-303447-3a7jxl34	312	16	States	States	NNP
cord-303447-3a7jxl34	312	17	Opportunities	Opportunities	NNPS
cord-303447-3a7jxl34	312	18	for	for	IN
cord-303447-3a7jxl34	312	19	control	control	NN
cord-303447-3a7jxl34	312	20	of	of	IN
cord-303447-3a7jxl34	312	21	meningococcal	meningococcal	JJ
cord-303447-3a7jxl34	312	22	disease	disease	NN
cord-303447-3a7jxl34	312	23	in	in	IN
cord-303447-3a7jxl34	312	24	the	the	DT
cord-303447-3a7jxl34	312	25	US	US	NNP
cord-303447-3a7jxl34	312	26	Prevention	Prevention	NNP
cord-303447-3a7jxl34	312	27	and	and	CC
cord-303447-3a7jxl34	312	28	control	control	NN
cord-303447-3a7jxl34	312	29	of	of	IN
cord-303447-3a7jxl34	312	30	meningococcal	meningococcal	JJ
cord-303447-3a7jxl34	312	31	disease	disease	NN
cord-303447-3a7jxl34	312	32	and	and	CC
cord-303447-3a7jxl34	312	33	meningococcal	meningococcal	JJ
cord-303447-3a7jxl34	312	34	disease	disease	NN
cord-303447-3a7jxl34	312	35	and	and	CC
cord-303447-3a7jxl34	312	36	college	college	NN
cord-303447-3a7jxl34	312	37	students	student	NNS
cord-303447-3a7jxl34	312	38	:	:	:
cord-303447-3a7jxl34	312	39	recommendations	recommendation	NNS
cord-303447-3a7jxl34	312	40	of	of	IN
cord-303447-3a7jxl34	312	41	the	the	DT
cord-303447-3a7jxl34	312	42	Advisory	Advisory	NNP
cord-303447-3a7jxl34	312	43	Committee	Committee	NNP
cord-303447-3a7jxl34	312	44	on	on	IN
cord-303447-3a7jxl34	312	45	Immunization	Immunization	NNP
cord-303447-3a7jxl34	312	46	Practices	Practices	NNPS
cord-303447-3a7jxl34	312	47	(	(	-LRB-
cord-303447-3a7jxl34	312	48	ACIP	ACIP	NNP
cord-303447-3a7jxl34	312	49	)	)	-RRB-
cord-303447-3a7jxl34	312	50	Active	Active	NNP
cord-303447-3a7jxl34	312	51	Bacterial	Bacterial	NNP
cord-303447-3a7jxl34	312	52	Core	Core	NNP
cord-303447-3a7jxl34	312	53	Surveillance	Surveillance	NNP
cord-303447-3a7jxl34	312	54	Report	Report	NNP
cord-303447-3a7jxl34	312	55	,	,	,
cord-303447-3a7jxl34	312	56	Emerging	Emerging	NNP
cord-303447-3a7jxl34	312	57	Infections	Infections	NNPS
cord-303447-3a7jxl34	312	58	Program	Program	NNP
cord-303447-3a7jxl34	312	59	Network	Network	NNP
cord-303447-3a7jxl34	312	60	Changing	change	VBG
cord-303447-3a7jxl34	312	61	epidemiology	epidemiology	NN
cord-303447-3a7jxl34	312	62	of	of	IN
cord-303447-3a7jxl34	312	63	pertussis	pertussis	NN
cord-303447-3a7jxl34	312	64	in	in	IN
cord-303447-3a7jxl34	312	65	the	the	DT
cord-303447-3a7jxl34	312	66	United	United	NNP
cord-303447-3a7jxl34	312	67	States	States	NNP
cord-303447-3a7jxl34	312	68	:	:	:
cord-303447-3a7jxl34	312	69	increasing	increase	VBG
cord-303447-3a7jxl34	312	70	reported	report	VBN
cord-303447-3a7jxl34	312	71	incidence	incidence	NN
cord-303447-3a7jxl34	312	72	among	among	IN
cord-303447-3a7jxl34	312	73	adolescents	adolescent	NNS
cord-303447-3a7jxl34	312	74	and	and	CC
cord-303447-3a7jxl34	312	75	adults	adult	NNS
cord-303447-3a7jxl34	313	1	Final	final	JJ
cord-303447-3a7jxl34	313	2	:	:	:
cord-303447-3a7jxl34	314	1	2003	2003	CD
cord-303447-3a7jxl34	314	2	reports	report	NNS
cord-303447-3a7jxl34	314	3	of	of	IN
cord-303447-3a7jxl34	314	4	notifiable	notifiable	JJ
cord-303447-3a7jxl34	314	5	diseases	disease	NNS
cord-303447-3a7jxl34	314	6	Trends	trend	NNS
cord-303447-3a7jxl34	314	7	in	in	IN
cord-303447-3a7jxl34	314	8	pertussis	pertussis	NN
cord-303447-3a7jxl34	314	9	among	among	IN
cord-303447-3a7jxl34	314	10	infants	infant	NNS
cord-303447-3a7jxl34	314	11	in	in	IN
cord-303447-3a7jxl34	314	12	the	the	DT
cord-303447-3a7jxl34	314	13	United	United	NNP
cord-303447-3a7jxl34	314	14	States	States	NNP
cord-303447-3a7jxl34	314	15	Societal	Societal	NNP
cord-303447-3a7jxl34	314	16	costs	cost	NNS
cord-303447-3a7jxl34	314	17	and	and	CC
cord-303447-3a7jxl34	314	18	morbidity	morbidity	NN
cord-303447-3a7jxl34	314	19	of	of	IN
cord-303447-3a7jxl34	314	20	pertussis	pertussis	NN
cord-303447-3a7jxl34	314	21	in	in	IN
cord-303447-3a7jxl34	314	22	adolescents	adolescent	NNS
cord-303447-3a7jxl34	314	23	and	and	CC
cord-303447-3a7jxl34	314	24	adults	adult	NNS
cord-303447-3a7jxl34	314	25	Morbidity	morbidity	NN
cord-303447-3a7jxl34	314	26	of	of	IN
cord-303447-3a7jxl34	314	27	pertussis	pertussis	NN
cord-303447-3a7jxl34	314	28	in	in	IN
cord-303447-3a7jxl34	314	29	adolescents	adolescent	NNS
cord-303447-3a7jxl34	314	30	and	and	CC
cord-303447-3a7jxl34	314	31	adults	adult	NNS
cord-303447-3a7jxl34	314	32	Evaluation	Evaluation	NNP
cord-303447-3a7jxl34	314	33	of	of	IN
cord-303447-3a7jxl34	314	34	strategies	strategy	NNS
cord-303447-3a7jxl34	314	35	for	for	IN
cord-303447-3a7jxl34	314	36	use	use	NN
cord-303447-3a7jxl34	314	37	of	of	IN
cord-303447-3a7jxl34	314	38	acellular	acellular	JJ
cord-303447-3a7jxl34	314	39	pertussis	pertussis	NN
cord-303447-3a7jxl34	314	40	vaccine	vaccine	NN
cord-303447-3a7jxl34	314	41	in	in	IN
cord-303447-3a7jxl34	314	42	adolescents	adolescent	NNS
cord-303447-3a7jxl34	314	43	and	and	CC
cord-303447-3a7jxl34	314	44	adults	adult	NNS
cord-303447-3a7jxl34	314	45	:	:	:
cord-303447-3a7jxl34	315	1	a	a	DT
cord-303447-3a7jxl34	315	2	cost	cost	NN
cord-303447-3a7jxl34	315	3	-	-	HYPH
cord-303447-3a7jxl34	315	4	benefit	benefit	NN
cord-303447-3a7jxl34	315	5	analysis	analysis	NN
cord-303447-3a7jxl34	315	6	Infant	infant	NN
cord-303447-3a7jxl34	315	7	pertussis	pertussis	NN
cord-303447-3a7jxl34	315	8	:	:	:
cord-303447-3a7jxl34	316	1	who	who	WP
cord-303447-3a7jxl34	316	2	was	be	VBD
cord-303447-3a7jxl34	316	3	the	the	DT
cord-303447-3a7jxl34	316	4	source	source	NN
cord-303447-3a7jxl34	316	5	?	?	.
cord-303447-3a7jxl34	317	1	New	new	JJ
cord-303447-3a7jxl34	317	2	pertussis	pertussis	NN
cord-303447-3a7jxl34	317	3	vaccination	vaccination	NN
cord-303447-3a7jxl34	317	4	strategies	strategy	NNS
cord-303447-3a7jxl34	317	5	beyond	beyond	IN
cord-303447-3a7jxl34	317	6	infancy	infancy	NN
cord-303447-3a7jxl34	317	7	:	:	:
cord-303447-3a7jxl34	317	8	recommendations	recommendation	NNS
cord-303447-3a7jxl34	317	9	by	by	IN
cord-303447-3a7jxl34	317	10	the	the	DT
cord-303447-3a7jxl34	317	11	global	global	JJ
cord-303447-3a7jxl34	317	12	pertussis	pertussis	NN
cord-303447-3a7jxl34	317	13	initiative	initiative	NN
cord-303447-3a7jxl34	317	14	Pertussis	pertussis	NN
cord-303447-3a7jxl34	317	15	vaccination	vaccination	NN
cord-303447-3a7jxl34	317	16	strategies	strategy	NNS
cord-303447-3a7jxl34	317	17	for	for	IN
cord-303447-3a7jxl34	317	18	neonates	neonate	NNS
cord-303447-3a7jxl34	317	19	-	-	:
cord-303447-3a7jxl34	317	20	an	an	DT
cord-303447-3a7jxl34	317	21	exploratory	exploratory	JJ
cord-303447-3a7jxl34	317	22	costeffectiveness	costeffectiveness	NN
cord-303447-3a7jxl34	317	23	analysis	analysis	NN
cord-303447-3a7jxl34	317	24	Human	human	JJ
cord-303447-3a7jxl34	317	25	papillomavirus	papillomavirus	NN
cord-303447-3a7jxl34	317	26	and	and	CC
cord-303447-3a7jxl34	317	27	cervical	cervical	JJ
cord-303447-3a7jxl34	317	28	cancer	cancer	NN
cord-303447-3a7jxl34	317	29	Safety	safety	NN
cord-303447-3a7jxl34	317	30	and	and	CC
cord-303447-3a7jxl34	317	31	immunogenicity	immunogenicity	NN
cord-303447-3a7jxl34	317	32	trial	trial	NN
cord-303447-3a7jxl34	317	33	in	in	IN
cord-303447-3a7jxl34	317	34	adult	adult	NN
cord-303447-3a7jxl34	317	35	volunteers	volunteer	NNS
cord-303447-3a7jxl34	317	36	of	of	IN
cord-303447-3a7jxl34	317	37	a	a	DT
cord-303447-3a7jxl34	317	38	human	human	JJ
cord-303447-3a7jxl34	317	39	papillomavirus	papillomavirus	NN
cord-303447-3a7jxl34	317	40	16	16	CD
cord-303447-3a7jxl34	317	41	L1	L1	NNP
cord-303447-3a7jxl34	317	42	virus	virus	NN
cord-303447-3a7jxl34	317	43	-	-	HYPH
cord-303447-3a7jxl34	317	44	like	like	JJ
cord-303447-3a7jxl34	317	45	particle	particle	NN
cord-303447-3a7jxl34	317	46	vaccine	vaccine	NN
cord-303447-3a7jxl34	317	47	A	a	DT
cord-303447-3a7jxl34	317	48	controlled	control	VBN
cord-303447-3a7jxl34	317	49	trial	trial	NN
cord-303447-3a7jxl34	317	50	of	of	IN
cord-303447-3a7jxl34	317	51	a	a	DT
cord-303447-3a7jxl34	317	52	human	human	JJ
cord-303447-3a7jxl34	317	53	papillomavirus	papillomavirus	NN
cord-303447-3a7jxl34	317	54	type	type	NN
cord-303447-3a7jxl34	317	55	16	16	CD
cord-303447-3a7jxl34	317	56	vaccine	vaccine	NN
cord-303447-3a7jxl34	317	57	Efficacy	Efficacy	NNP
cord-303447-3a7jxl34	317	58	of	of	IN
cord-303447-3a7jxl34	317	59	a	a	DT
cord-303447-3a7jxl34	317	60	bivalent	bivalent	JJ
cord-303447-3a7jxl34	317	61	L1	L1	NNP
cord-303447-3a7jxl34	317	62	virus	virus	NN
cord-303447-3a7jxl34	317	63	-	-	:
cord-303447-3a7jxl34	317	64	like	like	JJ
cord-303447-3a7jxl34	317	65	particle	particle	NN
cord-303447-3a7jxl34	317	66	vaccine	vaccine	NN
cord-303447-3a7jxl34	317	67	in	in	IN
cord-303447-3a7jxl34	317	68	prevention	prevention	NN
cord-303447-3a7jxl34	317	69	of	of	IN
cord-303447-3a7jxl34	317	70	infection	infection	NN
cord-303447-3a7jxl34	317	71	with	with	IN
cord-303447-3a7jxl34	317	72	human	human	JJ
cord-303447-3a7jxl34	317	73	papillomavirus	papillomavirus	NN
cord-303447-3a7jxl34	317	74	types	type	NNS
cord-303447-3a7jxl34	317	75	16	16	CD
cord-303447-3a7jxl34	317	76	and	and	CC
cord-303447-3a7jxl34	317	77	18	18	CD
cord-303447-3a7jxl34	317	78	in	in	IN
cord-303447-3a7jxl34	317	79	young	young	JJ
cord-303447-3a7jxl34	317	80	women	woman	NNS
cord-303447-3a7jxl34	317	81	:	:	:
cord-303447-3a7jxl34	317	82	a	a	DT
cord-303447-3a7jxl34	317	83	randomised	randomised	JJ
cord-303447-3a7jxl34	317	84	controlled	control	VBN
cord-303447-3a7jxl34	317	85	trial	trial	NN
cord-303447-3a7jxl34	317	86	Intussusception	Intussusception	NNP
cord-303447-3a7jxl34	317	87	among	among	IN
cord-303447-3a7jxl34	317	88	recipients	recipient	NNS
cord-303447-3a7jxl34	317	89	of	of	IN
cord-303447-3a7jxl34	317	90	rotavirus	rotavirus	JJ
cord-303447-3a7jxl34	317	91	vaccine	vaccine	NN
cord-303447-3a7jxl34	317	92	:	:	:
cord-303447-3a7jxl34	317	93	reports	report	NNS
cord-303447-3a7jxl34	317	94	to	to	IN
cord-303447-3a7jxl34	317	95	the	the	DT
cord-303447-3a7jxl34	317	96	Vaccine	Vaccine	NNP
cord-303447-3a7jxl34	317	97	Adverse	Adverse	NNP
cord-303447-3a7jxl34	317	98	Event	Event	NNP
cord-303447-3a7jxl34	317	99	Reporting	Reporting	NNP
cord-303447-3a7jxl34	317	100	System	System	NNP
cord-303447-3a7jxl34	317	101	Intussusception	Intussusception	NNP
cord-303447-3a7jxl34	317	102	among	among	IN
cord-303447-3a7jxl34	317	103	infants	infant	NNS
cord-303447-3a7jxl34	317	104	given	give	VBN
cord-303447-3a7jxl34	317	105	an	an	DT
cord-303447-3a7jxl34	317	106	oral	oral	JJ
cord-303447-3a7jxl34	317	107	rotavirus	rotavirus	JJ
cord-303447-3a7jxl34	317	108	vaccine	vaccine	NN
cord-303447-3a7jxl34	317	109	Available	available	JJ
cord-303447-3a7jxl34	317	110	at	at	IN
cord-303447-3a7jxl34	317	111	:	:	:
cord-303447-3a7jxl34	317	112	www.pediatrics	www.pediatrics	NNP
cord-303447-3a7jxl34	317	113	.	.	.
cord-303447-3a7jxl34	318	1	aappublications.org/cgi/reprint/112/1/e6?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=	aappublications.org/cgi/reprint/112/1/e6?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=	NNP
cord-303447-3a7jxl34	318	2	&	&	CC
cord-303447-3a7jxl34	318	3	author1=	author1=	NNP
cord-303447-3a7jxl34	319	1	Iwamoto&searchid=1107975380001_13871&stored_search=&FIRSTINDEX=0&sortspec=	Iwamoto&searchid=1107975380001_13871&stored_search=&FIRSTINDEX=0&sortspec=	NNS
cord-303447-3a7jxl34	320	1	relevance&journalcode=	relevance&journalcode=	NNP
cord-303447-3a7jxl34	321	1	pediatrics	pediatrics	NNP
cord-303447-3a7jxl34	321	2	Varicella	Varicella	NNP
cord-303447-3a7jxl34	321	3	disease	disease	NN
cord-303447-3a7jxl34	321	4	after	after	IN
cord-303447-3a7jxl34	321	5	introduction	introduction	NN
cord-303447-3a7jxl34	321	6	of	of	IN
cord-303447-3a7jxl34	321	7	varicella	varicella	NN
cord-303447-3a7jxl34	321	8	vaccine	vaccine	NN
cord-303447-3a7jxl34	321	9	in	in	IN
cord-303447-3a7jxl34	321	10	the	the	DT
cord-303447-3a7jxl34	321	11	United	United	NNP
cord-303447-3a7jxl34	321	12	States	States	NNP
cord-303447-3a7jxl34	321	13	Contagiousness	Contagiousness	NNP
cord-303447-3a7jxl34	321	14	of	of	IN
cord-303447-3a7jxl34	321	15	varicella	varicella	NN
cord-303447-3a7jxl34	321	16	in	in	IN
cord-303447-3a7jxl34	321	17	vaccinated	vaccinated	JJ
cord-303447-3a7jxl34	321	18	cases	case	NNS
cord-303447-3a7jxl34	321	19	:	:	:
cord-303447-3a7jxl34	321	20	a	a	DT
cord-303447-3a7jxl34	321	21	household	household	NN
cord-303447-3a7jxl34	321	22	contact	contact	NN
cord-303447-3a7jxl34	321	23	study	study	NN
cord-303447-3a7jxl34	321	24	Contacts	contact	NNS
cord-303447-3a7jxl34	321	25	with	with	IN
cord-303447-3a7jxl34	321	26	varicella	varicella	NN
cord-303447-3a7jxl34	321	27	or	or	CC
cord-303447-3a7jxl34	321	28	with	with	IN
cord-303447-3a7jxl34	321	29	children	child	NNS
cord-303447-3a7jxl34	321	30	and	and	CC
cord-303447-3a7jxl34	321	31	protection	protection	NN
cord-303447-3a7jxl34	321	32	against	against	IN
cord-303447-3a7jxl34	321	33	herpes	herpes	NNP
cord-303447-3a7jxl34	321	34	zoster	zoster	NN
cord-303447-3a7jxl34	321	35	in	in	IN
cord-303447-3a7jxl34	321	36	adults	adult	NNS
cord-303447-3a7jxl34	321	37	:	:	:
cord-303447-3a7jxl34	321	38	a	a	DT
cord-303447-3a7jxl34	321	39	case	case	NN
cord-303447-3a7jxl34	321	40	-	-	HYPH
cord-303447-3a7jxl34	321	41	control	control	NN
cord-303447-3a7jxl34	321	42	study	study	NN
cord-303447-3a7jxl34	321	43	Influenza	Influenza	NNP
cord-303447-3a7jxl34	321	44	-	-	HYPH
cord-303447-3a7jxl34	321	45	associated	associate	VBN
cord-303447-3a7jxl34	321	46	hospitalizations	hospitalization	NNS
cord-303447-3a7jxl34	321	47	in	in	IN
cord-303447-3a7jxl34	321	48	the	the	DT
cord-303447-3a7jxl34	321	49	United	United	NNP
cord-303447-3a7jxl34	321	50	States	States	NNP
cord-303447-3a7jxl34	321	51	Enhanced	Enhanced	NNP
cord-303447-3a7jxl34	321	52	virulence	virulence	NN
cord-303447-3a7jxl34	321	53	of	of	IN
cord-303447-3a7jxl34	321	54	influenza	influenza	NN
cord-303447-3a7jxl34	321	55	A	a	DT
cord-303447-3a7jxl34	321	56	viruses	virus	NNS
cord-303447-3a7jxl34	321	57	with	with	IN
cord-303447-3a7jxl34	321	58	the	the	DT
cord-303447-3a7jxl34	321	59	haemagglutinin	haemagglutinin	NNP
cord-303447-3a7jxl34	321	60	of	of	IN
cord-303447-3a7jxl34	321	61	the	the	DT
cord-303447-3a7jxl34	321	62	1918	1918	CD
cord-303447-3a7jxl34	321	63	pandemic	pandemic	NN
cord-303447-3a7jxl34	321	64	virus	virus	NN
cord-303447-3a7jxl34	321	65	Risk	risk	NN
cord-303447-3a7jxl34	321	66	factors	factor	NNS
cord-303447-3a7jxl34	321	67	associated	associate	VBN
cord-303447-3a7jxl34	321	68	with	with	IN
cord-303447-3a7jxl34	321	69	severe	severe	JJ
cord-303447-3a7jxl34	321	70	influenza	influenza	NN
cord-303447-3a7jxl34	321	71	infections	infection	NNS
cord-303447-3a7jxl34	321	72	in	in	IN
cord-303447-3a7jxl34	321	73	childhood	childhood	NN
cord-303447-3a7jxl34	321	74	:	:	:
cord-303447-3a7jxl34	321	75	implication	implication	NN
cord-303447-3a7jxl34	321	76	for	for	IN
cord-303447-3a7jxl34	321	77	vaccine	vaccine	NN
cord-303447-3a7jxl34	321	78	strategy	strategy	NN
cord-303447-3a7jxl34	321	79	Burden	Burden	NNP
cord-303447-3a7jxl34	321	80	of	of	IN
cord-303447-3a7jxl34	321	81	interpandemic	interpandemic	JJ
cord-303447-3a7jxl34	321	82	influenza	influenza	NN
cord-303447-3a7jxl34	321	83	in	in	IN
cord-303447-3a7jxl34	321	84	children	child	NNS
cord-303447-3a7jxl34	321	85	younger	young	JJR
cord-303447-3a7jxl34	321	86	than	than	IN
cord-303447-3a7jxl34	321	87	5	5	CD
cord-303447-3a7jxl34	321	88	years	year	NNS
cord-303447-3a7jxl34	321	89	:	:	:
cord-303447-3a7jxl34	321	90	a	a	DT
cord-303447-3a7jxl34	321	91	25-year	25-year	JJ
cord-303447-3a7jxl34	321	92	prospective	prospective	JJ
cord-303447-3a7jxl34	321	93	prospective	prospective	JJ
cord-303447-3a7jxl34	321	94	study	study	NN
cord-303447-3a7jxl34	321	95	Influenza	Influenza	NNP
cord-303447-3a7jxl34	321	96	and	and	CC
cord-303447-3a7jxl34	321	97	the	the	DT
cord-303447-3a7jxl34	321	98	rates	rate	NNS
cord-303447-3a7jxl34	321	99	of	of	IN
cord-303447-3a7jxl34	321	100	hospitalization	hospitalization	NN
cord-303447-3a7jxl34	321	101	for	for	IN
cord-303447-3a7jxl34	321	102	respiratory	respiratory	JJ
cord-303447-3a7jxl34	321	103	disease	disease	NN
cord-303447-3a7jxl34	321	104	among	among	IN
cord-303447-3a7jxl34	321	105	infants	infant	NNS
cord-303447-3a7jxl34	321	106	and	and	CC
cord-303447-3a7jxl34	321	107	young	young	JJ
cord-303447-3a7jxl34	321	108	children	child	NNS
cord-303447-3a7jxl34	321	109	Centers	Centers	NNPS
cord-303447-3a7jxl34	321	110	for	for	IN
cord-303447-3a7jxl34	321	111	Disease	Disease	NNP
cord-303447-3a7jxl34	321	112	Control	Control	NNP
cord-303447-3a7jxl34	321	113	and	and	CC
cord-303447-3a7jxl34	321	114	Prevention	Prevention	NNP
cord-303447-3a7jxl34	321	115	.	.	.
cord-303447-3a7jxl34	322	1	Prevention	prevention	NN
cord-303447-3a7jxl34	322	2	and	and	CC
cord-303447-3a7jxl34	322	3	control	control	NN
cord-303447-3a7jxl34	322	4	of	of	IN
cord-303447-3a7jxl34	322	5	influenza	influenza	NN
cord-303447-3a7jxl34	322	6	:	:	:
cord-303447-3a7jxl34	322	7	recommendations	recommendation	NNS
cord-303447-3a7jxl34	322	8	of	of	IN
cord-303447-3a7jxl34	322	9	the	the	DT
cord-303447-3a7jxl34	322	10	Advisory	Advisory	NNP
cord-303447-3a7jxl34	322	11	Committee	Committee	NNP
cord-303447-3a7jxl34	322	12	on	on	IN
cord-303447-3a7jxl34	322	13	Immunization	Immunization	NNP
cord-303447-3a7jxl34	322	14	Practices	Practices	NNPS
cord-303447-3a7jxl34	323	1	(	(	-LRB-
cord-303447-3a7jxl34	323	2	ACIP	ACIP	NNP
cord-303447-3a7jxl34	323	3	)	)	-RRB-
cord-303447-3a7jxl34	323	4	Update	update	NN
cord-303447-3a7jxl34	323	5	:	:	:
cord-303447-3a7jxl34	324	1	influenza	influenza	NN
cord-303447-3a7jxl34	324	2	-	-	HYPH
cord-303447-3a7jxl34	324	3	associated	associate	VBN
cord-303447-3a7jxl34	324	4	deaths	death	NNS
cord-303447-3a7jxl34	324	5	reported	report	VBN
cord-303447-3a7jxl34	324	6	among	among	IN
cord-303447-3a7jxl34	324	7	children	child	NNS
cord-303447-3a7jxl34	324	8	aged	age	VBN
cord-303447-3a7jxl34	324	9	b	b	NN
cord-303447-3a7jxl34	324	10	18	18	CD
cord-303447-3a7jxl34	324	11	years	year	NNS
cord-303447-3a7jxl34	324	12	-	-	:
cord-303447-3a7jxl34	324	13	United	United	NNP
cord-303447-3a7jxl34	324	14	States	States	NNP
cord-303447-3a7jxl34	324	15	,	,	,
cord-303447-3a7jxl34	324	16	2003	2003	CD
cord-303447-3a7jxl34	324	17	-	-	SYM
cord-303447-3a7jxl34	324	18	04	04	CD
cord-303447-3a7jxl34	325	1	influenza	influenza	NN
cord-303447-3a7jxl34	325	2	season	season	NNP
cord-303447-3a7jxl34	325	3	Vaccine	Vaccine	NNP
cord-303447-3a7jxl34	325	4	technologies	technology	NNS
cord-303447-3a7jxl34	325	5	Progress	Progress	NNP
cord-303447-3a7jxl34	325	6	in	in	IN
cord-303447-3a7jxl34	325	7	immunologic	immunologic	JJ
cord-303447-3a7jxl34	325	8	adjuvant	adjuvant	NN
cord-303447-3a7jxl34	325	9	development	development	NN
cord-303447-3a7jxl34	325	10	Financing	financing	NN
cord-303447-3a7jxl34	325	11	vaccines	vaccine	NNS
cord-303447-3a7jxl34	325	12	in	in	IN
cord-303447-3a7jxl34	325	13	the	the	DT
cord-303447-3a7jxl34	325	14	21st	21st	JJ
cord-303447-3a7jxl34	325	15	century	century	NN
cord-303447-3a7jxl34	325	16	:	:	:
cord-303447-3a7jxl34	326	1	assuring	assure	VBG
cord-303447-3a7jxl34	326	2	access	access	NN
cord-303447-3a7jxl34	326	3	and	and	CC
cord-303447-3a7jxl34	326	4	availability	availability	NN
cord-303447-3a7jxl34	326	5	Genesis	Genesis	NNP
cord-303447-3a7jxl34	326	6	of	of	IN
cord-303447-3a7jxl34	326	7	a	a	DT
cord-303447-3a7jxl34	326	8	highly	highly	RB
cord-303447-3a7jxl34	326	9	pathogenic	pathogenic	JJ
cord-303447-3a7jxl34	326	10	and	and	CC
cord-303447-3a7jxl34	326	11	potentially	potentially	RB
cord-303447-3a7jxl34	326	12	pandemic	pandemic	JJ
cord-303447-3a7jxl34	326	13	H5N1	H5N1	NNP
cord-303447-3a7jxl34	326	14	influenza	influenza	NN
cord-303447-3a7jxl34	326	15	virus	virus	NN
cord-303447-3a7jxl34	326	16	in	in	IN
cord-303447-3a7jxl34	326	17	eastern	eastern	JJ
cord-303447-3a7jxl34	326	18	Asia	Asia	NNP